UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-K

(Mark One)


þ		ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended June ~~25, 2006~~24, 2007


o		TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to .

Commission file number: 0-12933

LAM RESEARCH CORPORATION

(Exact name of registrant as specified in its charter)


Delaware		94-2634797
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification No.)

4650 Cushing Parkway		94538
Fremont, California		(Zip code)
(Address of principal executive offices)

Registrant’s telephone number, including area code: (510) 572-0200
Securities registered pursuant to Section 12(b) of the Act:
~~Common Stock, Par Value $0.001 Per Share~~


Title of class		Name of exchange on which registered
Common Stock, Par Value $0.001 Per Share		NASDAQ Global Select Market

Securities registered pursuant to Section 12(g) of the Act:
None
(Title of class)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yesþo Nooþ

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yeso Noþ

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yesþo Nooþ

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act.

~~Large accelerated filer~~þ ~~Accelerated filer~~o ~~Non-accelerated filer~~o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yeso Noþ

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):


Large accelerated filerþ		Accelerated filero		Non-accelerated filer o (Do not check if a smaller reporting company)		Smaller reporting companyo

The aggregate market value of the Registrant’s Common Stock, $0.001 par value, held by non-affiliates of the Registrant, as of December ~~25, 2005,~~24, 2006, the last business day of the most recently completed second fiscal quarter with respect to the fiscal year covered by this Form 10-K, was ~~$3,442,134,484.~~$5,014,214,243. Common Stock held by each officer and director and by each person who owns 5% or more of the outstanding Common Stock has been excluded from this computation in that such persons may be deemed to be affiliates. This determination of affiliate status is not necessarily a conclusive determination of such status for other purposes.

As of ~~August 4, 2006,~~March 10, 2008, the Registrant had ~~141,861,073~~124,781,047 outstanding shares of Common Stock.

Documents Incorporated by Reference

Parts of the Registrant’s Proxy Statement for the Annual Meeting of Stockholders to be held on November 2, 2006 are incorporated by reference into Part III of this Form 10-K Report. (The Report of the Audit Committee, Compensation Committee, and the Comparative Stock Performance graph of the Registrant’s Proxy Statement are expressly not incorporated by reference herein.)None.

Explanatory Note

In this Annual Report on Form 10-K as of and for the year ended June 24, 2007 (the “2007 Form 10-K”), Lam Research Corporation, a Delaware corporation (“Lam Research” or “the Company”), is restating its consolidated balance sheet as of June 25, 2006 and the related consolidated statements of operations, stockholders’ equity, and cash flows for the years ended June 25, 2006 and June 26, 2005, as a result of a voluntary independent stock option review described below. The Company also recorded adjustments affecting previously-reported financial statements for fiscal years 1997 through 2004, the effects of which are summarized in cumulative adjustments to additional paid-in capital, deferred stock-based compensation, and retained earnings as of June 27, 2004. In addition, the Company is restating the unaudited quarterly condensed financial statements for interim periods of fiscal year 2006, and unaudited condensed balance sheets as of March 25, 2007, December 24, 2006 and September 24, 2006. There was no effect of the restatement on the consolidated statements of operations for the first three quarters of fiscal year 2007.

On July 18, 2007, the Company announced that its Board of Directors had initiated a voluntary independent review regarding the timing of the Company’s past stock option grants and other related issues. The voluntary internal review arose after the Company’s independent registered public accounting firm performed auditing procedures relating to the Company’s historical stock option grant programs and procedures as part of the firm’s fiscal year-end 2007 audit. The Board of Directors appointed a special committee consisting of two independent board members (the “Independent Committee”) to conduct a comprehensive review of the Company’s historical stock option practices. The Independent Committee promptly engaged independent outside legal counsel and forensic accountants to assist with the review. On December 21, 2007, the Company announced that the Independent Committee had reached a preliminary conclusion that the actual measurement dates for financial accounting purposes of certain stock option grants issued in the past differed from the recorded grant dates of such awards. Upon the recommendation of management and the Independent Committee, the Audit Committee of the Board of Directors concluded that the financial statements for fiscal years 1997 through 2005, and the interim periods contained therein should no longer be relied upon. The Independent Committee’s review was completed in February 2008.

The review covered stock option grants awarded in fiscal years 1997 through 2005 (the “Review Period”). The scope of the review included evaluating 100% of “Company-wide” grants, director grants, Section 16 officer grants, and new hire grants, as well as a sampling of grants deemed “other grants”, representing approximately 94% of all stock option grants during the Review Period. This Review Period comprised approximately 16,000 separate stock option grants on approximately 500 separately recorded grant dates. These grants involved approximately 58 million underlying shares of Common Stock and included grants to domestic and international employees. Share amounts have been adjusted as applicable to reflect the March 2000 3-for-1 stock split. The Independent Committee’s review also included procedures to identify potential modifications of stock option grants and grants awarded to consultants, and testing of cash exercises. The Company had not awarded any Company-wide stock option grants since October 2002 and stopped issuing stock option grants during fiscal year 2005 and only issued restricted stock units (“RSUs”) thereafter. The Independent Committee did not include fiscal years 2006 and 2007 in the scope of its review based on several factors including but not limited to the fact that the Company only issued RSUs after fiscal year 2005 and the Company’s equity granting processes and controls had been documented and tested as part of its assessment of the operating effectiveness of internal control over financial reporting as required by Section 404 of the Sarbanes Oxley Act of 2002. Additionally, no information arose during the stock option review that would indicate a need to expand the scope of the review to include other periods.

Consistent with applicable accounting literature and guidance from the SEC staff, the Company organized the grants during the review period into categories based on the grant type and the process by which the grant was finalized. The Company analyzed the evidence from the Independent Committee’s review related to each category including, but not limited to, physical documents, electronic documents, and underlying electronic data about documents. Based on the relevant facts and circumstances, the Company applied the applicable accounting standards to determine, for grants within each category, the proper measurement date. If the measurement date was not the originally recorded grant date, accounting adjustments were made as required, resulting in stock-based compensation expense and related tax effects. The significant majority of the measurement date changes result from stock options granted prior to fiscal year 2003. As a result of the findings of the review, the Company has recognized incremental stock-based compensation and associated payroll tax expense of $96.4 million on a pre-tax basis ($65.8 million after taxes) in the aggregate during fiscal years 1997 through 2006 which includes incremental stock-based compensation expense of $1.2 million recognized in accordance with Financial Accounting Standards No. 123 (revised), “Share-Based Payment” (“SFAS No. 123R”) during fiscal year 2006.

The Independent Committee also concluded that there was no intentional misconduct on the part of Company management or the Company’s independent directors. During its review of the Company’s historical stock option practices, the Independent Committee did not find evidence of any other financial reporting or accounting issues unrelated to stock-based compensation.

The Company determined revised measurement dates for approximately 33 million options granted during fiscal year 1997 to March 2005. The additional aggregate stock-based compensation expense noted above is net of forfeitures related to employee terminations. To determine revised measurement dates, management evaluated all of the available evidence. For those grants where the revised measurement date could not be determined with certainty, management applied judgment to determine what it believes to be the most appropriate measurement date in accordance with Accounting Principles Board (“APB”) Opinion No. 25, “Accounting for Stock Issued to Employees” (“APB No. 25”) and other applicable accounting rules, and considered the amount of additional compensation expense that could result had different dates been selected. For a broader discussion of the judgments underlying the revised measurement dates, see “Management’s Discussion and Analysis of

PART I

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

With the exception of historical facts, the statements contained in this discussion are forward-looking statements, which are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Certain, but not all, of the forward-looking statements in this report are specifically identified. The identification of certain statements as “forward-looking” is not intended to mean that other statements not specifically identified are not forward-looking. Forward-looking statements include, but are not limited to, statements that relate to our future revenue, product development, demand, acceptance and market share, competitiveness, gross margins, levels of research and development (R&D), ~~outsourcing plans~~outsourced activities and operating expenses, tax expenses, our management’s plans and objectives for our current and future operations, management’s plans for repurchasing Company stock pursuant to the authorization of our Board, the levels of customer spending or R&D activities, general economic conditions and the sufficiency of financial resources to support future operations, and capital expenditures. Such statements are based on current expectations and are subject to risks, uncertainties, and changes in condition, significance, value and effect, including without limitation those discussed below under the heading “Risk Factors” within Item 1A ofand elsewhere in this report and other documents we file from time to time with the Securities and Exchange Commission (SEC), such as our quarterly reports onForm 10-Q and our current reports onForm ~~8-K.~~8-K. Such risks, uncertainties and changes in condition, significance, value and effect could cause our actual results to differ materially from those expressed herein and in ways not readily foreseeable. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and are based on information currently and reasonably known to us. We undertake no obligation to release the results of any revisions to these forward-looking statements, which may be made to reflect events or circumstances ~~which~~that occur after the date hereof or to reflect the occurrence or effect of anticipated or unanticipated events. All references to fiscal years apply to our fiscal years, which ended June 24, 2007, June 25, 2006, and June 26, ~~2005, and June 27, 2004.~~2005.

Item 1.Business

�� Lam Research Corporation ~~(Lam~~(“Lam Research,” “we,” or the ~~Company), a Delaware corporation,~~“Company”) was founded in 1980 and is headquartered in Fremont, California. The mailing address for our principal executive offices is 4650 Cushing Parkway, Fremont, California 94538, and our telephone number is (510) 572-0200. Additional information about Lam Research is available on our web site at http://www.lamresearch.com. Our Forms 10-K, Forms 10-Q, and Forms 8-K are available online at the Securities and Exchange Commission (SEC) web site on the Internet. The address of that site is http://www.sec.gov. We also make available free of charge the Forms 10-K, Forms 10-Q, and Forms 8-K and any amendments to those reports on our corporate web site at http://www.lamresearch.com as soon as reasonably ~~possible~~practicable after we file them with or furnish them to the SEC.

We design, manufacture, market, and service semiconductor processing equipment used in the fabrication of integrated circuits and are recognized as a major provider of such equipment to the worldwide semiconductor industry. Semiconductor wafers are subjected to a complex series of process steps that result in the simultaneous creation of many individual integrated circuits. ~~Our products selectively remove portions of various films from the wafer in the creation of semiconductors.~~ We leverage our expertise in these areas to develop ~~intellectual property (IP) for~~ integrated processing ~~solutions.~~solutions which typically benefit our customers through reduced cost, lower defect rates, enhanced yields, or faster processing time.

Etch Process

Etch processes, which are repeated numerous times during the wafer fabrication cycle, are required to manufacture every type of semiconductor device produced today. ToLam Research etch ~~devices designed~~products selectively remove portions of various films from the wafer in the creation of semiconductors by utilizing various plasma-based technologies to create critical device features at current and future technology ~~nodes, our etch systems employ various technologies utilized to generate plasma sources, a critical requirement of the etch process.~~

The etch process defines linewidths and other microscopic and sub-microscopic features on integrated circuits. Plasma etching was developed to meet the demand for device geometries smaller than 3 microns.nodes. Plasma consists of charged and neutral species that react with exposed portions of the wafer surface to remove dielectric, metal, or polysilicon material and produce the finely delineated features and patterns of an integrated circuit.

Advanced integrated circuit manufacturing requires etch systems capable of creating structures for the ~~90/65~~45 nanometer (nm) ~~technology node for current-generation products and for the 65 nm~~ and below technology ~~nodes for future semiconductor products.~~nodes. At this time, memory manufacturers are ~~continuing to transition~~transitioning from aluminum to copper conductive lines, while leading logic manufacturers are progressing with the implementation of more fragile dielectric insulating materials ~~(low k~~(low-κ and porous ~~low k)~~low-κ). ~~Advanced manufacturing facilities are producing integrated circuits on 300 millimeter (mm) (12 inch) silicon wafers while other facilities use wafer diameters of 200 mm (8 inch) and smaller.~~ Semiconductor manufacturers ~~will~~ continue to require more precise

control over the etching process in order to accommodate ~~these~~ decreasing linewidths and increasing wafer diameters. ~~Our~~Lam Research etch products and services are defined around the ~~Alliance~~^{2300^®} ~~and 2300~~^{^®} ~~Etch Series platforms.~~ etch series.

Dielectric Etch Products

~~Exelan~~2300^{^®} Exelan^{^®}, 2300^{^®}Exelan ~~High Performance, Exelan HPT, 2300 Exelan, 2300 Exelan~~ ^{^®}Flex™, and 2300^{^®} Exelan^{^®} Flex45™ ~~Systems~~systems. The Exelan family of dielectric etch products ~~improves~~addresses volume manufacturing productivity requirements and enables ~~our~~ customers to create ~~today’s most~~ advanced semiconductor devices. These systems, based on Lam’s patented Dual Frequency Confined (DFC) technology, can be extended to keep pace with the semiconductor industry’s roadmap for etching smaller features and newer dielectric materials. Exelan was introduced to meet the requirements for manufacturing copper conductive lines using dual damascene etch schemes. Exelan has been extended through a series of performance improvement upgrades, Exelan High Performance and Exelan HPT, to meet the etch requirements for the sub-130 nm technology node. The 2300 Exelan, which was introduced to address the industry’s transition to 300 mm wafers, is a 200 mm and 300 mm wafer capable product. The 2300 Exelan Flex and 2300 Exelan Flex45 systems extend the capability of the 2300 Exelan family of products to address ~~the~~ requirements for 65the 45 nm and below technology nodes. These systems are based on Lam Research’s patented Dual Frequency Confined^TM plasma technology, which enablesin situprocessing, where multiple chemistries can be run sequentially in the same process chamber.

Upgrades to the 2300 Exelan product line provide enabling capability for etching smaller features and alternative dielectric materials as outlined in the semiconductor industry’s manufacturing roadmap.

Conductor Etch Products

~~TCP~~2300^{^® 9400} Versys^{^®}, 2300^{^®} Versys^{^®} Kiyo™, 2300^{^®} Versys^{^®} Kiyo45™, 2300^{^®} Versys^{^®} Metal High Performance, and ~~TCP~~2300^{^® 9600 Series and 2300} Versys^{^® Series Systems} Metal45™ systems. The ~~first TCP~~Versys family of products ~~were introduced in late 1992. They use Lam’s~~for etching silicon and metal films utilizes Lam Research’s patented Transformer Coupled Plasma™ source ~~technology,~~technology; a high-density, low-pressure plasma source that ~~can etch~~addresses leading-edge device structure requirements for etching features ~~for~~at the ~~130~~45 nm and below technology nodes. ~~For 200 mm wafer sizes, we offer the TCP~~^® ~~9400PTX and TCP~~^® ~~9400DFM for silicon etch applications, the TCP~~^® ~~9400DSiE™ for MEMS (micro-electromechanical systems) based deep silicon etch, and the TCP~~^® ~~9600PTX and TCP~~^® ~~9600DFM for metal etch applications. These~~The systems ~~are used in the production of a broad range of advanced logic and memory devices as well as MEMS applications.~~

The 2300 Versys system for etching silicon and metal films employs a scaled design of TCP technology to address leading-edge device structure requirements. The 2300 Versys system has the capability to process 200 mm and 300 mm wafer sizes. The 2300 Versys HP addresses metal etch requirements for the 90 nm node and beyond. The 2300 Versys Metal45™ addresses backend metal etch uniformity and throughput needs for memory customers at 70 nm and beyond as well as metal hard mask applications for logic customers at 45 nm and beyond. The 2300 Versys Star™ silicon etch system enablesenable sequential step tuning of gas flow and wafer temperature, which ~~provides~~allowsin situ processing of multi-layer stacks. Advanced Chamber Control and Conditioning (AC3™) technology reduces processing drift and maintains the ~~critical dimension uniformity required~~same chamber conditions for ~~sub-110 nm technology nodes. The 2300 Versys Kiyo™ and Versys Kiyo45 enable processing at sub-65 nm technology nodes.~~

Lam 2300 process chambers can be converted within our customers’ facilities from 200 mm to 300 mm, which has the advantage of providing customers with greater flexibility and lower costs. This capability, combined with an overall system footprint comparable to 200 mm systems, allows semiconductor manufacturers to develop integrated circuits using 200 mm wafers instead of more expensive 300 mm wafers and later scale up to 300 mm wafer processing.subsequent wafers.

~~Resist Strip~~Deep Silicon Etch Products

TCP^{^®} 9400DSiE™ and 2300^{^®} Syndion™ systems. The TCP 9400DSiE employs Lam ~~offers integrated strip modules that remove the photoresist following metal and~~Research’s TCP technology to facilitate deep silicon etch processes used in micro-electro mechanical systems (MEMS), power device, and passive component fabrication. The TCP-based technology provides the process flexibility needed to address a broad range of requirements for ~~both 200 mm~~the manufacture of MEMS devices.

The 2300 Syndion, which also employs TCP technology, addresses 3-D IC through-silicon via (TSV) etch applications. TSVs provide the interconnects for die-to-die and ~~300 mm wafer manufacturing. Stripping~~wafer-to-wafer stacking, eliminating wire bonding to increase device packing density (smaller form factor) and improve performance (higher process speed and lower power requirements). Important for TSV applications, the ~~resist on~~Syndion’s TCP-based technology enables sequential processing the same chamber while ensuring etch rate uniformity and profile symmetry to prevent tilting. The technology also supports clean mode operation and provides bias voltage control for process repeatability.

Patterning Process

During semiconductor device manufacturing, lithography processes establish the templates for patterns to be created during subsequent etch processes.

Patterning Products

2300^{^®} Motif ™ system.The 2300 Motif is a post-lithography pattern enhancement system ~~prevents exposure~~that enables the creation of features as small as 10 nm by using plasma-based technology to ~~air, protecting~~deposit a thin film on printed photoresist holes and spaces. The film is created by applying multiple short etch-deposition cycles until the ~~wafers from corrosion.~~target feature size is achieved. This capability addresses a customer technology need for a solution enabling the creation of features two to three generations ahead of lithography. The system also simplifies optical proximity correction by improving the lithography profile and provides a cost-effective approach to extending lithography tool sets in select applications.

Clean Process

The manufacture of semiconductor devices involves a series of processes such as etch and deposition, which leave particles and residues. The wafer must generally be cleaned following these steps to remove residues that could degrade device performance. Common wafer cleaning steps include post-etch/post-strip cleans and pre-diffusion/pre-deposition cleans (also referred to as “critical cleans”), during which the wafer surface is prepared for subsequent diffusion/deposition steps.

For 65 nm technologies and below, resist stripping after ion implantation is becoming a critical step because of the difficulty in fully cleaning resist residues without removing too much of the silicon. To address this emerging market, Lam has extended its successful silicon etch product line used in combination with a microwave resist stripper for both 200 mm and 300 mm wafer processing.

~~Cleaning Process~~

As semiconductor devices are manufactured through a series of deposition and patterning steps, wafers must be cleaned periodically to remove residues and contamination that could degrade device performance. These cleaning operations, which typically follow a plasma etch or strip step, involve placing a wafer in contact with a liquid cleaning agent, which removes surface residues through a combination of reaction and dissolution.

At the 65 nm technology node and below, wafer cleaning is becoming increasingly challenging because the smaller, more fragile devices are more susceptible to damage from the chemistries and mechanical forces of the cleaning process. As a result, many semiconductor manufacturers are transitioning from batch to single-wafer cleaning systems, which enable better control of the cleaning process. Lam provides technologies that it believes address the damage concerns of wafer cleaning at sub-65 nm, allowing chemical cleaning to be extended to future technology nodes.

~~2300 cleaning products.~~Based on the production-proven 2300 Etch platform, Lam’s products are designed to offer cleaning capability for sub-65 nm technologies. Lam’s proprietary Confined Chemical Cleaning™ technology provides a short chemical exposure time that limits contact with device structures, thereby lowering the risk of damage. In addition, the short exposure time allows greater flexibility in selecting cleaning chemicals for effective removal of process residues.

~~There were no fiscal year 2006 revenues from 2300 cleaning products.~~

~~2300 Bevel Clean product.~~Lam offers bevel clean modules that remove films on the edge of the wafer using edge confined plasma technology. For 65 nm technologies and below, a primary source of device yield limiters are coming from defects transferred from the wafer ~~edge.~~edge bevel can significantly limit device yield. During device patterning, complex interactions of film deposition, lithography, etching, and chemical mechanical polishing (CMP) result in a wide range of unstable film stacks on the wafer edge. In subsequent process steps these film layers can produce defects that are transported to the device area of the ~~wafer.~~wafer, and residues need to be removed from the wafer edge to eliminate these defect sources.

Wet Clean Products

Confined Chemical Cleaning™ (C3™) single-wafer technology-based systems.At the 65 nm technology node and below, devices become more susceptible to damage from the chemical environment and mechanical forces of the cleaning process. Lam Research’s single-wafer wet cleaning system, based on the Company’s proprietary C3 technology, provides high-selectivity wafer cleaning with minimal mechanically induced damage and allows flexibility in selecting cleaning chemicals that minimize damage to device structures. Advanced drying technology integrated into the cleaning unit facilitates low-defect processing of hydrophobic materials, such as advanced low-κ dielectrics. Short contact times, enabled by an innovative chemical delivery mechanism to enhance the transport of chemicals to and from the wafer surface, minimize potential erosion or etching of delicate features on the wafer, while allowing for highly selective and efficient residue removal.

Bevel Clean Products

2300^{^®} Coronus^TM bevel clean system.The 2300 Coronus plasma-based bevel clean system is a plasma-based technology that allows control of the wafer edge at multiple steps during the device fabrication process by selectively removing films from the wafer edge using edge-confined plasma technology. Removal of these films at select points in the integration flow ~~results in reduced~~reduces defects and ~~higher~~increases device yields. To address this emerging market, Lam’s edge confined plasma provides customers with the latitude to control the wafer edge at multiple steps during the device fabrication process. Plasma processing can remove a broad range of films with precisePrecise control of the processing ~~zone.~~zone coupled with Lam Research’s Dynamic Alignment, which provides accurate wafer placement, ensures a repeatable processing area, wafer to wafer.

Customers

Our customers include many of the world’s leading semiconductor manufacturers. Customers continue to establish joint ventures, alliances and ~~technology~~ licensing arrangements, which have the potential to positively or negatively impact our competitive ~~position.~~position and market opportunity. In fiscal year 2007, revenues from Hynix Semiconductor and Samsung Electronics Company, Ltd., each accounted for approximately 14% of total revenues. In fiscal year 2006, revenues from Samsung Electronics Company, Ltd., accounted for approximately 15% of total revenues and revenues from Toshiba Corporation accounted for approximately 12% of total revenues. In fiscal year 2005, revenues from Samsung Electronics Company, Ltd., accounted for approximately 13% of total ~~revenues, and, in fiscal year 2004, revenues from ST Microelectronics accounted for approximately 15% of total~~ revenues.

A material reduction in orders from our customers in the semiconductor industry could adversely affect our results of operations and projected financial condition. Our business depends upon the expenditures of semiconductor manufacturers. Semiconductor manufacturers’ ~~business,~~businesses, in turn, ~~depends~~depend on many factors, including their economic capability, the current and anticipated market demand for integrated circuits and the availability of equipment capacity to support that demand.

Backlog

Our unshipped orders backlog includes orders for systems, spares, and services where written customer requests have been accepted and the delivery of products or provision of services is anticipated within the next 12 months. Our policy is to revise our backlog for order cancellations and to make adjustments to reflect, among other things, spares volume estimates and customer delivery date changes. WeIn general, we schedule production of our systems based upon purchase orders in backlog and our customers’ delivery requirements. Included in our systems backlog are orders for which written requests have been accepted, prices and product specifications have been agreed upon, and shipment of systems is expected within one year. The spares and services backlog includes customer orders for products that have not yet shipped and for services that have not yet been provided. Where specific spare parts and customer service purchase contracts do not contain discrete delivery dates, we use volume estimates at the contract price and over the contract period, not exceeding 12 months, in calculating backlog amounts.

As of June ~~25, 2006~~24, 2007 and June ~~26, 2005,~~25, 2006, our backlog was approximately ~~$521~~$643 million and ~~$351~~$521 million, respectively. Generally, orders for our products and services are subject to cancellation by our customers with limited penalties. Because some orders are received for shipments in the same quarter and due to possible customer changes in delivery dates and cancellations of orders, our backlog at any particular date is not necessarily indicative of business volumes ornor actual revenue levels for succeeding periods.

Manufacturing

Our manufacturing operations consist mainly of assembling and testing components, sub-assemblies, and modules that are then integrated into finished systems prior to shipment to or at the location of our customers. Most of the assembly and testing of our products is conducted in cleanroom environments.

We have agreements with third parties to outsource certain aspects of our manufacturing, production warehousing, and logistics functions. We ~~continue to~~ believe that these outsourcing contracts provide us more flexibility to scale our operations up or down in a more timely and cost effective manner, enabling us to respond to the cyclical nature of our business. We believe that we have selected reputable providers and have secured their performance on terms documented in written contracts. However, it is possible that one or more of these providers could fail to perform as we expect, and such failure could have an adverse impact on our business and have a negative effect on our operating results and financial condition. Overall, we believe we have effective mechanisms to manage risks associated with our outsourcing relationships. Refer to Note 1516 of our Consolidated Financial Statements, included in Item 8 herein, for further information concerning our outsourcing commitments.

Certain components and ~~subassemblies~~sub-assemblies included in our products are only obtained from a single supplier. We believe that, in many cases, alternative sources could be obtained and qualified to supply these products. Nevertheless, a prolonged inability to obtain these components could have an adverse effect on our operating results and could unfavorably impact our customer relationships.

Environmental Matters

We are subject to a variety of governmental regulations related to the management of hazardous materials. We are currently not aware of any pending notices of violation, fines, lawsuits, or investigations arising from environmental matters that would have any material effect on our business. We believe that we are in general compliance with these regulations and that we have obtained (or will obtain or are otherwise addressing) all necessary environmental permits to conduct our business. Nevertheless, the failure to comply with present or future regulations could result in fines being imposed on us, suspension of production, and cessation of our operations or reduction in our customers’ acceptance of our products. These regulations could require us to alter our current operations, to acquire significant equipment, or to incur substantial other expenses to comply with environmental regulations. Our failure to control the use, sale, transport or disposal of hazardous substances could subject us to future liabilities.

Employees

As of ~~August 4, 2006,~~March 10, 2008, we had approximately ~~2,430~~3,000 regular full-time employees.

Each of our employees is required to sign an agreement to maintain the confidentiality of our proprietary information. All employees are required to sign an acknowledgement that they have read and agree to abide by a statement of standards of business conduct. In the semiconductor and semiconductor equipment industries, competition for highly skilled employees is intense. Our future success depends, to a significant extent, upon our continued ability to attract and retain qualified employees particularly in the R&D and customer support functions.

Competition

The semiconductor capital equipment industry is characterized by rapid change and is highly competitive throughout the world. ~~In order to~~To compete effectively, we invest significant financial resources to continue to strengthen and enhance our product and services portfolio and to maintain customer service and support locations globally. Semiconductor manufacturers evaluate capital equipment suppliers in many areas, including, but not limited to, process performance, productivity, customer support, defect control, and overall cost of ownership, which can be affected by many factors such as equipment design, reliability, software advancements, etc. Our ability to succeed in the marketplace will depend upon our ability to maintain existing products and introduce product enhancements and new products on a timely basis. In addition, semiconductor manufacturers must make a substantial investment to qualify and integrate new capital equipment into semiconductor production lines. As a result, once a semiconductor manufacturer has selected a particular supplier’s equipment and qualified it for production, the manufacturer generally maintains that selection for that specific production application and technology ~~node.~~node provided that there is demonstrated performance to specification by the installed base. Accordingly, we may experience difficulty in selling to a given customer if that customer has qualified a competitor’s equipment. We must also continue to meet the expectations of our installed base of customers through the delivery of high-quality and ~~cost efficient~~cost-efficient spare parts in the presence of third-party spares provider competition.

We face significant competition with all of our products and services. Certain of our existing and potential competitors have substantially greater financial resources and ~~more extensive~~larger engineering, manufacturing, marketing, and customer service and support organizations than we do. We expect our competitors to continue to improve the design and performance of their current products and processes and to introduce new products and processes with enhanced price/performance characteristics. If our competitors make

acquisitions or enter into strategic relationships with leading semiconductor manufacturers, or other entities, covering products similar to those we sell, our ability to sell our products to those customers could be adversely affected. There can be no assurance that we will continue to compete successfully in the future. Our primary competitors in the etch market are Tokyo Electron, Ltd. and Applied Materials, Inc.

Patents and Licenses

Our policy is to seek patents on inventions relating to new or enhanced products and processes developed as part of our ongoing research, engineering, manufacturing, and support activities. We currently hold a number of United States and foreign patents covering various aspects of our products and processes. We believe that the duration of our patents generally exceeds the useful life of the technologies and processes disclosed and claimed therein. Our patents, which cover material aspects of our past and present core products, have current durations ranging from approximately 31 to 1720 years. We believe that, although the patents we own and may obtain in the future will be of value, they will not alone determine our success, which depends principally upon our engineering, marketing, support, and delivery skills. However, in the absence of patent protection, we may be vulnerable to competitors who attempt to imitate our products, manufacturing techniques, and processes. In addition, other companies and inventors may receive patents that contain claims applicable or similar to our products and processes. The sale of products covered by patents of others could require licenses that may not be available on terms acceptable to us, or at all. For further discussion of legal matters, see Item 3, “Legal Proceedings,” of this Annual Report on Form 10-K as of and for the year ended June 24, 2007 (the “2007 Form 10-K).

Recent Acquisitions

During the quarter ended December 24, 2006, we acquired the U.S. silicon growing and silicon fabrication assets of Bullen Ultrasonics, Inc. We were the largest customer of the Bullen Ultrasonics silicon business. The silicon business has become a division of Lam Research post-acquisition.

The acquisition includes assets related to Bullen Ultrasonics’ silicon growing and silicon fabrication business, including assets of Bullen Ultrasonics and Bullen Semiconductor (Suzhou) Co., Ltd., a wholly foreign-owned enterprise established in Suzhou, Jiangsu, People’s Republic of China (PRC). The closing of the U.S. asset acquisition occurred on November 13, 2006. The acquisition of the Suzhou assets has not yet occurred as of the date of this filing. The assets acquired consist of fixtures, intellectual property, equipment, inventory, material and supplies, contracts relating to the conduct of the business, certain licenses and permits issued by government authorities for use in connection with the operations of Eaton, Ohio and Suzhou manufacturing facilities, real property and leaseholds connected with such facilities, data and records related to the operation of the silicon growing and silicon fabrication business and certain proprietary rights.

Pursuant to the First Amendment to the Asset Purchase Agreement dated October 5, 2006, the parties to the Asset Purchase Agreement agreed that the closing of the sale of the Suzhou assets would take place within 5 business days following receipt by the parties of all necessary approvals, consents and authorizations of governmental and provincial authorities in the PRC and satisfaction of other customary conditions and covenants. We will pay the $2.5 million purchase price for the Suzhou assets upon the receipt of the approvals and satisfaction of conditions noted above.

The acquisition supports the competitive position and capability primarily of our dielectric Etch products by providing access to and control of critical intellectual property and manufacturing technology related to the production of silicon parts in our processing chambers. We funded the purchase price of the acquisition with existing cash resources.

See the description of our acquisition of SEZ Holding AG under the heading “Subsequent Events” in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” of this 2007 Form 10-K.

Other Cautionary Statements

See the discussion of risks in the section of this 2007 Form 10-K entitled Item 1A, “Risk ~~Factors.”~~Factors” and elsewhere in this report.

EXECUTIVE OFFICERS OF THE COMPANY

As of ~~August 16, 2006,~~March 10, 2008, the executive officers of Lam Research were as follows:


Name	Age			Title
James W. Bagley		6769	Executive Chairman

Stephen G. Newberry		5254	President and Chief Executive Officer

Martin B. Anstice		3940	~~Group~~Senior Vice President, Chief Financial Officer and Chief Accounting Officer

~~Nicolas J. Bright~~		50	~~Executive Vice President, Regional Business and Global Products~~

Ernest E. Maddock		4849	~~Group~~Senior Vice President, Global Operations

Abdi Hariri		4547	Group Vice President, Customer Support Business Group
Richard A. Gottscho		55	Group Vice President and General Manager, Etch Businesses
Thomas J. Bondur		40	Vice President, ~~and General Manager, Customer Support Business Group~~Global Field Operations

James W. Bagley ~~was~~became Chief Executive Officer and a Director of the Company ~~since~~with the merger of Lam Research and OnTrak Systems, Inc., in 1997. Effective September 1, 1998, he was appointed Chairman of the Board. On June 27, 2005, Mr. Bagley transitioned from Chairman of the Board and Chief Executive Officer to Executive Chairman of the Board of ~~Lam.~~Lam Research. Mr. Bagley currently is a director of Teradyne, Inc. and Micron Technology, Inc. From June 1996 to August 1997, Mr. Bagley served as Chairman of the Board and Chief Executive Officer of OnTrak Systems, Inc. He was formerly Chief Operating Officer and Vice Chairman of the Board of Applied Materials, Inc., where he also served in other senior executive positions during his 15-year tenure. Mr. Bagley held various management positions at Texas Instruments, Inc., before he joined Applied Materials, Inc.

Stephen G. Newberry joined the Company in August 1997 as Executive Vice President and Chief Operating Officer. He was appointed President and Chief Operating Officer of Lam Research in July 1998 and President and Chief Executive Officer in June 2005. Mr. Newberry currently serves as a director of Lam Research ~~Corporation;~~Corporation and of SEMI, the industry’s trade ~~association; and Nextest Systems Corporation.~~association. Prior to joining Lam Research, Mr. Newberry served as Group Vice President of Global Operations and Planning at Applied Materials, Inc. During his 17 years at Applied Materials, he held various positions ~~of increased responsibility including assignments~~ in manufacturing, product development, sales and marketing, and customer service. Mr. Newberry is a graduate of the U.S. Naval Academy (BS Ocean Engineering) and the Harvard Graduate School of Business ~~Program~~(Program for Management ~~Development~~Development) and served 5five years in naval aviation prior to joining Applied Materials.

Martin B. Anstice joined Lam Research in April 2001 as Senior Director, Operations Controller, was promoted to the position of Managing Director and Corporate Controller in May 2002, and was promoted to Group Vice President, Chief Financial Officer, and Chief Accounting Officer in June ~~2004.~~2004 and named Senior Vice President, Chief Financial Officer and Chief Accounting Officer in March 2007. Mr. Anstice began his career at Raychem Corporation where, during his 13-year tenure, he held numerous finance roles of increasing responsibility in Europe and North America. Subsequent to Tyco International’s acquisition of Raychem in 1999, he assumed responsibilities supporting mergers and acquisition activities of Tyco Electronics. Mr. Anstice is an associate member of the Chartered Institute of Management Accountants in the United Kingdom.

~~Nicolas J. Bright joined the Company in May 1998 as~~Ernest E. Maddock, Senior Vice President of ~~Technology~~Global Operations since March 2007 and Engineering. He currently holds the position of Executive Vice President, Regional Business and Global Products. Prior to joining Lam, Mr. Bright was employed by Applied Materials, Inc. During his 16-year tenure at that Company, Mr. Bright held senior management positions in engineering and technology within etch, ion implant, and automation business units. He has also held positions at General Electric Co. in the United Kingdom and ABB in Sweden. Mr. Bright holds numerous patents in semiconductor manufacturing disciplines.

~~Ernest E. Maddock,~~previously Group Vice President of Global Operations since October 2003, currently oversees Global Operations which consists of: Information Technology, Global Supply Chain, Production Operations, Corporate Quality, Global Security, ~~and~~ Global Real Estate ~~and~~& Facilities. Additionally, Mr. Maddock heads Bullen Semiconductor, a division of Lam Research. Mr. Maddock joined the Company in November 1997. Mr. Maddock’s previously held positions with the Company include Vice President of the Customer Support Business Group. Prior to his employment with Lam Research, he was Managing Director, Global Logistics and Repair Services Operations, and Chief Financial Officer, Software Products Division, of NCR Corporation. He has also held a variety of executive roles in finance and operations in several industries ranging from commercial real estate to telecommunications.

Abdi Hariri was named Group Vice President of the Customer Support Business Group in March 2007. Prior to his current position, Mr. Hariri had been Vice President and General Manager of the Customer Support Business Group since August ~~2004, joined~~2004. Mr. Hariri previously served as the ~~Company in April 1989~~General Manager of Lam Research Co. Ltd. (Japan) for approximately 18 months and has served in a number of different assignments with the Field Sales and Product Groups. ~~Prior to his current appointment, Mr. Hariri served as the General Manager of Lam Research Co. Ltd. (Japan) for approximately 18 months.~~ His experience prior to his appointment in Japan included over ~~thirteen~~13 years at the Company with various responsibilities, including global business development and engineering. Prior to his employment at Lam Research, Mr. Hariri served as a Process Engineer at Siliconix, Inc. He holds a Masters Degree in Chemical Engineering from Stanford University.

Richard A. Gottscho, Group Vice President and General Manager, Etch Products since March 2007, joined the Company in January 1996 and has served at various Director and Vice President levels in support of etch products, CVD products, and corporate research. Prior to joining Lam Research, Dr. Gottscho was a member of Bell Laboratories for 15 years where he started his career working in plasma processing. During his tenure at Bell, he headed research departments in electronics materials, electronics packaging, and flat panel displays. Dr. Gottscho is the author of numerous papers, patents, and lectures in plasma processing and process control. He is a recipient of the American Vacuum Society’s Peter Mark Memorial Award and is a fellow of the American Physical and American Vacuum Societies, has served on numerous editorial boards of refereed technical publications, program committees for major conferences in plasma science and engineering, and was vice-chair of a National Research Council study on plasma science in the 1980s. Dr. Gottscho earned Ph.D. and B.S. degrees in physical chemistry from the Massachusetts Institute of Technology and the Pennsylvania State University, respectively.

Thomas J. Bondur, Vice President, Global Field Operations since March 2007, joined Lam in August 2001 and has served in various roles in business development and field operations in Europe and the United States. Prior to joining Lam Research, Mr. Bondur spent eight years in the semiconductor industry with Applied Materials in various roles in Santa Clara and France including Sales, Business Management and Process Engineering. Mr. Bondur holds a degree in Business from the State University of New York.

710

Item 1A.Risk Factors

In addition to the other information in this 2007 Form 10-K, the following risk factors should be carefully considered in evaluating the Company and its business because such factors may significantly impact our business, operating results, and financial condition. As a result of these risk factors, as well as other risks discussed in our other SEC filings, our actual results could differ materially from those projected in any forward-looking statements. No priority or significance is intended, ornor should be attached, to the order in which the risk factors appear.

The Results of Our Independent Committee Review of Our Historical Stock Option Practices and Resulting Restatements May Continue to Have Adverse Effects on Our Financial Results.

The review by a special committee of our Board of Directors consisting of two independent Board members (the “Independent Committee”) of our historical stock option practices and the resulting restatement of our historical financial statements have required us to expend significant management time and incur significant accounting, legal, and other expenses during fiscal year 2008. The resulting restatements have had a material adverse effect on our results of operations. We have restated our historical results of operations to record additional non-cash, stock-based compensation expense of $95.2 million in the aggregate for the periods from fiscal 1997 to fiscal 2006 (excluding the impact of related payroll and income taxes). We expect to amortize less than $0.1 million of compensation expense under Financial Accounting Standards No. 123 (revised), “Share-Based Payment” (“SFAS No. 123R”) in periods subsequent to fiscal year 2006 to properly account for previously issued stock options with deemed incorrect measurement dates. Furthermore, to address potential adverse tax consequences certain of our employees have incurred or may incur as a result of the issuance and/or exercise of misdated stock options, we will take remedial actions to make such employees, including our Chief Executive Officer and other affected executive officers, whole for any or all such additional tax liabilities currently estimated to be in the range of approximately $50 million to $55 million. Such actions may cause us to incur additional cash or noncash compensation expense. See the “Explanatory Note” immediately preceding Part I, Item 1 and Note 3, “Restatements of Consolidated Financial Statements,” to Notes to Consolidated Financial Statements of this 2007 Form 10-K for further discussion.

We May Be Subject to the Risks of Lawsuits in Connection With Our Historical Stock Option Practices, the Resulting Restatements, and the Remedial Measures We Have Taken.

We, and our current and former directors and officers, may become the subject of government inquiries, shareholder derivative and class action lawsuits and other legal proceedings relating to our historical stock option practices and resulting restatements in the future. We have received a letter from a stockholder demanding that our Board of Directors take certain actions, including potentially legal action, in connection with our historical stock option practices, and threatening to sue if our Board of Directors does not comply with the stockholder’s demands. Our Board of Directors is currently reviewing the letter. We may also be subject to other kinds of lawsuits. Should any of these events occur, they could require us to expend significant management time and incur significant accounting, legal and other expenses. This could divert attention and resources from the operation of our business and adversely affect our financial condition and results of operations. In addition, the ultimate outcome of these potential actions could have a material adverse effect on our business, financial condition, results of operations, cash flows and the trading price for our securities. Litigation may be time-consuming, expensive and disruptive to normal business operations, and the outcome of litigation is difficult to predict. The defense of these potential lawsuits could result in significant expenditures.

Subject to certain limitations, we are obliged to indemnify our current and former directors, officers and employees in connection with any government inquiry or litigation related to our historical stock option practices that may arise. We currently hold insurance policies for the benefit of our directors and officers, although there can be no assurance that the insurance would cover all of the expenses that would be associated with any proceedings.

Judgment and Estimates Utilized by Us in Determining Stock Option Grant Dates and Related Adjustments may be Subject to Change due to Subsequent SEC Guidance or Other Disclosure Requirements.

In determining the restatement adjustments in connection with the stock option review, management used all reasonably available relevant information to form conclusions it believes are appropriate as to the most likely option granting actions that occurred, the dates when such actions occurred, and the determination of grant dates for financial accounting purposes based on when the requirements of the accounting standards were met. We considered various alternatives throughout the course of the review and restatement, and we believe the approaches used were the most appropriate, and that the choices of measurement dates used in our review of stock option grant accounting and restatement of our financial statements were reasonable and appropriate in our circumstances. However, the SEC may issue additional guidance on disclosure requirements related to the financial impact of past stock option grant measurement date errors that may require us to amend this filing or other filings with the SEC to provide additional disclosures pursuant to such additional guidance. Any such circumstance could also lead to future delays in filing our subsequent SEC reports and delisting of our Common Stock from the NASDAQ Global Select Market. Furthermore, if we are subject to adverse findings in any of these matters, we could be required to pay damages or penalties or have other remedies imposed upon us which could harm our business, financial condition, and results of operations.

We Have not Been in Compliance With SEC Reporting Requirements and NASDAQ Listing Requirements. If We are Unable to Attain Compliance With, or Thereafter Remain in Compliance With SEC Reporting Requirements and NASDAQ Listing Requirements, There may be a Material Adverse Effect on Our Business and Our Stockholders.

As a consequence of the Independent Committee review of our historical stock option practices and resulting restatements of our financial statements, we have not been able to file our periodic reports with the SEC on a timely basis and continue to face the possibility of delisting of our stock from the NASDAQ Global Select Market. We have now filed this 2007 Form 10-K and we believe that this filing, together with the expected filing of the Quarterly Report on Form 10-Q as of and for the quarter ended September 23, 2007 (the “First Quarter 2008 Form 10-Q”) and the Quarterly Report on Form 10-Q as of and for the quarter ended December 23, 2007 (the “Second Quarter 2008 Form 10-Q”) with the SEC will remediate the Company’s non-compliance with Marketplace Rule 4310(c) (14), subject to the affirmative completion by the NASDAQ Stock Market Inc. (“NASDAQ”) of its compliance protocols and its notification to the Company accordingly. However, if NASDAQ disagrees with the Company’s position or if the SEC disagrees with the manner in which the financial impact of past stock option grants have been accounted for and reported, or not reported, there could be further delays in filing subsequent SEC reports or other actions that might result in delisting of the Company’s Common Stock from the NASDAQ Global Select Market.

See the “Explanatory Note” immediately preceding Part I, Item 1 and Note 3, “Restatements of Consolidated Financial Statements,” to Consolidated Financial Statements of this 2007 10-K for further discussion. Until we have returned to full compliance with SEC reporting requirements and NASDAQ listing requirements, the possibility of a NASDAQ delisting exists. If this happens, the price of our stock and the ability of our stockholders to trade in our stock would be adversely affected. In addition, we would be subject to a number of restrictions regarding the registration of our stock under federal securities laws, and we would not be able to allow our employees to exercise their outstanding options, which could adversely affect our business and results of operations.

As a result of the delayed filings of our Quarterly Report on Form 10-Q for the quarters ended September 23, 2007 and December 23, 2007, as well as of this 2007 Form 10-K, we will be ineligible to register our securities on Form S-3 for sale by us or resale by others until one year from the date the last delinquent filing is made. We may use Form S-1 to raise capital or complete acquisitions, but doing so could increase transaction costs and adversely impact our ability to raise capital or complete acquisitions of other companies in a timely manner.

It may be Difficult or More Costly to Obtain Director and Officer Liability Insurance Coverage as a Result of Our Stock Option Restatement.

The issues arising from our restatement may make it more difficult to obtain director and officer liability insurance coverage in the future. If we are able to obtain this coverage, it could be significantly more costly than in the past, which could have an adverse effect on our financial results and cash flow. If we are unable to secure appropriate director and officer liability insurance coverage on reasonable terms, our directors and officers could face increased risks of personal liability in connection with the performance of their duties. In that event, we believe we could have difficulty attracting and retaining qualified directors and officers, which could adversely affect our business.

Our Quarterly Revenues and Operating Results ~~are~~Are Unpredictable

Our revenues and operating results may fluctuate significantly from quarter to quarter due to a number of factors, not all of which are in our control. We manage our expense levels based in part on our expectations of future revenues. If revenue levels in a particular quarter do not meet our expectations, our operating results may be adversely affected. Because our operating expenses are based in part on anticipated future revenues, and a certain amount of those expenses are relatively fixed, a change in the timing of recognition of revenue and/or the level of gross profit from a single transaction can unfavorably affect operating results in a particular quarter. Factors that may cause our financial results to fluctuate unpredictably include, but are not limited to:

•		economic conditions in the electronics and semiconductor ~~industry~~industries generally and the equipment industry specifically;

•		the extent that customers use our products and services in their business;

•		timing of customer acceptances of equipment;

•		the size and timing of orders from customers;

•		customer cancellations or delays in our shipments, installations, and/or acceptances;

•		changes in average selling prices, customer mix, and product mix;

•		our ability in a timely manner to develop, introduce and market new, enhanced, and competitive products;

•		our competitors’ introduction of new products;

Further, because a significant amount of our R&D and administrative operations and capacity is located at our Fremont, California campus, natural, physical, logistical or other events or disruptions affecting these facilities (including labor disruptions, earthquakes, and power failures) could adversely impact our financial performance.

We Derive Our Revenues Primarily from a Relatively Small Number of High-Priced Systems

System sales constitute a significant portion of our total revenue. Our systems can typically range in price up to approximately ~~$6.0~~$6 million per unit, and our revenues in any given quarter are dependent upon the acceptance of a rather limited number of such systems. As a result, the inability to declare revenue on even a few systems can cause a significant adverse impact on our revenues for that quarter.

Variations in the Amount of Time it Takes for Our Customers to Accept Our Systems May Cause Fluctuation in Our Operating Results

We generally recognize revenue for new system sales on the date of customer acceptance or the date the contractual customer acceptance provisions lapse. As a result, the fiscal period in which we are able to recognize new systems revenues is typically subject to the length of time that our customers require to evaluate the performance of our equipment after shipment and installation, which could cause our quarterly operating results to fluctuate.

The Semiconductor Equipment Industry Isis Volatile and Reduced Product Demand Has a Negative Impact on Shipments

Our business depends on the capital equipment expenditures of semiconductor manufacturers, which in turn depend on the current and anticipated market demand for integrated circuits and products using integrated circuits. The semiconductor industry is cyclical in nature and historically experiences periodic downturns. Business conditions historically have changed rapidly and unpredictably.

Fluctuating levels of investment by semiconductor manufacturers could continue to materially affect our aggregate shipments, revenues and operating results. Where appropriate, we will attempt to respond to these fluctuations with cost management programs aimed at aligning our expenditures with anticipated revenue streams, which sometimes result in restructuring charges. Even during periods of reduced revenues, we must continue to invest in research and development and maintain extensive ongoing worldwide customer service and support capabilities to remain competitive, which may temporarily harm our financial results.

We Depend on New Products and Processes for Our Success. Consequently, We are Subject to Risks Associated with Rapid Technological Change

Rapid technological changes in semiconductor manufacturing processes subject us to increased pressure to develop technological advances enabling such processes. We believe that our future success depends in part upon our ability to develop and offer new products with improved capabilities and to continue to enhance our existing products. If new products have reliability or quality problems, our performance may be impacted by reduced orders, higher manufacturing costs, delays in acceptance of and payment for new products, and additional service and warranty expenses. We may be unable to develop and manufacture new products successfully or new products that we introduce may fail in the marketplace. Our failure to complete commercialization of these new products in a timely manner could result in unanticipated costs and inventory obsolescence, which would adversely affect our financial results.

In order to develop new products and processes, we expect to continue to make significant investments in R&D and to pursue joint development relationships with customers, suppliers or other members of the industry. We must manage product transitions and joint development relationships successfully, as introduction of new products could adversely affect our sales of existing products. Moreover, future technologies, processes or product developments may render our current product offerings obsolete, leaving us with non-competitive products, or obsolete inventory, or both.

913

We ~~Are~~are Subject to Risks Relating to Product Concentration and Lack of Product Revenue Diversification

We derive a substantial percentage of our revenues from a limited number of products, and we expect these products to continue to account for a large percentage of our revenues in the near term. Continued market acceptance of these products is, therefore, critical to our future success. Our business, operating results, financial condition, and cash flows could therefore be adversely affected by:

•		a decline in demand for even a limited number of our products;

•		a failure to achieve continued market acceptance of our key products;

•		export restrictions or other regulatory or legislative actions which limit our ability to sell those products to key customer or market segments;

•		an improved version of products being offered by a competitor in the market in which we ~~participate in;~~participate;

•		increased pressure from competitors that offer broader product lines;

•		technological change that we are unable to address with our products; ~~and~~or

•		a failure to release new or enhanced versions of our products on a timely basis.

In addition, the fact that we offer a more limited product line creates the risk that our customers may view us as less important to their business than our competitors that offer additional products as well. This may impact our ability to maintain or expand our business with certain customers. Such product concentration may also subject us to additional risks associated with technology changes. Since we are primarily a provider of etch equipment, our business is affected by our customers’ use of etching steps in their processes. Should technologies change so that the manufacture of semiconductor chips requires fewer etching steps, this might have a larger impact on our business than it would on the business of our less concentrated competitors.

We Have a Limited Number of Key Customers

Sales to a limited number of large customers constitute a significant portion of our overall revenue, new orders and profitability. As a result, the actions of even one customer may subject us to revenue swings that are difficult to predict. Similarly, significant portions of our credit risk may, at any given time, be concentrated among a limited number of customers, so that the failure of even one of these key customers to pay its obligations to us could significantly impact our financial results.

Strategic Alliances May Have Negative Effects on ~~our~~Our Business

Increasingly, semiconductor companies are entering into strategic alliances with one another to expedite the development of processes and other manufacturing technologies. Often, one of the outcomes of such an alliance is the definition of a particular tool set for a certain function or a series of process steps that use a specific set of manufacturing equipment. While this could work to our advantage if ~~Lam’s~~Lam Research’s equipment becomes the basis for the function or process, it could work to our disadvantage if a competitor’s tools or equipment become the standard equipment for such function or process. In the latter case, even if ~~Lam’s~~Lam Research’s equipment was previously used by a customer, that equipment may be displaced in current and future applications by the tools standardized by the alliance.

Similarly, our customers may team with, or follow the lead of, educational or research institutions that establish processes for accomplishing various tasks or manufacturing steps. If those institutions utilize a competitor’s equipment when they establish those processes, it is likely that customers will tend to use the same equipment in setting up their own manufacturing lines. These actions could adversely impact our market share and subsequent business.

We ~~Are~~are Dependent Upon a Limited Number of Key Suppliers

We obtain certain components and sub-assemblies included in our products from a single supplier or a limited group of suppliers. We have established long-term contracts with many of these suppliers. These long-term contracts can take a variety of forms. We may renew these contracts periodically. In some cases, these suppliers sold us products during at least the last four years, and we expect that we will continue to renew these contracts in the future or that we will otherwise replace them with competent alternative suppliers. However, several of our ~~outsourced assembly~~ suppliers are relatively new providers to us so that our experience with them

Our Outsource Providers May Fail to Perform as We Expect

Outsource providers have played and will play key roles in our manufacturing operations and in many of our transactional and administrative functions, such as information technology, facilities management, and certain elements of our finance organization. Although we aim at selecting reputable providers and secure their performance on terms documented in written contracts, it is possible that one or more of these providers could fail to perform as we expect and such failure could have an adverse impact on our business.

In addition, the expansive role of outsource providers has required and will continue to require us to implement changes to our existing operations and to adopt new procedures to deal with and manage the performance of these outsource providers. Any delay or failure in the implementation of our operational changes and new procedures could adversely affect our customer relationships and/or have a negative effect on our operating results.

Once a Semiconductor Manufacturer Commits to Purchase a Competitor’s Semiconductor Manufacturing Equipment, the Manufacturer Typically Continues to Purchase ~~That~~that Competitor’s Equipment, Making Itit More Difficult for Us to Sell ~~our~~Our Equipment to ~~That~~that Customer

Semiconductor manufacturers must make a substantial investment to qualify and integrate wafer processing equipment into a semiconductor production line. We believe that once a semiconductor manufacturer selects a particular supplier’s processing equipment, the manufacturer generally relies upon that equipment for that specific production line application. Accordingly, we expect it to be more difficult to sell to a given customer if that customer initially selects a competitor’s equipment.

We ~~Are~~are Subject to Risks Associated with Our Competitors’ Strategic Relationships and Their Introduction of New Products and We May Lack the Financial Resources or Technological Capabilities of Certain of Our Competitors Needed to Capture Increased Market Share

We expect to face significant competition from multiple current and future competitors. We believe that other companies are developing systems and products that are competitive to ours and are planning to introduce new products, which may affect our ability to sell our existing products. We face a greater risk if our competitors enter into strategic relationships with leading semiconductor manufacturers covering products similar to those we sell or may develop, as this could adversely affect our ability to sell products to those manufacturers.

We believe that to remain competitive we will require significant financial resources to offer a broad range of products, to maintain customer service and support centers worldwide, and to invest in product and process R&D. Certain of our competitors have substantially greater financial resources and more extensive engineering, manufacturing, marketing, and customer service and support resources than we do and therefore have the potential to increasingly dominate the semiconductor equipment industry. These competitors may deeply discount or give away products similar to those that we sell, challenging or even exceeding our ability to make similar accommodations and threatening our ability to sell those products. For these reasons, we may fail to continue to compete successfully worldwide.

In addition, our competitors may provide innovative technology that may have performance advantages over systems we currently, or expect to, offer. They may be able to develop products comparable or superior to those we offer or may adapt more quickly to new technologies or evolving customer requirements. In particular, while we currently are developing additional product enhancements that we believe will address future customer requirements, we may fail in a timely manner to complete the development or introduction of these additional product enhancements successfully, or these product enhancements may not achieve market acceptance or be competitive. Accordingly, we may be unable to continue to compete in our markets, competition may intensify, or future competition may have a material adverse effect on our revenues, operating results, financial condition, and/or cash flows.

Certain international sales depend on our ability to obtain export licenses from the U.S. Government. Our failure or inability to obtain such licenses would substantially limit our markets and severely restrict our revenues. Many of the challenges noted above are applicable in China, which is a fast developing market for the semiconductor equipment industry and therefore an area of potential significant growth for our business. As the business volume between China and the rest of the world grows, there is inherent risk, based on the complex relationships between China, Taiwan, Japan, and the United ~~States, that political~~States. Political and diplomatic influences might lead to trade disruptions which would adversely affect our business with China and/or Taiwan and perhaps the entire Asia region. A significant trade disruption in these areas could have a material, adverse impact on our future revenue and profits.

We are potentially exposed to adverse as well as beneficial movements in foreign currency exchange rates. The majority of our sales and expenses are denominated in U.S. dollars except for certain of our revenues in Japan that are denominated in Japanese ~~Yen,~~yen, certain of our spares and service contracts which are denominated in other currencies, and expenses related to our non-U.S. sales and support offices which are denominated in these countries’ local currency.

We currently enter into foreign currency forward contracts to minimize the short-term impact of the exchange rate fluctuations on Japanese ~~Yen-denominated~~yen-denominated assets and forecasted Japanese ~~Yen-denominated~~yen-denominated revenue where we currently believe our primary exposure to currency rate fluctuation lies and will continue to enter into hedging transactions, for the purposes outlined, in the foreseeable future. However, these hedging transactions may not achieve their desired effect because differences between the actual timing of customer acceptances and our forecasts of those acceptances may leave us either over- or under-hedged on any given transaction. Moreover, by hedging our ~~Yen-denominated~~yen-denominated assets with currency forward contracts, we may miss favorable currency trends that would have been advantageous to us but for the hedges. Additionally, we currently do not enter into such forward contracts for currencies other than the ~~Yen,~~yen, and we therefore are subject to both favorable and unfavorable exchange rate fluctuations to the extent that we transact business (including intercompany transactions) in other currencies.

Our Financial Results May Bebe Adversely Impacted Byby Higher ~~Than~~than Expected Tax Rates Oror Exposure Toto Additional Income Tax Liabilities

As a global company, our effective tax rate is highly dependent upon the geographic composition of worldwide earnings and tax regulations governing each region. We are subject to income taxes in both the United States and various foreign jurisdictions, and significant judgment is required to determine worldwide tax liabilities. Our effective tax rate could be adversely affected by changes in the split of earnings between countries with differing statutory tax rates, in the valuation of deferred tax assets, in tax laws or by

material audit assessments, which could affect our profitability. In particular, the carrying value of deferred tax assets, which are predominantly in the United States, is dependent on our ability to generate future taxable income in the United States. In addition, the amount of income taxes we pay is subject to ongoing audits in various jurisdictions, and a material assessment by a governing tax authority could affect our profitability.

~~Changes in Accounting Standards for Equity-Based Compensation May Adversely Affect our Operating Results, Our Stock Price, and Our Competitiveness in the Employee Marketplace~~

The adoption of SFAS No. 123(R) required us to expense all equity-based compensation provided to employees and directors beginning with our quarter ending September 25, 2005. The environment for skilled employees that are knowledgeable about our products and services is a competitive one, and we believe that equity-based compensation is an important part of the overall compensation that we offer to attract and retain such employees. SFAS No. 123(R) has decreased and will continue to decrease our earnings based on its measure of the value of equity-based compensation. There is some risk that the design of our compensation plans is ineffective at balancing our profitability and employee retention objectives.

A Failure to Comply with Environmental Regulations May Adversely Affect Our Operating Results

We are subject to a variety of governmental regulations related to the discharge or disposal of toxic, volatile or otherwise hazardous chemicals. We believe that we are in general compliance with these regulations and that we have obtained (or will obtain or are otherwise addressing) all necessary environmental permits to conduct our business. These permits generally relate to the disposal of hazardous wastes. Nevertheless, the failure to comply with present or future regulations could result in fines being imposed on us, suspension of production, cessation of our operations or reduction in our customers’ acceptance of our products. These regulations could require us to alter our current operations, to acquire significant equipment or to incur substantial other expenses to comply with environmental regulations. Our failure to control the use, sale, transport or disposal of hazardous substances could subject us to future liabilities.

If We ~~Are~~are Unable to Adjust the Scale of Our Business in Response to Rapid Changes in Demand in the Semiconductor Equipment Industry, Our Operating Results and Our Ability to Compete Successfully May Bebe Impaired

The business cycle in the semiconductor equipment industry has historically been characterized by frequent periods of rapid change in demand that challenge our management to adjust spending and resources allocated to operating activities. During periods of rapid growth or decline in demand for our products and services, we face significant challenges in maintaining adequate financial and business controls, management processes, information systems and procedures and in training, managing, and appropriately sizing our supply chain, our work force, and other components of our business on a timely basis. Our success will depend, to a significant extent, on the ability of our executive officers and other members of our senior management to identify and respond to these challenges effectively. If we do not adequately meet these challenges, our gross margins and earnings may be impaired during periods of demand decline, and we may lack the infrastructure and resources to scale up our business to meet customer expectations and compete successfully during periods of demand growth.

If We Choose to Acquire or Dispose of Product Lines and Technologies, We May Encounter Unforeseen Costs and Difficulties That Could Impair Our Financial Performance

An important element of our management strategy is to review acquisition prospects that would complement our existing products, augment our market coverage and distribution ability, or enhance our technological capabilities. As a result, we may make acquisitions of complementary companies, products or technologies, such as our March 2008 acquisition of SEZ Holding AG, or we may reduce or dispose of certain product lines or technologies ~~which~~that no longer fit our long-term strategies. Managing an acquired business, disposing of product technologies or reducing personnel entails numerous operational and financial risks, including difficulties in assimilating acquired operations and new personnel or separating existing business or product groups,

In addition, any acquisitions could result in changes such as potentially dilutive issuances of equity securities, the incurrence of debt and contingent liabilities, the amortization of related intangible assets, and goodwill impairment charges, any of which could materially adversely affect our business, financial condition, and results of operations and/or the price of our Common Stock.

The Market for Our Common Stock is Volatile, Which May Affect Our Ability to Raise Capital or Make Acquisitions

The market price for our Common Stock is volatile and has fluctuated significantly over the past years. The trading price of our Common Stock could continue to be highly volatile and fluctuate widely in response to factors, including but not limited to the following:

•		general market, semiconductor, or semiconductor equipment industry conditions;

•		global economic fluctuations;

•		variations in our quarterly operating results;

•		variations in our revenues or earnings from levels experienced by other companies in our industry or forecasts by securities analysts;

•		announcements of restructurings, technological innovations, reductions in force, departure of key employees, consolidations of operations, or introduction of new products;

•		government regulations;

•		developments in, or claims relating to, patent or other proprietary rights;

•		success or failure of our new and existing products;

•		liquidity of ~~Lam;~~Lam Research;

•		disruptions with key customers or suppliers; or

•		political, economic, or environmental events occurring globally or in any of our key sales regions.

In addition, the stock market experiences significant price and volume fluctuations. Historically, we have witnessed significant volatility in the price of our Common Stock due in part to the actual or anticipated movement in interest rates and the price of and markets for semiconductors. These broad market and industry factors have and may again adversely affect the price of our Common Stock, regardless of our actual operating performance. In the past, following volatile periods in the price of stock, many companies became the object of securities class action litigation. If we are sued in a securities class action, we could incur substantial costs, and it could divert management’s attention and resources and have an unfavorable impact on the price for our Common Stock.

Intellectual Property and Other Claims Against Us Can Bebe Costly and Could Result in the Loss of Significant Rights Which ~~Are~~are Necessary to Our Continued Business and Profitability

Third parties may assert infringement, unfair competition or other claims against us. From time to time, other parties send us notices alleging that our products infringe their patent or other intellectual property rights. In addition, our Bylaws and indemnity obligations provide that we will indemnify officers and directors against losses that they may incur in legal proceedings resulting from their service to ~~Lam.~~Lam Research. In such cases, it is our policy either to defend the claims or to negotiate licenses or other settlements on commercially reasonable terms. However, we may be unable in the future to negotiate necessary licenses or reach agreement on other settlements on commercially reasonable terms, or at all, and any litigation resulting from these claims by other parties may materially adversely affect our business and financial results. Moreover, although we seek to obtain insurance to protect us from claims and cover losses to our property, there is no guarantee that such insurance will fully indemnify us for any losses that we may incur.

We May Fail to Protect Our Proprietary Technology Rights, Which ~~Would~~Could Affect Our Business

Our success depends in part on our proprietary technology. While we attempt to protect our proprietary technology through patents, copyrights and trade secret protection, we believe that our success also depends on increasing our technological expertise, continuing our development of new systems, increasing market penetration and growth of our installed base, and providing comprehensive support and service to our customers. However, we may be unable to protect our technology in all instances, or our competitors may develop similar or more competitive technology independently. We currently hold a number of United States and foreign patents and pending patent applications. However, other parties may challenge or attempt to invalidate or circumvent any patents the United States or foreign governments issue to us or these governments may fail to issue patents for pending applications. In addition, the rights granted or anticipated under any of these patents or pending patent applications may be narrower than we expect or, in fact provide no competitive advantages.

We ~~Are~~are Subject to the Internal Control Evaluation and Attestation Requirements of Section 404 of the Sarbanes-Oxley Act of 2002

Pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, we are required to include in our annual report our assessment of the effectiveness of our internal control over financial reporting and our audited financial statements as of the end of each fiscal year. Furthermore, our independent registered public accounting firm ~~(Firm)~~(the “Independent Registered Public Accounting Firm” or the “Firm”) is required to ~~attest to whether our assessment of the effectiveness of our internal control over financial reporting is fairly stated in all material respects and separately~~ report on whether it believes we maintained, in all material respects, effective internal control over financial reporting as of the end of each fiscal year. We have successfully completed our assessment and obtained our Independent Registered Public Accounting Firm’s attestation as to the effectiveness of our internal control over financial reporting as of June ~~25, 2006.~~24, 2007. In future years, if we fail to timely complete this assessment, or if our Independent Registered Public Accounting Firm cannot timely attest to our assessment, we could be subject to regulatory sanctions and a loss of public confidence in our internal control. In addition, any failure to implement required new or improved controls, or difficulties encountered in their implementation, could harm our operating results or cause us to fail to timely meet our regulatory reporting obligations.

Our Independent Registered Public Accounting Firm Must Confirm Its Independence in Order for Us to Meet Our Regulatory Reporting Obligations on a Timely Basis

Our ~~independent registered public accounting firm~~Independent Registered Public Accounting Firm communicates with us at least annually regarding any relationships between the Firm and Lam Research that, in the Firm’s professional judgment, might have a bearing on the Firm’s independence with respect to us. If, for whatever reason, our ~~independent registered public accounting firm~~Independent Registered Public Accounting Firm finds that it cannot confirm that it is independent of Lam Research based on existing securities laws and registered public accounting firm independence standards, we could experience delays or other failures to meet our regulatory reporting obligations.

1518

Item 1B.Unresolved Staff Comments

None.

Item 2.Properties

Our executive offices and principal operating and R&D facilities are located in Fremont, California, and are held under operating leases expiring from fiscal years 2008 to 2014. These leases generally include options to renew or purchase the facilities. ~~As a result of~~Please see additional information under the ~~restructuring of our operations, we have subleased some of our idle facilities, (refer to Note 15 of our Consolidated Financial Statements, included~~heading “Subsequent Events” in Item ~~8 herein, for further information concerning our property leases).~~7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” of this 2007 Form 10-K regarding renewal of these leases and entry into additional leases. In addition, we lease properties for our service, technical support and sales personnel throughout the United States, Europe, Taiwan, Korea, Japan, and Asia ~~Pacific.~~Pacific and own a manufacturing facility located in Eaton, Ohio. Our fiscal year ~~2006~~2007 rental payments for the space occupied during that period aggregated approximately ~~$8.9~~$11 million. Our facilities lease obligations are subject to periodic increases, and we believe that our existing facilities are well-maintained and in good operating condition.

Item 3.Legal Proceedings

From time to time, we have received notices from third parties alleging infringement of such parties’ patent or other intellectual property rights by our products. In such cases it is our policy to defend the claims, or if considered appropriate, negotiate licenses on commercially reasonable terms. However, no assurance can be given that we will be able to negotiate necessary licenses on commercially reasonable terms, or at all, or that any litigation resulting from such claims would not have a material adverse effect on our consolidated financial position, liquidity, operating results, or our consolidated financial statements taken as a whole.

Item 4.Submission of Matters to a Vote of Security Holders

None.

PART II

Item 5.Market for the Registrant’s Common ~~Stock and~~Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

The information required by this Item with respect to the market price of the Company’s Common Stock, number of holders thereof, and payment of dividends is incorporated by reference from Item 6, “Selected ~~Consolidated~~ Financial ~~Data,”~~Data”, below.

In October 2004, we announced that our Board of Directors had authorized the repurchase of up to $250 million of our ~~common stock~~Common Stock from the public market or in private purchases. The terms of the repurchase program ~~permit~~permitted us to repurchase shares through September 30, 2007. In August 2005, we announced that our Board of Directors had authorized the repurchase of an additional $500 million of our ~~common stock~~Common Stock from the public market or private purchase. The terms of the repurchase program ~~permit~~permitted us to repurchase shares through September 30, 2008. In February 2007, we announced that our Board of Directors had authorized the repurchase of up to an additional $750 million of our Common Stock from the public market or private purchase. The terms of the repurchase program permitted us to repurchase shares at a pace determined by management. We ~~plan to continue to execute~~completed the ~~authorized repurchases.~~repurchase of all amounts available under our share repurchase authorizations during the quarter ended June 24, 2007. Share repurchases under the authorizations were as follows:

Total Number Average Amount Available
of Shares Total Cost of Price Paid For Repurchase
Period Repurchased Repurchase Per Share Under the Plan
(in thousands, except per share data)
As of June 26, 2005 5,855 $ 167,081 $ 28.54 $ 82,919
Additional authorization of $500 million — August 24, 2005 $ 582,919
Quarter Ending September 25, 2005 2,644 78,690 29.76 $ 504,229
Quarter Ending December 25, 2005 1,848 61,917 33.50 $ 442,312
Quarter Ending March 26, 2006 1,698 73,602 43.36 $ 368,710
Quarter Ending June 25, 2006 788 37,002 46.93 $ 331,708

Total 12,833 $ 418,292 $ 32.59


	Total Number				Total Number of Shares		Remaining Amount
	of Shares		Average		Purchased as Part of		Available Under
	Repurchased		Price Paid		Publicly Announced		the Repurchase
Period	(1)		per Share		Plans or Programs		Programs
	(in thousands, except per share data)
As of June 25, 2006		12,833	$	32.59		12,833	$	331,708
Quarter Ending September 24, 2006		27		40.20		—	$	331,708
Quarter Ending December 24, 2006		1,452		51.83		1,447	$	256,696
Additional authorization of up to $750 million — February 23, 2007		—		—		—	$	1,006,696
Quarter Ending March 25, 2007		5,221		45.78		5,214	$	768,006
March 26, 2007 - April 22, 2007		2,493		50.41		2,490	$	642,458
April 23, 2007 - May 20, 2007		7,842		53.86		7,841	$	220,135
May 21, 2007 - June 24, 2007		4,168		52.86		4,164	$	—

Total		34,036	$	44.13		33,989


(1)		In addition to shares repurchased under Board authorized repurchase programs and included in this column are approximately 47,000 shares which the Company withheld through net share settlements during fiscal year 2007 upon the vesting of restricted stock unit awards under the Company’s equity compensation plans to cover tax withholding obligations.

1620

Item 6. Selected ~~Consolidated~~ Financial Data

Year Ended
June 25, June 26, June 27, June 29, June 30,
2006 2005 2004 2003 2002
(in thousands, except per share data)
OPERATIONS:
Total revenue $ 1,642,171 $ 1,502,453 $ 935,946 $ 755,234 $ 943,114
Gross margin 827,394 764,092 431,049 303,829 266,089
Restructuring charges, net(1) — 14,201 8,327 15,901 44,850
Operating income (loss)(2) 406,265 391,002 106,180 (5,385 ) (119,838 )
Loss on equity derivative contracts in Company stock (EITF 00-19) — — — (16,407 ) (8,236 )
Net income (loss) 335,755 299,341 82,988 (7,739 ) (90,051 )
Net income (loss) per share:
Basic $ 2.42 $ 2.17 $ 0.63 $ (0.06 ) $ (0.71 )
Diluted(3) $ 2.34 $ 2.10 $ 0.59 $ (0.06 ) $ (0.71 )
BALANCE SHEET:
Working capital $ 1,140,143 $ 865,703 $ 519,782 $ 655,794 $ 757,880
Total assets 2,313,344 1,448,815 1,198,626 1,198,275 1,632,291
Long-term obligations, less current portion 350,969 2,786 9,554 332,209 359,691
The following tables include selected summary financial data for each of our last five fiscal years. As discussed in Note 3, “Restatements of Consolidated Financial Statements” to Consolidated Financial Statements, our selected financial data as of and for the years ended June 25, 2006, June 26, 2005, June 27, 2004, and June 29, 2003, have been restated to correct our past accounting for stock option grants and other related adjustments. These data should be read in conjunction with Item 8, “Financial Statements and Supplementary Data”, and Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in this 2007 Form 10-K.


	Year Ended
	June 24,		June 25,		June 26,		June 27,		June 29,
	2007		2006		2005		2004		2003
			As reported		As reported		As reported		As reported
	(in thousands, except per share data)
OPERATIONS:
Total revenue	$	2,566,576	$	1,642,171	$	1,502,453	$	935,946	$	755,234
Gross margin		1,305,054		827,394		764,092		431,049		303,829
Restructuring charges, net		—		—		14,201		8,327		15,901
Operating income (loss)		778,660		406,265		391,002		106,180		(5,385	)
Loss on equity derivative contracts in Company stock (EITF 00-19)		—		—		—		—		(16,407	)
Net income (loss)		685,816		335,755		299,341		82,988		(7,739	)
Net income (loss) per share:
Basic	$	4.94	$	2.42	$	2.17	$	0.63	$	(0.06	)
Diluted	$	4.85	$	2.34	$	2.10	$	0.59	$	(0.06	)
BALANCE SHEET:
Working capital	$	743,563	$	1,140,143	$	865,703	$	519,782	$	655,794
Total assets		2,101,605		2,313,344		1,448,815		1,198,626		1,198,275
Long-term obligations, less current portion		252,487		350,969		2,786		9,554		332,209


	Year Ended
	June 24,		June 25,			June 26,			June 27,			June 29,
	2007		2006			2005			2004			2003
			Adjustments			Adjustments			Adjustments			Adjustments
	(in thousands, except per share data)
OPERATIONS:
Total revenue	$	—	$	—		$	—		$	—		$	—
Gross margin		—		(382	)		(628	)		(946	)		(2,749	)
Restructuring charges, net		—		—			—			—			—
Operating income (loss)		—		(1,497	)		(2,860	)		(9,387	)		(15,384	)
Loss on equity derivative contracts in Company stock (EITF 00-19)		—		—			—			—			—
Net income (loss)		—		(545	)		(2,089	)		(5,502	)		(10,442	)
Net income (loss) per share:
Basic	$	—	$	(0.00	)	$	(0.02	)	$	(0.04	)	$	(0.08	)
Diluted	$	—	$	(0.00	)	$	(0.01	)	$	(0.04	)	$	(0.08	)
BALANCE SHEET:
Working capital	$	—	$	(1,423	)	$	(28,333	)	$	(20,416	)	$	(16,923	)
Total assets		—		14,038			23,534			23,492			20,043
Long-term obligations, less current portion		—		—			—			—			—

See the “Explanatory Note” immediately preceding Part I, Item 1 and Note 3, “Restatement of Consolidated Financial Statements” to Consolidated Financial Statements in Item 8 for an explanation of these adjustments.


	Year Ended
	June 24,		June 25,		June 26,		June 27,		June 29,
	2007		2006		2005		2004		2003
			As restated		As restated		As restated		As restated
	(in thousands, except per share data)
OPERATIONS:
Total revenue	$	2,566,576	$	1,642,171	$	1,502,453	$	935,946	$	755,234
Gross margin		1,305,054		827,012		763,464		430,103		301,080
Restructuring charges, net(1)		—		—		14,201		8,327		15,901
Operating income (loss)(2)		778,660		404,768		388,142		96,793		(20,769	)
Loss on equity derivative contracts in Company stock (EITF 00-19)		—		—		—		—		(16,407	)
Net income (loss)		685,816		335,210		297,252		77,486		(18,181	)
Net income (loss) per share:
Basic	$	4.94	$	2.42	$	2.16	$	0.59	$	(0.14	)
Diluted(3)	$	4.85	$	2.33	$	2.09	$	0.54	$	(0.14	)
BALANCE SHEET:
Working capital	$	743,563	$	1,138,720	$	837,370	$	499,366	$	638,871
Total assets		2,101,605		2,327,382		1,472,349		1,222,118		1,218,318
Long-term obligations, less current portion		252,487		350,969		2,786		9,554		332,209


(1)		Restructuring charges, net exclude restructuring charges (recoveries) included in cost of goods sold and reflected in gross margin of ~~($1.7) million, ($1.0)~~$(1.7) million and ~~$5.9~~$(1.0) million for fiscal years 2004 and 2003, respectively. Restructuring amounts included in cost of goods sold and ~~2002, respectively. These amounts~~reflected in gross margin primarily relate to the write-off of selected, older product line inventories in connection with our restructuring plans and ~~the~~ partial recovery of the charges from the subsequent sale of a portion of such inventories. These restructuring charges/(recoveries) are included as a component of cost of goods sold in accordance with Emerging Issues Task Force 96-9, “Classification of Inventory Markdowns and Other Costs Associated with a Restructuring” (EITF 96-9). There were no restructuring charges or recoveries included in cost of goods sold in fiscal years 2007, 2006, and 2005. Fiscal year 2005 restructuring charges consist only of additional liabilities related to prior restructuring plans.

(2)		Operating income during the fiscal ~~year~~years ended June 24, 2007 and June 25, 2006 includes ~~$22.8~~$35.6 million and $24.0 million, respectively, of equity-based compensation expense as a result of the adoption of Statement of Financial Accounting Standards No. 123R, “Share-Based ~~Payment.”~~Payment” at the beginning of fiscal year 2006.

(3)		Diluted net income per share for the fiscal year ended June 27, 2004 includes the assumed conversion of the convertible subordinated 4% notes. Accordingly, interest expense, net of taxes, of $3.2 million has been added back to net income for computing diluted ~~net~~ earnings per share.

1723

Stock and Dividend Information:

Our Common Stock is traded on the Nasdaq Global Select Market under the symbol LRCX. The price range per share is the highest and lowest bid prices, as reported by ~~the National Association of Security Dealers,~~The NASDAQ Stock Market, Inc., on any and all trading ~~day~~days during the respective quarter.

As of ~~August 4, 2006,~~March 10, 2008 we had ~~444~~348 stockholders of record.

In fiscal years ~~2006~~2007 and ~~2005~~2006 we did not declare or pay cash dividends to our stockholders. We currently have no plans to declare or pay cash dividends.

During fiscal year ~~2006,~~2007, we repurchased ~~6,978,403~~21,156,586 shares of ~~common stock~~Common Stock at a total ~~price~~cost of ~~$251.2 million~~$1.08 billion under terms of our repurchase programs discussed earlier in Item 5 of this ~~Annual Report~~2007 Form 10-K thereby completing all currently available repurchase programs.


	Three Months Ended
	June 24,		March 25,		December 24,		September 24,
	2007		2007		2006		2006
	(in thousands, except per share data)
QUARTERLY FISCAL YEAR 2007:
Total revenue	$	678,519	$	650,270	$	633,400	$	604,387
Gross margin		342,729		326,245		322,916		313,164
Operating income		200,349		188,973		194,505		194,833
Net income		170,231		164,741		167,326		183,518
Net income per share
Basic	$	1.31	$	1.17	$	1.18	$	1.29
Diluted	$	1.28	$	1.15	$	1.15	$	1.27
Price range per share	$	46.58-$56.04	$	43.10-$54.68	$	42.06-$57.05	$	36.66-$47.46
Number of shares used in per share calculations:

Basic		130,169		140,423		142,306		141,928
Diluted		132,868		143,052		145,346		144,850


	Three Months Ended
	June 25,		March 26,		December 25,		September 25,
	2006		2006		2005		2005
	As restated (1)		As restated (1)		As restated (1)		As restated (1)
	(in thousands, except per share data)
QUARTERLY FISCAL YEAR 2006:
Total revenue	$	525,596	$	437,423	$	358,245	$	320,907
Gross margin		274,178		219,514		177,332		155,988
Operating income		159,445		109,652		76,411		59,260
Net income		122,448		86,002		77,481		49,279
Net income per share
Basic	$	0.87	$	0.61	$	0.57	$	0.36
Diluted	$	0.85	$	0.59	$	0.54	$	0.35
Price range per share	$	41.54-$53.74	$	35.44-$48.57	$	28.37-$39.18	$	27.77-$32.61
Number of shares used in per share calculations:

Basic		141,168		140,122		136,572		136,453
Diluted		144,708		144,743		142,439		141,760


(1)		See Note 3 “Restatements of Consolidated Financial Statements” to Consolidated Financial Statements


Consolidated Balance Sheet

March 25, 2007	As
(in thousands)	reported			Adjustments (1)			As restated
ASSETS
Cash and cash equivalents	$	494,807		$	—		$	494,807
Short-term investments		638,878			—			638,878
Accounts receivable, net		461,365			—			461,365
Inventories		228,435			—			228,435
Deferred income taxes		54,765			—			54,765
Prepaid expenses and other current assets		66,118			—			66,118

Total current assets		1,944,368			—			1,944,368

Property and equipment, net		107,388			—			107,388
Restricted cash		360,038			—			360,038
Deferred income taxes		28,672			24,486			53,158
Goodwill		55,892			—			55,892
Intangible assets, net		61,615			—			61,615
Other assets		51,897			—			51,897

Total assets	$	2,609,870		$	24,486		$	2,634,356


LIABILITIES AND STOCKHOLDERS’ EQUITY
Trade accounts payable	$	142,814		$	—		$	142,814
Accrued expenses and other current liabilities		333,948			1,423			335,371
Deferred profit		166,109			—			166,109

Total current liabilities		642,871			1,423			644,294

Long-term debt		250,000			—			250,000
Other long-term liabilities		821			—			821

Total liabilities		893,692			1,423			895,115

Commitments and contingencies
Stockholders’ equity:
Preferred stock		—			—			—
Common stock		137			—			137
Additional paid-in capital		1,078,130			88,908			1,167,038
Treasury stock		(720,555	)		—			(720,555	)
Accumulated other comprehensive loss		(6,600	)		—			(6,600	)
Retained earnings		1,365,066			(65,845	)		1,299,221

Total stockholders’ equity		1,716,178			23,063			1,739,241

Total liabilities and stockholders’ equity	$	2,609,870		$	24,486		$	2,634,356


(1)		Adjustments for stock-based compensation expense (benefit), relating to deemed incorrect measurement dates, certain stock option modifications and related payroll and income tax expense (benefit) impacts.

Consolidated Balance Sheet


December 24, 2006	As
(in thousands)	reported			Adjustments (1)			As restated
ASSETS
Cash and cash equivalents	$	629,117		$	—		$	629,117
Short-term investments		574,845			—			574,845
Accounts receivable, net		456,427			—			456,427
Inventories		212,299			—			212,299
Deferred income taxes		40,799			—			40,799
Prepaid expenses and other current assets		43,169			—			43,169

Total current assets		1,956,656			—			1,956,656

Property and equipment, net		97,034			—			97,034
Restricted cash		415,038			—			415,038
Deferred income taxes		37,516			14,038			51,554
Goodwill		55,892			—			55,892
Intangible assets, net		64,641			—			64,641
Other assets		52,929			—			52,929

Total assets	$	2,679,706		$	14,038		$	2,693,744


LIABILITIES AND STOCKHOLDERS’ EQUITY
Trade accounts payable	$	111,429		$	—		$	111,429
Accrued expenses and other current liabilities		350,140			1,423			351,563
Deferred profit		176,794			—			176,794

Total current liabilities		638,363			1,423			639,786

Long-term debt		300,000			—			300,000
Long-term liabilities less current portion		833			—			833

Total liabilities		939,196			1,423			940,619

Commitments and contingencies
Stockholders’ equity:
Preferred stock		—			—			—
Common stock		142			—			142
Additional paid-in capital		1,032,946			78,460			1,111,406
Treasury stock		(486,003	)		—			(486,003	)
Accumulated other comprehensive loss		(6,900	)		—			(6,900	)
Retained earnings		1,200,325			(65,845	)		1,134,480

Total stockholders’ equity		1,740,510			12,615			1,753,125

Total liabilities and stockholders’ equity	$	2,679,706		$	14,038		$	2,693,744


(1)		Adjustments for stock-based compensation expense (benefit), relating to deemed incorrect measurement dates, certain stock option modifications and related payroll and income tax expense (benefit) impacts.

Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion of our financial condition and results of operations contains forward-looking statements, which are subject to risks, uncertainties and changes in condition, significance, value and effect. Our actual results could differ materially from those anticipated in the forward-looking statements as a result of certain factors, including but not limited to those discussed in “Risk Factors” and elsewhere in this ~~Annual Report on~~2007Form 10-K and other documents we file from time to time with the Securities and Exchange Commission. (See “Cautionary Statement Regarding Forward-Looking Statements” in Part I of this ~~Annual Report on~~2007Form 10-K ).

The semiconductor industry is cyclical in nature and has historically experienced periodic downturns and upturns. Today’s leading indicators of changes in customer investment patterns may not be any more reliable than in prior years. Demand for our equipment can vary significantly from period to period as a result of various factors, including, but not limited to, economic conditions (generally and in the semiconductor industry), supply, demand, and prices for semiconductors, customer capacity requirements, and our ability to develop and market competitive products. For these and other reasons, our results of operations for fiscal years 2007, 2006, ~~2005,~~ and ~~2004~~2005 may not necessarily be indicative of future operating results.

Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) provides a description of our results of operations and should be read in conjunction with our Consolidated Financial Statements and accompanying Notes to Consolidated Financial Statements included in this ~~Annual Report on~~2007 Form 10-K. MD&A consists of the following sections:

Restatement of Previously Issued Financial Statementsexplains the results of the voluntary stock option review and related restatement of our financial statements.

Executive Summaryprovides a summary of the key highlights of our results of operations

Results of Operationsprovides an analysis of operating results

Critical Accounting Policies and Estimatesdiscusses accounting policies that reflect the more significant judgments and estimates used in the preparation of our consolidated financial statements

Liquidity and Capital Resourcesprovides an analysis of cash flows, contractual obligations and financial position

Subsequent Eventsdiscusses events impacting our operations that have occurred after June 24, 2007

Restatement of Previously Issued Financial Statements

In this 2007 Form 10-K, the Company is restating its consolidated balance sheet as of June 25, 2006 and the related consolidated statements of operations, stockholders’ equity, and cash flows for the years ended June 25, 2006 and June 26, 2005 as a result of determinations from a voluntary independent stock option review conducted by the Independent Committee. The Company also recorded adjustments affecting previously-reported financial statements for fiscal years 1997 through 2004, the effects of which are summarized in cumulative adjustments to additional paid-in capital, deferred stock-based compensation, and retained earnings as of June 27, 2004. This restatement is also described in the Explanatory Note to this 2007 10-K, immediately preceding Part I Item I and in Note 3, “Restatement of Consolidated Financial Statements”, to Consolidated Financial Statements. This 2007 Form 10-K also reflects the restatement of “Selected Financial Data” in Item 6 for the years ended June 25, 2006, June 26, 2005, June 27, 2004 and June 29, 2003. In addition, the Company is restating the unaudited quarterly condensed financial statements for interim periods of fiscal year 2006, and unaudited condensed balance sheets as of March 25, 2007, December 24, 2006 and September 24, 2006. There was no effect of the restatement on the consolidated statements of operations for the first three quarters of fiscal year 2007.

Financial information included in the reports on Form 10-K, Form 10-Q and Form 8-K filed or furnished by Lam Research prior to January 24, 2008, and the related opinions of its Independent Registered Public Accounting Firm and all earnings press releases and similar communications issued by the Company prior to January 24, 2008 are superseded in their entirety by this 2007 Form 10-K and other reports on Form 10-Q and Form 8-K filed by the Company with the Securities and Exchange Commission on or after January 24, 2008.

Independent Committee Review

On July 18, 2007, the Company announced that its Board of Directors had initiated a voluntary independent review regarding the timing of and accounting for the Company’s past stock option grants and other related issues. The voluntary internal review arose after the Company’s Independent Registered Public Accounting Firm performed auditing procedures relating to the Company’s historical stock option grant programs and procedures as part of the firm’s fiscal year-end 2007 audit. The Board of Directors appointed a special committee consisting of two independent board members (the “Independent Committee”) to conduct a comprehensive review of the Company’s historical stock option practices. The Independent Committee promptly engaged independent outside legal counsel and forensic accountants to assist with the review. On December 21, 2007, the Company announced that the Independent Committee had reached a preliminary conclusion that the actual measurement dates for financial accounting purposes of certain stock option grants issued in the past differed from the recorded grant dates of such awards. Upon the recommendation of management and the Independent Committee, the Audit Committee of the Board of Directors concluded that the financial statements for fiscal years 1997 through 2005, and the interim periods contained therein should no longer be relied upon. The Independent Committee’s review was completed in February 2008.

Scope of the Independent Committee Review

The review covered stock option grants awarded in fiscal years 1997 through 2005 (the “Review Period”). The scope of the review included evaluating 100% of “Company-wide” grants, director grants, Section 16 officer grants, and new hire grants, as well as a sampling of grants deemed “other grants”, representing approximately 94% of all stock option grants during the Review Period. This Review Period comprised approximately 16,000 separate stock option grants on approximately 500 separately recorded grant dates. These grants involved approximately 58 million underlying shares of Common Stock and included grants to domestic and international employees. Share amount have been adjusted as applicable to reflect the March 2000 3-for-1 stock split. The Independent Committee’s review also included procedures to identify potential modifications of stock option grants, and grants awarded to consultants, and testing of cash exercises. The Company had not awarded any Company-wide stock option grants since October 2002 and stopped issuing stock option grants during fiscal year 2005 and only issued restricted stock units (“RSUs”) thereafter. The Independent Committee did not include fiscal years 2006 and 2007 in the scope of its review based on several factors including but not limited to the fact that the Company only issued RSUs after fiscal year 2005 and the Company’s equity granting processes and controls had been documented and tested as part of its assessment of the operating effectiveness of internal control over financial reporting as required by Section 404 of the Sarbanes Oxley Act of 2002. Additionally, no information arose during the stock option review that would indicate a need to expand the scope of the review to include other periods.

The Independent Committee’s review included the collection and processing of over 3.5 million electronic documents, which included hard drives and network share drives of numerous individuals, the Company’s network servers, and backup tapes. The Independent Committee’s advisors also collected and reviewed hard copy documents from numerous sources and conducted 61 interviews of 47 individuals, predominantly current or former directors, officers and employees of the Company.

Stock Option Review Results

Consistent with applicable accounting literature and guidance from the SEC staff, the Company organized the grants during the review period into categories based on the grant type and the process by which the grant was finalized. The Company analyzed the evidence from the Independent Committee’s review related to each category including, but not limited to, physical documents, electronic documents, and underlying electronic data about documents. Based on the relevant facts and circumstances, the Company applied the applicable accounting standards to determine, for grants within each category, the proper measurement date. If the measurement date was not the originally recorded grant date, accounting adjustments were made as required, in some cases resulting in stock-based compensation expense and related tax effects. The significant majority of the measurement date changes result from stock options granted prior to fiscal year 2003. As a result of the findings of the review, the Company has recognized incremental stock-based compensation and associated payroll tax expense of $96.4 million on a pre-tax basis ($65.8 million after taxes) in the aggregate during fiscal years 1997 through 2006 which includes incremental stock-based compensation expense of $1.2 million recognized in accordance with SFAS No. 123R during fiscal year 2006.

Company-wide Grants

Company-wide grants were awarded on ten dates during the Review Period, and are associated with approximately half of the shares underlying option grants encompassed in the review. These ten dates include grants issued on six dates for broad-based and primarily discretionary grants (“focal grants”), two grant dates that were formula-based grants (“supplemental grants”) and two grant dates designed to address certain previously granted stock options for which the exercise price was higher than the then-current fair value of the Company’s Common Stock (“cancel and replace grants”). As a result of its review, the Company determined that the actual measurement dates for certain stock option grants differed from the recorded grant dates. The Company determined that the actual measurement date, meaning when the required actions necessary to grant the option were completed, including the determination of the number of shares underlying the options to be granted to each employee and the exercise price, was the correct measurement date to determine what, if any stock-based compensation was appropriate. Any intrinsic value of the options on the measurement date, measured as the difference between the stated exercise price and the market price, has been recorded as compensation expense during the periods when employees were providing services in exchange for the options.

With respect to the focal grants, the Company concluded that a process to determine the total number of shares underlying the options, grant date and exercise price generally commenced prior to the recorded grant date, but that in certain cases the specific allocation of those shares among the various option recipients was not finalized until after the original recorded grant date. To address these circumstances, the Company has revised the measurement date for accounting purposes for these option grants to a date after the original grant date, when the allocation of the shares was first known to be finalized. The Company has recognized stock-based compensation expense, net of forfeitures, of $61.2 million on a pre-tax basis as a result of these revised measurement dates.

With respect to the supplemental grants, the Company determined that the general formula for determining the number of shares underlying the option grant to which each recipient would be entitled was not sufficiently finalized for accounting purposes at the original recorded grant date. To address these circumstances, the Company has revised the measurement date for accounting purposes for these grants to the date when this formula was first known to be finalized. The Company has recognized stock-based compensation expense, net of forfeitures, of $5.6 million on a pre-tax basis as a result of these revised measurement dates.

The cancel and replace grants involved recipients electing to exchange certain stock options, for which the exercise price was higher than the then-current fair value of the Company’s Common Stock, in return for a new grant of options. The Company determined that in both instances, the election deadline was after the recorded grant date. The measurement date should have been the later of the recorded grant date or the date of election because the elections were revocable up to the last day of the offer period. To address these circumstances, the Company has revised the measurement date for accounting purposes for these grants to the last possible date of election. The Company has recognized stock-based compensation expense, net of forfeitures, of $0.2 million on a pre-tax basis as a result of these revised measurement dates.

Grants to Directors and Section 16 Officers

Director grants were awarded on ten dates during the stock option review period. Grants to directors were typically governed by the requirements of the underlying stock option plan documents, as grant dates and amounts were typically fixed by the respective stock option plan. There were instances when the grant dates were not consistent with dates fixed by the respective stock option plan. In all instances the grant date was within 1 to 3 days of the dates provided by the plan. To address these circumstances, the Company has revised the measurement date for accounting purposes for these grants to the date as required by the stock option plan. The Company has recognized stock-based compensation expense, net of forfeitures, of $2.8 million on a pre-tax basis as a result of the revised measurement dates.

Section 16 officer grants were awarded on 23 grant dates during the stock option review period. The Company determined that the actual measurement date, meaning when the required actions necessary to grant the option were completed, including the determination of the number of shares underlying the options to be granted to each employee and the exercise price, was the correct measurement date to determine the market price of the option shares. Any intrinsic value of the options on the measurement date, measured as the difference between the stated exercise price and the market price, has been recorded as compensation expense during the periods when employees were providing services in exchange for the options. In instances where the original recorded grant date was not consistent with the correct measurement date, the Company has revised the measurement date for accounting purposes for these grants to a date after the original grant date, when the number of shares underlying the options to be granted to each employee and the exercise price were first known to be finalized. The Company has recognized stock-based compensation expense, net of forfeitures, of $1.0 million on a pre-tax basis as a result of the revised measurement dates. Additionally, it was determined that for one grant the recorded grant price was based on an average of closing prices of the Company’s stock immediately prior to the grant date. The option plan under which this option was granted allowed for similar pricing. To address this circumstance the Company has recognized stock-based compensation expense of $2.1 million on a pre-tax basis for this grant, which was equal to the difference between the closing price of the stock on the date of grant and the originally recorded grant exercise price.

Grants to Consultant

The Company concluded that six granting actions to a non-employee consultant were incorrectly accounted for as employee as opposed to non-employee stock awards. To address this circumstance, the Company has recognized a stock-based compensation expense of $3.2 million on a pre-tax basis under “fair value” accounting in accordance with the requirements of EITF Issue No. 96-18, “Accounting for Equity Instruments that are Issued to Other than Employees for Acquiring or in Conjunction with Selling Goods or Services”.

Grants to New Hires

New hire grants were generally approved prior to the employee’s hire date and granted as of the last day of the month of hire prior to calendar year 1999 and on the first day of the individual’s employment with the Company beginning in calendar year 1999. In instances where approval was not evidenced on or before the original recorded grant date, the Company has revised the measurement date for accounting purposes for these grants to a date after the original grant date, when the required approval was first evidenced, but not before the employee’s hire date. The Company has recognized stock-based compensation expense, net of forfeitures, of $1.7 million on a pre-tax basis as a result of these revised measurement dates.

Other Grants

For the remaining population reviewed of stock options granted during the stock option review period, the Company has concluded that certain actual measurement dates differed from the recorded grant dates primarily due to a lack of contemporaneous documentation evidencing approval as of the original recorded grant date. In these circumstances, the Company has revised the measurement date for accounting purposes for these grants to a date after the original grant date, when the shares underlying the options to be granted to each employee and the exercise price were first known to be finalized. The primary issue with these grants was that there was insufficient evidence to conclude that the specific allocation of those shares among the various grant recipients was finalized at the original recorded grant date. To address these circumstances, the Company has revised the measurement date for accounting purposes for these grants to a date after the original grant date, when the allocation of the shares underlying the options and exercise price was first known to be finalized. The Company has recognized stock-based compensation expense, net of forfeitures, of $8.2 million on a pre-tax basis as a result of these revised measurement dates.

Deemed Modifications to Stock Option Grants Connected with Terminations or Leaves of Absences

Compensation expense was also recognized as a result of deemed modifications to certain employee stock option grant awards in connection with certain employees’ terminations or leaves of absence. Typically such modifications related to extensions of the time employees could exercise options following their termination of employment or that enabled the employee to vest in additional shares in relation to a leave of absence or subsequent to their termination, thus triggering a new measurement date under the accounting literature applicable at that time. The Company has recognized stock-based compensation expense, net of forfeitures, of $9.2 million on a pre-tax basis as a result of these new measurement dates.

Use of Judgment

The Company evaluated all available evidence for each individual grant within the scope of the independent review and the revised measurement dates represent the earliest date when the terms of the options granted to individual recipients were known with finality. The proposed measurement date for certain grants could not be determined with certainty based on available evidence. In light of the judgment used in establishing the measurement dates, alternate approaches to those used by the Company could have resulted in different stock-based compensation expense than that recorded by the Company in the restatements. While the Company has considered these alternative approaches, it believes its approach is the most appropriate under the circumstances.

The Company prepared a sensitivity analysis to determine the hypothetical minimum and maximum compensation expense charge that it might have recorded for these grants if it had used different judgments to determine the revised measurement dates. The Company applied its sensitivity methodology on a grant date by grant date basis to examine the largest hypothetical variations in stock-based compensation expense within a reasonable range of possible measurement dates for each grant event.

After developing the range for each grant event included in the Company’s sensitivity analysis, the Company selected the highest and lowest closing sale price of its Common Stock within the date range to determine the range of potential compensation expense adjustments for the grants. The Company then compared these aggregated amounts to the stock-based compensation expense that it recorded for the stock option grants analyzed. If the Company had used the highest closing sale price of its Common Stock within the date range for these grant events, its stock-based compensation expense adjustment relating to these grants would have increased, net of forfeitures, by approximately $30 million on a pre-tax basis. Conversely, had the Company used the lowest closing sale price of its Common Stock within the date range for the grants analyzed, its stock-based compensation expense adjustment relating to these grants would have decreased, net of forfeitures, by approximately $26 million on a pre-tax basis. Substantially all of the hypothetical increases or decreases of stock-based compensation expense resulting from the Company’s sensitivity analysis relates to periods prior to fiscal 2005.

Findings and Recommendations of the Independent Committee

As a result of its review, the Independent Committee identified certain deficiencies relating to the Company’s historical practices and accounting with respect to stock options, including the following areas:

	•		Historical Board and Compensation Committee procedures regarding the issuance and approval of stock option grants;

	•		Historical coordination among departments relating to the administration of the stock option grant process;

	•		Historical compliance with and application of accounting standards with respect to stock option grants;

	•		Compliance with certain of the Company’s stock option plans; and

	•		Historical record-keeping with respect to stock option grants.

As a result of the deficiencies identified, the Independent Committee developed recommendations targeted at strengthening the Company’s processes with respect to equity compensation and relating accounting. These recommendations were presented to the Board of Directors on February 1, 2008 and include the areas of: approval authority for equity compensation awards; oversight and administration of the awards process; coordination among relevant departments; training with respect to equity compensation; and record-keeping. The Company is currently reviewing all of the Independent Committee’s recommendations as well as a potential timetable for implementation, but the Company believes that the substance of many of the recommendations of the Independent Committee have already been incorporated into the Company’s current equity compensation processes. This belief is consistent with the determination by the Independent Committee and the Company that the granting of RSUs after fiscal year 2005 was not within the scope of the Independent Committee review in part due to the documentation and testing required by Section 404 of the Sarbanes-Oxley Act of 2002.

The Independent Committee concluded that there was no intentional misconduct on the part of Company management or the Company’s independent directors.

Effect of Restatement on Consolidated Financial Statements

The Company previously applied Accounting Principles Board (“APB”) Opinion No. 25, “Accounting for Stock Issued to Employees”, and its related interpretations and provided the required pro forma disclosures under Statement of Financial Accounting Standards (“SFAS”) No. 123, “Accounting for Stock-Based Compensation”, through its fiscal year ended June 26, 2005. Under APB Opinion No. 25, a non-cash, stock-based compensation expense was required to be recognized for any option for which the exercise price was below the market price on the actual measurement date. Because certain of the Company’s options were assessed as having an exercise price below the market price on the actual measurement date based on the Company’s revised measurement dates as a result of the stock option review as more fully described above, there is a non-cash deferred compensation charge for each of these options under APB Opinion No. 25 equal to the number of shares underlying the options, multiplied by the difference between the exercise price and the market price on the actual measurement date. That deferred compensation expense is amortized over the vesting period of the option. The Company also recorded compensation expense under “fair value” accounting when applicable, for example, for the grants to the nonemployee consultant noted above.

Commencing in its fiscal year ended June 25, 2006, the Company adopted SFAS No. 123(R), “Share-Based Payment”. As a result, beginning in fiscal year 2006, the additional stock-based compensation expense required to be recorded for each option with a revised measurement date, as more fully described above, is equal to the fair value of the option on revised measurement date, amortized over the remaining service period of the option. The Company did not record these stock-based compensation expenses under APB Opinion No. 25 nor SFAS No. 123(R) related to its options based on the revised measurement dates in the Company’s previously issued financial statements, and that is why the Company is restating them in this filing. The Company restated its historical results of operations to record additional pre-tax, non-cash, stock-based compensation expense of (a) $94.0 million for the fiscal years ended June 30, 1997 through June 26, 2005 under APB Opinion No. 25 and other applicable accounting rules, and (b) $1.2 million for the year ended June 25, 2006 under SFAS No. 123(R). As of June 25, 2006, there was less than $0.1 million of remaining compensation expense to be recorded under SFAS No. 123(R) for stock options with revised measurement dates. In addition the Company recorded pre-tax payroll related tax expenses of $1.2 million through June 25, 2006.

Diluted shares in fiscal years 2005 and 2006 also increased as a result of the adjustments for stock options with revised measurement dates. The Company uses the treasury stock method to calculate the weighted-average shares used in the diluted EPS calculation. As part of the restatement, the Company revised its treasury stock calculations in accordance with SFAS No. 128, “Earnings Per Share”. These calculations assume that (i) all dilutive options with revised measurement dates are exercised, (ii) the Company repurchases shares with the proceeds of these hypothetical exercises along with the tax benefit resulting from the hypothetical exercises, and (iii) any average unamortized deferred stock-based compensation is also used to repurchase shares.

As described for each element above, the Company evaluated the impact of the restatements on its global tax provision. As a result, we recorded a cumulative tax benefit of $30.6 million through June 25, 2006. The Company and its subsidiaries file tax returns in multiple tax jurisdictions around the world. In certain jurisdictions, including, but not limited to, the United States, the Company is able to claim a tax deduction relative to stock options. In those jurisdictions, where a tax deduction is claimed, the Company has recorded deferred tax assets, totaling $6.2 million at June 25, 2006, to reflect future tax deductions to the extent the Company believes such assets to be recoverable. Based on this review, the Company now believes that it should not have taken a United States tax deduction in prior years for stock option related amounts pertaining to certain executives under Internal Revenue Code (IRC) Section 162(m). Section 162(m) limits the deductibility of compensation above certain thresholds. As a result, the Company’s tax carryforward attributes have decreased by approximately $14.6 million as of June 25, 2006.

For those stock option grants determined to have incorrect measurement dates for accounting purposes and that had been originally issued as incentive stock options, or ISOs, the Company recorded a liability for payroll tax contingencies in the event such grants would not be respected as ISOs under the principles of the IRC and the regulations therein. The Company recorded expense and accrued liabilities for certain foreign payroll tax contingencies. The total payroll tax accrual was approximately $1.2 million for annual periods from our fiscal year 1997 through fiscal year 2006. This cumulative expense resulted from payroll tax expense recorded in prior periods has been partially offset by benefits relating to the expiration of the related statute of limitations.

As a result of the restatement, the cumulative effect of the related after-tax expenses for the fiscal years ended June 30, 1997 through June 25, 2006 was $65.8 million, as compared to $96.4 million in pre-tax charges as previously discussed. These additional stock-based compensation and other expenses had no effect on the Company’s reported revenue, cash, cash equivalents or short-term investments for each of the restated periods. The Company has also restated the pro forma amortization of deferred stock-based employee compensation included in reported net income, net of tax, and total stock-based employee compensation expenses determined under fair value based method, net of tax, under SFAS No. 123 in Note 14, “Equity-Based Compensation Plans” to Consolidated Financial Statements to reflect the effect of the stock-based compensation expense resulting from the correction of these past stock option grants.

As a result of the determinations from a voluntary independent stock option review, the Company considered the application of Section 409A of the IRC to certain stock option grants where, under APB No. 25, intrinsic value existed at the time of grant. In the event such stock option grants are not considered as issued at fair market value at the original grant date under the IRC and applicable regulations thereunder, these options are subject to Section 409A. On March 30, 2008, the Board of Directors of the Company authorized the Company to assume the liability of any and all employees, including the Company’s Chief Executive Officer and certain executive officers, with options subject to Section 409A. The liability is currently estimated to be in the range of approximately $50 million to $55 million. The determinations from the voluntary independent stock option review are more fully described in Note 3, “Restatement of Consolidated Financial Statements” to Consolidated Financial Statements in Item 8 and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 7 of the Company’s 2007 Form 10-K.

The financial statement effect of the restatement of stock-based compensation expense and related payroll and income taxes, by year, is as follows (in thousands):


						Adjustment to
						income tax expense
	Adjustment to		Adjustment to			(benefit) relating to
	stock-based		payroll tax			stock-based			Total
Fiscal	compensation		expense			compensation and			restatement
Year	expense		(benefit)			payroll tax expense			expense

1997	$	1,770	$	—		$	(668	)	$	1,102
1998		2,352		226			(219	)		2,359
1999		5,291		136			(1,286	)		4,141
2000		19,151		1,511			(6,953	)		13,709
2001		23,395		220			(6,792	)		16,823
2002		13,056		159			(4,082	)		9,133
2003		15,739		(355	)		(4,942	)		10,442
2004		10,448		(1,061	)		(3,885	)		5,502

Cumulative through June 27, 2004		91,202		836			(28,827	)		63,211

2005		2,724		136			(771	)		2,089
2006		1,225		272			(952	)		545

Total	$	95,151	$	1,244		$	(30,550	)	$	65,845

The financial statement effect of the restatement on previously reported stock-based compensation expense, including income tax effect by year, is as follows (in thousands):


	Stock-based						Income tax benefit			Restated stock-
	compensation				Stock-based		relating to restated			based
	expense, as		Stock-based		compensation		stock-based			compensation
Fiscal	previously		compensation		expense, as		compensation			expense, net of
Year	reported		expense adjustments		restated		expense			income tax

1997	$	—	$	1,770	$	1,770	$	(668	)	$	1,102
1998		—		2,352		2,352		(132	)		2,220
1999		—		5,291		5,291		(1,234	)		4,057
2000		—		19,151		19,151		(6,423	)		12,728
2001		542		23,395		23,937		(6,961	)		16,976
2002		1,724		13,056		14,780		(4,698	)		10,082
2003		593		15,739		16,332		(5,116	)		11,216
2004		3,167		10,448		13,615		(4,537	)		9,078

Cumulative through June 27, 2004		6,026		91,202		97,228		(29,769	)		67,459

2005		864		2,724		3,588		(1,086	)		2,502
2006		22,768		1,225		23,993		(5,211	)		18,782

Total	$	29,658	$	95,151	$	124,809	$	(36,066	)	$	88,743

As a result of these adjustments, the Company’s audited consolidated financial statements and related disclosures as of June 25, 2006 and for each of the two years in the period ended June 25, 2006 have been restated. The Company also recorded adjustments affecting previously-reported financial statements for fiscal years 1996 through 2004, the effects of which are summarized in cumulative adjustments to additional paid-in capital, deferred stock-based compensation, and retained earnings as of June 27, 2004.

Late SEC Filings and NASDAQ Delisting Proceedings

On August 27, 2007, the Company received a NASDAQ Staff Determination letter stating that, as a result of the delayed filing of its 2007 Form 10-K, the Company was not in compliance with the filing requirements for continued listing as set forth in Marketplace Rule 4310(c)(14) and was therefore subject to delisting from the NASDAQ Global Select Market. On November 7, 2007, the Company received an additional letter from NASDAQ of similar substance related to its First Quarter 2008 Form 10-Q. On January 14, 2008, the NASDAQ Listing Qualifications Panel granted the Company’s request for continued listing, provided that it filed a written summary of the Independent Committee’s findings with NASDAQ, as well as the 2007 Form 10-K and First Quarter 2008 Form 10-Q on or before February 13, 2007. On February 5, 2008, the Company received an additional letter from NASDAQ stating that, as a result of the delayed filing of its Second Quarter 2008 Form 10-Q, the Company was not in compliance with the filing requirements for continued listing as set forth in Marketplace Rule 4310(c)(14) and was therefore subject to delisting from the NASDAQ Global Select Market. On February 8, 2008, the Company received a notice from the NASDAQ Listing and Hearings Review Council that advised the Company that any delisting determination by the NASDAQ Listing Qualifications Panel had been stayed pending further review by the Review Council. The Company was given until March 28, 2008 to submit additional information to assist the Review Council in its assessment of the Company’s listing status. On February 12, 2008, the Company filed a written summary of the Independent Committee’s findings with NASDAQ. The Company believes that the filing of this 2007 Form 10-K, together with the expected filing of the First Quarter 2008 Form 10-Q and the Second Quarter 2008 Form 10-Q, with the SEC will remediate the Company’s non-compliance with Marketplace Rule 4310(c)(14), subject to NASDAQ’s affirmative completion of its compliance protocols and its notification to the Company accordingly. However, if NASDAQ disagrees with the Company’s position or if the SEC disagrees with the manner in which the financial effect of past stock option grants have been accounted for and reported, or not reported, there could be further delays in filing subsequent SEC reports or other actions that might result in delisting of the Company’s Common Stock from the NASDAQ Global Select Market.

Costs of Restatement and Legal Activities

During the first two quarters of fiscal year 2008, the Company incurred expenses totaling approximately $9.5 million for legal, accounting, tax and other professional services in connection with the Independent Committee’s review, the Company’s own internal review and recertification procedures, the preparation of the June 24, 2007 consolidated financial statements and the restated consolidated financial statements. There were no such expenses incurred as a result of the stock option review during fiscal year 2007.

Shareholder Litigation Relating to Historical Stock Option Practices

We, and our current and former directors and officers, may become the subject of government inquiries, shareholder derivative and class action lawsuits and other legal proceedings relating to our historical stock option practices and resulting restatements in the future. We have received a letter from a stockholder demanding that our Board of Directors take certain actions, including potentially legal action, in connection with our historical stock option practices, and threatening to sue if our Board of Directors does not comply with the stockholder’s demands. Our Board of Directors is currently reviewing the letter. We may also be subject to other kinds of lawsuits. Should any of these events occur, they could require us to expend significant management time and incur significant accounting, legal and other expenses. This could divert attention and resources from the operation of our business and adversely affects our financial condition and results of operations. In addition, the ultimate outcome of these potential actions could have a material adverse effect on our business, financial condition, results of operations, cash flows and the trading price for our securities. Litigation may be time-consuming, expensive and disruptive to normal business operations, and the outcome of litigation is difficult to predict. The defense of these potential lawsuits could result in significant expenditures.

Executive Summary

~~Lam Research Corporation (Lam or~~We design, manufacture, market, and service semiconductor processing equipment used in the ~~Company) is~~fabrication of integrated circuits and are recognized as a major provider of ~~wafer fabrication~~such equipment ~~and services~~ to the ~~world’s~~worldwide semiconductor industry. Semiconductor wafers are subjected to a complex series of process steps that result in the simultaneous creation of many individual integrated circuits. We ~~actively market and sell product offerings~~leverage our expertise in these areas to develop integrated processing solutions that ~~include single-wafer plasma etch systems with a wide range of applications, and an array of services designed to optimize the utilization of these systems by~~typically benefit our ~~customers.~~customers through reduced cost, lower defect rates, enhanced yields, or faster processing time.

The following summarizes certain key quarterly and annual financial information for the periods indicated below (in thousands, except per share data and percentages) and demonstrates the strength of our ~~strong~~ performance ~~and the quarter-over-quarter growth in all areas~~ throughout fiscal year ~~2006:~~2007:


	Three Months Ended												Year Ended			Three Months Ended												Year Ended
	June 25,			March 26,			December 25,			September 25,			June 25,			June 24,			March 25,			December 24,			September 24,			June 24,
	2006			2006			2005			2005			2006			2007			2007			2006			2006			2007
Revenue	$	525,596		$	437,423		$	358,245		$	320,907		$	1,642,171		$	678,519		$	650,270		$	633,400		$	604,387		$	2,566,576
Gross margin		274,151			219,654			177,510			156,079			827,394			342,729			326,245			322,916			313,164			1,305,054
Gross margin as a percent of total revenue		52.2	%		50.2	%		49.5	%		48.6	%		50.4	%		50.5	%		50.2	%		51.0	%		51.8	%		50.8	%
Net income		122,149			86,337			77,778			49,491			335,755			170,231			164,741			167,326			183,518			685,816
Diluted net earnings per share	$	0.84		$	0.60		$	0.55		$	0.35		$	2.34
Diluted net income per share																$	1.28		$	1.15		$	1.15		$	1.27		$	4.85

our customers, ~~expanding~~targeted to expand our leadership position in ~~Etch, leveraging~~etch, leverage our ~~Etch~~etch expertise into adjacent markets and meet our objective of delivering best-in-class financial ~~performance.~~performance over the long term.

~~Customer demand increased throughout fiscal year 2006.~~ Fiscal year ~~2006 new orders entered into backlog~~2007 shipments were approximately $2.6 billion. Fiscal year 2007 revenues increased ~~31%~~56% compared to fiscal year ~~2005 with growth occurring in all regions as a function of the increase in customer demand.~~

~~Fiscal year~~ 2006 ~~revenues, derived from our shipment levels and installation and acceptance timelines, increased 9% compared to fiscal year 2005~~ revenues reflecting the increase in customer demand which we believe included market share gains in both the dielectric and conductor product segments of the etch market, with ~~the strongest geographic~~positive revenue momentum in ~~Japan and Korea.~~all regions.

Gross margin as a percent of revenues remained greater than 50% for the ~~second~~third consecutive ~~year. Fiscal~~year and increased sequentially to 50.8% compared to fiscal year 2006 ~~quarterly~~ gross margin asof 50.4%.

Our fiscal 2007 performance is demonstrated by the significant increase in operating margin to 30.3% compared with 24.6% in fiscal year 2006, a ~~percent~~sequential increase of ~~revenues showed steady~~92% compared to the 56% growth ~~on increasing volume.~~

in revenue. Total operating expenses increased ~~13%~~25% during fiscal year ~~2006~~2007 compared to fiscal year ~~2005, primarily~~2006, driven by ~~increases in~~ discretionary ~~R&D spending~~investments related to our multi-product and adjacent market expansion plans. These investments included increased compensation costs as we expanded our headcount to support our growth plans during fiscal year 2007 by more than 20% to approximately 2,900 employees. Incentive-based compensation levels grew consistent with our strong performance in profitability and share price. We also invested in discretionary spending on supplies and materials to support our new product development and market expansion plans, equity-based compensation expense, salary costs as a result of increased headcount, planned increases in employee base compensation, and employee incentive-based costs. Fiscal year 2005 operating expenses included $14.2 million in restructuring charges related to prior restructuring plans.customer evaluation activities.

Equity-based compensation expense recognized during fiscal year ~~2006~~2007 in cost of goods sold and operating expenses was ~~$5.0~~$6.4 million and ~~$17.8~~$29.1 million, ~~respectively.~~respectively compared to $5.4 million and $18.6 million, respectively, in the prior year. The fiscal year 2007 increase reflects the addition of our 2007 restricted stock unit focal grant which was awarded at a higher stock price than the prior year focal grant.

Worthy of note is the growth in cash flows from operating activities during fiscal year 2007 which more than doubled from fiscal year 2006 performance to $823.6 million representing approximately 32% of revenues, an increase of 124.2% sequentially.

Results of Operations

~~New Orders~~Shipments and Backlog

~~New orders entered into backlog during~~


	Three Months Ended								Year Ended
	June 24,		March 25,		December 24,		September 24,		June 24,
	2007		2007		2006		2006		2007
Shipments (in millions)	$	694	$	620	$	645	$	640	$	2,599

During fiscal year ~~2006 are presented in~~2007, 300 mm applications represented approximately 88% of total etch systems shipments, and 94% of etch systems shipments were for applications at less than or equal to the ~~table below.~~90 nm technology node. We classify total etch systems shipments market segmentation for fiscal year 2007 as Memory at approximately 73%, Foundry at 15%, and IDM Logic/Other at 12%.

Unshipped orders in backlog as of June ~~25, 2006~~24, 2007 were approximately ~~$521~~$642.6 million. The basis for recording new orders is defined in our backlog policy. Our unshipped orders backlog includes orders for systems, spares, and services where written customer requests have been accepted and the delivery of products or provision of services is anticipated within the next 12 months. Our policy is to revise our backlog for order cancellations and to make adjustments to reflect, among other things, spares volume estimates and customer delivery date changes. Please refer to “Backlog” in Part I Item 1, “Business” of this ~~Annual Report on~~2007 Form 10-K for additional information on our backlog policy.

2143

~~Regional geographic breakdown of new orders is as follows:~~

Three Months Ended Year Ended
June 25, March 26, December 25, September 25, June 25,
2006 2006 2005 2005 2006
New Orders (in millions) $ 640 $ 520 $ 403 $ 326 $ 1,889

North America 12 % 15 % 13 % 17 % 14 %
Europe 16 % 15 % 12 % 15 % 15 %
Asia Pacific 44 % 28 % 29 % 33 % 34 %
Korea 11 % 29 % 23 % 13 % 19 %
Japan 17 % 13 % 23 % 22 % 18 %

Three Months Ended Year Ended
June 26, March 27, December 26, September 26, June 26,
2005 2005 2004 2004 2005
New Orders (in millions) $ 315 $ 315 $ 387 $ 429 $ 1,446

North America 9 % 16 % 14 % 20 % 15 %
Europe 12 % 19 % 9 % 19 % 15 %
Asia Pacific 35 % 29 % 25 % 26 % 28 %
Korea 16 % 14 % 40 % 15 % 22 %
Japan 28 % 22 % 12 % 20 % 20 %

Fiscal year 2005 started with a declining trend in new orders which stabilized in the March 2005 and June 2005 quarters. The four quarters ending June 25, 2006 showed sequentially increasing demand in new orders driven by increased capital investments by our customers and our market share gains. During fiscal year 2006, 300 millimeter applications represented approximately 81% of total systems new orders and 83% of total systems new orders were for applications at less than or equal to the 90 nanometer technology node. We classify total systems new orders market segmentation for fiscal year 2006 as Memory at approximately 54%, IDM Logic/Other at 27% and Foundry at 19% of the total.

We expect new orders for the quarter ending September 24, 2006 to increase 5% to 10% compared with the quarter ended June 25, 2006. This expectation is a forward-looking statement and actual results could differ materially as a result of certain factors as referred to in Part I of this Annual Report on Form 10-K.

Revenue

Year Ended
June 25, June 26, June 27,
2006 2005 2004
(in thousands)
Revenue $ 1,642,171 $ 1,502,453 $ 935,946


	Year Ended
	June 24,			June 25,			June 26,
	2007			2006			2005
Revenue (in thousands)	$	2,566,576		$	1,642,171		$	1,502,453

North America		16	%		14	%		16	%
Europe		9	%		13	%		12	%
Asia Pacific		18	%		12	%		19	%
Taiwan		22	%		17	%		19	%
Korea		21	%		22	%		19	%
Japan		14	%		22	%		15	%

The increase in revenues during fiscal ~~year~~years 2007 and 2006 ~~and fiscal year 2005~~ reflected ~~the~~an improved market environment which was evidenced by expanded levels of capital investments by semiconductor ~~manufacturers.~~manufacturers and our market share expansion. We believe we ~~have~~ gained market share in both the dielectric and conductor product segments of the etch market over this period, with ~~particularly~~ strong ~~geographic~~revenue performance in Taiwan, China, North America, and Korea during fiscal year 2007 and in Japan and Korea during fiscal year ~~2006~~2006. The increase in revenues was correlated to the amount of shipments and ~~the overall Asia region during fiscal year 2005.~~our installation and acceptance timelines. The overall Asia region ~~continues~~continued to account for a significant portion of our revenues as a substantial amount of the worldwide capacity additions for semiconductor manufacturing continues to occur in ~~this~~that region. Our deferred revenue balance increased to $295.5 million as of June 24, 2007 compared to $229.7 million as of June 25, 2006, ~~compared to $150.5 million at June 26, 2005, consistent with overall business volumes.~~as shipments outpaced revenues during fiscal year 2007. The anticipated future revenue value of orders shipped from backlog to Japanese customers that are not recorded as deferred revenue was approximately ~~$74~~$51 million as of June ~~25, 2006:~~24, 2007; these shipments are classified as inventory at cost until title transfers.

The increase in interest income during fiscal year 2007 compared with the prior year is primarily due to increases in our average balances of cash and cash equivalents, short-term investments, and restricted cash and investments throughout fiscal year 2007 and to a lesser extent, increases in interest rate yields. Although the average total cash and cash equivalents and short-term investments balances increased throughout the year, the balances at the end of fiscal year 2007 decreased by approximately $490 million compared to the prior year, primarily due to share repurchase activity of approximately $1.1 billion throughout fiscal year 2007, of which approximately $768 million occurred during the June 2007 quarter.

The increase in interest expense during fiscal year 2007 was due to the $350 million of long-term debt entered into by our wholly-owned subsidiary on June 16, 2006 to facilitate the repatriation of foreign earnings under the American Jobs Creation Act of 2004 (AJCA). The balance of our long-term debt was $250 million as of June 24, 2007.

In June 2007 we recognized a gain of $3.0 million related to the sale of a private equity investment.

The favorable legal judgment of $15.8 million during fiscal year 2007 was obtained in a lawsuit filed by the Company alleging breach of purchase order contracts by one of its customers. The Supreme Court of California denied review of lower and appellate court judgments in favor of Lam Research during the quarter ended September 24, 2006.

The sequential increase in interest income during fiscal year 2006 compared to fiscal year 2005 was due to the combined effect of increased cash and cash equivalents, short-term ~~investments,~~securities, and restricted cash and investments balances as well as increases in interest rate yields.

~~During fiscal year 2006, average interest rate yields on the Company’s portfolio increased approximately 170 basis points compared to fiscal year 2005.~~ The Company’s total balances of cash, ~~and~~ cash equivalents, short-term ~~investments,~~securities, and restricted cash and investments, increased approximately $626 million from fiscal year 2005. This increase included the Company’s wholly-owned subsidiary’s drawdown against a $350 million Credit Agreement to support the Company’s foreign earnings repatriation of $500 million under the ~~American Jobs Creation Act of 2004 (AJCA).~~AJCA. The remaining increase of $276 million was primarily driven by ~~$361~~$367 million from cash flows from operating activities.

The sequential increase in interest income during fiscal year 2005 compared to fiscal year 2004 was due primarily to the increase in interest rate yields. Interest expense and debt issue cost amortization decreased due to the early retirement of our convertible subordinated $300.0 million 4% notes (4% Notes) in June 2004.

Income Tax Expense

Our annual income tax expense was ~~$105.5~~$161.9 million, ~~$99.8~~$104.6 million and ~~$27.7~~$99.0 million, in fiscal years 2007, 2006, ~~2005,~~ and ~~2004,~~2005, respectively. Our effective tax rate for fiscal ~~year~~years 2007, 2006, and 2005 was ~~23.9%. The effective tax rate for fiscal year 2006, excluding the discrete event discussed below, was 18.4%.~~19.1%, 23.8% and 25.0%, respectively. The decrease in our effective tax rate in fiscal year ~~2006~~2007 was due to the change in the geographical mix of income in jurisdictions with a lower tax rate as well as certain discrete events resulting in a net tax benefit of $21.5 million, or 2.5% benefit on the effective tax rate. These discrete events included favorable adjustments for previously estimated tax liabilities upon the filing of the Company’s U.S. and certain foreign income tax returns, the reversal of tax reserves with respect to certain transfer pricing items now settled and an increased benefit related to the extension of the federal research credit as it pertains to the Company’s fiscal year 2006. These favorable adjustments were partially offset by an increase in tax expense related to the application of foreign tax rulings.

The fiscal year 2006 effective tax rate was 23.8%, compared to the fiscal year 2005 effective tax rate of 25.0%, and reflects the increase in income in jurisdictions with a lower tax rate, the realization of state R&D tax credits not previously benefited, favorable tax rulings on prior year tax returns filed and the reversal of tax reserves with respect to the agreement of a ~~bi-lateral~~bilateral advanced pricing arrangement. These favorable adjustments for the year were partially offset by a discrete event for the repatriation during fiscal year 2006 of a $500 million extraordinary dividend under the American Jobs Creation Act of 2004, combined with the impact of the accounting for equity-based awards in accordance with SFAS No. 123R and the deductibility of those awards in some jurisdictions, and the expiration of the research tax credit on December 31, 2005.

The fiscal year 2005 tax rate was 25.0%, which primarily reflects the impact of R&D tax credits and foreign income taxed at lower than U.S. statutory tax rates. In fiscal year 2004, we released a valuation allowance on specific deferred tax assets after we determined that the valuation allowance was no longer required. This resulted in a $12.7 million credit recorded to income tax expense, during fiscal year 2004.

Deferred Income Taxes

~~We had~~Deferred income taxes reflect the net effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Our gross deferred tax assets, ~~related~~ primarily tocomprised of reserves and accruals that are not currently deductible and tax credit carryforwards, ~~of $119.2~~were $123.3 million and ~~$142.1~~$133.3 million inat the end of fiscal years 2007 and 2006, ~~and 2005,~~ respectively. ~~The~~These gross deferred tax assets were offset by deferred tax liabilities of ~~$27.0~~$34.2 million and ~~$22.2~~$27.1 million at the end of fiscal years 2007 and 2006, respectively.

Deferred tax assets decreased in fiscal ~~years 2006~~year 2007 primarily due to the utilization of tax credits, adjustments for previously estimated tax liabilities upon the filing of income tax returns in various jurisdictions, the impact of certain elections related to foreign tax rulings, the conclusion of negotiations on certain transfer pricing items, and ~~2005, respectively. Pursuant to Statement of Financial Accounting Standards No. 123 (revised 2004), “Share-Based Payment” (SFAS No. 123R),~~ the ~~additional~~incremental tax benefit associated with the accumulated stock award attributes is not recognized until the deduction reduces cash taxes payable. As such, we have elected to net our net operating loss and tax credit carryforward deferred tax assets and related valuation allowance for the accumulated stock award tax benefits determined under Accounting Principles Board (APB) Opinion No. 25 “Accounting for Stock Issued to Employees” (APB No. 25). We will track these stock award attributes separately and will only realize these attributes in accordance with Footnote 82 of SFAS 123(R). These additional tax benefits of net operating loss and tax credit carryforwards related to ~~the tax benefit from the exercise of employee stock awards were $125.2 million and $106.0 million in fiscal years 2006 and 2005, respectively.~~stock-based compensation deductions.

We record a valuation allowance to reduce our deferred tax assets to the amount that is more likely than not to be realized. Realization of our net deferred tax assets is dependent on future taxable income. We believe it is more likely than not that such assets will be realized; however, ultimate realization could be negatively impacted by market conditions and other variables not known or anticipated at this time. In the event that we determine that we would not be able to realize all or part of our net deferred tax assets, an adjustment would be charged to earnings in the period such determination is made. Likewise, if we later determine that it is more likely than not that the deferred tax assets would be realized, then the previously provided valuation allowance would be reversed. We evaluate the realizability of the deferred tax assets quarterly and will continue to assess the need for additional valuation allowances, if any. ~~During fiscal year 2004, we released a valuation allowance of $12.7 million on specific deferred tax assets after we determined that the valuation allowance was no longer required.~~

~~Subsequent Events~~

On July 12, 2006, the Supreme Court of California denied review of lower and appellate court judgments in favor of Lam with respect to a lawsuit filed by us alleging breach of purchase order contracts by one of our customers. As a result of the denied review, the prior rulings from the trial and appellate courts stand resulting in a judgment in favor of Lam of approximately $15.8 million, which includes approximately $2.0 million in post-judgment interest. We plan to record this amount in other income (expense), net during the quarter ending September 24, 2006.

2546

Critical Accounting Policies and Estimates

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make certain judgments, estimates and assumptions that could affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. We based our estimates and assumptions on historical experience and on various other assumptions believed to be applicable and ~~evaluated~~evaluate them on an ~~on-going~~ongoing basis to ensure they ~~remained~~remain reasonable under current conditions. Actual results could differ significantly from those estimates.

The significant accounting policies used in the preparation of our financial statements are described in Note 2 of our Consolidated Financial Statements. Some of these significant accounting policies are considered to be critical accounting policies. A critical accounting policy is defined as one that has both a material impact on our financial condition and results of operations and requires us to make difficult, complex and/or subjective judgments, often as a result of the need to make estimates about matters that are inherently uncertain.

We believe that the following critical accounting policies reflect the more significant judgments and estimates used in the preparation of our consolidated financial statements.

Revenue Recognition:We recognize all revenue when persuasive evidence of an arrangement exists, delivery has occurred and title has passed or services have been rendered, the selling price is fixed or determinable, collection of the receivable is reasonably assured, and we have completed our system installation obligations, received customer acceptance or are otherwise released from our installation or customer acceptance obligations. In the event that terms of the sale provide for a lapsing customer acceptance period, we recognize revenue upon the expiration of the lapsing acceptance period or customer acceptance, whichever occurs first. In circumstances where the practices of a customer do not provide for a written acceptance or the terms of sale do not include a lapsing acceptance provision, we recognize revenue where it can be reliably demonstrated that the delivered system meets all of the ~~agreed to~~agreed-to customer specifications. In situations with multiple deliverables, revenue is recognized upon the delivery of the separate elements to the customer and when we receive customer acceptance or are otherwise released from our customer acceptance obligations. Revenue from ~~multiple element~~multiple-element arrangements is allocated among the separate elements based on their relative fair values, provided the elements have value on a ~~stand alone~~stand-alone basis, there is objective and reliable evidence of fair value, the arrangement does not include a general right of return relative to the delivered item and delivery or performance of the undelivered item(s) is considered probable and substantially in our control. The maximum revenue recognized on a delivered element is limited to the amount that is not contingent upon the delivery of additional items. Revenue related to sales of spare parts and system upgrade kits is generally recognized upon shipment. Revenue related to services is generally recognized upon completion of the services requested by a customer order. Revenue for extended maintenance service contracts with a fixed payment amount is recognized on a straight-line basis over the term of the contract.

Inventory Valuation: Inventories are stated at the lower of cost or market using standard costs which approximate actual costs on a first-in, first-out basis. We maintain a perpetual inventory system and continuously record the quantity on-hand and standard cost for each product, including purchased components, subassemblies, and finished goods. We maintain the integrity of perpetual inventory records through periodic physical counts of quantities on hand. Finished goods are reported as inventories until the point of title transfer to the customer. Generally, title transfer is documented in the terms of sale. When the terms of sale do not specify, we assume title transfers when we complete physical transfer of the products to the freight carrier unless other customer practices prevail. Transfer of title for shipments to Japanese customers generally occurs at time of customer acceptance.

Standard costs are ~~re-assessed~~reassessed at least annually and reflect achievable acquisition costs, generally the most recent vendor contract prices for purchased parts, currently obtainable assembly and test labor utilization levels, methods of manufacturing, and overhead for internally manufactured products. Manufacturing labor and overhead costs are attributed to individual product standard costs at a level planned to absorb spending at average utilization volumes. All intercompany profits related to the sales and purchases of inventory between our legal entities are eliminated from our consolidated financial statements.

Management evaluates the need to record adjustments for impairment of inventory at least quarterly. Our policy is to assess the valuation of all inventories including manufacturing raw materials, work-in-process, finished goods, and spare parts in each reporting period. ~~Obsolete~~Generally, obsolete inventory or inventory in excess of management’s estimated usage requirements over the next 12 to 36 months is written down to its estimated market value if less than cost. Inherent in the estimates of market value are management’s forecasts related to our future manufacturing schedules, customer demand, technological and/or market obsolescence, general semiconductor market conditions, possible alternative uses, and ultimate realization of excess inventory. If future customer demand or market

In addition to the provision of standard warranties, we offer customer-paid extended warranty services. Revenues for extended maintenance and warranty services with a fixed payment amount are recognized on a straight-line basis over the term of the contract. Related costs are recorded either as incurred or when related liabilities are determined to be probable and estimable.

Equity-based Compensation — Employee Stock Purchase Plan and Employee Stock Plans: ~~Beginning on June 27, 2005 we~~We account for our employee stock purchase plan (ESPP) and stock plans under the provisions of SFAS No. 123R. SFAS No. 123R requires the recognition of the fair value of equity-based compensation in net income. The fair value of our restricted stock units was calculated based upon the fair market value of Company stock at the date of grant. The fair value of our stock options and ESPP awards was estimated using a Black-Scholes option valuation model. This model requires the input of highly subjective assumptions and elections in adopting and implementing SFAS No. 123R, including expected stock price volatility and the estimated life of each award. The fair value of equity-based awards is amortized over the vesting period of the award and we have elected to use the straight-line method for awards granted after the adoption of SFAS No. 123R and continue to use a graded vesting method for awards granted prior to the adoption of SFAS No. 123R.

We make quarterly assessments of the adequacy of our tax credit pool to determine if there are any deficiencies ~~which~~that require recognition in our consolidated statements of operations. Prior to the adoption of SFAS No. 123R, we accounted for our ESPP and stock option plans under the provisions of Accounting Principles Board (APB) Opinion No. 25 “Accounting For Stock Issued to Employees” (APB No. 25) and Financial Accounting Standards Board (FASB) Interpretation No. 44, “Accounting for Certain Transactions Involving Stock Compensation — an Interpretation of APB Opinion No. 25” and made pro forma footnote disclosures as required by Statement of Financial Accounting Standards (SFAS) No. 148, “Accounting For Stock-Based Compensation — Transition and Disclosure”, which amends SFAS No. 123, “Accounting For Stock-Based Compensation”. Pro forma net income and pro forma net income per share disclosed in the footnotes to our consolidated financial statements were estimated using a Black-Scholes option valuation model. As a result of the adoption of SFAS No. 123R, we will only recognize a benefit from stock-based compensation in paid-in-capital if an incremental tax benefit is realized after all other tax attributes currently available to us have been utilized. In addition, we have elected to account for the indirect benefits of stock-based compensation on the research tax credit and the extraterritorial income deduction through the income statement (continuing operations) rather than through paid-in-capital. We have also elected to net deferred tax assets and the associated valuation allowance related to net operating loss and tax credit carryforwards for the accumulated stock award tax benefits determined under APB No. 25 for income tax footnote disclosure purposes. We will track these stock award attributes separately and will only recognize these attributes through paid-in-capital in accordance with Footnote 82 of ~~SFAS123(R).~~SFAS No. 123R.

In connection with our restatement of the consolidated financial statements, we have applied judgment in choosing whether to revise measurement dates and if revised which measurement date to select for prior option grants. Information regarding the restatement is set forth above in “Restatement of Previously Issued Financial Statements” and in Note 3, “Restatement of Consolidated Financial Statements” in Notes to Consolidated Financial Statements of this Form 10-K.

Income Taxes:Deferred income taxes reflect the net effect of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. We record a valuation allowance to reduce our deferred tax assets to the amount that is more likely than not to be realized. Realization of our net deferred tax assets is dependent on future taxable income. We believe it is more likely than not that such assets will be realized; however, ultimate realization could be negatively impacted by market conditions and other variables not known or anticipated at this time. In the event that we determine that we would not be able to realize all or part of our net deferred tax assets, an adjustment would be charged to earnings in the period such determination is made. Likewise, if we later determine that it is more likely than not that the deferred tax assets would be realized, then the previously provided valuation allowance would be reversed.

We calculate our current and deferred tax provision based on estimates and assumptions that could differ from the actual results reflected in income tax returns filed during the subsequent year. Adjustments based on filed returns are recorded when identified.

We provide for income taxes on an interim basis on the basis of annual estimated effective income tax rates. Our estimated effective income tax rate reflects the underlying profitability of the Company, the level of R&D spending, the regions where profits are recorded and the respective tax rates imposed. We carefully monitor these factors and adjust the effective income tax rate, if necessary. If actual results differ from estimates, we could be required to record an additional valuation allowance on deferred tax assets or adjust our effective income tax rate, which could have a material impact on our business, results of operations, and financial condition.

The calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax laws. Our estimate for the potential outcome of any uncertain tax issue is highly judgmental. Resolution of these uncertainties in a manner inconsistent with the Company’s expectations could have a material impact on the Company’s results of operation and financial condition. The Company accounts for the income tax contingencies in accordance with SFAS No. 5, “Accounting for ~~Contingencies.”~~Contingencies”.

Goodwill and Intangible Assets:We account for goodwill and other intangible assets in accordance with Statement of Financial Accounting Standards No. 142, “Goodwill and Other Intangible Assets”, (SFAS No. 142). SFAS No. 142 requires that goodwill and identifiable intangible assets with indefinite useful lives no longer be amortized, but instead be tested for impairment at least annually. SFAS No. 142 also requires that intangible assets with estimable useful lives be amortized over their respective estimated useful lives to their estimated residual values and reviewed for impairment in accordance with SFAS No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets”. We review goodwill for impairment at least annually. In addition, we review goodwill and other intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable.

Recent Accounting Pronouncements

In July 2006, the ~~Financial Accounting Standards Board (FASB)~~FASB issued FASB Interpretation Number 48, “Accounting for Income Tax Uncertainties” (FIN 48). FIN 48 ~~defines~~clarifies the accounting for income taxes, by prescribing a minimum recognition threshold ~~for recognizing the benefits of~~a tax ~~return positions~~position is required to meet before being recognized in the financial ~~statements as “more-likely-than-not” to be sustained by the taxing authority. The recently issued literature~~statements. FIN 48 also provides guidance on ~~the derecognition,~~derecognizing, measurement, ~~and~~ classification, ~~of income tax uncertainties, along with any related~~ interest and ~~penalties. FIN 48 also includes guidance concerning~~penalties, accounting ~~for income tax uncertainties~~ in interim periods, disclosure, and ~~increases the level of disclosures associated with any recorded income tax uncertainties.~~

transition. FIN 48 is effective for fiscal years beginning after December 15, 2006. ~~Any differences between the amounts recognized in the statements~~We will adopt FIN 48 as of ~~financial position prior to~~June 25, 2007. As a result of the adoption of FIN 48, we expect to decrease the recorded liability for unrecognized tax benefits by approximately $26.2 million as well as reclass approximately $64.4 million from current to non-current income taxes payable. We expect the cumulative effect of adopting FIN 48 to be a $17.6 million increase to our opening retained earnings in the first quarter of fiscal year 2008.

In September 2006, the Staff of the SEC issued Staff Accounting Bulletin No. 108, “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements” (SAB 108). SAB 108 provides guidance on the consideration of the effects of prior year misstatements in quantifying current year misstatements for the purpose of determining whether the current year’s financial statements are materially misstated. We applied the provisions of SAB 108 beginning in the first quarter of fiscal year 2007.

In September 2006, the Financial Accounting Standards Board (FASB) issued Statement of Financial Accounting Standards No. 157, “Fair Value Measurements”, (SFAS No. 157), which defines fair value, establishes guidelines for measuring fair value and expands disclosures regarding fair value measurements. SFAS No. 157 does not require any new fair value measurements but rather eliminates inconsistencies in guidance found in various prior accounting pronouncements. SFAS No. 157 is effective for fiscal years beginning after November 15, 2007. Earlier adoption is permitted, provided the ~~amounts reported after adoption will be accounted~~company has not yet issued financial statements, including interim periods, for ~~as a cumulative-effect adjustment recorded to the beginning balance of retained earnings.~~that fiscal year. We are currently ~~in the process of determining~~evaluating the impact, if any, of adopting the provisions of ~~FIN 48~~SFAS No. 157 on our financial position, results of operations and liquidity.

In February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities — Including an amendment of FASB Statement No. 115” (SFAS No. 159). This statement permits entities to choose to measure many financial instruments and certain other items at fair value that are not currently required to be measured at fair value and establishes presentation and disclosure requirements designed to facilitate comparisons between entities that choose different measurement attributes for similar types of assets and liabilities. SFAS No. 159 is effective as of the beginning of an entity’s first fiscal year that begins after November 15, 2007, provided the entity also elects to apply the provisions of SFAS No. 157. We expect to adopt SFAS No. 159 beginning June 30, 2008 and are currently evaluating the impact that this pronouncement may have on our consolidated financial statements.

In December 2007, the FASB issued SFAS No. 141 (revised 2007), “Business Combinations” (SFAS No. 141R). SFAS 141R establishes principles and requirements for how an acquirer recognizes and measures in its financial statements the identifiable assets acquired, the liabilities assumed, any noncontrolling interest in the acquiree and the goodwill acquired. SFAS No. 141R also establishes disclosure requirements to enable the evaluation of the nature and financial effects of the business combination. SFAS No. 141R is effective as of the beginning of an entity’s fiscal year that begins after December 15, 2008. We expect to adopt SFAS No. 141R beginning in fiscal year 2010 and are currently evaluating the potential impact, if any, of the adoption of SFAS No. 141R on our consolidated financial statements.

Significant changes in assets and liabilities included increases in ~~accounts receivable and inventory~~deferred profit of ~~$175.3~~$51.1 million ~~and $58.7 million, respectively,~~ due to ~~the~~ increased volume of ~~business.~~shipments, $44.8 million in accrued expenses primarily due to increased incentive-based compensation on higher profit levels, and an increase in accounts payable of $9.1 million. These ~~changes~~amounts were partially offset by an increase in ~~deferred profit~~inventories of ~~$50.4~~$56.3 million ~~due to~~on increased business volume, ~~of shipments,~~ an increase in ~~accounts payable~~prepaid expenses and other assets of ~~$48.3~~$19.2 million ~~and increases in accrued liabilities of $88.4 million primarily~~on a pre-tax basis due to ~~VAT~~certain supply arrangement and ~~income~~ taxes ~~payable related to higher profit levels, and an increase in accrued compensation based on incentive-based compensation.~~receivable.

Cash Flows from Investing Activities

Net cash used for investing activities during fiscal year ~~2006~~2007 was ~~$244.3~~$82.8 million and ~~consisted~~included the acquisition of ~~a transfer to~~Bullen assets of $177.1 million and capital expenditures of $60.0 million partially offset by the reclassification of $110.0 million from restricted cash and investments ~~of $385.0 million~~ due to ~~our guarantee agreement related to~~ the ~~obligations~~repayment of $100.0 million of our ~~wholly-owned subsidiary under the $350.0~~long-term debt and $45.2 million ~~credit agreement entered into during the quarter ended June 25, 2006. Our obligations under the Guarantee Agreement are collateralized by readily marketable securities~~ in ~~an amount equal to 110% of the outstanding balance of our obligations under the Guarantee Agreement.~~

In addition, we purchased $42.1 million for capital expenditures, consisting primarily of engineering equipment, and the purchase of intangible assets of intellectual property. Partially offsetting these uses of cash were proceeds from the net sales of short-term ~~investments of $182.8 million.~~investments.

Cash Flows from Financing Activities

Net cash ~~provided by~~used for financing activities during fiscal year ~~2006~~2007 was ~~$310.7 million consisting~~$1.1 billion in total reflecting $1.1 billion of ~~$350.0 million from the issuance of~~stock repurchases thereby completing all available share repurchase authorizations. We also made payments on our long-term debt ~~$194.6~~and capital leases of $100.2 million. Partially offsetting these uses of cash were $60.6 million from the issuance of our ~~common stock~~Common Stock related to employee equity-based plans, and ~~$17.8~~$45.0 million of excess tax ~~benefits~~benefit on equity-based compensation plans ~~partially offset by stock repurchases~~which represents the benefits of ~~$251.2 million.~~

During fiscal year 2006, we repurchased approximately 7.0 million shares of common stock at a total price of $251.2 million under Board authorized repurchase programs which run through September 30, 2008. As of June 25, 2006 the total amount remaining available for repurchase under Board authorizations was $331.7 million. We expect to continue to repurchase shares consistent with the Board authorizations, the level of which will be determined by, including but not limited to, the needstax deductions in excess of the ~~business and the stock price and daily trading volumes of our stock.~~compensation cost recognized.

Given the cyclical nature of the semiconductor equipment industry, we believe that maintaining sufficient liquidity reserves is important to support sustaining levels of investment in R&D and capital infrastructure. Based upon our current business outlook, our levels of cash, cash equivalents, and short-term investments at June ~~25, 2006~~24, 2007 are expected to be sufficient to support our presently anticipated levels of operations, investments, debt service requirements, and capital expenditures through at least the next 12 months.

In the longer term, liquidity will depend to a great extent on our future revenues and our ability to appropriately manage our costs based on demand for our products. Should additional funding be required, we may need to raise the required funds through borrowings or public or private sales of debt or equity securities. We believe that, in the event of such requirements, we will be able to access the capital markets on terms and in amounts adequate to meet our objectives. However, given the possibility of changes in market conditions or other occurrences, there can be no certainty that such funding will be available in needed quantities or on terms favorable to us.

Long-Term Debt and Interest Expense

On June 16, 2006, our wholly-owned subsidiary, Lam Research International SARL (LRI), as borrower, entered into a $350 million Credit Agreement (the LRI Credit Agreement).

Under the LRI Credit Agreement, on June 19, 2006, LRI borrowed $350 million in principal amount. The loan under the LRI Credit Agreement shall be fully repaid not later than five years following the closing date and will bear interest at LIBOR plus a spread (applicable margin) ranging from 0.10% to 0.50%, depending upon a consolidated leverage ratio, as defined in the LRI Credit Agreement. ~~The initial spread under the Credit Agreement is 0.10%.~~ LRI may prepay the loan under the LRI Credit Agreement in whole or in part at any time without penalty, subject to reimbursement of lenders’ breakage and redeployment costs in certain cases. The amounts in the table above include the remaining principal payment of ~~$350~~$250 million due on June 19, 2011 and interest payments estimated based on the current LIBOR rate in effect as of ~~5.5%~~June 24, 2007 of 5.320% and ~~initial spread~~applicable margin of ten basis points. $100.0 million of the original $350.0 million debt was repaid during fiscal year 2007. The fair value of long-term debt approximates its carrying value due to the variable interest rate applicable to the debt. Please see additional information under “Subsequent Events” below regarding termination of the LRI Credit Agreement and our entry into a new credit agreement.

We used the proceeds from the credit facility entered into by LRI to facilitate a portion of the repatriation of $500 million of foreign earnings in ~~the June~~fiscal year 2006 ~~quarter~~ under the provisions of the American Jobs Creation ~~Act of 2004 (AJCA). We have now completed our repatriation of foreign earnings under the provisions of the AJCA.~~Act.

Guarantees

We account for our guarantees in accordance with Financial Accounting Standards Board (FASB) Interpretation No. 45 “Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others” (FIN No. 45). FIN No. 45 requires a company that is a guarantor to make specific disclosures about its obligations under certain guarantees that it has issued. FIN No. 45 also requires a company (the Guarantor) to recognize, at the inception of a guarantee, a liability for the obligations it has undertaken in issuing the guarantee.

We lease several facilities at our headquarters location in Fremont, California. As part of certain of the lease agreements, we have the option to purchase the remaining buildings at any time for a total purchase price for all remaining properties related to these leases of approximately $85.0 million. We are required to guarantee the lessor a residual value on the properties of up to $75.0 million at the end of the lease terms in fiscal year 2008 (in the event that the leases are not renewed, we do not exercise the purchase options, the lessor sells the properties and the sale price is less than the lessor’s costs). We maintain cash collateral of $85.0 million as part of the lease agreements as of June ~~25, 2006~~24, 2007 in separate, specified certificates of deposit and interest-bearing accounts ~~which~~that are recorded as restricted cash and investments in our Consolidated Balance Sheet. The lessor under the lease agreements is a substantive independent leasing company that does not have the characteristics of a variable interest entity ~~(VIE)~~ as defined by FASB Interpretation No. 46, “Consolidation of Variable Interest Entities” and is therefore not consolidated by us. We obtained compliance waivers from the lessor with respect to our obligation to deliver financial statements to the lessor under the terms provided in the lease agreements. Please see additional information under “Subsequent Events” below for renewal of the leases noted above and entry into additional leases.

We have issued certain indemnifications to our lessors under some of our agreements. We have entered into certain insurance contracts ~~which~~that may limit our exposure to such indemnifications. As of June ~~25, 2006,~~24, 2007, we have not recorded any liability on our financial statements in connection with these indemnifications, as we do not believe, based on information available, that it is probable that any amounts will be paid under these guarantees.

On June 16, 2006, our wholly-owned subsidiary, LRI, as borrower, entered into the $350 million LRI Credit Agreement. In connection with the LRI Credit Agreement, ~~entered into by LRI noted above,~~ we entered into a Guarantee Agreement (the ~~Guarantee Agreement)~~“Guarantee Agreement”) guaranteeing the obligations of LRI under the LRI Credit Agreement. Our obligations under the Guarantee Agreement are collateralized by readily marketable securities in an amount equal to 110% of the outstanding balance of our obligations under the Guarantee Agreement, representing ~~$385.0~~$275.0 million at June ~~25, 2006.~~24, 2007 as we had paid down $100.0 million of the existing debt during fiscal year 2007. This collateral is reflected in the balance of restricted cash and investments in our Consolidated Balance Sheet. We obtained compliance waivers from the lender with respect to our obligation to deliver financial statements to the lender under the terms provided in the Guarantee Agreement. Please see additional information under “Subsequent Events” below regarding termination of the LRI Credit Agreement and the Guarantee Agreement, our entry into a new credit agreement, and the entry of our wholly-owned subsidiary Bullen Semiconductor Corporation into a new guarantee agreement with respect to the new credit agreement.

Generally, we indemnify, under pre-determined conditions and limitations, our customers for infringement of third-party intellectual property rights by our products or services. We seek to limit our liability for such indemnity to an amount not to exceed the sales price of the products or services subject to ~~our~~its indemnification obligations. We do not believe, based on information available, that it is probable that any material amounts will be paid under these guarantees.

We offer standard warranties on our systems that run generally for a period of 12 months from system acceptance not to exceed 14 months from the date of shipment of the system to the customer. The liability amount is based on actual historical warranty spending activity by type of system, customer, and geographic region, modified for any known differences such as the impact of system reliability improvements.

3152

Subsequent Events

SEZ Transaction: On March 11, 2008, we completed the tender offer for the outstanding shares of SEZ Holding AG (“SEZ”), the leading supplier of single-wafer clean technology and products to the global semiconductor manufacturing industry. Upon the completion of the tender, we acquired approximately 94% of the outstanding shares of SEZ. We expect to take additional steps as necessary to acquire the SEZ shares that remain outstanding.

The tender offer was conducted pursuant to the terms of a Transaction Agreement entered into on December 10, 2007 by and between the Company and SEZ (the “Transaction Agreement”). Under the terms of the Transaction Agreement, we acquired all shares of SEZ that were tendered in the offer at a price of CHF 38 per share in cash, for a total price of CHF 606 million, which approximated US$584 million.

In December 2007, we purchased a call option with a notional amount of approximately CHF 641 million to hedge the currency exposure in connection with the anticipated purchase of the shares of SEZ as noted above. The call option premium cost was $10.3 million. The mark-to-market value of the fair value of the call option as of December 23, 2007 was $3.1 million resulting in a $7.2 million unrealized loss recorded in other income (expense), net in our condensed consolidated statements of operations for the quarter ended December 23, 2007. In February 2008 we extended the expiration date of the call option at an additional premium cost of $2.4 million. We exercised the call option during March 2008 which resulted in a gain of $40.7 million which we will record in other income (expense), net in our condensed consolidated statements of operations for the quarter ending March 30, 2008.

Operating Leases: On December 18, 2007, we entered into a series of two operating leases (the “Livermore Leases”) regarding certain improved properties in Livermore, California. On December 21, 2007, we entered into a series of four amended and restated operating leases (the “New Fremont Leases,” and collectively with the Livermore Leases, the “Operating Leases”) with regard to certain improved properties at our headquarters in Fremont, California. Each of the Operating Leases is an off-balance sheet arrangement.

The Operating Leases (and associated documents for each Operating Lease) were entered into by us and BNP Paribas Leasing Corporation (“BNPPLC”).

Each Livermore Lease facility has an approximately seven-year term (inclusive of an initial construction period during which BNPPLC’s and our obligations will be governed by the Construction Agreement entered into with regard to such Livermore Lease facility) ending on the first business day in January, 2015. Total scheduled rent payments under the Livermore Leases are estimated to be approximately $25.7 million in the aggregate (based on one-month LIBOR rates at the time of entering into the leases), following completion of improvements to each property.

Each New Fremont Lease has an approximately seven-year term ending on the first business day in January, 2015. Total scheduled rent payments under the New Fremont Leases are approximately $32.4 million in the aggregate (based upon three-month LIBOR rates at the time of entering into the leases).

Under each Operating Lease, we may, at our discretion and with 30 days’ notice, elect to purchase the property that is the subject of the Operating Lease for an amount approximating the sum required to prepay the amount of BNPPLC’s investment in the property and any accrued but unpaid rent. Any such amount may also include an additional make-whole amount for early redemption of the outstanding investment, which will vary depending on prevailing interest rates at the time of prepayment.

We are required, pursuant to the terms of the Operating Leases and associated documents, to maintain collateral in an aggregate of approximately $165.0 million (upon completion of the Livermore construction) in separate interest-bearing accounts with BNPPLC (or a third party, currently State Street Bank and Trust, with regard to the Livermore Leases) as security for our obligations under the Operating Leases.

Upon expiration of the term of an Operating Lease, the property subject to that Operating Lease may be remarketed. We have guaranteed to BNPPLC that each property will have a certain minimum residual value, as set forth in the applicable Operating Lease. The aggregate guarantee made by us under the Operating Leases is no more than approximately $141.8 million (although, under certain default circumstances, the guarantee with regard to an Operating Lease may be 100% of BNPPLC’s investment in the applicable property; in the aggregate, the amounts payable under such guarantees will be no more than $165.0 million plus related indemnification or other obligations).

Under each Operating Lease and its associated documents, we are subject to a financial covenant requiring us to maintain unrestricted cash, unencumbered cash investments, and unencumbered marketable securities of at least $300.0 million (not including the collateral maintained as security for our obligations under the Operating Leases).

The Operating Leases are subject to customary default provisions, including, without limitation, those relating to payment defaults under the Operating Leases and associated documents, payment defaults under other indebtedness of us, performance defaults under the Operating Leases (including cross-defaults between each of the Operating Leases), and events of bankruptcy. In the event that such defaults occur and are continuing, BNPPLC may accelerate repayment of a portion or all of its investment under the applicable Operating Leases; alternatively, BNPPLC may require us to pay all amounts due under one or more Operating Leases through the end of the term of the applicable Operating Leases.

Credit Agreements: On March 3, 2008, we, as borrower, entered into a Credit Agreement, dated as of March 3, 2008 (the “Credit Agreement”) with ABN AMRO BANK N.V (the “Agent”), as administrative agent for the lenders party to the Credit Agreement, and such lenders. Bullen Semiconductor Corporation, our wholly-owned domestic subsidiary(“Bullen”), entered into a guarantee (the “Bullen Guarantee”) to guarantee our obligations under the Credit Agreement. In connection with the Credit Agreement, we and Bullen entered into certain collateral documents (collectively, the “Collateral Documents”) including a Security Agreement by us (the “Security Agreement”), a Security Agreement by Bullen (the “Bullen Security Agreement”), a Pledge Agreement by us (the “Pledge Agreement”) and other Collateral Documents to secure our obligations under the Credit Agreement. The Collateral Documents encumber current and future accounts receivables, inventory, equipment and related assets of us and Bullen, as well as 100% of our ownership interest in Bullen and 65% of our ownership interest in Lam Research International BV, our wholly-owned subsidiary. In addition, any future domestic subsidiaries of us will also enter into a similar guarantee and collateral documents to encumber the foregoing type of assets.

Under the Credit Agreement, we borrowed $250 million in principal amount for general corporate purposes. The loan under the Credit Agreement is a non-revolving term loan with the following repayment terms: (a) $12.5 million of the principal amount due on each of (i) September 30, 2008, (ii) March 31, 2009 and (iii) September 30, 2009 and (b) the payment of the remaining principal amount on March 6, 2010. The outstanding principal amount bears interest at LIBOR plus 0.75% per annum or, alternatively, at the Agent’s “prime rate.” We may prepay the loan under the Credit Agreement in whole or in part at any time without penalty. The Credit Agreement contains customary representations, warranties, affirmative covenants and events of default, as well as various negative covenants (including maximum leverage ratio, minimum liquidity and minimum EBITDA).

As a condition to funding under the Credit Agreement, the outstanding balance ($250 million) under the LRI Credit Agreement was repaid in full. LRI is our wholly-owned subsidiary. In addition, the Guarantee Agreement was also terminated. Our obligations under the Guarantee Agreement were fully collateralized by cash and cash equivalents.

Section 409A: As a result of the determinations from a voluntary independent stock option review, the Company considered the application of Section 409A of the IRC to certain stock option grants where, under APB No. 25, intrinsic value existed at the time of grant. In the event such stock option grants are not considered as issued at fair market value at the original grant date under the IRC and applicable regulations thereunder, these options are subject to Section 409A. On March 30, 2008, the Board of Directors of the Company authorized the Company to assume the liability of any and all employees, including the Company’s Chief Executive Officer and certain executive officers, with options subject to Section 409A. The liability is currently estimated to be in the range of approximately $50 million to $55 million. The determinations from the voluntary independent stock option review are more fully described in Note 3, “Restatement of Consolidated Financial Statements” to Consolidated Financial Statements in Item 8 and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Item 7 of the Company’s 2007 Form 10-K.

Item 7A.Quantitative and Qualitative Disclosures ~~about~~About Market Risk

Our exposure to market risk for changes in interest rates relates primarily to our investment portfolio and variable rate long-term debt. We target to maintain a conservative investment policy, which focuses on the safety and preservation of our invested funds by limiting default risk, market risk, and reinvestment risk. The table below presents principal amounts and related weighted-average tax equivalent interest rates by year of maturity for our investment portfolio at June ~~25, 2006~~24, 2007 and June ~~26, 2005:~~25, 2006:


																								June 26,																										June 25,
	June 25, 2006																							2005			June 24, 2007																							2006
	Fiscal Year Ending																										Fiscal Year Ending
	June 24,			June 29,			June 28,			June 27,			June 26,			There-						Fair					June 29,			June 28,			June 27,			June 26,			June 24,
	2007			2008			2009			2010			2011			After			Total			Value		Total			2008			2009			2010			2011			2012			There-after			Total			Fair Value		Total
										(in thousands, except percentages)																	(in thousands, except percentages)
Cash equivalents
Variable rate	$	730,887		$	—		$	—		$	—		$	—		$	—		$	730,887		$	730,887	$	—
Principal Amount with variable rate - - Money Market Fund																											$	529,968																	$	529,968		$	529,968		730,887
Average rate		4.95	%		—			—			—			—			—			4.95	%		—		—			5.24	%																	5.24	%				4.95	%
Fixed rate	$	113,566		$	—		$	—		$	—		$	—		$	—		$	113,566		$	113,509	$	378,183

Principal Amount with fixed rate — Securities																											$	—																	$	—					113,566
Average rate		5.10	%		—			—			—			—			—			5.10	%		—		3.05	%																									5.10	%
Short-term investments
Fixed rate	$	42,125		$	25,411		$	31,346		$	23,819		$	6,760		$	12,870		$	142,331		$	139,524	$	328,846

Short-term investment
Principal Amount with fixed rate																											$	30,636		$	28,829		$	15,761		$	6,979		$	8,482		$	6,859		$	97,546		$	96,724		142,331
Average rate		3.86	%		3.93	%		4.43	%		4.26	%		5.14	%		4.37	%		4.19	%		—		3.99	%		4.68	%		4.98	%		4.69	%		5.16	%		5.07	%		4.64	%		4.85	%				4.19	%
Restricted cash and investments
Variable rate	$	70,575		$	—		$	—		$	—		$	—		$	—		$	70,575		$	70,575	$	—

Restricted Cash/Investments
Principal Amount with fixed rate — Time Deposit																											$	85,038																	$	85,038		$	85,038
Average rate		5.64	%		—			—			—			—			—			5.64	%		—		—			5.25	%																	5.25	%
Fixed rate	$	328,643		$	25,395		$	14,968		$	4,552		$	9,082		$	17,810		$	400,450		$	399,463	$	85,038
Average rate		5.08	%		4.94	%		5.27	%		4.83	%		5.89	%		5.66	%		5.12	%		—		3.00	%

Principal Amount with variable rate - - Auction Rate Notes/VRDN																											$	12,100		$	1,000														$	13,100		$	13,096		70,575
Average rate (taxable equivalent yield)																												3.87	%		5.73	%														4.24	%				5.64	%
Principal Amount with fixed rate - - Restricted Securities																											$	50,696		$	96,759		$	65,231		$	28,992		$	16,610		$	4,869		$	263,157		$	261,904		400,450
Average rate (taxable equivalent yield)																												3.67	%		3.00	%		3.66	%		3.82	%		3.89	%		4.53	%		3.68	%				5.12	%


Total investment securities	$	1,285,796		$	50,806		$	46,314		$	28,371		$	15,842		$	30,680		$	1,457,809		$	1,453,958	$	792,067		$	708,438		$	126,588		$	80,992		$	35,971		$	25,092		$	11,728		$	988,809		$	986,730		1,457,809

Average rate		4.68	%		4.44	%		4.70	%		4.35	%		5.57	%		5.12	%		4.41	%		—		3.43	%		4.45	%		3.91	%		3.86	%		4.08	%		4.29	%		4.60	%		4.27	%		—		4.41	%


Long-term debt
Variable rate	$	—		$	—		$	—		$	—		$	350,000		$	—		$	350,000		$	350,000	$	—
Long-term debt — Variable rate																											$	—		$	—		$	—		$	250,000		$	—		$	—		$	250,000		$	250,000	$	350,000
Average rate		—			—			—			—			5.65	%		—			5.65	%		—		—			—			—			—			5.42	%		—			—			5.42	%		—		5.65	%

The following table presents the hypothetical fair values of fixed income securities as a result of selected potential market decreases and increases in interest rates. Market changes reflect immediate hypothetical parallel shifts in the yield curve of plus or minus 50 basis points (“BPS”), 100 BPS, and 150 BPS. The hypothetical fair values as of June 24, 2007 are as follows:


	Valuation of Securities Given an Interest Rate						Fair Value as of		Valuation of Securities Given an Interest Rate
	Decrease of X Basis Points						June 24, 2007		Increase of X Basis Points
	(150 BPS)		(100 BPS)		(50 BPS)		0.00%		50 BPS		100 BPS		150 BPS
	(in thousands)

U.S. Treasury	$	3,003	$	2,969	$	2,936	$	2,902	$	2,869	$	2,835	$	2,801
Government Sponsored Entity		21,697		21,583		21,470		21,356		21,242		21,129		21,015
Corporate		208,737		207,750		206,763		205,776		204,788		203,800		202,813
Municipal		232,389		230,502		228,615		226,728		224,841		222,954		221,067

	$	465,826	$	462,804	$	459,784	$	456,762	$	453,740	$	450,718	$	447,696

We mitigate default risk by investing in high credit quality securities and by positioning our portfolio to respond appropriately to a significant reduction in a credit rating of any investment issuer or guarantor. The portfolio includes only marketable securities with active secondary or resale markets to achieve portfolio liquidity and maintain a prudent amount of diversification.

We conduct business on a global basis in several major international currencies. As such, we are potentially exposed to adverse as well as beneficial movements in foreign currency exchange rates. The majority of our sales and expenses are denominated in U.S. dollars except for certain of our revenues in Japan that are denominated in Japanese ~~Yen,~~yen, certain of our spares and service contracts which are denominated in other currencies, and expenses related to our non-U.S. sales and support offices which are denominated in these countries’ local currency. We currently enter into foreign currency forward contracts to minimize the short-term impact of the exchange rate fluctuations on Japanese ~~Yen-denominated~~yen-denominated assets and forecasted Japanese ~~Yen-denominated~~yen-denominated revenue where we currently believe our primary exposure to currency rate fluctuation lies. To protect against the reduction in value of forecasted Japanese ~~Yen-denominated~~yen-denominated revenues, we enter into foreign currency forward exchange rate contracts that generally expire within 12 months, and no later than 24 months. These foreign currency forward exchange rate contracts are designated as cash flow hedges and are carried on our Balance Sheet at fair value with the effective portion of the contracts’ gains or losses included in accumulated other comprehensive income (loss) and subsequently recognized in earnings in the same period the hedged revenue is recognized. We also enter into foreign currency forward contracts to hedge the gains and losses generated by the remeasurement of Japanese ~~Yen-denominated~~yen-denominated net receivable balances. The change in fair value of these balance sheet hedge contracts is recorded into earnings as a component of other income and expense and offsets the change in fair value of the foreign currency denominated intercompany and trade receivables, recorded in other income and expense, assuming the hedge contract fully covers the intercompany and trade receivable balances.

On June ~~25, 2006,~~24, 2007, the notional amount of outstanding Japanese ~~Yen~~yen forward contracts that are designated as balance sheet hedges was ~~$23.5~~$30.2 million. The unrealized gain on the contracts on June ~~25, 2006,~~24, 2007, was $0.1 million. ~~A 15% appreciation~~As of June 24, 2007, a hypothetical adverse foreign currency exchange rate movement of 10 percent and 15 percent in the Japanese ~~Yen~~yen would result in ~~an unrealized~~a potential loss in fair value of ~~$4.1 million. Depreciation in the exchange rate~~our balance sheet hedge forward contracts of ~~the Japanese Yen of approximately 15% would result in an unrealized gain of $3.1 million.~~$3.0 million and $4.5 million, respectively. These changes in fair values would be offset in other income and expense by corresponding change in fair values of the foreign currency denominated intercompany and trade receivables assuming the hedge contract fully covers the intercompany and trade receivable balances. On June ~~25, 2006,~~24, 2007, the notional amount of outstanding Japanese ~~Yen~~yen forward contracts that are designated as cash flow hedges was ~~$193.8~~$77.6 million. ~~A 15% appreciation~~As of June 24, 2007, a hypothetical adverse foreign currency exchange rate movement of 10 percent and 15 percent in the Japanese ~~Yen would~~

Item 8.~~Consolidated~~ Financial Statements and Supplementary Data

The Consolidated Financial Statements required by this Item are set forth on the pages indicated atin Item 15(a). The unaudited quarterly results of our operations for our two most recent fiscal years are incorporated herein by reference under Item 6, “Selected ~~Consolidated~~ Financial Data”.

Item 9.Changes in and Disagreements ~~with~~With Accountants on Accounting and Financial Disclosure

None.

Item 9A.Controls and Procedures

Stock Option Grant Practices and Restatement

As discussed in Note 3, “Restatement of Consolidated Financial Statements” to Consolidated Financial Statements of this 2007 Form 10-K, we are restating our consolidated balance sheet as of June 25, 2006 and the related consolidated statements of operations, stockholders’ equity, and cash flows for the years ended June 25, 2006 and June 26, 2005 as a result of a voluntary independent stock option review conducted by a special committee appointed by the Board of Directors that consisted of two independent board members (the “Independent Committee”). The Company also recorded adjustments affecting previously-reported financial statements for fiscal years 1997 through 2004, the effects of which are summarized in cumulative adjustments to additional paid-in capital, deferred stock-based compensation, and retained earnings as of June 27, 2004. This 2007 Form 10-K also reflects the restatement of “Selected Financial Data” in Item 6 as of and for the years ended June 25, 2006, June 26, 2005, June 27, 2004 and June 29, 2003. In addition, we are restating the unaudited quarterly condensed financial statements for interim periods of fiscal year 2006, and unaudited condensed balance sheets as of March 25, 2007, December 24, 2006 and September 24, 2006. There was no effect of the restatement on the consolidated statements of operations for the first three quarters of fiscal year 2007.

Findings and Recommendations of the Independent Committee

	•		Historical Board and Compensation Committee procedures regarding the issuance and approval of stock option grants;

	•		Historical coordination among departments relating to the administration of the stock option grant process;

	•		Historical compliance with and application of accounting standards with respect to stock option grants;

	•		Compliance with certain of the Company’s stock option plans; and

	•		Historical record-keeping with respect to stock option grants.

The Independent Committee concluded that there was no intentional misconduct on the part of Company management or the Company’s independent directors.

Disclosure Controls and Procedures

As required by Exchange Act Rule 13a-15(b), as of ~~the close of fiscal year~~ June ~~25, 2006,~~24, 2007, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rule 13a-15(e). Based upon that evaluation, our Chief Executive Officer along with our Chief Financial Officer, concluded that our disclosure controls and procedures are effective at the reasonable assurance level.

We intend to review and evaluate the design and effectiveness of our disclosure controls and procedures on an ongoing basis and to correct any material deficiencies that we may discover. Our goal is to ensure that our senior management has timely access to material information that could affect our business.

3356

Management’s Report on Internal Control Over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Management has used the framework set forth in the report entitled “Internal Control—Integrated Framework” published by the Committee of Sponsoring Organizations of the Treadway Commission to evaluate the effectiveness of the Company’s internal control over financial reporting. Based on that evaluation, management has concluded that the Company’s internal control over financial reporting was effective as of June ~~25, 2006~~24, 2007 at providing reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

Ernst & Young LLP, an independent registered public accounting firm, has audited ~~management’s assessment of~~ the Company’s internal control over financial reporting, as stated in their report, which is included ~~at the end of~~in Part ~~II,~~IV, Item 815 of this ~~Annual Report on~~2007 Form 10-K.

Changes in Internal Control Over Financial Reporting

There has been no change in our internal control over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Effectiveness of Controls

While we believe the present design of our disclosure controls and procedures and internal control over financial reporting is effective at the reasonable assurance level, future events affecting our business may cause us to modify our disclosure controls and procedures or internal control over financial reporting. The effectiveness of controls cannot be absolute because the cost to design and implement a control to identify errors or mitigate the risk of errors occurring should not outweigh the potential loss caused by the errors that would likely be detected by the control. Moreover, we believe that a control system cannot be guaranteed to be 100% effective all of the time. Accordingly, a control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met.

Item 9B. Other Information

~~None~~None.

3457

PART III

We have omitted from this Report certain information required by Part III because we, as the Registrant, will file a definitive proxy statement with the Securities and Exchange Commission (SEC) within 120 days after the end of our fiscal year, pursuant to Regulation 14A, as promulgated by the SEC, for our Annual Meeting of Stockholders to be held November 2, 2006 (the Proxy Statement), and certain information included therein is incorporated herein by reference. (However, the Report of the Audit Committee, Compensation Committee and the Comparative Stock Performance graph of the Registrant’s Proxy Statement are expressly not incorporated by reference herein.) For information regarding our executive officers, see Part I of this Form 10-K under the caption “Executive Officers of the Company”, which information is incorporated herein by this reference.

Item 10.Directors, ~~and~~ Executive Officers, ~~of the Registrant~~and Corporate Governance

DIRECTORS

Listed below are the Company’s ten directors whose terms expire at the next annual meeting of stockholders.


			Director		Principal Occupation and Business Experience
Director	Age*		Since		During Past Five Years
James W. Bagley		69		1997	Mr. Bagley is the Executive Chairman of the Board of Directors. He has been a director of the Company since the merger of Lam Research and OnTrak Systems, Inc., in 1997, and has served as Chairman of the Board since 1998. Mr. Bagley was appointed to the office of Executive Chairman in 2005. From 1997 until 2005, Mr. Bagley served as Chief Executive Officer of the Company.

					From 1996 to 1997, Mr. Bagley served as Chairman of the Board and Chief Executive Officer of OnTrak Systems, Inc. He was formerly Chief Operating Officer and Vice Chairman of the Board of Applied Materials, Inc., where he also served in other senior executive positions during his 15-year tenure. Mr. Bagley held various management positions at Texas Instruments, Inc., before he joined Applied Materials. Mr. Bagley is currently a director of Micron Technology, Inc. and Teradyne, Inc.

David G. Arscott⁽¹⁾		63		1980	Mr. Arscott has been a director of the Company since 1980, and was Chairman of the Board of Directors from 1982 to 1984. He is currently, and has been since 1988, a General Partner of Compass Technology Group, an investment management firm. From 1978 to 1988, Mr. Arscott was a Managing General Partner of Arscott, Norton & Associates, a venture capital firm. Mr. Arscott is a director of Dragnet Solutions, Inc., Percutaneous Systems, Inc., and Toolwire, Inc.

Robert M. Berdahl^(2,3)		70		2001	Dr. Berdahl has been a director of the Company since 2001. Dr. Berdahl is currently, and has been since May 2006, the President of the Association of American Universities. From 2004 to May 2006, Dr. Berdahl held the position of Professor in the History Department of the University of California, Berkeley and Professor of Public Policy in the Goldman School of Public Policy, UC Berkeley. From 1997 to 2004, Dr. Berdahl served as Chancellor of the University of California, Berkeley. From 1993 to 1997, Dr. Berdahl was President of the University of Texas at Austin, and from 1986 to 1993, he was Vice Chancellor of Academic Affairs of the University of Illinois at Urbana-Champaign.


			Director		Principal Occupation and Business Experience
Director	Age*		Since		During Past Five Years
Richard J. Elkus, Jr.^(2,3)		73		1997	Mr. Elkus has been a director of the Company since 1997. He is currently, and has been since 1996, Chairman of Voyan Technology. From 1994 until 1997, Mr. Elkus was Vice Chairman of the Board and Executive Vice President of Tencor Instruments, Inc. Mr. Elkus is also currently a director of SOPRA S.A., the National Science and Technology Medals Foundation, and the Scripps Research Institute.

Jack R. Harris⁽²⁾		65		1982	Mr. Harris has been a director of the Company since 1982. Mr. Harris is currently, and since 2001 has been, Executive Chairman of Metara, Inc., and is currently, and since 1999, has been, Chairman of HT, Inc. From 1986 until 1999, Mr. Harris was Chairman, Chief Executive Officer, and President of Optical Specialties, Inc.

Grant M. Inman^(1,3)		66		1981	Mr. Inman has been a director of the Company since 1981. Mr. Inman is currently, and since 1998 has been, a General Partner of Inman Investment Management. From 1985 until 1998, Mr. Inman was a General Partner of Inman & Bowman, a venture capital investment partnership. Mr. Inman is currently a director of Paychex, Inc., Wind River Systems, Inc., and AlphaCard Systems.

Catherine P. Lego⁽¹⁾		51		2006	Ms. Lego has been a director of the Company since 2006. Ms. Lego is currently, and since 1999 has been, the General Partner of The Photonics Fund, LLP, a venture capital investment firm. She is also, and since 1992 has been, a member of Lego Ventures, LLC, a technology consulting firm. Ms. Lego is currently a director of SanDisk Corporation, StrataLight Communications, and WJ Communications, Inc.

Stephen G. Newberry		54		2005	Mr. Newberry has been a director and the Chief Executive Officer of the Company since 2005. Mr. Newberry joined the Company in August 1997 as Executive Vice President and Chief Operating Officer. He was appointed President and Chief Operating Officer of Lam in July 1998 and President and Chief Executive Officer in June 2005. Mr. Newberry currently serves as a director of Lam Research Corporation and of SEMI, the industry’s trade association. Prior to joining Lam, Mr. Newberry served as Group Vice President of Global Operations and Planning at Applied Materials, Inc. During his 17 years at Applied Materials, he held various positions in manufacturing, product development, sales and marketing, and customer service. Mr. Newberry is a graduate of the U.S. Naval Academy (BS Ocean Engineering) and the Harvard Graduate School of Business (Program for Management Development) and served five years in naval aviation prior to joining Applied Materials.


			Director		Principal Occupation and Business Experience
Director	Age*		Since		During Past Five Years
Seiichi Watanabe⁽¹⁾		66		2005	Dr. Watanabe has been a director of the Company since 2005. Dr. Watanabe is currently, and since 2007 has been, the Executive Director of TechGate Investment, Inc., of Japan. From 2005 to June 2007, he was the Executive General Manager, Research & Development, for Terumo Corporation of Japan. From 2004 to 2005, Dr. Watanabe served as an Advisor to Sony Corporation following his retirement from Sony in 2004. During his tenure at Sony from 1993 to 2004, Dr. Watanabe served as Executive Vice President of Environmental Affairs, President of Frontier Science Laboratories (Sony), President of the Semiconductor Division, and Director of the Research Center. Dr. Watanabe is also currently a director of Cool.revo, Inc. of Japan, and of Zeta Bridge Corporation of Japan.

Patricia S. Wolpert⁽²⁾		58		2006	Ms. Wolpert has been a director of the Company since 2006. Ms. Wolpert is currently, and since 2003 has been, the owner of Wolpert Consulting LLC, a sales and marketing consulting firm. From 1972 to 2003, Ms. Wolpert served in a variety of executive positions with International Business Machines, Inc., including: Vice President, Sales Transformation, Americas; Vice President, Central Region, Americas; Vice President, System Sales, South America; and various other executive positions. Ms. Wolpert is currently a director and Chairman of the Board of Teradyne, Inc.


*		As of March 10, 2008

(1)		Member of Audit Committee.

(2)		Member of Compensation Committee.

(3)		Member of Nominating/Governance Committee.

EXECUTIVE OFFICERS

The information ~~concerning our directors~~ required by this ~~Item~~item is incorporated by reference ~~to our Proxy Statement under~~from the ~~heading “Proposal No. 1-Election~~Section entitled “Executive Officers of ~~Directors.”~~the Company” in Part I, Item I.

CORPORATE GOVERNANCE

Lam Research’s Board of Directors and management are committed to responsible corporate governance to ensure that the Company is managed for the long-term benefit of its stockholders. To that end, the Board of Directors and management periodically review and update, as appropriate, the Company’s corporate governance policies and practices. In doing so, the Board and management review published guidelines and recommendations of institutional shareholder organizations and current best practices of similarly situated public companies. The Board and management also regularly evaluate and, when appropriate, revise Lam Research’s corporate governance policies and practices in accordance with the requirements of the Sarbanes-Oxley Act of 2002 and the rules and listing standards issued by the SEC and NASDAQ.

Corporate Governance Policies and Practices

Lam Research has instituted a variety of policies and practices to foster and maintain responsible corporate governance, including the following:

Corporate Governance Guidelines –The Company adheres to written Corporate Governance Guidelines, adopted by the Board and reviewed from time to time by the Nominating/Governance Committee, selected provisions of which are detailed below.

Corporate Code of Ethics –The Company maintains a Code of Ethics that applies to all Lam Research employees, officers, and ~~directors~~members of the ~~Company. Our Code of Ethics is publicly available on the investor relations page of our website at www.lamresearch.com. To the extent required by law, any amendments to, or waivers from, any provision~~Board. A copy of the Code of Ethics ~~will promptly be disclosed~~is available on the Company’s web site atwww.lamresearch.com, via the Investor Relations page.

Global Standards of Business Conduct Policy –The Company maintains written standards of business conduct applicable to ~~the public. To the extent permitted~~its employees worldwide.

Board Committee Charters –Each of Lam Research’s Audit, Compensation, and Nominating/ Governance Committees has written charters adopted by ~~such legal requirements, we intend to make such public disclosure by posting the relevant material on our website~~Lam Research’s Board of Directors that establish practices and procedures for each committee in accordance with applicable corporate governance rules and regulations. Lam Research’s Audit, Compensation, and Nominating/Governance Committee Charters are available on the Company’s web site atwww.lamresearch.com, via the Investor Relations page.

Board Nomination Policies and Procedures

	•		Board Membership Criteria –Lam Research’s Corporate Governance Guidelines provide that nominees for director are evaluated on the basis of a range of criteria, including (but not limited to) business and industry experience, wisdom, integrity, analytical ability, ability to make independent judgments, understanding of the Company’s business and competitive environment, willingness and ability to devote adequate time to Board duties, and other appropriate considerations. No director shall be nominated or re-nominated after having attained the age of seventy-five years, and no director may serve on more than a total of four boards of public companies (including the Company’s Board).

	•		Nomination Procedure –The Nominating/Governance Committee is responsible for identifying, evaluating, and recommending candidates for election to the Board, with due consideration for recommendations made by other Board members, the CEO, stockholders, and other sources. In addition to the above criteria, the Nominating/ Governance Committee also considers the appropriate balance of experience, skills, and characteristics desirable among the members of the Board. The independent members of the Board review the Nominating/Governance Committee recommendations and nominate candidates for election by the Company’s stockholders.

Director Independence

	•		Requirements –Lam Research’s Corporate Governance Guidelines require that at least a majority of the Board shall be independent in accordance with NASDAQ rules and other applicable criteria for independence. In addition, no non-employee director may serve as a consultant or service provider to the Company without the approval of a majority of the independent directors.

	•		Current Board Members –The Board has determined that the following directors are independent in accordance with NASDAQ criteria for director independence: David Arscott, Robert Berdahl, Richard Elkus, Jr., Jack Harris, Grant Inman, Catherine Lego, Seiichi Watanabe, and Patricia Wolpert.

	•		Board Committees –All members of each of the Company’s three standing committees– the Audit, Compensation, and Nominating/Governance Committees–are required to be independent in accordance with NASDAQ and other applicable criteria. See“Board Meetings and Committees”below for a description of the responsibilities of the Board’s standing committees.

	•		Lead Independent Director –Pursuant to the Corporate Governance Guidelines, the Board may designate an independent director as the Lead Independent Director. Upon appointment, the Lead Independent Director is responsible for coordinating the activities of the independent members of the Board and acting as the principal liaison between the independent directors and the Executive Chairman and CEO when necessary and appropriate. Director Robert Berdahl has served as the Lead Independent Director since 2004.

	•		Executive Sessions of Independent Directors –The Board and its standing committees periodically hold meetings of only the independent directors or Committee members without management present.

Board Access to Independent Advisors

The Board as a whole, and each of the Board committees separately, have authority to retain and terminate such independent consultants, counselors, or advisors to the Board or a respective committee as each may deem necessary or appropriate.

Board Training and Self-Assessment

The Corporate Governance Guidelines provide that directors are expected to attend one or more training sessions or conferences to enhance their ability to fulfill their responsibilities. Each of the directors who served during fiscal year 2007 fulfilled this expectation. In fiscal year 2005, a majority of the directors then serving attended at least one conference certified by an institutional investor services organization. From time to time, the Nominating/Governance Committee conducts a review of the functioning of the Board and the Board committees.

Director and Executive Officer Stock Ownership

	•		The Company maintains guidelines for stock ownership by members of the Board. Pursuant to the Company’s Corporate Governance Guidelines, each director is expected to own at least 5,000 shares of Lam Research Common Stock by the later of five years after commencing service on the Board or November 2010.

	•		The Company maintains guidelines for stock ownership by designated members of the executive management team. Under the guidelines, executives designated by the Compensation Committee, including the Chief Executive Officer, the Chief Financial Officer, and certain other officers, are expected to own a number of shares of Lam Research Common Stock equal in value to a multiple of each executive’s base annual salary. The multiple varies according to the seniority of the office. Executives are expected to achieve the requisite stock ownership levels by the later of five years following appointment to office or December 2010.

Director Resignation or Notification Upon Change in Executive Officer Status

	•		The Corporate Governance Guidelines provide that a director who is also an executive officer of the Company shall submit a resignation of his directorship to the Board if the officer ceases to be an executive officer of the Company.

	•		The Corporate Governance Guidelines require that a non-employee director notify the Nominating/Governance Committee if such director experiences a change of executive position held at another company. Upon any such notification, the Nominating/Governance Committee will review the appropriateness of the director’s continued Board membership under the circumstances, and the director will be expected to act in accordance with the Nominating/Governance Committee’s recommendation.

Shareholder Communications with Board of Directors

	•		Direct Communications- Any stockholder desiring to communicate with the Board of Directors or with any director regarding the Company may write to the Board or the director, c/o George M. Schisler, Jr., Office of the Secretary, Lam Research Corporation, 4650 Cushing Parkway, Fremont, CA 94538. The Office of the Secretary will forward all such communications to the director(s). In addition, any stockholder, employee, or other person may communicate any complaint regarding any accounting, internal accounting control, or audit matter to the attention of the Board’s Audit Committee by sending written correspondence to: Lam Research Corporation, Attention: Board Audit Committee, P.O. Box 5010, Fremont, CA 94536.

	•		Annual Meeting –The Company encourages its directors to attend the annual meeting of stockholders each year. All of Lam Research’s then-current directors attended the 2006 annual meeting.

Additional Policies and Practices

In addition to the measures discussed above, the Company maintains various other policies and practices to promote responsible corporate governance, such as:

	•		Preparation of a plan of succession for the offices of the CEO and other senior executives.

	•		Periodic review of committee charters for each of the Audit, Compensation, and Nominating/Governance Committees which address corporate governance issues.

	•		Evaluation and approval of the CEO’s and Executive Chairman’s compensation by the independent members of the Board, based on recommendations of the Compensation Committee.

	•		Evaluation and determination of the compensation of other executive officers by the Compensation Committee.

	•		Maintenance of disclosure control policies and procedures, including a Disclosure Control Committee.

	•		Maintenance of a Compliance Committee, composed of the Chief Financial Officer and other Company managers and staff, for the purpose of identifying and addressing securities regulation compliance matters.

	•		Maintenance of a procedure for receipt and treatment by the Audit Committee of anonymous and/or confidential employee complaints or concerns regarding audit or accounting matters.

	•		Comparison by the Board and its committees of the Company’s corporate governance policies with industry best practices and those of its peers.

	•		Availability of final proxy vote results on the Lam Research web site promptly following final compilation of the voting results.

Board Meetings and Committees

The Board of Directors of the Company held a total of eleven regularly scheduled or special meetings during fiscal year 2007. All of the directors who served for the entire fiscal year attended at least 75% of the aggregate number of Board meetings and meetings of Board committees on which they were a member during fiscal year 2007, with the exception of Mr. Newberry, who attended 73% of such meetings.

The Board of Directors has an Audit Committee, a Compensation Committee, and a Nominating/Governance Committee.

The Company has anAudit Committeeestablished in accordance with Section 3(a)(58)(A) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). During fiscal year 2007, the Audit Committee consisted of Board members Arscott, Inman, Lego, and Watanabe. All Audit Committee members are non-employee directors who are independent in accordance with the NASDAQ criteria for audit committee member independence. The Audit Committee held nine meetings during fiscal year 2007. The Audit Committee appoints and provides for the compensation of the Company’s Independent Registered Public Accounting Firm; oversees and evaluates the work and performance of the Independent Registered Public Accounting Firm; reviews the scope of the audit; considers comments made by the Independent Registered Public Accounting Firm with respect to accounting procedures and internal controls and the consideration given thereto by the Company’s management; approves in accordance with applicable securities laws all professional services to be provided to the Company by its Independent Registered Public Accounting Firm; reviews internal accounting procedures and controls with the Company’s financial and accounting staff; oversees a procedure that provides for the receipt, retention and treatment of complaints received by the Company and for the confidential and anonymous submission by employees regarding questionable accounting or auditing matters; reviews and approves all related-party transactions; and performs related duties as set forth in applicable securities laws, NASDAQ corporate governance guidelines, and the Committee charter. The Lam Research Board of Directors has determined that Ms. Lego is an audit committee financial expert as set forth in Item 407(d)(5)(ii) of Regulation S-K of the rules promulgated by the SEC ~~rules.~~and that Ms. Lego is independent in accordance with the NASDAQ criteria for audit committee independence

During fiscal year 2007, theCompensation Committeeconsisted of Board members Berdahl, Elkus, Harris, and Wolpert. All Compensation Committee members are independent, non-employee directors. The Compensation Committee held seven meetings during fiscal year 2007. The Compensation Committee recommends the salary level, incentives, and other forms of compensation for the Chief Executive Officer and the Executive Chairman, subject to approval by the independent members of the Board. It also approves salary levels, incentives, and other forms of compensation for the other executive officers of the

Company. The committee reviews and recommends to the Board all compensation arrangements applicable to the members of the Board. The Compensation Committee reviews, recommends and approves, subject to stockholder and/or Board approval as required, the creation, amendment, or termination of certain equity-based compensation plans of the Company and such other compensation plans as the Board may designate. In addition, this committee has authority with respect to grants of stock options, restricted stock and stock units, deferred stock, and performance share awards to officers and other employees of the Company

During fiscal year 2007, theNominating/Governance Committeeconsisted of Board members Berdahl, Elkus, and Inman. All Nominating/Governance Committee members are independent, non-employee directors. The Nominating/Governance Committee held three meetings during fiscal year 2007. This committee recommends, for approval by the independent members of the Board, nominees for election as directors of the Company. Pursuant to the committee’s charter and the Corporate Governance Guidelines, the Nominating/Governance Committee is also responsible for recommending the composition of Board committees for approval by the Board, reviewing and assessing the Corporate Governance Guidelines from time to time and recommending changes for approval by the Board, reviewing the functioning of the Board and its committees and reporting the evaluation to the Board, and reviewing the suitability of each director for continuing service on the Board. No material changes to the procedures by which stockholders may nominate or recommend nominees were made during fiscal year 2007.

SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

Section 16(a) of the Exchange Act requires the Company’s executive officers, directors, and persons who own more than 10% of a registered class of the Company’s equity securities to file an initial report of ownership on Form 3 and changes in ownership on Forms 4 or 5 with the SEC. Executive officers, directors, and greater-than-10% stockholders are also required by SEC rules to furnish the Company with copies of all Section 16(a) forms they file. Specific due dates for these reports have been established, and the Company is required to disclose in this 2007 Form 10-K any failure to file such reports on a timely basis. Based solely on its review of the copies of such forms received by it, and written representations from certain reporting persons, the Company believes that all of these requirements were satisfied during the 2007 fiscal year.

Item 11.Executive Compensation

COMPENSATION DISCUSSION AND ANALYSIS

Overview

Lam Research’s Compensation Committee (the “Committee”) oversees and administers compensation policies, programs, and practices applicable to the Company’s executive officers. The ~~information~~Committee also reviews policies and programs on at least a calendar year basis and recommends, where appropriate, material changes for the independent members of the Board’s consideration and approval. In addition, the Committee establishes and periodically reviews corporate goals and objectives for the Chief Executive Officer; evaluates the CEO’s performances in light of those goals and objectives; and, based on such evaluation, recommends, for approval by the independent members of the Board, the CEO’s compensation packages, including any employment agreement.

This Compensation Discussion and Analysis (CD&A) discusses our compensation program for the period including fiscal year 2007 and covers actions regarding executive compensation that were taken through March 21, 2008 for our executive officers listed below (the “named executive officers”) whose compensation is detailed in the tables below:


Name		Title
Stephen G. Newberry		President and Chief Executive Officer

Martin B. Anstice		Senior Vice President, Chief Financial Officer and Chief Accounting Officer

Ernest E. Maddock		Senior Vice President, Global Operations

Abdi Hariri		Group Vice President, Customer Support Business Group

Richard Gottscho		Group Vice President and General Manager, Etch Businesses

Nicolas J. Bright*		Executive Vice President of Products


*		During most of fiscal 2007, Mr. Bright was our Executive Vice President, Regional Business and Global Products, which was an executive officer position. His current position which he assumed in March 2007 is no longer an executive officer position.

CD&A consists of the following sections:

Philosophy & Objectivesexplains the philosophy and objectives of our compensation program

Executive Compensation Program Components and Processexplains the major elements of our compensation program as well as the process by which the compensation of our executive officers is determined

Peer Groupidentifies the peer group to which we compare our compensation program

Base Salary, Annual Incentive AwardsandMulti-Year Cash-Based Incentive Program (MYIP)each explain a major element of our compensation program

Equity Incentive Compensationexplains the role of equity incentive awards in our compensation program

Compensation of Chief Executive OfficerandCompensation of Executive Chairmansummarizes the employment agreements that we have with our Chief Executive Officer and our Executive Chairman

Change in Control and Severance Arrangementsexplains the role of such arrangements in our compensation program

Elective Deferred Compensation Plansummarizes this plan and the role it has in our compensation program

Retirement Benefits Under the 401(k) Plan and Not-Generally-Available Benefit Programsummarizes our retirement benefits under the 401(k) plan as well as other benefits provided to our executive officers that are not generally available to all of our employees

Medical and Dental Insurance Retirement Benefitsummarizes this element of our compensation program

Executive Stock Ownership Guidelinessets forth the stock ownership guidelines that we have adopted for our executive officers

Accounting and Tax Considerationsexplain the accounting and tax matters that we consider when setting compensation

This CD&A discusses our executive compensation in the context of a calendar year because our compensation program is designed and evaluated on a calendar year basis rather than a fiscal year basis. However, as required by applicable SEC rules, the compensation tables that follow this ~~Item~~CD&A report the executive compensation payments and awards made during fiscal 2007.

Philosophy and Objectives

Lam Research’s compensation program is ~~incorporated~~designed and evaluated on a calendar year basis rather than a fiscal year basis because the Company’s business planning, performance goal setting, pay and benefit cycles are all run on a calendar year. The principal objectives of our compensation program are to:

	•		Maintain competitive programs to attract, retain and motivate high-caliber executives,

	•		Maximize the Company’s long-term success by appropriately rewarding executive officers for their achievements,

	•		Focus executive efforts on long-term strategic goals for the Company by closely aligning executive financial interests with stockholder interests while minimizing undue dilution of the Company’s shares, and

	•		Structure compensation programs to take into account the accounting treatment and tax deductibility of executive compensation expense.

In formulating and administering the individual elements of our executive compensation program we focus on:

	•		Developing compensation packages for our executive officers that are comparable to similarly situated executives in high technology companies;

	•		Emphasizing pay for performance that rewards achievement of both short- and long-term business objectives;

	•		Establishing appropriate quantitative and strategic performance objectives and metrics; and

	•		Matching recognition of compensation expense as much as possible to the fiscal period in which performance occurs.

Within this framework, the Committee reviews the information, analysis and compensation proposals provided by ~~reference~~management and meets with our Executive Chairman, senior management, and specialists from Human Resources, Finance and Legal. Management makes recommendations to the Committee on the base salary, annual incentive award targets and long-term incentive compensation for the named executive officers. The Committee considers management’s recommendations with respect to executive compensation in light of competitive compensation data and relevant business objectives. At the request of the committee the Executive Chairman discusses management’s compensation recommendations with the Committee. The Committee also regularly holds executive sessions not attended by any members of management. The Committee makes recommendations to the independent members of our Board of Directors on the compensation of our Chief Executive Officer for the final determination and approval by such members of our Board of Directors.

Executive Compensation Program Components and Process

Components. Lam Research’s executive compensation program consists of the major components listed in the table below. We consider each element to be appropriate to meet one or more of the principal objectives of our compensation policy. We generally target compensation near the 50^th percentile of our peer group, yet allow our executives the ability to achieve higher levels of compensation (up to and above the 75^th percentile of our peer group) if warranted by superior company and individual performance. Furthermore, we also consider factors such as job performance, job scope and responsibilities, skill set, prior experience, the executive’s time in his or her position with Lam Research, internal consistency regarding pay levels for similar positions or skill levels within the Company, external pressures to attract and retain talent, and market conditions generally. In general, pay differentials between our executive officers reflect these factors and we believe are consistent with pay differentials between similar positions at our peer companies.


Component	Purpose	Target Market Position
1. Base salary	Enable recruitment and retention of high caliber employees at a competitive level of compensation	50^th percentile
2. Annual incentive awards	Reward executives for achieving shorter-term corporate and functional performance objectives	50^th – 75^th percentile, depending on performance results
3. MYIP	Align executive performance goals with corporate objectives associated with long-term shareholder value creation; promote executive retention	50^th – 75^th percentile, depending on performance results
4. Deferred compensation benefits
5. Retirement benefits	Provide competitive benefits; promote executive retention	50^th percentile
6. Other benefit programs

We also have included severance provisions in employment agreements we have entered into with Messrs. Bagley, Newberry and Bright. These employment agreements are described in more detail below as well as in the “Potential Payments Upon Termination or Change-in-Control” section below. We typically do not offer severance provisions in our agreements with executive officers but we retain the flexibility to do so on an individual basis for recruitment and retention purposes and in order to provide a period during which a former executive is incentivized not to engage in competitive activities.

Process: Generally.At the beginning of each calendar year, the Committee reviews base salaries, annual incentives and long-term incentives and revises the overall compensation package from time to time when appropriate in light of Lam Research’s current business strategies and performance and changes in regulatory, tax and accounting rules and interpretations, while also taking into account the interests of our stockholders. For instance, in 2006, we substantially revised the long-term incentive element of our compensation program when we introduced the cash-based MYIP in consideration of, among other concerns, changes to accounting rules regarding expense recognition for equity-based awards.

When appropriate, the Committee has also adjusted compensation components to account for the level of previous earnings by an executive officer. For example, in February 2006, the Committee provided a supplemental one-year plan under the MYIP for Messrs. Anstice, Maddock and Hariri in consideration for the absence of equity incentive grants to them in the years prior to the adoption of the MYIP and the relatively low level of equity incentive awards made to them in comparison to executive officers in similar positions from our peer group. Messrs. Anstice, Maddock, and Hariri have not received an equity award since 2002.

Process: Annual Incentive Awards. Our annual incentive awards provide for cash payments based on the corporate, organizational and individual performance results achieved each calendar year. Corporate performance is determined primarily by operating income as a percent of revenue. Organizational and individual performance metrics generally fall in one or more of the following categories: business process improvement, customer relationships, market share gains, organizational capability, new product development, decreased cycle times, and employee retention efforts. Typically, the Committee meets in January and/or February to review the operating profit performance target and target incentive amounts for the first half of the calendar year and in August to review those targets for the second half of the calendar year. By reviewing performance targets and accrued incentive amounts every six months, the Committee retains the ability to make adjustments as necessary to reflect changing business conditions and corporate objectives.

Process: MYIP.The MYIP was designed and proposed to the Committee by management and is a program under Lam Research’s stockholder-approved 2004 Executive Incentive Plan (the “EIP”). The cash-based incentive structure of the MYIP is intended to provide competitive levels of compensation to our ~~Proxy Statement~~senior executives while (i) allowing the Company to accrue compensation expense during the period in which performance occurs, (ii) as a non-equity program, minimizing dilution of stockholder value, and (iii) incentivizing senior management retention by generally requiring continuous employment through the payment determination date which is typically approximately two years following the start of the performance period. Performance factors are established by the Committee annually and funding is accrued on a periodic basis. A new MYIP cycle typically commences at the beginning of each calendar year and lasts for eight consecutive calendar quarters. For instance, our first MYIP cycle commenced in the first quarter of calendar year 2006 and ran through the end of calendar year 2007 (the “2006

MYIP”), a second MYIP commenced in the first quarter of calendar year 2007 and runs through the end of calendar year 2008 (the “2007 MYIP”), and a third MYIP commenced in the first quarter of calendar year 2008 and runs through the end of calendar year 2009 (the “2008 MYIP”). To date, the MYIP program performance metrics have been comprised of a formula based on attainment of the Company’s operating profit target for each year and stock price, because the Committee believes these measurements represent the best indicators of the performance of the Company and our executive team during the performance periods. For the 2006 MYIP, target award levels were determined after consideration of a study conducted during 2005 and 2006 by Mercer Consulting, an objective third party consulting firm. Mercer Consulting was engaged by management to provide information on the amounts that executives of the peer group realized pursuant to long-term equity-based incentive programs and to provide a recommendation on a competitive target award in lieu of equity grants for participants of the 2006 MYIP. For the 2007 and 2008 MYIPs, the Committee (and the independent members of the Board with respect to the CEO) set target awards after consideration of the overall compensation package for the named executive officers, the potential rewards from the MYIP and the competitive compensation environment. Typically, the Committee (and the independent members of the Board with respect to the CEO) meets in January and/or February to review and determine the operating profit performance metric for the then-current calendar year for each cyle of the MYIP then in effect.

Process: Setting Targets.The Committee establishes performance goals so that the specific performance targets will be challenging but achievable based on expected levels of performance from executive officers while providing that below expected performance would reduce the executive’s award. Performance goals are set such that very strong performance is required to earn payments above the target bonus amounts. The Company believes that our specific operating profit targets for awards granted as annual incentive awards and under the ~~heading~~MYIP are confidential information and their disclosure would result in competitive harm to the Company. In 2006 and 2007 Lam Research achieved significant market share growth, leading to a substantial expansion of revenues and profitability growth. Together, these results led to the payment of above target bonuses as annual incentive awards and contributed to a maximum payout under the applicable MYIP performance cycle. For calendar years 2007 and 2008, the Committee revised the operating profit growth targets upward to provide a greater degree of difficulty in meeting those targets in light of the business plan and outlook each year.

Peer Group

The Committee also determines the levels of compensation and the mix and weighting of compensation components after reviewing data from a peer group of comparably-sized companies in the high technology industry and from nationally published survey data.

The peer group companies are selected based on their comparability to Lam Research’s revenue size and business purpose, and with whom we believe we are likely to compete for talent. Based on these criteria, the peer group may be modified from one year to the next. For 2007, the peer group consisted of the following companies:


Analog Devices, Inc.		National Semiconductor Corporation

Applied Materials, Inc.		Novellus Systems Inc.

Cymer, Inc.		NVIDIA Corporation

Cypress Semiconductor Corporation		Plexus Corp.

Fairchild Semiconductor International, Inc.		SanDisk Corporation

KLA-Tencor Corporation		Teradyne, Inc.

LSI Corporation		Varian Semiconductor Equipment Associates, Inc.

MEMC Electronic Materials, Inc.		Xilinx, Inc.

Molex Incorporated

In addition to peer group data, our human resources department engaged outside consultants from Radford, the Presidio Group and F.W. Cook & Co. to analyze published survey market data on base salary, bonus targets, equity awards and total compensation.

Base Salary

For 2007 and 2008, after taking into consideration peer group compensation and management’s recommendations, the Committee (and the independent members of the Board with respect to the CEO) set the base salaries of each of the named executive officers (see table below) as follows:


	Calendar		Calendar			Calendar
Name	Year 2006		Year 2007			Year 2008
Stephen G. Newberry	$	710,000	$	800,000		$	800,000
Martin B. Anstice	$	340,000	$	380,000		$	400,000
Ernest E. Maddock	$	375,000	$	400,000		$	416,000
Abdi Hariri	$	275,000	$	300,000		$	315,000
Richard A. Gottscho	$	312,000	$	340,000		$	360,000
Nicolas J. Bright	$	435,000	$	461,100	*	NA		*


*		In connection with Mr. Bright’s Employment Agreement, his base salary was further increased to $500,000 in February 2007. The Company does not expect Mr. Bright to be a named executive officer for fiscal year 2008.

Annual Incentive Awards

Generally

Annual incentive awards for our executive officers for a specific calendar year are based on an individual performance factor, a corporate performance factor and a target bonus amount based upon a percentage of annual eligible salary. The actual incentive award is calculated by multiplying the individual factor by the corporate factor by the target bonus amount. The portion of the award based upon individual performance is subject to a maximum multiplier determined at the beginning of the calendar year. The corporate performance factor is applied using a fixed ratio based on the Company’s actual operating profit achievement. The calculated incentive award for executive officers (other than the CEO) may be increased by the Committee, and may be subject to negative discretion by the Committee (or the independent members of the Board with respect to the CEO) after the performance period.

The individual metrics for calendar years 2006 and 2007 were given equal weight with the corporate performance factor which was based upon operating income as a percent of revenue. These objectives and relative weightings were selected based upon management recommendations and Committee and Board determination that they represented the most important metrics of company performance during the applicable calendar years and as a complement to the focus on the operating profit metric under the MYIP discussed below. For calendar years 2006 and 2007, the portion of the award based upon individual performance was subject to a maximum multiplier of 1.5 on the performance factor.

Mr. Newberry

Annual incentive awards for Mr. Newberry for calendar years 2006, 2007, and 2008 were made under Lam Research’s EIP so that his bonus amounts would qualify for deductibility under Section 162(m) of the Internal Revenue Code of 1986, as amended (“Section 162(m)”), discussed further below.

Calendar Year 2006. The Board approved Mr. Newberry’s target bonus amount for calendar year 2006 at 100% of his annual eligible salary. The metrics for Mr. Newberry’s individual performance were market share (weighted at 30%), revenue and gross margin (weighted at 35%) and cash from operations (weighted at 35%). These objectives, together, were given equal weight with the corporate performance factor which was based upon operating income as a percent of revenue. For calendar year 2006, no discretion was exercised by the Board in determining Mr. Newberry’s annual incentive award. Mr. Newberry’s actual calendar year 2006 incentive award was calculated at 2.13 times his target bonus amount, equal to a payout of $1,485,716. This amount is included in the Non-Equity Incentive Plan Compensation column of the Summary Compensation Table below.

Calendar Year 2007. In February 2007, the Committee selected, and the independent members of the Board approved, the annual bonus plan factors for Mr. Newberry for calendar year 2007 and established targets for the first half of calendar 2007. Each of the factors and their relative weighting for Mr. Newberry’s 2007 annual bonus award were unchanged from the 2006 calendar year plan except that under the corporate performance factor, actual operating profit growth targets were revised upward to provide a greater degree of difficulty in meeting those targets in light of the business plan and outlook for calendar year 2007. No changes were made to Mr. Newberry’s performance targets for the second half of calendar year 2007. For calendar year 2007, no discretion was exercised by the Board in determining Mr. Newberry’s annual incentive award. In February 2008, the Committee recommended and the independent members of the Board approved that Mr. Newberry’s calendar year 2007 annual incentive award be calculated at 1.80 times his target bonus amount, equal to a payout of $1,427,690.

In March 2008, based upon the Committee's recommendations, the independent members of the Board approved Mr. Newberry’s target bonus amount for calendar year 2008 at 125% of base salary, subject to a cap of 2.25 times the target bonus amount.

Other Named Executive Officers

The individual performance factors for each executive also include organizational performance objectives based upon applicable business unit performance goals. These objectives generally fall in one or more of the following categories: business process improvement, customer relationships, market share gains, organizational capability, new product development, decreased cycle times, and employee retention efforts. Target bonus amounts ranged from 65% to 85% of annual salary for each executive. The differences in target bonus amounts among the named executive officers are determined based on job scope and responsibilities and the competitive compensation data.

Calendar Year 2006. In February 2007, the Committee approved incentive award payouts for calendar year 2006 performance at amounts ranging from 1.90 to 2.05 times the executives’ target bonus award reflecting each executive’s individual performance results. Actual dollar amounts are reported in the Non-Equity Incentive Plan Compensation column of the Summary Compensation Table below. The Committee did not exercise discretion to increase or reduce any awards during calendar year 2006.

Calendar Year 2007. In January 2008, the Committee approved incentive award payouts for calendar year 2007 performance at amounts ranging from 1.61 to 1.80 times the executives’ target bonus award reflecting each executive’s individual performance results against the organizational objectives mentioned above. Additionally, new target bonus amounts for calendar year 2008 were set for the named executive officers. These amounts range from 70% to 80% of annual salary for each executive, subject to a cap of 2.25 times the target bonus amount.

Earned annual incentive awards for calendar years 2005, 2006, and 2007 are provided in the table below for the named executive officers.


	Earned Annual Incentive Award
	Calendar Year		Calendar Year		Calendar Year
Name	2005		2006		2007
Stephen G. Newberry	$	944,568	$	1,485,716	$	1,427,690
Martin B. Anstice	$	350,437	$	447,212	$	503,258
Ernest E. Maddock	$	362,135	$	510,745	$	490,602
Abdi Hariri	$	220,600	$	328,354	$	332,268
Richard A. Gottscho	$	274,938	$	419,207	$	403,546
Nicolas J. Bright	$	494,236	$	744,543	NA		*


*		The Company does not expect Mr. Bright to be a named executive officer for fiscal year 2008.

Multi-Year Cash-Based Incentive Program (“MYIP”)

The Committee selects certain executives to participate in each MYIP. During 2006 and 2007, cash awards under the MYIP were the only long-term incentive awards provided for the named executive officers with the exception of Mr. Gottscho, who received a grant of restricted share units but was not a participant in the 2006 or 2007 MYIPs. In addition, Messrs. Anstice, Maddock, and Hariri participated in a supplemental one-year plan under the MYIP based on the Company’s operating profit performance which covered performance in calendar year 2006. Awards under the supplemental plan were determined and paid in February 2007. The Committee established this supplemental plan in consideration of the absence of equity incentive grants to the participants since calendar year 2002.

In order to receive an award under the MYIP, participants generally must be continuously employed at Lam Research through the date(s) on which the Committee determines the actual award amounts under the applicable program (the “determination date”). The Committee has the discretion to waive or otherwise adjust the retention criteria for individual participants. For example, Mr. Bright is eligible to receive the target incentive amount established for his 2007 calendar year performance under the 2007 MYIP, provided that Mr. Bright remains employed by Lam Research through a vesting date of March 1, 2008.

The Company’s named executive officers excluding Mr. Gottscho were eligible for performance-based awards under the following MYIPs:


MYIP	Performance Period	Determination Date	Eligible NEO’s
Supplemental	Jan. 2006 – Dec. 2006	February 2007	Messrs. Anstice, Maddock & Hariri
2006	Jan. 2006 – Dec. 2007	February 2008	All (excluding Gottscho)
2007	Jan. 2007 – Dec. 2008	February 2009*	All (excluding Gottscho)
2008	Jan. 2008 – Dec. 2009	February 2010	All**


*		March 1, 2008 for Mr. Bright.

**		Mr. Bright is not a participant of the 2008 MYIP.

MYIP Performance Periods

Performance factors, comprised of a formula based on the attainment of the Company’s operating profit target, are established by the Committee annually and measured and accrued on a quarterly basis. In February 2006, the Committee (and the independent members of the Board with respect to the CEO) established the operating profit performance metric upon which actual incentive awards would be calculated for calendar 2006. In January 2007, the Committee (and the independent members of the Board with respect to the CEO) established the operating profit performance metric upon which actual incentive awards would be calculated for calendar 2007 under both the 2006 and 2007 MYIPs. In January 2008, the Committee established the operating profit performance metric upon which actual incentive awards would be calculated for calendar year 2008 under both the 2007 and 2008 MYIPs for the Company’s named executive officers excluding Mr. Newberry. In March 2008, based on recommendations of the Committee, the independent members of the Board established this metric for Mr. Newberry.

Additionally, the 2006, the 2007, and the 2008 MYIPs provide that the calculated award amounts are automatically increased (but may not be decreased) pursuant to a ratio comparing the Company’s stock price performance over the 50 trading day trailing average as of the end of each fiscal quarter to the 200 trading day trailing average as of the beginning of the program. Under each program, the actual award payable to each participant cannot exceed 2.5 times the target bonus amount set for each plan. During calendar year 2006 and 2007, the stock price factor did positively affect the amounts calculated pursuant to the formula set forth in the respective MYIP.

The Committee (and the independent members of the Board with respect to the CEO) has the opportunity to review the provisional accruals on a periodic basis and may choose to exercise negative discretion to reduce the amount of award accruals following such review. The Committee (and the independent members of the Board with respect to the CEO) did not exercise its negative discretion to reduce any award accruals during calendar years 2006 or 2007, with the exception of Mr. Bright, whose 2006 MYIP award payment was reduced from the calculated amount.

The aggregate individual target award amounts and the aggregate amounts earned for the named executive officers under each cycle of the MYIP (except for Mr. Gottscho who participates in the 2008 MYIP only) were:


	Aggregated Individual		Aggregated Individual			Earned Award as a %
MYIP	Target Amounts		Earned Awards			of Target Amount
2006	$	8,325,000	$	20,567,500			247	%
2007	$	9,157,500	NA		(1)	NA		(1)
2008 (2)	$	9,214,500	NA		(3)	NA		(3)
Supplemental	$	2,520,000	$	3,872,300			154	%


(1)		Earned awards under the 2007 MYIP are scheduled for a February 2009 payment.

(2)		Mr. Bright is not a participant of the 2008 MYIP.

(3)		Earned awards under the 2008 MYIP are scheduled for a February 2010 payment.

Equity Incentive Compensation

The Company believes that long-term equity incentive awards can be a useful part of its executive compensation program. However, as discussed above, the Company has chosen to grant primarily long-term cash incentive awards to its executive officers for calendar years 2006 and 2007. The Committee or Board may use its discretion to grant stock options or restricted stock units to executive officers in the future to provide competitive long-term incentives and to reward behaviors that result in long-term stockholder value growth. At this time, the Company does not have a formal policy with respect to the timing of granting equity awards.

Compensation of Chief Executive Officer

The Company and Mr. Newberry entered into an employment agreement (the “Newberry Agreement”) effective January 1, 2003, which continues in effect pursuant to an automatic one-year renewal provision. The Newberry Agreement provides for a base salary at a rate to be set at least annually by the Board. Under the Newberry Agreement, Mr. Newberry is entitled to participate in any performance incentive plan offered by the Company, in the Company’s executive deferred compensation plan(s), and in other benefit and compensation programs generally applicable to key executives of the Company. The Newberry Agreement includes severance provisions which are described below in the “Potential Payments Under Termination of Employment or Change-in-Control” section below.

Compensation of Executive Chairman

The Company and Mr. Bagley entered into a new employment agreement (the “Bagley Agreement”) effective January 1, 2006. The term of the Bagley Agreement is from January 1, 2006, to March 31, 2009, unless extended or earlier terminated in accordance with its provisions. Pursuant to the terms and conditions of the Bagley Agreement, Mr. Bagley will continue to serve as Executive Chairman of the Company during the term of the agreement. Mr. Bagley will receive an annual salary of $240,000 provided he remains employed by the Company. Subject to certain non-compete and other terms and conditions, the Bagley Agreement provides for a lump sum payment of $2.5 million on April 15, 2009. During the term of the Bagley Agreement, Mr. Bagley will not participate in any executive bonus plans maintained by the Company. Mr. Bagley however is eligible to participate in the standard executive benefit plans maintained by the Company. During the term of the Bagley Agreement, Mr. Bagley agrees not to perform services for any other for-profit enterprise that would interfere with his services to, or otherwise compete with, the Company. The Bagley Agreement includes severance provisions which are described below in the “Potential Payments Upon Termination or Change-in-Control” section below.

Change in Control and Severance Arrangements

Lam Research generally does not provide for severance or change in control benefits to executive officers except for individually negotiated arrangements such as those with Messrs. Newberry, Bagley and Bright. These arrangements are more fully described in the “Potential Payments Upon Termination of Employment or Change-in-Control” section below. We use such individually negotiated arrangements for recruitment and retention purposes and in order to provide a period during which a former executive will be incentivised not to engage in competitive activities.

However, as discussed below, we do provide medical and dental insurance retirement benefits to eligible former officers (and members of our Board). Furthermore, certain of the Company’s stock option plans and its Employee Stock Purchase Plan provide that, upon a merger of the Company with or into another corporation or the sale of substantially all of the assets of the Company, some or all of the options granted under certain of the stock option plans shall be accelerated so as to be fully exercisable, and all of the rights granted under the Employee Stock Purchase Plans shall be fully exercisable following the merger for a period from the date of notice by the Board. Following the expiration of such periods, the options and rights will terminate. The 2007 Stock Incentive Plan adopted by Company stockholders at the 2006 Annual Meeting allows the Company broad discretion to provide for vesting acceleration of awards on change-of-control transactions.

Elective Deferred Compensation Plan

Lam Research maintains a non-qualified deferred compensation plan, the Elective Deferred Compensation Plan (the “EDCP”), which allows eligible employees, including executive officers, to voluntarily defer receipt of all or a portion of his/her salary and all or a portion of a bonus payment until the date or dates elected by the participant, thereby allowing the participating employee to defer taxation on such amounts. The EDCP is offered to eligible employees, including the named executive officers, in order to allow them to defer more compensation than they would otherwise be permitted to defer under a tax-qualified retirement plan, such as The Lam Research Corporation Employee Savings Plus Plan (the “401(k) Plan”). Further, Lam Research offers the EDCP as a competitive practice to enable it to attract and retain top talent.

The EDCP is evaluated by the human resources group for competitiveness in the marketplace from time to time, but the level of benefits provided is not typically taken into account in determining an executive’s overall compensation package for a particular year due to its conservative nature.

Retirement Benefits Under the 401(k) Plan and Not-Generally-Available Benefit Programs

Each of Lam Research’s named executive officers is eligible for additional benefits generally available to Company employees such as matching contributions to Lam Research’s 401(k) plan and medical coverage benefits. Lam Research also provides additional benefits to its named executive officers that are not generally available to other Company employees, including the payment of term life insurance premiums, payment of medical co-insurance premiums and matching contributions to the EDCP in lieu of decreased contributions that would otherwise have been made had such EDCP deferrals not been made. The amount of the Company EDCP contribution that is not generally available to other Company employees is shown in the “All Other Compensation Table” below.

Medical and Dental Insurance Retirement Benefit

The Company provides a program to pay for post-retirement medical and dental insurance coverage for eligible former executive officers and members of Lam Research’s Board of Directors. To be eligible, a person must have served at the position of vice president or above or as a member of the Board of Directors, be at least age 55 at retirement, and have at least five years of continuous service with Lam Research. An executive officer or director must be enrolled in the Company’s U.S. group medical and dental plans at the time of his or her retirement. When the retired person reaches age 65, he or she is required to enroll in Medicare parts A and B which would be the primary payer for the executive’s health coverage. The benefit also covers the person’s spouse at the time of retirement for his or her lifetime as well as other eligible dependents. The benefit ceases if the person becomes employed by a competitor of Lam Research after leaving the Company’s service. We provide the benefit to our executives and members of our board to further the long-term retention of their services and/or provide a disincentive to later compete against the Company.

Executive Stock Ownership Guidelines

During fiscal year 2006, the Company adopted executive stock ownership guidelines, pursuant to which senior executives are expected and encouraged to own and maintain certain minimum levels of the Company’s Common Stock. The Committee believes that these guidelines are an appropriate addition to the Company’s equity compensation policies and, in conjunction with Lam Research’s equity and cash-based incentive plans, will further serve to align the long-term interests of the senior executives with those of the Company’s stockholders. Each executive is required to accumulate and maintain ownership of shares of the Company’s Common Stock, in the quantities indicated by the guidelines below, by the later of December 31, 2010, or the fifth anniversary of an executive’s hire date.


Position		Stock Ownership Guideline
Chief Executive Officer		5X Salary
Chief Financial Officer		3X Salary
All other senior executives		2X-3X Salary

Accounting and Tax Considerations

Mr. Hariri received taxable income in fiscal year 2007 on the tax payments made on Mr. Hariri’s behalf by the Company to compensate for the difference in income tax liabilities resulting from an expatriate assignment.

In determining which elements of compensation are to be paid, and how they are weighted, Lam Research also takes into account whether a particular form of compensation will be considered “performance-based” compensation for purposes of Section 162(m) of the Internal Revenue Code. Under Section 162(m), Lam Research generally receives a federal income tax deduction for compensation paid to any of its named executive officers only if the compensation is less than $1 million during any fiscal year or is “performance-based” under Section 162(m). In 2004, Lam Research adopted the EIP with a structure intended to provide for the tax deductibility of awards granted under the EIP. Accordingly, during fiscal 2007, the annual incentive awards granted to Mr. Newberry and to the greatest extent possible, all MYIP grants to Mr. Newberry and the other named executive officers were granted under Lam Research’s EIP. In November 2006, our stockholders approved an amendment to the EIP that increased the

amount of cash awards that may be paid to any one participant in respect of achievement of performance goals for any twelve-month period to $12 million. Prior to the amendment, the maximum amount of awards that could be paid to a participant in a twelve-month period and qualify for deductiblity under Section 162(m) was $2 million. Accordingly, we expect that all MYIP grants made after passage of the amendment will qualify for deductibility under Section 162(m). The prior $2 million limit for deductibility will likely apply to performance periods under grants prior to the amendment. The Committee currently intends to continue to seek a tax deduction for all of Lam Research’s executive compensation, to the extent it determines it is in the best interests of Lam Research.

To assist in the avoidance of additional tax under Section 409A of the Internal Revenue Code, Lam Research structured the MYIP and the EDCP, and structures its equity awards, in a manner intended to comply with the applicable Section 409A requirements. It is Lam Research’s general philosophy not to provide any executive officer or director with a gross-up or other reimbursement for tax amounts the individual might pay pursuant to Section 280G of the Internal Revenue Code.

SUMMARY COMPENSATION TABLE


															Change in
															Pension Value
															and Nonqualified
								Stock				Non-Equity			Deferred		All Other
	Fiscal							Awards		Option		Incentive Plan			Compensation		Compensation
Name and Principal Position	Year		Salary		Bonus			(3)		Awards (4)		Compensation			Earnings (11)		(12)		Total
Stephen G. Newberry Chief Executive Officer and President		2007	$	759,039	$	—		$	—	$	3,013	$	7,588,859	(5)	$	808	$	19,602	$	8,371,321
Martin B. Anstice Senior Vice President, Chief Financial Officer		2007		353,077		—			—		479		4,189,847	(6)		—		26,397		4,569,800
Ernest E. Maddock Senior Vice President, Global Operations		2007		383,174		—			—		2,681		3,369,508	(7)		3		21,429		3,776,795
Abdi Hariri Group Vice President, Customer Support Business Group		2007		283,173		—			—		1,028		2,728,276	(8)		66		26,987		3,039,530
Richard A. Gottscho Group Vice President and General Manager, Etch Businesses		2007		327,692		—			747,356		1,194		419,207	(9)		729		24,621		1,520,799
Nicolas J. Bright (1) Executive Vice President of Products		2007		456,250		787,500	(2)		—		7,712		1,925,690	(10)		633		26,463		3,204,248

Salary, bonus, and non-equity incentive plan compensation above includes amounts earned in fiscal year 2007 even if deferred at the election of the executive officer under the Company’s deferred compensation plans and/or the Company’s 401(k) Plan. All amounts listed as “Executive Contributions” in the “Non-Qualified Deferred Compensation Table”, which appears later in this document, represent contributions on amounts earned during fiscal year 2007 and disclosed in the Summary Compensation Table above.


(1)		Mr. Bright was the Company’s Executive Vice President, Regional Business & Global Products until his transition to his present, non-Section 16 officer position on March 1, 2007.

(2)		In March 2007, in connection with Mr. Bright’s transition to his current position with Lam Research, the Committee approved, and the Company and Mr. Bright entered into an arrangement whereby Mr. Bright will at minimum receive the target incentive amount established for his 2007 calendar year performance under the Company’s 2007 MYIP provided that Mr. Bright remains employed by Lam Research through a vesting date of March 1, 2008. The $787,500 above represents the amount attributable to fiscal year 2007 under this arrangement.

(3)		Amounts shown do not reflect compensation actually received by the named executive officer. Instead, the amounts shown are the compensation expenses recognized by Lam Research in fiscal 2007 for restricted stock units as determined pursuant to FASB Statement of Financial Accounting Standards Number 123(revised) “Share-Based Payment” (“SFAS 123R”). These compensation expenses reflect restricted stock units granted during fiscal 2007 and prior to fiscal 2007.

(4)		Amounts shown do not reflect compensation actually received by the named executive officer. Instead, the amounts shown are the compensation expenses recognized by Lam Research in fiscal 2007 for option awards as determined pursuant to SFAS 123R. These compensation expenses reflect option awards granted prior to fiscal 2007. These compensation expenses reflect


		option awards granted during fiscal year 2002. The assumptions used to calculate the fair value of these option awards are set forth in Note M in Notes to Consolidated Financial Statements of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2002.

(5)		Represents $1,485,716 earned by Mr. Newberry pursuant to his 2006 annual incentive award (which was made under the EIP and pursuant to the Company’s annual bonus plan for calendar year 2006), $4,718,128 accrued on Mr. Newberry’s behalf for performance during fiscal 2007 under the 2006 MYIP and $1,385,015 accrued for performance during fiscal 2007 under the 2007 MYIP. Mr. Newberry received the amounts accrued under the 2006 MYIP and will be eligible to receive the 2007 MYIP if he remains employed by Lam Research through the payment determination date in February 2009.

(6)		Represents $447,212 earned by Mr. Anstice pursuant to his 2006 annual incentive award, $1,207,483 earned for performance during fiscal 2007 under the supplemental plan, $1,959,838 accrued on Mr. Anstice’s behalf for performance during fiscal 2007 under the 2006 MYIP and $575,314 for performance during fiscal year 2007 under the 2007 MYIP. Mr. Anstice received the amounts accrued under the 2006 MYIP and will be eligible to receive the 2007 MYIP if he remains employed by Lam Research through the payment determination date in February 2009.

(7)		Represents $510,745 earned by Mr. Maddock pursuant to his 2006 annual incentive award, $558,348 earned for performance during fiscal 2007 under the supplemental plan, $1,778,371 accrued on Mr. Maddock’s behalf for performance during fiscal 2007 under the 2006 MYIP and $522,044 for performance during fiscal year 2007 under the 2007 MYIP. Mr. Maddock received the amounts accrued under the 2006 MYIP and will be eligible to receive the 2007 MYIP if he remains employed by Lam Research through the payment determination date in February 2009.

(8)		Represents $328,354 earned by Mr. Hariri pursuant to his 2006 annual incentive award, $522,032 earned for performance during fiscal 2007 under the supplemental plan, $1,451,732 accrued on Mr. Hariri’s behalf for performance during fiscal 2007 under the 2006 MYIP and $426,158 for performance during fiscal year 2007 under the 2007 MYIP. Mr. Hariri received the amounts accrued under the 2006 MYIP and will be eligible to receive the 2007 MYIP if he remains employed by Lam Research through the payment determination date in February 2009.

(9)		Represents $419,207 earned by Mr. Gottscho pursuant to his 2006 annual incentive award.

(10)		Represents $744,543 earned by Mr. Bright pursuant to this 2006 annual incentive award and $1,181,147 accrued on Mr. Bright’s behalf during fiscal 2007 under the 2006 MYIP.

(11)		Reflects interest earned on deferred compensation, to the extent that the interest rate exceeded 120% of the applicable federal long-term rate.

(12)		Please refer to the “All Other Compensation Table” which follows this table for additional information.

ALL OTHER COMPENSATION TABLE


							Company Contribution
			Company’s				to the Elective Deferred
			Matching		Company-paid		Compensation Plan in		Company-paid
			Contributions to		Term Life		lieu of matching		Medical
	Fiscal		the Company’s		Insurance		contributions to the		Insurance		Expatriate
Name	Year		401(k) Plan		Premiums (1)		401(k) Plan (2)		Premiums (3)		Income
Stephen G. Newberry		2007	$	—	$	1,699	$	—	$	17,903	$	—
Martin B. Anstice		2007		6,927		442		1,125		17,903		—
Ernest E. Maddock		2007		—		1,114		5,871		14,444		—
Abdi Hariri		2007		2,498		1,114		3,147		17,903		2,325	(4)
Richard A. Gottscho		2007		6,590		1,699		996		15,336		—
Nicolas J. Bright		2007		8,027		1,479		—		16,957		—


(1)		The amount of the term life benefit is $1,000,000.

(2)		The Company provides to executives a contribution to the EDCP equal to any matching contributions into the 401(k) that an executive would have been entitled to but did not receive as a result of compensation deferrals into the EDCP.

(3)		Represents the value of medical coverage under Lam Research’s self-funded medical plan and insurance premiums paid under Lam Research’s Executive Dental and Executive Medical Reimbursement Plans provided to the named executive officers in fiscal year 2007.

(4)		Represents taxable income to Mr. Hariri in fiscal year 2007 on the tax payments made on Mr. Hariri’s behalf by the Company to compensate for the difference in income tax liabilities due to an expatriate assignment.

GRANTS OF PLAN-BASED AWARDS


				Estimated Future Payouts Under Non-Equity Incentive Plan						Estimated Future Payouts Under Equity Incentive Plan Awards
																			All Other				All Other
																			Stock				Option			Exercise
																			Awards:				Awards:			or Base			Grant Date
																			Number of				Number			Price of			Fair Value of
																			Shares of				of Shares			Option			Stock and
																			Stock or				of Stock			Awards			Option
Name	Grant Date			Threshold ($)		Target ($)		Maximum ($)		Threshold (#)			Target (#)			Maximum (#)			Units				or Units			($/sh)			Awards
Stephen G. Newberry		02/07	(1)		—	$	3,575,000	$	8,937,500		—			—			—			—				—			—			—
		02/07	(2)		—	$	800,000	$	1,800,000
Martin B. Anstice		02/07	(1)		—	$	1,485,000	$	3,712,500		—			—			—			—				—			—			—
		02/07	(2)		—	$	285,000	$	641,250
Ernest E. Maddock		02/07	(1)		—	$	1,347,500	$	3,368,750		—			—			—			—				—			—			—
		02/07	(2)		—	$	300,000	$	675,000
Abdi Hariri		02/07	(1)		—	$	1,100,000	$	2,750,000		—			—			—			—				—			—			—
		02/07	(2)		—	$	210,000	$	472,500
Richard A. Gottscho		1/4/2007										—			—			—			8,400	(3)			—			—			436,128	(4)
		02/07	(2)		—	$	255,000	$	573,750
Nicolas J. Bright		02/07	(1)		—	$	1,650,000	$	4,125,000		—			—			—			—				—			—			—
		02/07	(2)		—	$	391,935	$	881,854


(1)		Represents awards granted under the 2007/2008 MYIP covering performance during calendar 2007 and 2008. Amounts shown are for performance over the two-year period.

(2)		Represents awards granted under the 2007 annual incentive award. Please see the “Annual Incentive Awards” section earlier in this document for details on actual payments made in February 2008 for the 2007 annual incentive awards.

(3)		These restricted stock units were granted on January 4, 2007. One-third of the awards will vest on April 15, 2008, August 1, 2008, and December 1, 2008 provided that Mr. Gottscho remains an employee of the Company on each such date.

(4)		Represents the grant date fair value of the restricted stock units based upon the closing stock price of $51.92 per share on the grant date of January 4, 2007.

OUTSTANDING EQUITY AWARDS AT THE END OF FISCAL YEAR 2007


	Option Awards											Stock Awards
																	Equity			Equity Incentive
																	Incentive Plan			Plan Awards:
						Equity Incentive						Number					Awards:			Market or
	Number of					Plan Awards:						of Shares			Market Value		Number of			Payout Value of
	Securities					Number of						or Units			of Shares or		Unearned			Unearned
	Underlying			Number of Securities		Securities						of Stock			Units of		Shares, Units			Shares, Units or
	Unexercised			Underlying		Underlying		Option		Option		That Have			Stock That		or Other			Other Rights
	Options (#)			Unexercised Options		Unexercised		Exercise		Expiration		Not			Have Not		Rights That			That Have Not
Name	Exercisable			(#) Unexercisable		Unearned Options		Price ($)		Date		Vested			Vested ($)		Have Not			Vested
Stephen G. Newberry		5,250	(1)		—		—	$	16.14		10/1/2011		—			—		—			—
		200,000	(2)		—		—	$	25.66		4/30/2009		—			—		—			—
		5,250	(3)		—		—	$	11.66		10/1/2008		—			—		—			—
Martin B. Anstice		2,000	(4)		—		—	$	24.25		3/19/2011		—			—		—			—
		849	(1)		—		—	$	16.14		10/1/2011		—			—		—			—
Ernest E. Maddock		2,050	(1)		—		—	$	16.14		10/1/2011		—			—		—			—
		1,000	(5)		—		—	$	22.79		12/24/2011		—			—		—			—
		28,800	(6)				—	$	22.05		2/27/2009		—			—		—			—
Abdi Hariri		822	(1)		—		—	$	16.14		10/1/2011		—			—		—			—
		1,000	(1)		—		—	$	16.14		10/1/2011		—			—		—			—
Richard A. Gottscho		—			—		—						8,400	(7)	$	446,124		—			—
		—			—		—						—			—		32,000	(8)	$	1,699,520
		—			—		—						8,400	(9)	$	446,124		—			—
Nicolas J. Bright		—			—		—						—			—		—			—


(1)		These options were granted on October 1, 2001. 100% of the options vested on October 1, 2006.

(2)		These options were granted on April 30, 2002. The options vested 25% annually on February 28 in 2003, 2004, 2005, and 2006.

(3)		These options were granted on August 2, 2002. 100% of the options vested on October 1, 2002.

(4)		These options were granted on March 19, 2001. 36,000 total options were granted with 25% vesting on the first, second, third and fourth anniversaries of the grant date.

(5)		These options were granted on December 24, 2001. 100% of the options vested on December 24, 2006.

(6)		These options were granted on February 27, 2002. 86,700 total options were granted and vested 13,800 on February 27, 2003, 15,300 on February 27, 2004, 28,800 on February 27, 2005, and 28,800 on February 27, 2006.

(7)		These restricted stock units (RSUs) were granted on August 4, 2005. 100% of the RSUs vested on August 4, 2007.

(8)		These restricted stock units (RSUs) were granted on May 12, 2006 and are subject to performance criteria and service period. 100% of the RSUs will vest on May 12, 2009 provided that the person remains an employee on such date.

(9)		These restricted stock units (RSUs) were granted on January 4, 2007. 33.33% will vest on April 15, 2008, August 1, 2008 and December 1, 2008 provided that the person remains an employee on each such date.

OPTION EXERCISES AND STOCK AWARD VESTING DURING FISCAL YEAR 2007


	Option Awards				Stock Awards
	Number of Shares				Number of Shares
	Acquired on		Value Realized on		Acquired on		Value Realized on
Name	Exercise		Exercise (1)		Vesting		Vesting
Stephen G. Newberry		—		—		—		—
Martin B. Anstice		—		—		—		—
Ernest E. Maddock		—		—		—		—
Abdi Hariri		—		—		—		—
Richard A. Gottscho		2,118	$	72,294		—		—
Nicolas J. Bright		6,949	$	223,703


(1)		The value realized equals the difference between the option exercise price and the fair market value of Lam Research’s Common Stock on the date of exercise, multiplied by the number of shares for which the option was exercised.

NON-QUALIFIED DEFERRED COMPENSATION TABLE


	Executive		Registrant
	Contributions in Fiscal		Contributions in Fiscal		Aggregate Earnings in		Aggregate			Aggregate Balance at
Name	Year 2007 (1)		Year 2007 (2)		Fiscal Year 2007 (3)		Withdrawals/Distributions			Fiscal Year End 2007
Stephen G. Newberry	$	—	$	—	$	55,478	$	—		$	993,275
Martin B. Anstice	$	75,000	$	—	$	35,888	$	—		$	236,202
Ernest E. Maddock	$	865,097	$	—	$	214,259	$	—		$	2,403,690
Abdi Hariri	$	502,114	$	—	$	124,146	$	(422,549	)	$	1,060,471
Richard A. Gottscho	$	90,803	$	—	$	50,837	$	—		$	964,735
Nicolas J. Bright	$	644,543	$	—	$	74,165	$	—		$	1,854,238


(1)		Under Lam Research’s EDCP, participants may defer up to 100% of base salary and/or bonus compensation. The minimum deferral amount is $5,000 in any plan year. Deferral elections may be changed each year during the fall enrollment period. The participants may elect to have their deferrals tracked to 16 variable rate funds. Participants may establish up to 5 distribution accounts, each to begin payment in a specific year or upon Retirement. Accounts must be elected at the time of enrollment. All amounts listed as “Executive Contributions” in the table above represent contributions on amounts earned during fiscal year 2007 and disclosed in the Summary Compensation Table earlier in this document.

(2)		Amounts credited to the EDCP consist only of cash compensation that has been earned and payment of which has been deferred by the participant. The amounts deferred under the EDCP are credited with interest in the sum of (a) the yield-to-maturity of five-year U.S. Treasury notes plus (b) 1.50% or with gains or losses that “mirror” the market performance of the funds selected by employees, net of management fees and expenses. Lam Research generally may not take a deduction with respect to amounts deferred under the EDCP until such amounts are paid out. However, in certain circumstances where an amount is determinable by formula or otherwise fixed at year end and paid within two and one-half months of year end, Lam Research may take a deduction before the amounts are paid.

(3)		The above-market or preferential earnings portion of these amounts are reported in the Summary Compensation Table under the column entitled “Change in Pension Value and Nonqualified Deferred Compensation Earnings.”

The Company first adopted a deferred compensation plan in 1994 (the “1994 Deferral Plan”). The 1994 Deferral Plan remains in effect but was closed to further contributions as of December 31, 2004. The Company adopted a new deferred compensation plan (the “EDCP”) effective January 1, 2005. Contributions by eligible executives on or after January 1, 2005, will be maintained in the EDCP. Both Deferred Compensation Plans are voluntary, non-tax-qualified, deferred compensation plans that encourage executives to save for retirement. Under the Deferred Compensation Plans, participants were and are entitled to defer compensation until retirement, death, other termination of employment, or until specified dates.

Potential Payments Upon Termination or Change-in-Control

The Company provides a program to pay for post-retirement medical and dental insurance coverage for eligible former executive officers (the “Executive Retirement Medical Benefit Plan”). Annually, Lam Research has an independent actuarial valuation of this post-retirement benefit conducted in accordance with the methodology prescribed by the Statement of Financial Accounting Standards 106, Employers’ Accounting for Postretirement Benefits Other ~~Information.”~~Than Pensions (SFAS No. 106). The most recent valuation conducted in August 2007 valued Lam Research’s accumulated post-retirement benefit obligation for the named executive officers, Mr. Bagley and directors under the plan at $603,000. The amounts for the named executive officers and Mr. Bagley are shown in the table below:


Name	FY 2007
Stephen Newberry	$	73,000
Martin Anstice	$	17,000
Ernest Maddock	$	71,000
Abdi Hariri	$	59,000
Richard Gottscho	$	72,000
Nicolas Bright	$	77,000
James Bagley	$	44,000

In addition, certain of the Company’s stock option plans and its Employee Stock Purchase Plan provide that, upon a merger of the Company with or into another corporation or the sale of substantially all of the assets of the Company, each outstanding option or right to purchase Common Stock shall be assumed, or an equivalent option or right substituted, by the successor corporation or a parent or subsidiary of the successor corporation. In the event that the successor corporation does not agree to assume the option or right or substitute an equivalent option or right, at the discretion of the plan administrator, some or all of the options granted under certain of the stock option plans shall be accelerated so as to be fully exercisable, and all of the rights granted under the Employee Stock Purchase Plans shall be fully exercisable following the merger for a period from the date of notice by the Board of Directors. Following the expiration of such periods, the options and rights will terminate. The 2007 Stock Incentive Plan adopted by Lam Research stockholders at the 2006 Annual Meeting allows the Company broad discretion to provide for vesting acceleration of awards on change-of-control transactions.

The tables below quantify the amount that would be payable to each of Messrs. Newberry, Bright and Bagley assuming the termination of his employment on June 24, 2007, and are estimates of the amounts which would be paid out to each executive upon his termination. The actual amounts to be paid out can only be determined at the time of the triggering events.

Newberry Agreement

The Newberry Agreement provides that in the event of involuntary termination without cause (as defined in the agreement) or a change in control of the Company followed by either involuntary termination or the acceptance of a position of materially lesser authority or responsibility offered to Mr. Newberry by the Company, or if the Company is acquired by another entity so that there will be no market for the Common Stock of the Company and the acquiring entity does not provide options comparable to unvested stock options held by Mr. Newberry, all unvested stock options granted to Mr. Newberry will automatically be accelerated in full so as to become fully vested. Mr. Newberry is presently fully vested in his stock options but such provision applies to any future grants. Mr. Newberry will have two years from the date of termination in which to exercise such options.

If Mr. Newberry’s employment is involuntarily terminated without cause, he will be entitled to receive a lump sum payment equal to fifteen (15) months of his then-annual base compensation, and he will receive annually any benefits under the Executive Retirement Medical Benefit Plan for which he qualifies following the date of termination. If Mr. Newberry resigns voluntarily, he will not be entitled to receive any severance benefits under the Newberry Agreement, with the exception of the benefits that he would qualify for under the Executive Retirement Medical Benefit Plan. In the event of Mr. Newberry’s death, his estate will be entitled to receive an amount equal to Mr. Newberry’s annual base salary payable in a lump sum. If Mr. Newberry becomes disabled, he will be entitled to receive his base salary for a period of twelve (12) months from the date disability is certified, as well as any bonus earned prior to the effective date of disability.

Bright Agreement

The employment agreement which the Company entered into with Mr. Bright effective August 1, 2003 (the “Bright Agreement”) provides that in the event of a change in control of the Company, subject to certain conditions set forth in the Bright Agreement, or involuntary termination of Mr. Bright without cause (as defined in the agreement), all unvested stock options granted to Mr. Bright will automatically be accelerated in full so as to become fully vested. Mr. Bright will have two years from the date of termination in which to exercise such options. Mr. Bright presently does not have any unvested or unexercised stock option grants but any new grants to Mr. Bright would be subject to such provisions. If Mr. Bright’s employment is involuntarily terminated without cause, he will be entitled to receive a lump sum payment equal to fifteen (15) months of his then-annual base compensation, and any annual benefits under the Executive Retirement Medical Benefit plan for which he qualifies following the date of termination. In the event of Mr. Bright’s death, his estate will be entitled to receive an amount equal to his annual base salary payable in a lump sum. If Mr. Bright becomes disabled, he will be entitled to receive his base salary for a period of twelve (12) months from the date disability is certified, as well as any bonus earned prior to the effective date of disability.


Nicolas J. Bright
Executive Vice
President of
Products
	Voluntary
	Termination		Involuntary Termination
Executive Benefits and
Payments Upon			Disability or				Not for		Change in
Termination			Death		For Cause		Cause		Control
Compensation
Severance	$	—	$	500,000	$	—	$	625,000	$	—
Short-term Incentive	$	—	$	—	$	—	$	—	$	—
Long-term Incentives	$	—	$	—	$	—	$	—	$	—
2006-2007 MYIP	$	—	$	—	$	—	$	—	$	—
2007-2008 MYIP	$	—	$	—	$	—	$	—	$	—
Stock Options (Unvested and Accelerated)	$	—	$	—	$	—	$	—	$	—
Restricted Stock Units (Unvested and Accelerated)	$	—	$	—	$	—	$	—	$	—
Benefits and Perquisites
Health and Welfare Benefit Continuation (1)	$	77,000	$	77,000	$	—	$	77,000	$	77,000

Total	$	77,000	$	577,000	$	—	$	702,000	$	77,000


(1)		Assumes executive qualifies for Lam Research’s Executive Retirement Medical Benefit Plan and reflects the most recent independent actuarial valuation of this benefit.

Bagley Agreement

Pursuant to the Bagley Agreement, Mr. Bagley is entitled to certain severance benefits upon termination of his employment, depending on the reason for the early termination. If Mr. Bagley voluntarily resigns his employment position, he will not be eligible for any severance payment or benefits, but will remain eligible for the $2.5 million lump sum payment to be paid on April 15, 2009, provided the conditions precedent therefore are fulfilled. In the event of involuntary termination of employment without cause (as defined in the agreement) or due to disability, Mr. Bagley will be entitled to continued payment of his salary; to the lump sum payment when otherwise due; to continued annual medical benefits under the Executive Retirement Medical Benefit plan; and to exercise any vested stock options for two years after termination. If involuntary termination is due to death, additional benefits include acceleration of payment of the lump sum amount within ninety days after death and continued medical benefits for covered family members pursuant to plan eligibility. If Mr. Bagley is terminated for cause, Mr. Bagley will not be entitled to receive any severance benefits under the Bagley Agreement. There is no change-of-control benefits provision in the Agreement.

The Bagley Agreement provides that (i) prior to March 31, 2009, Mr. Bagley may not provide services to another entity that would constitute competition with the Company; and (ii) for a period of six months following termination of the Agreement, Mr. Bagley may not solicit any of the Company’s employees to become employed by any other business enterprise.

James W. Bagley
Executive Chairman of
the Company


	Voluntary Termination(2)				Involuntary Termination
Executive Benefits and
Payments Upon							Not for		Change in
Termination			Death		For Cause		Cause		Control
Compensation
Severance	$		$	2,500,000	$	—	$	420,000	NA
Short-term Incentive	$	—	$	—	$	—	$	—
Long-term Incentives
2006-2007 MYIP	$	—	$	—	$	—	$	—
2007-2008 MYIP	$	—	$	—	$	—	$	—
Stock Options (Unvested and Accelerated)	$	—	$	—	$	—	$	—
Restricted Stock Units (Unvested and Accelerated)	$	—	$	—	$	—	$	—
Benefits and Perquisites
Health and Welfare Benefit Continuation (1)	$	44,000	$	44,000	$	—	$	44,000	$	44,000

Total	$	44,000	$	2,544,000	$	—	$	464,000	$	44,000


(1)		Assumes executive qualifies for Lam Research’s Executive Retirement Medical Benefit Plan and reflects the most recent independent actuarial valuation of this benefit.

(2)		Remains eligible for the $2.5 million lump sum payment, provided the conditions precedent are fulfilled.

DIRECTOR COMPENSATION IN FISCAL YEAR 2007


									Change in Pension
									Value and
									Nonqualified
							Non-Equity		Deferred		All Other
	Fees Earned or		Stock Awards (2),				Incentive Plan		Compensation		Compensation
	Paid in Cash		(3), (4)		Option Awards		Compensation		Earnings (5)		(6), (7)		Total
Name	($)		($)		($)		($)		($)		($)		($)
David G. Arscott	$	46,000	$	239,750	$	—	$	—	$	68	$	—	$	285,818
Robert M. Berdahl	$	51,000	$	239,750	$	—	$	—	$	—	$	—	$	290,750
Richard J. Elkus, Jr	$	49,000	$	239,750	$	—	$	—	$	—	$	—	$	288,750
Jack R. Harris	$	46,000	$	239,750	$	—	$	—	$	—	$	—	$	285,750
Grant M. Inman	$	49,000	$	239,750	$	—	$	—	$	—	$	—	$	288,750
Catherine P. Lego	$	46,000	$	239,750	$	—	$	—	$	—	$	—	$	285,750
Seiichi Watanabe	$	46,000	$	379,676	$	—	$	—	$	—	$	5,630	$	431,306
Patricia S. Wolpert (1)	$	44,000	$	207,064	$	—	$	—	$	—	$	—	$	251,064


(1)		Director Patricia Wolpert received a pro-rated annual cash retainer equal to $18,000 during fiscal year 2007, in recognition of her services as a director during a portion of calendar year 2006, for which she had not previously received cash compensation. Ms. Wolpert was granted 2,500 restricted shares on December 5, 2006. The shares vested on August 14, 2007.

(2)		On February 15, 2007, each Director was granted 4,440 restricted stock units based on the closing price of the Company’s Common Stock of $45.14. The units vested on November 1, 2007, with receipt deferred until January 31, 2008.

(3)		Each Director (excluding Mr. Watanabe and Ms. Wolpert) received a grant of 5,000 restricted shares on January 31, 2006 based on the closing price of the Company’s Common Stock of $46.43. The units vested on January 31, 2007.

(4)		Mr. Watanabe was granted 10,000 restricted shares on January 31, 2006 based on the closing price of the Company’s Common Stock of $46.43. The units vested on January 31, 2007.

(5)		Reflects interest earned in fiscal year 2007 on deferred compensation, to the extent that the interest rate exceeded 120% of the applicable federal long-term rate.

(6)		Value of fees for visa and immigration services provided to Dr. Watanabe in Fiscal Year 2007.

(7)		Value of fees for tax services provided to Dr. Watanabe in Fiscal Year 2007.

Lam Research’s non-employee directors received the following compensation for their services for calendar year 2007: annual cash retainer of $42,000; cash retainer of $2,000 for service as the chair of a committee; and cash retainer of $2,000 for service as lead director. No additional compensation in the form of meeting fees was provided for calendar year 2007. For calendar year 2006, the non-employee directors received the following compensation: annual cash retainer of $36,000, cash retainer of $2,000 for service as the chair of a committee; cash retainer of $2,000 for service as lead director; and $1,000 for each meeting attended in person on a day other than a regularly scheduled board meeting. Lam Research’s non-employee directors will receive the following compensation for their services for calendar year 2008: annual cash retainer of $42,000; cash retainer of $7,500 for service as the chair of a committee other than the Audit Committee; cash retainer of $10,000 for service as the chair of the Audit Committee; and cash retainer of $7,500 for service as lead director.

In addition, former members of Lam Research’s Board of Directors can participate in the Company’s Executive Retirement Medical Benefit Plan if they meet the eligibility requirements. Lam Research’s accumulated post-retirement benefit obligation for the eligible directors under SFAS No. 106 is shown below:


Name	FY 2007
David G. Arscott	$	51,000
Robert M. Berdahl	$	41,000
Richard J. Elkus, Jr.	$	38,000
Jack R. Harris	$	47,000
Catherine P. Lego	$	13,000

Item 12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The table below sets forth the beneficial ownership of shares of Common Stock of the Company by: (i) each person or entity whom, based on information ~~required by this Item~~obtained, the Company knows to beneficially own more than 5% of the Company’s Common Stock, and the address of each such person or entity (“5% stockholder”); (ii) each current director of the Company; (iii) each named executive officer (“named executive”) described above in the Compensation Discussion & Analysis section; and (iv) all current directors and current executive officers as a group. With the exception of 5% stockholders, the information below concerning the number of shares beneficially owned is ~~incorporated by reference~~provided with respect to ~~our Proxy Statement~~holdings as of February 15, 2008, the most recent practicable date for such determination (the “Ownership Date”), and, with respect to the 5% stockholders, the information below is provided with respect to holdings as of December 31, 2007, unless otherwise identified. The percentage is calculated using 124,768,843 as the number of shares of the Company’s Common Stock outstanding as of the Ownership Date.


	Shares
	Beneficially			Percent of
Name of Person or Identity of Group	Owned⁽¹⁾			Class
Wellington Management Company LLP		13,631,400	⁽²⁾		10.9	%
75 State Street
Boston, Massachusetts 02109

AXA Assurances Mutuelles		9,188,800	⁽²⁾		7.4	%
25, Avenue Matignon
Paris, France 75008

AllianceBernstein LP		9,157,365	⁽²⁾		7.3	%
13456 Avenue of the Americas
New York, New York 10105

Capital Group International, Inc.		6,917,820	⁽²⁾		5.5	%
1100 Santa Monica Blvd.
Los Angeles, California 90025

James W. Bagley		183,000			*
David G. Arscott		111,175			*
Robert M. Berdahl		40,140			*
Richard J. Elkus, Jr.		122,810			*
Jack R. Harris		83,770			*
Grant M. Inman		152,190			*
Catherine P. Lego		9,440			*
Stephen G. Newberry		210,500			*
Seiichi Watanabe		11,440			*
Patricia S. Wolpert		6,940			*
Martin B. Anstice		8,117			*
Nicolas J. Bright		1,152	⁽³⁾		*
Richard A. Gottscho		3,030			*
Abdi Hariri		4,398			*
Ernest E. Maddock		32,374			*
All current directors and current executive officers as a group (15 persons)⁽⁴⁾		993,112			*


*		Less than one percent


(1)		Includes shares subject to outstanding stock options and restricted stock units (RSUs) that are exercisable within 60 days after February 15, 2008, if any, with respect to:


James Bagley	2,000 options	Seiichi Watanabe	0 RSUs
David Arscott	63,000 options & RSUs	Patricia Wolpert	0 RSUs
Robert Berdahl	33,000 options & RSUs	Martin Anstice	2,849 options
Richard Elkus, Jr.	81,000 options & RSUs	Thomas Bondur	11,466 options
Jack Harris	63,000 options & RSUs	Nicolas Bright	0 options
Grant Inman	51,000 options & RSUs	Richard Gottscho	2,800 options
Catherine Lego	0 RSUs	Abdi Hariri	1,822 options
Stephen Newberry	210,500 options	Ernest Maddock	31,850 options


(2)		Beneficial ownership calculations for 5% stockholders are based on publicly filed Schedules 13D or 13G, which 5% stockholders are required to file with the SEC, and which generally set forth ownership interests as of December 31, 2007.

(3)		Includes 120 shares held in trust for Mr. Bright’s dependent children.

(4)		Current directors and current executive officers, as of February 15, 2008, include: Mr. Bagley, Mr. Arscott, Dr. Berdahl, Mr. Elkus, Mr. Harris, Mr. Inman, Ms. Lego, Mr. Newberry, Dr. Watanabe, Ms. Wolpert, Mr. Anstice, Mr. Bondur, Mr. Gottscho, Mr. Hariri, and Mr. Maddock.

SECURITIES AUTHORIZED FOR ISSUANCE UNDER
EQUITY COMPENSATION PLANS

The following table provides information as of June 24, 2007, regarding securities authorized for issuance under the ~~headings “Proposal No. 1-Election~~Company’s equity compensation plans. The equity compensation plans of ~~Directors”, “Security Ownership of Certain Beneficial Owners~~the Company include the 1991 Stock Option Plan, the 1996 Performance-Based Restricted Stock Plan, the 1997 Stock Incentive Plan, the 1999 Stock Option Plan, the 2007 Equity Incentive Plan, and ~~Management” and “Securities Authorized for Issuance Under Equity Compensation Plans.”~~the 1999 Employee Stock Purchase Plan.

Number of Securities

Remaining Available

for Future Issuance

Number of Securities

Weighted-Average

Under Equity

to be Issued Upon

Exercise Price of

Compensation Plans

Exercise of

Outstanding Options,

(excluding securities

Outstanding Options,

Warrants, and

reflected in column

Plan Category

Warrants, and Rights

Rights⁽⁵⁾

(a))

(a)

(b)

(c)

Equity compensation plans approved by security holders

1,734,273

⁽¹⁾⁽²⁾

19.09

26,084,502

⁽³⁾

Equity compensation plans not approved by security holders

3,394,542

⁽⁴⁾

20.68

2,669,719

Total

5,128,815

20.37

28,754,221


⁽¹⁾		Includes shares issuable under the Company’s 1997 Stock Incentive Plan (the “1997 Plan”). The 1997 Plan was adopted by the Board in May 1997 and approved by the stockholders of the Company in August 1997. In October 2002, the Board amended the 1997 Plan to provide for the issuance of restricted stock unit awards, allow all 1997 Plan participants to participate in exchanges of stock options previously permitted under the 1997 Plan, and provide that vesting of restricted stock, deferred stock, performance share and restricted stock unit awards would be determined by the Administrator of the Plan at the time of the award grant.

		Pursuant to the provisions of the 1997 Plan approved by the Company’s stockholders, the number of shares reserved for issuance under the plan will automatically be increased each calendar quarter if and to the extent necessary to provide that the ratio of (a) the number of shares reserved for issuance under all of the Company’s stock-based incentive plans to (b) the total number of shares of Lam Research Common Stock outstanding on a fully-diluted basis will be equal to 18.5%; provided, that the number of shares reserved for issuance under the Lam 1997 Stock Plan will in no event exceed fifteen million shares. During fiscal year 2007, there were no additional amounts reserved for issuance.


⁽²⁾		Includes shares issuable under the Company’s 2007 Stock Incentive Plan, as amended (the “2007 Plan”). The 2007 Plan was adopted by the Board in August 2006, approved by the stockholders of the Company in November 2006, and amended by the Board in November 2006. The 2007 Plan reserves for issuance up to 15,000,000 shares of the Company’s Common Stock.

⁽³⁾		Includes 3,313,227 shares available for future issuance under the 1999 Employee Stock Purchase Plan (“1999 ESPP”). This number does not include shares that may be added to the 1999 ESPP share reserve in the future in accordance with the terms of the 1999 ESPP, as amended.

⁽⁴⁾		Includes shares issuable under the Company’s 1999 Stock Option Plan (the “1999 Option Plan”). The 1999 Option Plan reserves for issuance up to 27,500,000 shares of the Company’s Common Stock.

		The 1999 Option Plan was adopted by the Board as of November 5, 1998 (the “Effective Date”) and amended and restated as of October 16, 2002 and November 7, 2002. All directors, officers and employees of Lam and its designated subsidiaries, as well as consultants, advisors or independent contractors who provide valuable services to the Company or such subsidiaries, are eligible to participate in the 1999 Option Plan.

		Nonstatutory stock options, deferred stock, restricted stock, performance shares, and restricted stock unit awards (collectively, the “Awards”) may be granted under the plan. Stock options granted under the 1999 Option Plan must have an exercise price that is not less than the fair market value of the Company’s Common Stock on the date of the grant. The Administrator shall determine the participants to whom Awards shall be granted and the terms of such Awards. The 1999 Option Plan terminates ten years from the Effective Date.

		In the event of a corporate transaction such as a change of control, the 1999 Option Plan provides that each outstanding Award shall be assumed, or an equivalent Award substituted, by the successor corporation or a parent or subsidiary of the successor corporation. In the event that the successor corporation does not agree to assume the Award or substitute an equivalent Award, subject to limitations that may be placed on an Award on the date of grant, outstanding Awards shall accelerate and become fully exercisable.

⁽⁵⁾		Does not include restricted stock units (RSUs) with an exercise price of $0.00.

Item 13.Certain Relationships and Related Transactions, and Director Independence

No family relationships exist or existed during fiscal year 2007 among any of the Company’s directors and executive officers. No related-party transactions occurred during fiscal year 2007. The information ~~required by this Item~~regarding the identity of each director who is “independent” in accordance with NASDAQ and other applicable criteria is incorporated by reference ~~to our Proxy Statement under the heading “Certain Relationships~~from Item 10, “Directors, Executive Officers and ~~Related Transactions”.~~Corporate Governance—Director Independence” and “Directors, Executive Officers and Corporate Governance—Board Meetings and Committees”, above.

Item 14.Principal Accounting Fees and Services

Ernst & Young LLP has audited the Company’s consolidated financial statements since the Company’s inception.

Fees Billed by Ernst & Young LLP

The table below shows the fees billed by Ernst & Young LLP for audit and other services provided to the Company in fiscal years 2007 and 2006.


Services / Type of Fee	Fiscal Year 2007		Fiscal Year 2006

Audit Fees⁽¹⁾	$	2,132,000	$	2,137,000
Audit-Related Fees⁽²⁾		147,000		136,000
Tax Fees⁽³⁾		—		—
All Other Fees⁽⁴⁾		—		—

TOTAL	$	2,279,000	$	2,273,000


⁽¹⁾		Audit fees represent fees for professional services provided in connection with the audits of annual financial statements, reviews of quarterly financial statements, and audit services related to other statutory or regulatory filings or engagements. In addition, audit fees include those fees related to Ernst & Young LLP’s audit of the effectiveness of the Company’s internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act.


⁽²⁾		Audit-related fees consist of assurance and related services that are reasonably related to the audit or review of the Company’s financial statements and are not reported above under “Audit Fees.”

⁽³⁾		Tax fees represent fees for services primarily related to international tax compliance.

⁽⁴⁾		All other fees relate principally to fees for subsidiary-related services.

The Audit Committee reviewed summaries of the services provided by Ernst & Young LLP and the related fees during fiscal year 2007 and has determined that the provision of non-audit services was compatible with maintaining the independence of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm. The Audit Committee approved 100% of the services and related fee amounts for services provided by Ernst & Young LLP during fiscal year 2007.

Policy on Audit Committee Pre-Approval of Audit and Non-Audit Services

It is the responsibility of the Audit Committee to approve, in accordance with Sections 10A(h) and (i) of the Exchange Act and the Rules and Regulations of the SEC, all professional services, to be provided to the Company by its Independent Registered Public Accounting Firm, ~~Fees~~provided that the Audit Committee shall not approve any non-audit services proscribed by Section 10A(g) of the Exchange Act in the absence of an applicable exemption.

It is the policy of the Company that the Audit Committee pre-approves all audit and ~~Services~~

~~The information required~~permissible non-audit services provided by ~~this Item is incorporated by reference to our Proxy Statement under~~ the ~~heading “Relationship with~~Company’s Independent Registered Public Accounting ~~Firm.”~~Firm, consistent with the criteria set forth in the Audit Committee Charter and applicable laws and regulations. The Committee has delegated to the Chair of the Committee the authority to pre-approve such services, provided that the Chair shall report any decision on his part to pre-approve such services to the full Audit Committee at its next regular meeting. These services may include audit services, audit-related services, tax services, and other services. The Independent Registered Public Accounting Firm and Company management are required to periodically report to the Audit Committee regarding the extent of services provided by the Independent Registered Public Accounting Firm pursuant to any such pre-approval.

3588

LAM RESEARCH CORPORATION

CONSOLIDATED BALANCE SHEETS

(in thousands, except per share data)


							June 24,			June 25,
	June 25,			June 26,			2007			2006
	2006			2005						As restated (1)
ASSETS
Cash and cash equivalents	$	910,815		$	482,250		$	573,967		$	910,815
Short-term investments		139,524			327,003			96,724			139,524
Accounts receivable, less allowance for doubtful accounts of $3,822 as of June 25, 2006 and $3,865 as of June 26, 2005		407,347			232,005
Accounts receivable, less allowance for doubtful accounts of $3,851 as of June 24, 2007 and $3,822 as of June 25, 2006								410,013			407,347
Inventories		168,714			110,051			235,431			168,714
Deferred income taxes		53,625			76,660			61,727			53,625
Prepaid expenses and other current assets		26,344			16,867			38,499			26,344

Total current assets		1,706,369			1,244,836			1,416,361			1,706,369
Property and equipment, net		49,893			41,082			113,725			49,893
Restricted cash and investments		470,038			85,038			360,038			470,038
Deferred income taxes		38,533			43,224			27,414			52,571
Goodwill								59,741			—
Intangible assets, net								70,909			14,643
Other assets		48,511			34,635			53,417			33,868

Total assets	$	2,313,344		$	1,448,815		$	2,101,605		$	2,327,382


LIABILITIES AND STOCKHOLDERS’ EQUITY
Trade accounts payable	$	108,504		$	60,218		$	117,617		$	108,504
Accrued expenses and other current liabilities		317,637			229,207			364,296			319,060
Deferred profit		140,085			89,708			190,885			140,085

Total current liabilities		566,226			379,133			672,798			567,649
Long-term debt		350,000			—			250,000			350,000
Other long-term liabilities		969			2,786			2,487			969

Total liabilities		917,195			381,919			925,285			918,618
Commitments and contingencies
Stockholders’ equity:
Preferred stock, at par value of $0.001 per share; authorized - 5,000 shares, none outstanding		—			—			—			—
Common stock, at par value of $0.001 per share; authorized - 400,000 shares; issued and outstanding - 141,785 shares at June 25, 2006 and 137,313 shares at June 26, 2005		142			137
Common stock, at par value of $0.001 per share; authorized - 400,000 shares; issued and outstanding - 123,535 shares at June 24, 2007 and 141,785 shares at June 25, 2006								124			142
Additional paid-in capital		973,391			744,672			1,194,215			1,051,851
Deferred stock-based compensation		—			(1,225	)
Treasury stock, at cost, 13,532 shares at June 25, 2006 and 7,215 shares at June 26, 2005		(416,447	)		(186,064	)
Treasury stock, at cost, 34,168 shares at June 24, 2007 and 13,532 shares at June 25, 2006								(1,483,169	)		(416,447	)
Accumulated other comprehensive loss		(11,205	)		(10,789	)		(4,302	)		(11,205	)
Retained earnings		850,268			520,165			1,469,452			784,423

Total stockholders’ equity		1,396,149			1,066,896			1,176,320			1,408,764

Total liabilities and stockholders’ equity	$	2,313,344		$	1,448,815		$	2,101,605		$	2,327,382

LAM RESEARCH CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)


										Year Ended
	YEAR ENDED									June 24,			June 25,			June 26,
	June 25,			June 26,			June 27,			2007			2006			2005
	2006			2005			2004						As restated (1)			As restated (1)
Total revenue	$	1,642,171		$	1,502,453		$	935,946		$	2,566,576		$	1,642,171		$	1,502,453
Cost of goods sold		814,777			738,361			506,548			1,261,522			815,159			738,989
Cost of goods sold — restructuring recoveries		—			—			(1,651	)

Total cost of goods sold		814,777			738,361			504,897

Gross margin		827,394			764,092			431,049			1,305,054			827,012			763,464

Research and development		228,891			194,115			170,479			285,348			229,378			195,289
Selling, general and administrative		192,238			164,774			146,063			241,046			192,866			165,832
Restructuring charges, net		—			14,201			8,327			—			—			14,201

Total operating expenses		421,129			373,090			324,869			526,394			422,244			375,322

Operating income		406,265			391,002			106,180			778,660			404,768			388,142
Other income (expense):
Interest income		38,189			17,537			9,915			71,666			38,189			17,537
Interest expense		(677	)		(1,413	)		(4,634	)		(17,817	)		(677	)		(1,413	)
Favorable legal judgment											15,834			—			—
Other, net		(2,490	)		(8,004	)		(811	)		(620	)		(2,490	)		(8,004	)

		35,022			8,120			4,470

Income before income taxes		441,287			399,122			110,650			847,723			439,790			396,262
Income tax expense		105,532			99,781			27,662			161,907			104,580			99,010

Net income	$	335,755		$	299,341		$	82,988		$	685,816		$	335,210		$	297,252

Net income per share:
Basic net income per share	$	2.42		$	2.17		$	0.63		$	4.94		$	2.42		$	2.16

Diluted net income per share	$	2.34		$	2.10		$	0.59		$	4.85		$	2.33		$	2.09

Number of shares used in per share calculations:
Basic		138,581			137,727			131,776			138,714			138,581			137,727

Diluted		143,732			142,417			144,928			141,524			143,759			142,460

LAM RESEARCH CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)


										Year Ended
	YEAR ENDED									June 24,			June 25,			June 26,
	June 25,			June 26,			June 27,			2007			2006			2005
	2006			2005			2004						As restated (1)			As restated (1)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$	335,755		$	299,341		$	82,988		$	685,816		$	335,210		$	297,252
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		22,000			25,517			28,240			38,097			22,000			25,517
Deferred income taxes		27,726			89,352			10,862			17,055			37,222			89,310
Restructuring charges, net		—			14,201			6,676			—			—			14,201
Amortization of premiums on securities		2,683			3,285			3,966
Asset impairment charge		—			—			3,025
Loss on disposal of long-lived assets		—			—			732
Amortization of premiums/discounts on securities											(658	)		2,683			3,285
Equity-based compensation expense		22,768			864			3,167			35,554			23,993			3,588
Net noncash gain on retirement of 4% Notes		—			—			(7,505	)
Income tax benefit on equity-based compensation plans		27,786			2,050			1,421			62,437			17,338			1,140
Excess tax benefit on equity-based compensation plans		(17,805	)		—			—			(44,990	)		(11,110	)		—
Other, net		(326	)		(431	)		(251	)		1,283			(326	)		(431	)
Changes in working capital accounts:
Accounts receivable, net of allowance		(178,542	)		13,470			(138,361	)		(513	)		(178,542	)		13,470
Inventories		(59,038	)		(2,588	)		5,136			(56,336	)		(59,038	)		(2,588	)
Prepaid expenses and other assets		(9,270	)		(455	)		6,528			(19,180	)		(9,270	)		(455	)
Trade accounts payable		48,341			(33,108	)		57,847			9,055			48,341			(33,108	)
Deferred profit		50,675			(18,936	)		63,105			51,112			50,675			(18,936	)
Accrued expenses and other liabilities		87,934			33,368			29,573			44,827			88,206			33,685

Net cash provided by operating activities		360,687			425,930			157,149			823,559			367,382			425,930


CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets		(42,080	)		(22,849	)		(24,026	)		(59,968	)		(42,080	)		(22,849	)
Acquisitions of businesses											(181,108	)		—			—
Sales of other investments											3,000			—			—
Purchases of available-for-sale securities		(129,464	)		(247,392	)		(463,476	)		(1,058,081	)		(129,464	)		(247,392	)
Sales and maturities of available-for-sale securities		312,252			184,083			530,406			1,103,311			312,252			184,083
Transfer of restricted cash and investments		(385,000	)		27,430			6,000			110,000			(385,000	)		27,430
Other, net		—			—			(398	)

Net cash provided by / (used for) investing activities		(244,292	)		(58,728	)		48,506
Net cash used for investing activities											(82,846	)		(244,292	)		(58,728	)


CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on long-term debt and capital lease obligations		(112	)		—			(300,012	)		(100,171	)		(112	)		—
Net proceeds from issuance of long-term debt		349,632			—			—			—			349,632			—
Proceeds from settlement of swap		—			—			10,870
Excess tax benefit on equity-based compensation plans		17,805			—			—			44,990			11,110			—
Treasury stock purchases		(251,211	)		(167,081	)		—			(1,083,745	)		(251,211	)		(167,081	)
Reissuances of treasury stock		15,171			458			13,242			18,123			15,171			458
Proceeds from issuance of common stock		179,400			114,304			64,152			42,468			179,400			114,304

Net cash provided by / (used for) financing activities		310,685			(52,319	)		(211,748	)
Net cash provided by (used for) financing activities											(1,078,335	)		303,990			(52,319	)

Effect of exchange rate changes on cash		1,485			3,964			2,153			774			1,485			3,964
Net increase in cash and cash equivalents		428,565			318,847			(3,940	)
Net increase (decrease) in cash and cash equivalents											(336,848	)		428,565			318,847
Cash and cash equivalents at beginning of year		482,250			163,403			167,343			910,815			482,250			163,403

Cash and cash equivalents at end of year	$	910,815		$	482,250		$	163,403		$	573,967		$	910,815		$	482,250


Schedule of noncash transactions
Acquisition of leased equipment	$	1,088		$	—		$	—
Schedule of noncash transactions Acquisition of leased equipment										$	—		$	1,088		$	—


Supplemental disclosures:
Cash payments for interest	$	531		$	1,341		$	13,600		$	17,700		$	531		$	1,341

Cash payments for income taxes	$	11,873		$	7,339		$	4,165		$	53,508		$	11,873		$	7,339

LAM RESEARCH CORPORATION

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(in thousands)


													DEFERRED			ACCUMULATED																					DEFERRED
	COMMON						ADDITIONAL						STOCK-			OTHER															ADDITIONAL						STOCK-			ACCUMULATED
	STOCK			COMMON			PAID-IN			TREASURY			BASED			COMPREHENSIVE			RETAINED						COMMON						PAID-IN						BASED			OTHER			RETAINED
	SHARES			STOCK			CAPITAL			STOCK			COMPENSATION			INCOME (LOSS)			EARNINGS			TOTAL			STOCK			COMMON			CAPITAL,			TREASURY			COMPENSATION			COMPREHENSIVE			EARNINGS			TOTAL
Balance at June 29, 2003		127,435		$	127		$	560,273		$	(38,670	)		(2,769	)	$	(13,694	)	$	143,817		$	649,084
																									SHARES			STOCK			As restated (1)			STOCK			As restated (1)			INCOME (LOSS)			As restated (1)			As restated (1)
Sale of common stock		6,224			7			64,145			—			—			—			—			64,152
Income tax benefit from stock option transactions		—						1,421			—			—			—			—			1,421
Reissuance of treasury stock		1,329			1			—			18,928			—			—			(5,686	)		13,243
Deferred stock-based compensation		—			—			2,237			—			(2,237	)		—			—			—
Amortization of deferred compensation		—			—			—			—			3,167			—			—			3,167
Components of comprehensive income:
Net income		—			—			—			—			—			—			82,988			82,988
Foreign currency translation adjustment		—			—			—			—			—			1,808			—			1,808
Unrealized loss on fair value of derivative financial instruments, net		—			—			—			—			—			(293	)		—			(293	)
Unrealized loss on financial instruments, net		—			—			—			—			—			(2,665	)		—			(2,665	)
Less: reclassification adjustment for gains included in earnings		—			—			—			—			—			(439	)		—			(439	)

Total comprehensive income																							81,399
Balance at June 27, 2004, as previously reported																										134,988		$	135		$	628,076		$	(19,742	)	$	(1,839	)	$	(15,283	)	$	221,119		$	812,466
Cumulative effect of restatements (1)																										—			—			91,476			—			(5,607	)		—			(63,211	)		22,658

Balance at June 27, 2004		134,988		$	135		$	628,076		$	(19,742	)	$	(1,839	)	$	(15,283	)	$	221,119		$	812,466

Balance at June 27, 2004, as restated (1)																										134,988		$	135		$	719,552		$	(19,742	)	$	(7,446	)	$	(15,283	)	$	157,908		$	835,124
Sale of common stock		8,155			8			114,296			—			—			—			—			114,304			8,155			8			114,296			—			—			—			—			114,304
Purchase of treasury stock		(5,855	)		(6	)		—			(167,075	)		—			—			—			(167,081	)		(5,855	)		(6	)		—			(167,075	)		—			—			—			(167,081	)
Income tax benefit from stock option transactions		—			—			2,050			—			—			—			—			2,050			—			—			1,140			—			—			—			—			1,140
Reissuance of treasury stock		25			—			—			753			—			—			(295	)		458			25			—			—			753			—			—			(295	)		458
Deferred stock-based compensation		—			—			(173	)		—			173			—			—			—
Amortization of deferred compensation		—			—			423			—			441			—			—			864
Reversal of deferred stock-based compensation due to forfeitures																										—			—			(837	)		—			837			—			—			—
Amortization of deferred-stock based compensation																										—			—			(428	)		—			4,016			—			—			3,588
Components of comprehensive income:
Net income		—			—			—			—			—			—			299,341			299,341			—			—			—			—			—			—			297,252			297,252
Foreign currency translation adjustment		—			—			—			—			—			3,584			—			3,584			—			—			—			—			—			3,584			—			3,584
Unrealized gain on fair value of derivative financial instruments, net		—			—			—			—			—			1,650			—			1,650			—			—			—			—			—			1,650			—			1,650
Unrealized loss on financial instruments, net		—			—			—			—			—			(379	)		—			(379	)		—			—			—			—			—			(379	)		—			(379	)
Less: reclassification adjustment for gains included in earnings		—			—			—			—			—			(361	)		—			(361	)		—			—			—			—			—			(361	)		—			(361	)

Total comprehensive income																							303,835																								301,746

Balance at June 26, 2005		137,313		$	137		$	744,672		$	(186,064	)	$	(1,225	)	$	(10,789	)	$	520,165		$	1,066,896

Balance at June 26, 2005, as restated (1)																										137,313		$	137		$	833,723		$	(186,064	)	$	(2,593	)	$	(10,789	)	$	454,865		$	1,089,279

Sale of common stock		9,914			10			179,390			—			—			—			—			179,400			9,914			10			179,390			—			—			—			—			179,400
Purchase of treasury stock		(6,979	)		(6	)					(251,205	)		—			—			—			(251,211	)		(6,979	)		(6	)					(251,205	)		—			—			—			(251,211	)
Income tax benefit on equity-based compensation plans		—			—			27,786			—			—			—			—			27,786			—			—			17,338			—			—			—			—			17,338
Reissuance of treasury stock		658			1			—			20,822			—			—			(5,652	)		15,171			658			1			—			20,822			—			—			(5,652	)		15,171
Equity-based compensation expense		—			—			22,768			—			—			—			—			22,768			—			—			23,993			—			—			—			—			23,993
Deferred compensation adjustment		—			—			(1,225	)		—			1,225			—			—			—			—			—			(2,593	)		—			2,593			—			—			—
Exercise of warrant		879																					—			879			—			—			—			—			—			—			—
Components of comprehensive income:
Net income		—			—			—			—			—			—			335,755			335,755			—			—			—			—			—			—			335,210			335,210
Foreign currency translation adjustment		—			—			—			—			—			2,061			—			2,061			—			—			—			—			—			2,061			—			2,061
Unrealized gain on fair value of derivative financial instruments, net		—			—			—			—			—			6,200			—			6,200			—			—			—			—			—			6,200			—			6,200
Unrealized loss on financial instruments, net		—			—			—			—			—			(916	)		—			(916	)		—			—			—			—			—			(916	)		—			(916	)
Less: reclassification adjustment for gains included in earnings		—			—			—			—			—			(7,761	)		—			(7,761	)		—			—			—			—			—			(7,761	)		—			(7,761	)

Total comprehensive income																							335,339																								334,794

Balance at June 25, 2006		141,785		$	142		$	973,391		$	(416,447	)	$	—		$	(11,205	)	$	850,268		$	1,396,149

Balance at June 25, 2006, as restated (1)																										141,785		$	142		$	1,051,851		$	(416,447	)	$	—		$	(11,205	)	$	784,423		$	1,408,764

Sale of common stock																										2,388			2			42,466			—			—			—			—			42,468
Purchase of treasury stock																										(21,202	)		(21	)		—			(1,083,724	)		—			—			—			(1,083,745	)
Income tax benefit on equity-based compensation plans																										—			—			62,437			—			—			—			—			62,437
Reissuance of treasury stock																										564			1			1,907			17,002			—			—			(787	)		18,123
Equity-based compensation expense																										—			—			35,554			—			—			—			—			35,554
Components of comprehensive income:
Net income																										—			—			—			—			—			—			685,816			685,816
Foreign currency translation adjustment																										—			—			—			—			—			1,755			—			1,755
Unrealized gain on fair value of derivative financial instruments, net																										—			—			—			—			—			5,355			—			5,355
Unrealized gain on financial instruments, net																										—			—			—			—			—			82			—			82
Less: reclassification adjustment for losses included in earnings																										—			—			—			—			—			505			—			505

Total comprehensive income																																															693,513
Adjustment to initially apply SFAS No. 158																										—			—			—			—			—			(794	)		—			(794	)

Balance at June 24, 2007																										123,535		$	124		$	1,194,215		$	(1,483,169	)	$	—		$	(4,302	)	$	1,469,452		$	1,176,320

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
JUNE ~~25, 2006~~24, 2007

Note 1: Company and Industry Information

Lam Research Corporation ~~(Lam~~(“Lam Research” or the ~~Company)~~“Company”) designs, manufactures, markets, and services semiconductor processing equipment used in the fabrication of integrated circuits and is recognized as a major provider of ~~wafer fabrication~~such equipment ~~and services~~ to the ~~world’s~~worldwide semiconductor industry. Semiconductor wafers are subjected to a complex series of process steps that result in the simultaneous creation of many individual integrated circuits. The Company ~~actively markets and sells product offerings that include single-wafer plasma etch systems with a wide range of applications and an array of services designed~~leverages its expertise in these areas to ~~optimize the utilization of these systems by~~develop integrated processing solutions which typically benefit its ~~customers.~~customers through reduced cost, lower defect rates, enhanced yields, or faster processing time. The Company sells its products and services primarily to companies involved in the production of semiconductors in the United States, Europe, Taiwan, Korea, Japan, ~~Korea,~~ and Asia Pacific.

The semiconductor industry is cyclical in nature and has historically experienced periodic downturns and upturns. Today’s leading indicators of changes in customer investment patterns may not be any more reliable than in prior years. Demand for the Company’s equipment can vary significantly from period to period as a result of various factors, including, but not limited to, economic conditions, supply, demand, and prices for semiconductors, customer capacity requirements, and the Company’s ability to develop and market competitive products. For these and other reasons, the Company’s results of operations for fiscal years 2007, 2006, ~~2005,~~ and ~~2004~~2005 may not necessarily be indicative of future operating results.

Note 2: Summary of Significant Accounting Policies

The preparation of financial statements, in conformity with U.S. generally accepted accounting principles requires management to make judgments, estimates, and assumptions that could affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. The Company based its estimates and assumptions on historical experience and on various other assumptions believed to be applicable, and evaluates them on an on-going basis to ensure they remain reasonable under current conditions. Actual results could differ significantly from those estimates.

Revenue Recognition:The Company recognizes all revenue when persuasive evidence of an arrangement exists, delivery has occurred and title has passed or services have been rendered, the selling price is fixed or determinable, collection of the receivable is reasonably assured, and the Company has completed its system installation obligations, received customer acceptance or is otherwise released from its installation or customer acceptance obligations. In the event that terms of the sale provide for a lapsing customer acceptance period, the Company recognizes revenue upon the expiration of the lapsing acceptance period or customer acceptance, whichever occurs first. In circumstances where the practices of a customer do not provide for a written acceptance or the terms of sale do not include a lapsing acceptance provision, the Company recognizes revenue where it can be reliably demonstrated that the delivered system meets all of the ~~agreed to~~agreed-to customer specifications. In situations with multiple deliverables, revenue is recognized upon the delivery of the separate elements to the customer and when the Company receives customer acceptance or is otherwise released from its customer acceptance obligations. Revenue from ~~multiple element~~multiple-element arrangements is allocated among the separate elements based on their relative fair values, provided the elements have value on a stand alone basis, there is objective and reliable evidence of fair value, the arrangement does not include a general right of return relative to the delivered item and delivery or performance of the undelivered item(s) is considered probable and substantially in the Company’s control. The maximum revenue recognized on a delivered element is limited to the amount that is not contingent upon the delivery of additional items. Revenue related to sales of spare parts and system upgrade kits is generally recognized upon shipment. Revenue related to services is generally recognized upon completion of the services requested by a customer order. Revenue for extended maintenance service contracts with a fixed payment amount is recognized on a straight-line basis over the term of the contract.

Inventory Valuation: Inventories are stated at the lower of cost or market using standard costs, which approximate actual costs on a first-in, first-out basis. The Company maintains a perpetual inventory system and continuously records the quantity on-hand and standard cost for each product, including purchased components, subassemblies and finished goods. The Company maintains the integrity of perpetual inventory records through periodic physical counts of quantities on hand. Finished goods are reported as inventories until the point of title transfer to the customer. Generally, title transfer is documented in the terms of sale. When the terms of sale do not specify, the Company assumes title transfers when it completes physical transfer of the products to the freight carrier unless other customer practices prevail. Transfer of title for shipments to Japanese customers generally occurs at time of customer acceptance.

Standard costs are re-assessed at least annually and reflect achievable acquisition costs, generally the most recent vendor contract prices for purchased parts, currently obtainable assembly and test labor ~~performance~~utilization levels, methods of manufacturing, and overhead for internally manufactured

Warranty: Typically, the sale of semiconductor capital equipment includes providing parts and service warranty to customers as part of the overall price of the system. The Company offers standard warranties for its systems that run generally for a period of 12 months from system acceptance, not to exceed 14 months from shipment of the system to the customer. When appropriate, the Company records a provision for estimated warranty expenses to cost of sales for each system upon revenue recognition. The amount recorded is based on an analysis of historical activity, which uses factors such as type of system, customer, geographic region, and any known factors such as tool reliability trends. All actual parts and labor costs incurred in subsequent periods are charged to those established reserves through the application of detailed project ~~record keeping.~~record-keeping.

Actual warranty expenses are incurred on a system-by-system basis, and may differ from the Company’s original estimates. While the Company periodically monitors the performance and cost of warranty activities, if actual costs incurred are different than its estimates, the Company may recognize adjustments to provisions in the period in which those differences arise or are identified. The Company does not maintain general or unspecified reserves; all warranty reserves are related to specific systems.

In addition to the provision of standard warranties, the Company offers customer-paid extended warranty services. Revenues for extended maintenance and warranty services with a fixed payment amount are recognized on a straight-line basis over the term of the contract. Related costs are recorded either as incurred or when related liabilities are determined to be probable and estimable.

Equity-based Compensation — Employee Stock Purchase Plan and Employee Stock Plans: ~~Beginning on June 27, 2005 the~~The Company accounts for its employee stock purchase plan (ESPP) and stock plans under the provisions of SFAS No. 123R. SFAS No. 123R requires the recognition of the fair value of equity-based compensation in net income. The fair value of the Company’s restricted stock units was calculated based upon the fair market value of ~~its~~Company stock at the date of grant. The fair value of the Company’s stock options and ESPP awards was estimated using a Black-Scholes option valuation model. This model requires the input of highly subjective assumptions and elections in adopting and implementing SFAS No. 123R, including expected stock price volatility and the estimated life of each award. The fair value of equity-based awards is amortized over the vesting period of the award, and the Company has elected to use the straight-line method for awards granted after the adoption of SFAS No. 123R and continues to use a graded vesting method for awards granted prior to the adoption of SFAS No. 123R.

The Company makes quarterly assessments of the adequacy of its tax credit pool to determine if there are any deficiencies which require recognition in its consolidated statements of operations. Prior to the adoption of SFAS No. 123R, the Company accounted for its ESPP and stock option plans under the provisions of Accounting Principles Board (APB) Opinion No. 25 “Accounting For Stock Issued to Employees” (APB No. 25) and Financial Accounting Standards Board (FASB) Interpretation No. 44, “Accounting for Certain Transactions Involving Stock Compensation — an Interpretation of APB Opinion No. 25” and made pro forma footnote disclosures as required by Statement of Financial Accounting Standards (SFAS) No. 148, “Accounting For Stock-Based Compensation — Transition and Disclosure”, which amends SFAS No. 123, “Accounting For Stock-Based Compensation”. Pro forma net income and pro forma net income per share disclosed in the footnotes to the Company’s consolidated financial statements were estimated using a Black-Scholes option valuation model. As a result of the adoption of SFAS No. 123R, the Company will only recognize a benefit from stock-based compensation in paid-in-capital if an incremental tax benefit is realized after all other tax attributes currently available to the Company have been utilized. In addition, the Company has elected to account for the indirect benefits of stock-based compensation on the research tax credit and the extraterritorial income deduction through the income statement (continuing operations) rather than through paid-in-capital. The Company has also elected to net deferred tax assets and the associated valuation allowance related to net operating loss and tax credit carryforwards for the accumulated stock award tax benefits determined under APB No. 25 for income tax footnote disclosure purposes. The Company will track these stock award attributes separately and will only recognize these attributes through paid-in-capital in accordance with Footnote 82 of ~~SFAS123(R)~~SFAS No. 123R.

In connection with the Company’s restatement of the consolidated financial statements, the Company has applied judgment in choosing whether to revise measurement dates and if revised which measurement date to select for prior option grants. Information regarding the restatement is set forth below in Note 3, “Restatement of Consolidated Financial Statements” in these Notes to Consolidated Financial Statements and in “Restatement of Previously Issued Financial Statements” in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of the Company’s Annual Report on Form 10-K as of and for the year ended June 24, 2007 (the “2007 Form 10-K”).

Income ~~Taxes~~Taxes:- Deferred income taxes reflect the net effect of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The Company records a valuation allowance to reduce its deferred tax assets to the amount that is more likely than not to be realized. Realization of the Company’s net deferred tax assets is dependent on future taxable income. The Company believes it is more likely than not that such assets will be realized; however, ultimate realization could be negatively impacted by market conditions and other variables not known or anticipated at this time. In the event that the Company determines that it would not be able to realize all or part of its net deferred tax assets, an adjustment would be charged to earnings in the period such determination is made. Likewise, if the Company later determines that it is more likely than not that the deferred tax assets would be realized, then the previously provided valuation allowance would be reversed.

The Company calculates its current and deferred tax provision based on estimates and assumptions that could differ from the actual results reflected in income tax returns filed during the subsequent year. Adjustments based on filed returns are recorded when identified.

The Company provides for income taxes on an interim basis on the basis of annual estimated effective income tax rates. The Company’s estimated effective income tax rate reflects the underlying profitability of the Company, the level of R&D spending, the regions where profits are recorded and the respective tax rates imposed. The Company carefully monitors these factors and ~~adjusts~~adjust the effective income tax rate, if necessary. If actual results differ from estimates, the Company could be required to record an additional valuation allowance on deferred tax assets or adjust its effective income tax rate, which could have a material impact on ~~its~~the Company’s business, results of operations, and financial condition.

The calculation of the Company’s tax liabilities involves dealing with uncertainties in the application of complex tax laws. The Company’s estimate for the potential outcome of any uncertain tax issue is highly judgmental. Resolution of these uncertainties in a manner inconsistent with the Company’s expectations could have a material impact on the Company’s results of operation and financial condition. The Company accounts for the income tax contingencies in accordance with SFAS No. 5, “Accounting for Contingencies.”

Goodwill and Intangible Assets:The Company accounts for goodwill and other intangible assets in accordance with Statement of Financial Accounting Standards No. 142, “Goodwill and Other Intangible Assets,” (SFAS No. 142). SFAS No. 142 requires that goodwill and identifiable intangible assets with indefinite useful lives no longer be amortized, but instead be tested for impairment at least annually. SFAS No. 142 also requires that intangible assets with estimable useful lives be amortized over their respective estimated useful lives to their estimated residual values and reviewed for impairment in accordance with SFAS No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets.” The Company reviews goodwill for impairment at least annually. In addition, the Company reviews goodwill and other intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable.

Fiscal Year:The Company follows a 52/53-week fiscal reporting calendar and its fiscal year ends on the last Sunday of June each year. The Company’s most recent fiscal year ended on June ~~25, 2006~~24, 2007 and included 52 weeks. The fiscal years ended June ~~26, 2005~~25, 2006 and June ~~27, 2004~~26, 2005 also included 52 weeks. The Company’s next fiscal year, ending on June ~~24, 2007,~~29 2008 will include 5253 weeks.

Principles of Consolidation:The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.

Cash Equivalents and Short-Term Investments:All investments purchased with an original final maturity of three months or less are considered to be cash equivalents. All of the Company’s short-term investments are classified as available-for-sale at the respective balance sheet dates. The Company accounts for its investment portfolio at fair value. The investments classified as available-for-sale are recorded at fair value based upon quoted market prices, and any material temporary difference between the cost and fair value of an investment is presented as a separate component of accumulated other comprehensive income (loss.) Unrealized losses are charged against “Other income (expense)” when a decline in fair value is determined to be other than-temporary. The Company considers several factors to determine whether a loss is other-than-temporary. These factors include but are not limited to: (i) the extent to which the fair value is less than cost basis, (ii) the financial condition and near term prospects of the issuer, (iii) the length of time a security is in an unrealized loss position and (iv) the Company’s ability to hold the security for a period of time sufficient to allow for any anticipated recovery in fair value. The Company’s ongoing consideration of these factors could result in additional impairment charges in the future, which could adversely affect its results of operation. There were no impairment charges recorded on the Company’s investment portfolio in fiscal years 2007, 2006, or 2005. The specific identification method is used to determine the realized gains and losses on investments.

Property and Equipment:Property and equipment is stated at cost. Equipment is depreciated by the straight-line method over the estimated useful lives of the assets, generally three to seven years. Leasehold improvements are amortized by the straight-line method over the shorter of the life of the related asset or the term of the underlying lease.

Impairment of Long-Lived Assets: The Company routinely considers whether indicators of impairment of long-lived assets are present. If such indicators are present, the Company determines whether the sum of the estimated undiscounted cash flows attributable to the assets in question is less than their carrying value. If the sum is less, the Company recognizes an impairment loss based on the excess of the carrying amount of the assets over their respective fair values. Fair value is determined by discounted future cash flows, appraisals or other methods. If the assets determined to be impaired are to be held and used, the Company recognizes an impairment charge to the extent the present value of anticipated net cash flows attributable to the asset are less than the asset’s carrying value. The fair value of the asset then becomes the asset’s new carrying value, which the Company depreciates over the remaining estimated useful life of the asset. Assets to be disposed of are reported at the lower of the carrying amount or fair value less cost to sell.

Derivative Financial Instruments:The Company carries derivative financial instruments (derivatives) on the balance sheet at their fair values in accordance with Statement of Financial Accounting Standards No. 133, “Accounting for Derivative Instruments and Hedging Activities” (SFAS No. 133). The Company has a policy that allows the use of derivative financial instruments, specifically foreign currency forward exchange rate contracts, to hedge foreign currency exchange rate fluctuations on forecasted revenue transactions denominated in Japanese ~~Yen~~yen and other foreign currency denominated assets. The Company does not use derivatives for trading or speculative purposes.

The Company’s policy is to attempt to minimize short-term business exposure to foreign currency exchange rate risks using an effective and efficient method to eliminate or reduce such exposures. In the normal course of business, the Company’s financial position is routinely subjected to market risk associated with foreign currency exchange rate fluctuations. To protect against the reduction in value of forecasted Japanese ~~Yen-denominated~~yen-denominated revenues, the Company has instituted a foreign currency cash flow hedging program. The Company enters into foreign currency forward exchange rate contracts that generally expire within 12 months, and no later than 24 months. These foreign currency forward exchange contracts are designated as cash flow hedges and are carried on the Company’s balance sheet at fair value with the effective portion of the contracts’ gains or losses included in accumulated other comprehensive income (loss) and subsequently recognized in ~~earnings~~revenue in the same period the hedged revenue is recognized.

Each period, hedges are tested for effectiveness using regression testing. Changes in the ~~dollar offset method, by comparing the change in~~fair value of currency forwards due to changes in time value are excluded from the ~~derivative with the change~~assessment of effectiveness and are recognized in revenue in the ~~value of the anticipated sales transactions.~~current period. To qualify for hedge accounting, the hedge relationship must meet criteria relating both to the derivative instrument and the hedged item. These include identification of the hedging instrument, the hedged item, the nature of the risk being hedged and how the hedging instrument’s effectiveness in offsetting the exposure to changes in the hedged item’s fair value or cash flows will be measured.

To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge and the hedges must be highly effective in offsetting changes to future cash flows on hedged transactions. When derivative instruments are designated and qualify as effective cash flow hedges, the Company is able to defer changes in the fair value of the hedging instrument within accumulated other comprehensive income (loss) until the hedged exposure is realized. Consequently, with the exception of hedge ineffectiveness recognized, the Company’s results of operations are not subject to fluctuation as a result of changes in the fair value of the derivative instruments. If hedges are not highly effective or if the Company does not believe that the underlying hedged forecasted transactions would occur, the Company may not be able to account for its investments in derivative instruments as cash flow hedges. If this were to occur, ~~in a~~ future ~~period,~~ changes in the fair values of the Company’s derivative instruments would be recognized in earnings without the benefits of offsets or deferrals of changes in fair value arising from hedge accounting treatment.

The Company also enters into foreign currency forward exchange rate contracts to hedge the gains and losses generated by the remeasurement of Japanese ~~Yen-denominated net~~yen-denominated receivable balances. Under SFAS No. 133, these forward contracts are not designated for hedge accounting treatment. Therefore, the change in fair value of these derivatives is recorded into earnings as a component of other income and expense and offsets the change in fair value of the foreign currency denominated intercompany and trade receivables, recorded in other income and expense, assuming the hedge contract fully covers the intercompany and trade receivable balances.

To hedge foreign currency risks, the Company uses foreign currency exchange forward contracts, where possible and practical. These forward contracts are valued using standard valuation formulas with assumptions about future foreign currency exchange rates derived from existing exchange rates and interest rates observed in the market.

The Company considers its most current outlook in determining the level of foreign currency denominated intercompany revenues to hedge as cash flow hedges. The Company combines these forecasts with historical trends to establish the portion of its expected volume to be hedged. The revenues are hedged and designated as cash flow hedges to protect the Company from exposures to fluctuations in foreign currency exchange rates. In the event the underlying forecasted transaction does not occur, or it becomes probable that it will not occur, the related hedge gains and losses on the cash flow hedge are reclassified from accumulated other comprehensive income (loss) to interest and other income (expense) on the consolidated statement of operations at that time.

The Company does not believe that it is or was exposed to more than a nominal amount of credit risk in its interest rate and foreign currency hedges, as counterparties are established and well-capitalized financial institutions. The Company’s exposures are in liquid currencies (Japanese ~~Yen)~~yen), so there is minimal risk that appropriate derivatives to maintain the Company’s hedging program would not be available in the future.

Guarantees:The Company accounts for guarantees in accordance with FASB Interpretation No. 45, “Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees to Others, an interpretation of FASB Statements No. 5, 57 and 107 and a rescission of FASB Interpretation No. 34” (FIN No. 45). Accordingly, the Company evaluates its guarantees to determine whether (a) the guarantee is specifically excluded from the scope of FIN No. 45, (b) the guarantee is subject to FIN No. 45 disclosure requirements only, but not subject to the initial recognition and measurement provisions, or (c) the guarantee is required to be recorded in the financial statements at fair value. The Company has recorded a liability for certain guaranteed residual values related to specific facility lease agreements. The Company has evaluated its remaining guarantees and has concluded that they are either not within the scope of FIN No. 45 or do not require recognition in the financial statements. These guarantees generally include certain indemnifications to its lessors under operating lease agreements for environmental matters, potential overdraft protection obligations to financial institutions related to one of the Company’s subsidiaries, indemnifications to the Company’s customers for certain infringement of third-party intellectual property rights by its products and services, and the Company’s warranty obligations under sales of its products. Please see Note 1617 for additional information on the Company’s guarantees.

Foreign Currency Translation:The Company’s non-U.S. subsidiaries that operate in a local currency environment, where that local currency is the functional currency, primarily generate and expend cash in their local currency. Billings and receipts for their labor and services are primarily denominated in the local currency and the workforce is paid in local currency. Their individual assets and liabilities are primarily denominated in the local foreign currency and do not materially impact the Company’s cash flows. Accordingly, all balance sheet accounts of these local functional currency subsidiaries are translated at the fiscal period-end exchange rate, and income and expense accounts are translated using average rates in effect for the period, except for costs related to those balance sheet items that are translated using historical exchange rates. The resulting translation adjustments are recorded as cumulative translation adjustments, and are a component of accumulated other comprehensive income (loss). Translation adjustments are recorded in other income (expense), net, where the U.S. dollar is the functional currency.

Reclassifications:Certain amounts presented in the comparative financial statements for prior years have been reclassified to conform to the fiscal year 2007 presentation.

Note 3: Restatement of Consolidated Financial Statements

In these consolidated financial statements as of and for the year ended June 24, 2007. Lam Research is restating its consolidated balance sheet as of June 25, 2006 ~~presentation.~~and the related consolidated statements of operations, stockholders’ equity, and cash flows for the years ended June 25, 2006 and June 26, 2005 as a result of determinations from a voluntary independent stock option review described below. The Company also recorded adjustments affecting previously-reported financial statements for fiscal years 1997 through 2004, the effects of which are summarized in cumulative adjustments to additional paid-in capital, deferred stock-based compensation, and retained earnings as of June 27, 2004.

Independent Committee Review

On July 18, 2007, the Company announced that its Board of Directors had initiated a voluntary independent review regarding the timing and accounting of the Company’s past stock option grants and other related issues. The voluntary internal review arose after the Company’s Independent Registered Public Accounting Firm performed auditing procedures relating to the Company’s historical stock option grant programs and procedures as part of the firm’s fiscal year-end 2007 audit. The Board of Directors appointed a special committee consisting of two independent board members (the “Independent Committee”) to conduct a comprehensive review of the Company’s historical stock option practices. The Independent Committee promptly engaged independent outside legal counsel and forensic accountants to assist with the review. On December 21, 2007, the Company announced that the Independent Committee had reached a preliminary conclusion that the measurement dates for financial accounting purposes of certain stock option grants issued in the past differed from the recorded grant dates of such awards. Upon the recommendation of management and the Independent Committee, the Audit Committee of the Board of Directors concluded that the financial statements for fiscal years 1997 through 2005, and the interim periods contained therein should no longer be relied upon. The Independent Committee’s review was completed in February 2008.

Scope of the Independent Committee Review

The review covered stock option grants awarded in fiscal years 1997 through 2005 (the “Review Period”). The scope of the review included evaluating 100% of “Company-wide” grants, director grants, Section 16 officer grants, and new hire grants, as well as a sampling of grants deemed “other grants”, representing approximately 94% of all stock option grants during the Review Period. This Review Period comprised approximately 16,000 separate stock option grants on approximately 500 separately recorded grant dates. These grants involved approximately 58 million underlying shares of Common Stock and included grants to domestic and international employees. Share amounts have been adjusted as applicable to reflect the March 2000 3 for 1 stock split. The Independent Committee’s review also included procedures to identify potential modifications of stock option grants and grants awarded to consultants, and testing of cash exercises. The Company had not awarded any Company-wide stock option grants since October 2002 and stopped issuing stock option grants during fiscal year 2005 and only issued restricted stock units (“RSUs”) thereafter. The Independent Committee did not include fiscal years 2006 and 2007 in the scope of its review based on several factors including but not limited to the fact that the Company only issued RSUs after fiscal year 2005 and the Company’s equity granting processes and controls had been documented and tested as part of its assessment of the operating effectiveness of internal control over financial reporting as required by Section 404 of the Sarbanes Oxley Act of 2002. Additionally, no information arose during the stock option review that would indicate a need to expand the scope of the review to include other periods.

Stock Option Review Results

Consistent with applicable accounting literature and guidance from the Securities and Exchange Commission (“SEC”) staff, the Company organized the grants during the review period into categories based on the grant type and the process by which the grant was finalized. The Company analyzed the evidence from the Independent Committee’s review related to each category including, but not limited to, physical documents, electronic documents, and underlying electronic data about documents. Based on the relevant facts and circumstances, the Company applied the applicable accounting standards to determine, for grants within each category, the proper measurement date. If the measurement date was not the originally recorded grant date, accounting adjustments were made as required, in some cases resulting in stock-based compensation expense and related tax effects. The significant majority of the measurement date changes result from stock options granted prior to fiscal year 2003. As a result of the findings of the review, the Company has recognized incremental stock-based compensation and associated payroll tax expense of $96.4 million on a pre-tax basis ($65.8 million after taxes) in the aggregate during fiscal years 1997 through 2006, which includes incremental stock-based compensation expense of $1.2 million recognized under SFAS No. 123R during fiscal year 2006.

During its review of the Company’s historical stock option practices, the Independent Committee did not find evidence of any other financial reporting or accounting issues unrelated to stock-based compensation.

Company-wide Grants

Company-wide grants were awarded on ten dates during the Review Period, and are associated with approximately half of the shares underlying option grants encompassed in the review. These ten dates include grants issued on six dates for broad-based and primarily discretionary grants (“focal grants”), two grant dates that were formula-based grants (“supplemental grants”) and two grant dates designed to address certain previously granted stock options for which the exercise price was higher than the then-current fair value of the Company’s Common Stock (“cancel and replace grants”). As a result of its review, the Company determined that the actual measurement dates for certain stock option grants differed from the recorded grant dates. The Company determined that the actual measurement date, meaning when the required actions necessary to grant the option were completed, including the determination of the number of shares underlying the options to be granted to each employee and the exercise price, was the correct measurement date to determine what, if any, stock-based compensation was appropriate. Any intrinsic value of the options on the measurement date, measured as the difference between the stated exercise price and the market price, has been recorded as compensation expense during the periods when employees were providing services in exchange for the options.

With respect to the focal grants, the Company concluded that a process to determine the total number of shares underlying the options, grant date and exercise price generally commenced prior to the recorded grant date but that in certain cases the specific allocation of those shares among the various option recipients was not finalized until after the original recorded grant date. To address these circumstances, the Company has revised the measurement date for accounting purposes for these option grants to a date after the original grant date, when the allocation of the shares was first known to be finalized. The Company has recognized stock-based compensation expense, net of forfeitures, of $61.2 million on a pre-tax basis as a result of these revised measurement dates.

The cancel and replace grants involved recipients electing to exchange certain stock options, for which the exercise price was higher than the then current fair value of the Company’s Common Stock, in return for a new grant of options. The Company determined that in both instances, the election deadline was after the recorded grant date. The measurement date should have been the later of the recorded grant date or the date of election because the elections were revocable up to the last day of the offer period. To address these circumstances, the Company has revised the measurement date for accounting purposes for these grants to the last possible date of election. The Company has recognized stock-based compensation expense, net of forfeitures, of $0.2 million on a pre-tax basis as a result of these revised measurement dates.

Grants to Directors and Section 16 Officers

Section 16 officer grants were awarded on 23 grant dates during the stock option review period. The Company determined that the actual measurement date, meaning when the required actions necessary to grant the option were completed, including the determination of the number of shares underlying the options to be granted to each employee and the exercise price, was the correct measurement date to determine the market price of the option shares. Any intrinsic value of the options on the measurement date, measured as the difference between the stated exercise price and the market price, has been recorded as compensation expense during the periods when employees were providing services in exchange for the options. In instances where the original recorded grant date was not consistent with the correct measurement date, the Company has revised the measurement date for accounting purposes for these grants to a date after the original grant date, when the number of shares underlying the options to be granted to each employee and the exercise price were first known with to be finalized. The Company has recognized stock-based compensation expense, net of forfeitures, of $1.0 million on a pre-tax basis as a result of the revised measurement dates. Additionally, it was determined that for one grant the recorded grant price was based on an average of closing prices of the Company’s stock immediately prior to the grant date. The option plan under which this option was granted allowed for similar pricing. To address this circumstance the Company has recognized stock-based compensation expense of $2.1 million on a pre-tax basis for this grant, which was equal to the difference between the closing price of the stock on the date of grant and the originally recorded grant exercise price.

Grants to Consultant

Grants to New Hires

Other Grants

For the remaining population reviewed of stock options granted during the stock option review period, the Company has concluded that certain actual measurement dates differed from the recorded grant dates primarily due to a lack of contemporaneous documentation evidencing approval as of the original recorded grant date. In these circumstances, the Company has revised the measurement date for accounting purposes for these grants to a date after the original grant date, when the shares underlying the options to be granted to each employee and the exercise price were first known to be finalized. The primary issue with these grants was that there was insufficient evidence to conclude that the specific allocation of those shares among the various grant recipients was finalized at the original recorded grant date. To address these circumstances, the Company has revised the measurement date for accounting purposes for these grants to a date after the original grant date, when the allocation of the shares underlying the options and exercise price was first know to be finalized. The Company has recognized stock-based compensation expense, net of forfeitures, of $8.2 million on a pre-tax basis as a result of these revised measurement dates.

Deemed Modifications to Stock Option Grants Connected with Terminations or Leaves of Absences

Compensation expense was also recognized as a result of deemed modifications to certain employee stock option grant awards in connection with certain employees’ terminations or leaves of absence. Typically such modifications related to extensions of the time employees could exercise options following their termination of employment or that enabled the employee to vest in additional shares in relation to a leave of absence or subsequent to their termination thus triggering a new measurement date under the accounting literature applicable at that time. The Company has recognized stock-based compensation expense, net of forfeitures, of $9.2 million on a pre-tax basis as a result of these new measurement dates.

Use of Judgment

The Company evaluated all available evidence for each individual grant within the scope of the independent review and the revised measurement dates represent the earliest date when the terms of the options granted to individual recipients were known with finality. The proposed measurement date for certain grants could not be determined with certainty based on available evidence. In light of the judgment used to establish the measurement dates, alternate approaches to those used by the Company could have resulted in different stock-based compensation expense than that recorded by the Company in the restatements. While the Company has considered these alternative approaches, it believes its approach is the most appropriate under the circumstances.

100

Effect of Restatement on Consolidated Financial Statements

The Company previously applied Accounting Principles Board (“APB”) Opinion No. 25, “Accounting for Stock Issued to Employees”, and its related interpretations and provided the required pro forma disclosures under Statement of Financial Accounting Standards (“SFAS”) No. 123, “Accounting for Stock-Based Compensation”, through its fiscal year ended June 26, 2005. Under APB Opinion No. 25, non-cash, stock-based compensation expense was required to be recognized for any option for which the exercise price was below the market price on the actual measurement date. Because certain of the Company’s options were assessed as having an exercise price below the market price on the actual measurement date based on the Company’s revised measurement dates as a result of the stock option review as more fully described above, there is a non-cash deferred compensation charge for each of these options under APB Opinion No. 25 equal to the number of shares underlying the options, multiplied by the difference between the exercise price and the market price on the actual measurement date. That deferred compensation expense is amortized over the vesting period of the option. The Company also recorded compensation expense under “fair value” accounting when applicable, for example, for the grant to the nonemployee consultant noted above.

Commencing in its fiscal year ended June 25, 2006, the Company adopted SFAS No. 123(R), “Share-Based Payment”. As a result, beginning in fiscal year 2006, the additional stock-based compensation expense required to be recorded for each option with a revised measurement date, as more fully described above, is equal to the fair value of the option on the revised measurement date, amortized over the remaining service period of the option. The Company did not record these stock-based compensation expenses under APB Opinion No. 25 nor SFAS No. 123(R) related to its options based on the revised measurement dates in the Company’s previously issued financial statements, and that is why the Company is restating them in this filing. The Company restated its historical results of operations to record additional pre-tax, non-cash, stock-based compensation expense of (a) $94.0 million for the fiscal years ended June 30, 1997 through June 26, 2005 under APB Opinion No. 25 and other applicable accounting rules, and (b) $1.2 million for the year ended June 25, 2006 under SFAS No. 123(R). As of June 25, 2006, there was less than $0.1 million of remaining compensation expense to be recorded under SFAS No. 123(R) for stock options with revised measurement dates. In addition the Company recorded pre-tax payroll related tax expenses of $1.2 million through June 25, 2006.

As described for each element above, the Company evaluated the impact of the restatements on its global tax provision. The Company and its subsidiaries file tax returns in multiple tax jurisdictions around the world. In certain jurisdictions, including, but not limited to, the United States, the Company is able to claim a tax deduction relative to stock options. In those jurisdictions, where a tax deduction is claimed, the Company has recorded deferred tax assets, totaling $6.2 million at June 25, 2006, to reflect future tax deductions to the extent the Company believes such assets to be recoverable. Based on this review, the Company now believes that it should not have taken a United States tax deduction in prior years for stock option related amounts pertaining to certain executives under Internal Revenue Code (IRC) Section 162(m). Section 162(m) limits the deductibility of compensation above certain thresholds. As a result, the Company’s tax carryforward attributes have decreased by approximately $14.6 million as of June 25, 2006.

For those stock option grants determined to have incorrect measurement dates for accounting purposes and that had been originally issued as incentive stock options, or ISOs, the Company recorded a liability for payroll tax contingencies in the event such grants would not be respected as ISOs under the principles of the Internal Revenue Code (“IRC”) and the regulations therein. The Company recorded expense and accrued liabilities for certain foreign payroll tax contingencies. The total payroll tax accrued was approximately $1.2 million for annual periods from fiscal year 1997 through fiscal year 2006. This cumulative expense resulted from payroll tax expense recorded in prior periods has been partially offset by benefits relating to the expiration of the related statute of limitations.

As a result of the restatement, the cumulative effect of the related after-tax expenses for the fiscal years ended June 30, 1997 through June 25, 2006 was $65.8 million, as compared to $96.4 million in pre-tax charges as previously discussed. These additional stock-based compensation and other expenses had no effect on the Company’s reported revenue, cash, cash equivalents or marketable securities for each of the restated periods. The Company has also restated the pro forma amortization of deferred stock-based employee compensation included in reported net income, net of tax, and total stock-based employee compensation expenses determined under fair value based method, net of tax, under SFAS No. 123 in Note 14, “Equity-Based Compensation Plans” to Consolidated Financial Statements to reflect the effect of the stock-based compensation expense resulting from the correction of these past stock option grants.

101

The following tables reflect the impact of the restatement on the Company’s consolidated financial statements as of June 25, 2006 and for the years ended June 25, 2006 and June 26, 2005.

Consolidated Statements of Operations


	Year ended June 25, 2006									Year ended June 26, 2005
	As						As			As						As
(in thousands, except per share data)	reported			Adjustments(1)			restated			reported			Adjustments(1)			restated

Total revenues	$	1,642,171		$	—		$	1,642,171		$	1,502,453		$	—		$	1,502,453
Cost of goods sold		814,777			382			815,159			738,361			628			738,989

Gross margin		827,394			(382	)		827,012			764,092			(628	)		763,464

Research and development		228,891			487			229,378			194,115			1,174			195,289
Selling, general and administrative		192,238			628			192,866			164,774			1,058			165,832
Restructuring charges, net		—			—			—			14,201			—			14,201

Total operating expenses		421,129			1,115			422,244			373,090			2,232			375,322

Operating Income		406,265			(1,497	)		404,768			391,002			(2,860	)		388,142
Other Income (expense):
Interest income		38,189			—			38,189			17,537			—			17,537
Interest expense		(677	)		—			(677	)		(1,413	)		—			(1,413	)
Other, net		(2,490	)		—			(2,490	)		(8,004	)		—			(8,004	)

Total other income (expense)		35,022			—			35,022			8,120			—			8,120

Income before income taxes		441,287			(1,497	)		439,790			399,122			(2,860	)		396,262
Income tax expense		105,532			(952	)		104,580			99,781			(771	)		99,010

Net income	$	335,755		$	(545	)	$	335,210		$	299,341		$	(2,089	)	$	297,252

Net income per share:
Basic net income per share	$	2.42			—		$	2.42		$	2.17			—		$	2.16
Diluted net income per share	$	2.34			—		$	2.33		$	2.10			—		$	2.09
Number of shares used in per share calculations:
Basic		138,581			—			138,581			137,727			—			137,727

Diluted		143,732			27			143,759			142,417			43			142,460


(1)		Adjustments for stock-based compensation expense (benefit), relating to deemed incorrect measurement dates, certain stock option modifications and related payroll and income tax expense (benefit) impacts.

104

Consolidated Balance Sheet


	June 25, 2006
	As
(in thousands)	reported			Adjustments(1)			As restated
ASSETS
Current assets
Cash and cash equivalents	$	910,815		$	—		$	910,815
Short-term investments		139,524			—			139,524
Accounts receivable, net		407,347			—			407,347
Inventories		168,714			—			168,714
Deferred income taxes		53,625			—			53,625
Prepaid expenses and other current assets		26,344			—			26,344

Total current assets		1,706,369			—			1,706,369
Property and equipment, net		49,893			—			49,893
Restricted cash and investments		470,038			—			470,038
Deferred income taxes		38,533			14,038			52,571
Other assets		48,511			—			48,511

Total assets	$	2,313,344		$	14,038		$	2,327,382


LIABILITIES AND STOCKHOLDERS’ EQUITY

Trade accounts payable	$	108,504		$	—		$	108,504
Accrued expense and other current liabilities		317,637			1,423			319,060
Deferred profit		140,085			—			140,085

Total current liabilities		566,226			1,423			567,649
Long-term debt		350,000			—			350,000
Other long-term liabilities		969			—			969

Total liabilities		917,195			1,423			918,618
Commitments and contingencies
Stockholders’ equity:
Preferred stock		—			—			—
Common stock		142			—			142
Additional paid-in capital		973,391			78,460			1,051,851
Treasury stock		(416,447	)		—			(416,447	)
Accumulated other comprehensive income		(11,205	)		—			(11,205	)
Retained earnings		850,268			(65,845	)		784,423

Total stockholders’ equity		1,396,149			12,615			1,408,764

Total liabilities and stockholders’ equity	$	2,313,344		$	14,038		$	2,327,382


(1)		Adjustments for stock-based compensation expense (benefit), relating to deemed incorrect measurement dates, certain stock option modifications and related payroll and income tax expense (benefit) impacts.

105

Consolidated Statements of Cash Flows


	Year ended June 25, 2006									Year ended June 26, 2005
	As						As			As						As
(in thousands)	reported			Adjustments (1)			restated			reported			Adjustments (1)			restated
Cash flows from operating activities
Net income	$	335,755		$	(545	)	$	335,210		$	299,341		$	(2,089	)	$	297,252
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization		22,000			—			22,000			25,517			—			25,517
Deferred income taxes		27,726			9,496			37,222			89,352			(42	)		89,310
Restructuring charges, net		—			—			—			14,201			—			14,201
Amortization of premiums/discounts on securities		2,683			—			2,683			3,285			—			3,285
Equity-based compensation expense		22,768			1,225			23,993			864			2,724			3,588
Income tax benefit on equity-based compensation plans		27,786			(10,448	)		17,338			2,050			(910	)		1,140
Excess tax benefit on equity-based compensation plans		(17,805	)		6,695			(11,110	)		—			—			—
Other, net		(326	)		—			(326	)		(431	)		—			(431	)
Changes in working capital accounts:
Accounts receivable, net of allowances		(178,542	)		—			(178,542	)		13,470			—			13,470
Inventories		(59,038	)		—			(59,038	)		(2,588	)		—			(2,588	)
Prepaid expenses and other assets		(9,270	)		—			(9,270	)		(455	)		—			(455	)
Trade accounts payable		48,341			—			48,341			(33,108	)		—			(33,108	)
Deferred profit		50,675			—			50,675			(18,936	)		—			(18,936	)
Accrued expenses and other liabilities		87,934			272			88,206			33,368			317			33,685

Net cash provided by operating activities		360,687			6,695			367,382			425,930			—			425,930


Cash flows from investing activities:
Capital expenditures and intangible assets		(42,080	)		—			(42,080	)		(22,849	)		—			(22,849	)
Purchases of available-for-sale securities		(129,464	)		—			(129,464	)		(247,392	)		—			(247,392	)
Sales and maturities of available-for-sale securities		312,252			—			312,252			184,083			—			184,083
Transfer of restricted cash and investments		(385,000	)		—			(385,000	)		27,430			—			27,430

Net cash used in investing activities		(244,292	)		—			(244,292	)		(58,728	)		—			(58,728	)


Cash flows from financing activities:
Principal payment on long-term debt and capital lease obligations		(112	)		—			(112	)		—			—			—
Net proceeds from issuance of long-term debt		349,632			—			349,632			—			—			—
Excess tax benefit on equity-based compensation plans		17,805			(6,695	)		11,110			—			—			—
Treasury stock purchases		(251,211	)		—			(251,211	)		(167,081	)		—			(167,081	)
Reissuances of treasury stock		15,171			—			15,171			458			—			458
Proceeds from issuance of common stock		179,400			—			179,400			114,304			—			114,304

Net cash provided by (used for) financing activities		310,685			(6,695	)		303,990			(52,319	)		—			(52,319	)

Effect of exchange rate changes on cash		1,485			—			1,485			3,964			—			3,964
Net increase in cash and cash equivalents		428,565			—			428,565			318,847			—			318,847
Cash and cash equivalents at beginning of year		482,250			—			482,250			163,403			—			163,403

Cash and cash equivalents at end of year	$	910,815		$	—		$	910,815		$	482,250		$	—		$	482,250


Schedule of non-cash transactions
Acquisition of leased equipment	$	1,088		$	—		$	1,088			—		$	—		$	—


Supplemental disclosures:
Cash payments for interest	$	531		$	—		$	531		$	1,341		$	—		$	1,341

Cash payments for income taxes	$	11,873		$	—		$	11,873		$	7,339		$	—		$	7,339


(1)		Adjustments for stock-based compensation expense (benefit), relating to deemed incorrect measurement dates, certain stock option modifications and related payroll and income tax expense (benefit) impacts.

106

Note 3:4: Recent Accounting Pronouncements

transition. FIN 48 is effective for fiscal years beginning after December 15, 2006. ~~Any differences between the amounts recognized in the statements~~The Company will adopt FIN 48 as of ~~financial position prior to~~June 25, 2007. As a result of the adoption of FIN 48, ~~and~~ the ~~amounts reported after adoption will~~Company expects to decrease the recorded liability for unrecognized tax benefits by approximately $26.2 million as well as reclass approximately $64.4 million from current to non-current income taxes payable. The Company expects the cumulative effect of adopting FIN 48 to be ~~accounted for as~~ a ~~cumulative-effect adjustment recorded~~$17.6 million increase to the Company’s opening retained earnings in the first quarter of fiscal year 2008.

In September 2006, the Staff of the SEC issued Staff Accounting Bulletin No. 108, “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements” (SAB 108). SAB 108 provides guidance on the consideration of the effects of prior year misstatements in quantifying current year misstatements for the purpose of determining whether the current year’s financial statements are materially misstated. The Company applied the provisions of SAB 108 beginning ~~balance~~in the first quarter of ~~retained earnings.~~fiscal year 2007.

In September 2006, the Financial Accounting Standards Board (FASB) issued Statement of Financial Accounting Standards No. 157, “Fair Value Measurements,” (SFAS No. 157), which defines fair value, establishes guidelines for measuring fair value and expands disclosures regarding fair value measurements. SFAS No. 157 does not require any new fair value measurements but rather eliminates inconsistencies in guidance found in various prior accounting pronouncements. SFAS No. 157 is effective for fiscal years beginning after November 15, 2007. Earlier adoption is permitted, provided the company has not yet issued financial statements, including interim periods, for that fiscal year. The Company is currently ~~in the process of determining~~evaluating the impact, if any, of adopting the provisions of ~~FIN 48~~SFAS No. 157 on its financial position, results of operations and liquidity.

In February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities — Including an amendment of FASB Statement No. 115” (SFAS No. 159). This statement permits entities to choose to measure many financial instruments and certain other items at fair value that are not currently required to be measured at fair value and establishes presentation and disclosure requirements designed to facilitate comparisons between entities that choose different measurement attributes for similar types of assets and liabilities. SFAS No. 159 is effective as of the beginning of an entity’s first fiscal year that begins after November 15, 2007, provided the entity also elects to apply the provisions of SFAS No. 157. The Company expects to adopt SFAS No. 159 beginning June 30, 2008 and is currently evaluating the impact that this pronouncement may have on its consolidated financial statements.

In December 2007, the FASB issued SFAS No. 141 (revised 2007), “Business Combinations” (SFAS No. 141R). SFAS 141R establishes principles and requirements for how an acquirer recognizes and measures in its financial statements the identifiable assets acquired, the liabilities assumed, any noncontrolling interest in the acquiree and the goodwill acquired. SFAS No. 141R also establishes disclosure requirements to enable the evaluation of the nature and financial effects of the business combination. SFAS No. 141R is effective as of the beginning of an entity’s fiscal year that begins after December 15, 2008. The Company expects to adopt SFAS No. 141R in the beginning of fiscal year 2010 and is currently evaluating the potential impact, if any, of the adoption of SFAS No. 141R on its consolidated results of operations and financial condition.

Note 4:5: Financial Instruments

Investments at June ~~25, 2006~~24, 2007 and June ~~26, 2005~~25, 2006 consist of the following:

June 25, 2006 June 26, 2005
Unrealized Unrealized Fair Unrealized Unrealized Fair
Cost Gains Losses Value Cost Gains Losses Value
(in thousands)
Available for sale:
Institutional Money Market Funds $ 730,887 $ — $ — $ 730,887 $ 366,672 $ — $ — $ 366,672
Securities held with original maturities less than or equal to 90 days 113,566 — (57 ) 113,509 11,511 — — 11,511

Amounts included in cash and cash equivalents 844,453 — (57 ) 844,396 378,183 — — 378,183

Municipal Bonds and Notes 13,233 1 (37 ) 13,197 102,118 84 (686 ) 101,516
Treasury and Agency Notes 20,035 — (510 ) 19,525 50,362 27 (322 ) 50,067
Bank and Corporate Notes 109,063 13 (2,274 ) 106,802 176,366 125 (1,071 ) 175,420

Amounts included in short-term investments 142,331 14 (2,821 ) 139,524 328,846 236 (2,079 ) 327,003

Certificates of deposit and interest bearing accounts 85,038 — — 85,038 85,038 — — 85,038
Auction Rate Securities 70,575 — — 70,575 — — — —
Municipal Bonds and Notes 315,412 25 (1,012 ) 314,425 — — — —

Amounts included in restricted cash and investments 471,025 25 (1,012 ) 470,038 85,038 — — 85,038

Total Available-for-sale $ 1,457,809 $ 39 $ (3,890 ) $ 1,453,958 $ 792,067 $ 236 $ (2,079 ) $ 790,224


	June 24, 2007												June 25, 2006
			Unrealized			Unrealized		Unrealized							Unrealized			Unrealized		Unrealized
	Cost		Gain/(Loss)			Gain		(Loss)			Fair Value		Cost		Gain/(Loss)			Gain		(Loss)			Fair Value
Municipal Notes and Bonds	$	227,587	$	(859	)	$	25	$	(884	)	$	226,728	$	399,220	$	(1,023	)	$	26	$	(1,049	)	$	398,197
US Treasury & Agencies		2,990		(88	)		—		(88	)		2,902		6,261		(208	)		—		(208	)		6,053
Governement-Sponsored Enterprises		21,518		(162	)		2		(164	)		21,356		32,022		(952	)		1		(953	)		31,070
Bank and Corporate Notes		206,746		(970	)		43		(1,013	)		205,776		175,854		(1,612	)		13		(1,625	)		174,242

Total Short Term Investments and Restricted Cash	$	458,841	$	(2,079	)	$	70	$	(2,149	)	$	456,762	$	613,357	$	(3,795	)	$	40	$	(3,835	)	$	609,562

The Company accounts for its investment portfolio at fair value. Realized gains and (losses) from investments sold were approximately $0.5 million and $(1.3) million in fiscal year 2007 and approximately $0.1 million and $(0.5) million in fiscal year 2006, ~~and approximately $0.1 million and $(0.9) million in fiscal year 2005.~~respectively. Realized gains and (losses) for investments sold are specifically identified. Management assesses the fair value of investments in debt securities that are not actively traded through consideration of interest rates and their impact on the present value of the cash flows to be received from the investments. The Company also considers whether changes in the credit ratings of the issuer could impact the assessment of fair value. The fair value of the Company’s investments in auction rate preferred securities is based upon par value, which approximates fair value due to the nature of the instruments.

The Company’s available-for-sale securities are invested in financial instruments with a minimum rating of A2 / A, as rated by two of the following three rating agencies: Moody’s, Standard & Poor’s (S&P), or Fitch.

108

On June 16, 2006, the Company’s wholly-owned subsidiary, Lam Research International SARL (LRI), as borrower, entered into a $350 million Credit Agreement (the “LRI Credit ~~Agreement)~~Agreement”). Under the LRI Credit Agreement, on June 19, 2006, LRI borrowed $350 million in principal amount. The loan under the LRI Credit Agreement shall be fully repaid not later than five years following the closing ~~date. The loan under the Credit Agreement~~date and will bear interest at LIBOR plus a spread (applicable margin) ranging from 0.10% to 0.50%, depending upon a consolidated leverage ratio, as defined in the LRI Credit Agreement. ~~The initial spread under the Credit Agreement is 0.10%.~~ LRI may prepay the loan under the LRI Credit Agreement in whole or in part at any time without penalty, subject to reimbursement of lenders’ breakage and redeployment costs in certain cases. The Company obtained compliance waivers from the lender with respect to the Company’s obligation to deliver financial statements to the lender under the terms provided in the Guarantee Agreement. Please see Note 23 “Subsequent Events” below for information regarding termination of the LRI Credit Agreement and the Company’s entry into a new credit agreement. As of June 24, 2007 the remaining principal payment was $250 million and due on June 19, 2011 as $100.0 million of the original $350.0 million debt was repaid during fiscal year 2007. The fair value of long-term debt approximates its carrying value ~~of $350.0 million~~ due to the variable interest rate applicable to the debt.

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash equivalents, short-term investments, trade accounts receivable and derivative financial instruments used in hedging activities.

As of June 24, 2007, two customers accounted for approximately 10% and 14% of accounts receivable. As of June 25, 2006 one customer accounted for approximately 15% of accounts receivable.

As noted above, the Company’s available-for-sale securities are invested in financial instruments with a minimum rating of A2 / A, as rated by two of the following three rating agencies: Moody’s, Standard & Poor’s (S&P), or Fitch, respectively and its policy limits the amount of credit exposure with any one financial institution or commercial issuer.

Credit risk evaluations, including trade references, bank references and Dun & Bradstreet ratings are performed on all new customers, and subsequent to credit application approval, the Company monitors its customers’ financial statements and payment performance. In general, the Company does not require collateral on sales.

The fair value of the Company’s foreign currency forward contracts is estimated based upon the Japanese ~~Yen~~yen exchange rates at June ~~25, 2006~~24, 2007 and June ~~26, 2005,~~25, 2006, respectively.

At June ~~25, 2006~~24, 2007 and June ~~26, 2005,~~25, 2006, the notional amount of outstanding Japanese ~~Yen~~yen forward contracts that are designated as cash flow hedges was ~~$193.8~~$77.6 million and ~~$66.2~~$193.8 million, respectively. At June ~~25, 2006~~24, 2007 and June ~~26, 2005,~~25, 2006, the notional amount of Japanese ~~Yen~~yen forward contracts that are designated as balance sheet hedges was $30.2 million and $23.5 million, ~~and $32.6 million,~~ respectively.

Note 5:6: Derivative Financial Instruments and Hedging

The Company carries derivative financial instruments (derivatives) on the balance sheet at their fair values in accordance with Statement of Financial Accounting Standards No. 133, “Accounting for Derivative Instruments and Hedging Activities” (SFAS No. 133). The Company has a policy that allows the use of derivative financial instruments, specifically foreign currency forward exchange rate contracts, to hedge foreign currency exchange rate fluctuations on forecasted revenue transactions denominated in Japanese ~~Yen~~yen and other foreign currency denominated assets. The Company does not use derivatives for trading or speculative purposes.

109

foreign currency forward exchange rate contracts that generally expire within 12 months, and no later than 24 months. These foreign currency forward exchange contracts are designated as cash flow hedges and are carried on the Company’s balance sheet at fair value with the effective portion of the contracts’ gains or losses included in accumulated other comprehensive income (loss) and subsequently recognized in ~~earnings~~revenue in the same period the hedged revenue is recognized.

Each period, hedges are tested for effectiveness using regression testing. Changes in the ~~dollar offset method, by comparing~~fair value of currency forwards due to changes in time value are excluded from the assessment of effectiveness and are recognized in revenue in the current period. The change in forward time value ~~of the derivative with the change in the value of the anticipated sales transactions.~~was not material for all periods. There were no gains or losses during ~~fiscal years~~the twelve months ended June 24, 2007 and June 25, 2006 ~~and 2005~~ associated with ineffectiveness or forecasted transactions that failed to occur. To qualify for hedge accounting, the hedge relationship must meet criteria relating both to the derivative instrument and the hedged item. These include identification of the hedging instrument, the hedged item, the nature of the risk being hedged and how the hedging instrument’s effectiveness in offsetting the exposure to changes in the hedged item’s fair value or cash flows will be measured.

designated and qualify as effective cash flow hedges, the Company is able to defer changes in the fair value of the hedging instrument within accumulated other comprehensive income (loss) until the hedged exposure is realized. Consequently, with the exception of hedge ineffectiveness recognized, the Company’s results of operations are not subject to fluctuation as a result of changes in the fair value of the derivative instruments. If hedges are not highly effective or if the Company does not believe that the underlying hedged forecasted transactions would occur, the Company may not be able to account for its investments in derivative instruments as cash flow hedges. If this were to occur, ~~in a~~ future ~~period,~~ changes in the fair values of the Company’s derivative instruments would be recognized in earnings without the benefits of offsets or deferrals of changes in fair value arising from hedge accounting treatment. At June ~~25, 2006,~~24, 2007, the Company expects to reclassify the entire amount of ~~$1.2~~$3.7 million of ~~losses~~gains accumulated in other comprehensive income to earnings during the next 12 months due to the recognition in earnings of the hedged forecasted transactions.

The Company also enters into foreign currency forward exchange rate contracts to hedge the gains and losses generated by the remeasurement of Japanese ~~Yen-denominated~~yen-denominated receivable balances. Under SFAS No. 133, these forward contracts are not designated for hedge accounting treatment. Therefore, the change in fair value of these derivatives is recorded into earnings as a component of other income and expense and offsets the change in fair value of the foreign currency denominated intercompany and trade receivables, recorded in other income and expense, assuming the hedge contract fully covers the intercompany and trade receivable balances.

Note 6:7: Inventories

Inventories are stated at the lower of cost (first-in, first-out method) or market. Shipments to Japanese customers are classified as inventory and carried at cost until title transfers. Inventories consist of the following:


	June 25,		June 26,		June 24,		June 25,
	2006		2005		2007		2006
	(in thousands)				(in thousands)
Raw materials	$	78,038	$	51,251	$	122,530	$	78,038
Work-in-process		29,980		24,492		43,935		29,980
Finished goods		60,696		34,308		68,966		60,696

	$	168,714	$	110,051	$	235,431	$	168,714

Note ~~9: Stockholders’ Equity~~10: Stock Repurchase Program

In October, 2004, the Company announced that its Board of Directors had authorized the repurchase of up to $250 million of ~~Company common stock~~its Common Stock from the public market or in private purchases. The terms of the repurchase program ~~permit~~permitted the Company to repurchase shares through September 30, 2007. In August, 2005, the Company announced that its Board of Directors had authorized the repurchase of an additional $500 million of ~~the Company’s common stock~~its Common Stock from the public market or private purchase. The terms of the repurchase program ~~permit~~permitted the Company to repurchase shares through September 30, 2008. In February 2007, the Company announced that its Board of Directors had authorized the repurchase of up to an additional $750 million of its Common Stock from the public market or private purchase. The terms of the repurchase program permitted the Company to repurchase shares at a pace determined by management. The Company ~~plans to continue to execute~~completed the ~~authorized repurchases.~~repurchase of all amounts available under its share repurchase authorizations during the quarter ended June 24, 2007. Share repurchases under the authorizations were as follows:


							Remaining Amount
	Total Number				Average		Available Under
	of Shares		Total Cost of		Price Paid		the Repurchase
Period	Repurchased		Repurchase		Per Share		Programs
	(in thousands, except per share data)
As of June 25, 2006		12,833	$	418,292	$	32.59	$	331,708
Quarter Ending September 24, 2006		—		—
Quarter Ending December 24, 2006		1,447		75,012		51.83	$	256,696
Additional authorization of up to $750 million — February 23, 2007							$	1,006,696
Quarter Ending March 25, 2007		5,214		238,690		45.78	$	768,006
Quarter Ending June 24, 2007		14,495		768,006		52.98	$	—

Total		33,989	$	1,500,000	$	44.13


(1)		See Note 3 “Restatements of Consolidated Financial Statements” to Consolidated Financial Statements

For purposes of computing diluted net income per share, weighted-average common shares do not include potential dilutive securities that are anti-dilutive under the treasury stock method. The following potential dilutive securities were excluded:

Year Ended
June 25, June 26, June 27,
2006 2005 2004
(in thousands)
Number of potential dilutive securities excluded 305 3,035 3,403


	Year Ended
	June 24,		June 25,		June 26,
	2007		2006		2005
			As restated (1)		As restated (1)
	(in thousands)
Number of potential dilutive securities excluded		567		307		3,249


(1)		See Note 3 “Restatements of Consolidated Financial Statements” to Consolidated Financial Statements

Note ~~12:~~13: Comprehensive Income

The components of comprehensive income are as follows:


										Year Ended
	Year Ended									June 24,		June 25,			June 26,
	June 25,			June 26,			June 27,			2007		2006			2005
	2006			2005			2004					As restated (1)			As restated (1)
	(in thousands)									(in thousands)
Net income	$	335,755		$	299,341		$	82,988		$	685,816	$	335,210		$	297,252
Foreign currency translation adjustment		2,061			3,584			1,808			1,755		2,061			3,584
Unrealized gain (loss) on fair value of derivative financial instruments, net		6,200			1,650			(293	)
Unrealized loss on financial instruments, net		(916	)		(379	)		(2,665	)
Unrealized gain on fair value of derivative financial instruments, net											5,355		6,200			1,650
Unrealized gain (loss) on financial instruments, net											82		(916	)		(379	)
Reclassification adjustment for loss (gain) included in earnings		(7,761	)		(361	)		(439	)		505		(7,761	)		(361	)

Comprehensive income	$	335,339		$	303,835		$	81,399		$	693,513	$	334,794		$	301,746

A summary of stock plan transactions is as follows:


				Options Outstanding					Restricted Stock Units								Options Outstanding					Restricted Stock Units
							Weighted-					Weighted-								Weighted-					Weighted-
	Available			Number of			Average		Number of			Average		Available			Number of			Average		Number of			Average
	For Grant			Shares			Exercise Price		Shares			FMV at Grant
June 29, 2003		3,597,092			30,701,795		$	16.02		—		$	—
Additional amount authorized		—			—			—		—			—
Granted		(665,835	)		583,985		$	26.45		81,850		$	22.10
Exercised		—			(6,146,637	)	$	10.32		—			—
Canceled		1,602,440			(1,602,440	)	$	21.88		—			—
Expired		(26,645	)		—			—		—			—
														For Grant			Shares			Exercise Price		Shares			FMV at Grant
June 27, 2004		4,507,052			23,536,703		$	17.38		81,850		$	22.10		4,507,052			23,536,703		$	17.38		81,850		$	22.10
Additional amount authorized		6,000,000			—			—		—			—		6,000,000
Granted		(775,050	)		775,050		$	24.97		—			—		(775,050	)		775,050		$	24.97		—			—
Exercised					(7,405,002	)	$	13.57		—			—					(7,405,002	)	$	13.57
Canceled		1,286,953			(1,277,049	)	$	25.14		(9,904	)	$	22.10		1,286,953			(1,277,049	)	$	25.14		(9,904	)	$	22.10
Expired		—			—			—		—			—		—

June 26, 2005															11,018,955			15,629,702		$	18.91		71,946		$	22.10
Granted															(1,053,584	)		—			—		1,053,584		$	33.90
Exercised																		(9,890,026	)	$	18.16
Canceled															263,696			(211,738	)	$	24.37		(51,958	)	$	29.07
Expired															(281,670	)
Vested restricted stock		—			—			—		—			—										(28,060	)	$	22.97

June 26, 2005		11,018,955			15,629,702		$	18.91		71,946		$	22.10
June 25, 2006															9,947,397			5,527,938		$	20.04		1,045,512		$	33.60
Additional amount authorized		—			—			—		—			—		15,000,000
Granted		(1,053,584	)		—			—		1,053,584		$	33.90		(1,091,897	)		—			—		1,091,897		$	50.39
Exercised					(9,890,026	)	$	18.16		—			—					(2,179,367	)	$	19.57
Canceled		263,696			(211,738	)	$	24.37		(51,958	)	$	29.07		148,837			(63,431	)	$	19.34		(85,406	)	$	40.52
Expired		(281,670	)		—			—		—			—		(4,500	)
Vested restricted stock										(28,060	)	$	22.97										(208,328	)	$	34.51

June 25, 2006		9,947,397			5,527,938		$	20.04		1,045,512		$	33.60
June 24, 2007															23,999,837			3,285,140		$	20.37		1,843,675		$	43.14

The ~~1997~~2007 Stock Incentive Plan ~~and the 1999 Stock Option Plan provide~~provides for the grant of non-qualified equity-based awards to eligible employees, consultants and advisors, and non-employee directors of the Company and its subsidiaries. ~~Initially, 9.0 million~~Additional shares ~~were~~are reserved for issuance pursuant to awards previously granted under ~~each plan. During fiscal year 2005, an additional 6.0 million~~the Company’s 1997 Stock Incentive Plan and its 1999 Stock Option Plan. As of June 24, 2007 there were a total of 5,128,815 shares subject to options and restricted stock units issued and outstanding under the Company’s Stock Plans. As of June 24, 2007, there were ~~reserved~~a total of 23,999,837 shares available for future issuance under the 1997, 1999, and 2007 Plans (the “Plans”) of which 14,046,931 are available from the 2007 Stock Incentive ~~Plan evergreen provision. There were no additional amounts reserved for issuance during fiscal years 2006 and 2004.~~Plan.

The ~~1999 Employee Stock Purchase Plan (the 1999 ESPP)~~ESPP allows employees to designate a portion of their base compensation to be used to purchase the Company’s Common Stock at a purchase price per share of the lower of 85% of the fair market value of the Company’s Common Stock on the first or last day of the applicable offering period. Typically, each offering period lasts 12 months and comprises three interim purchase dates. The 1999 ESPP, approved by the Company’s stockholders at the Annual Meeting of Stockholders on November 5, 1998, replaced the existing 1984 Employee Stock Purchase Plan (1984 ESPP). At June 29, 2003 the Company had 9.0 million shares of Lam Common Stock reserved for issuance under the 1999 ESPP: 3.0 million shares may be issued at any time and additional shares (previously 6.0 million total additional shares) may be issued for each share of the Company’s Common Stock which the Company redeems in public-market or private purchases and designated for this purpose. In fiscal year 2004, the Company’s stockholders approved an amendment to the 1999 ESPP to (i) each year automatically increase the number of shares available for issuance under the ~~Plan~~plan by a specific amount on a one-for-one basis with shares of Common Stock that the Company will redeem in public market and private purchases for such purpose and (ii) to authorize the Plan Administrator (the ~~Compensation~~“Compensation Committee of the ~~Board)~~Board”) to set a limit on the number of shares a ~~Plan~~plan participant can purchase on any single ~~Plan~~plan exercise date. The automatic annual increase provides that the number of shares in the ~~Plan~~plan reserve available for issuance shall be increased on the first business day of each calendar year commencing with 2004, on a one-for-one basis with each share of Common Stock that the Company redeems, in public-market or private purchases, and designates for this purpose, by a number of shares equal to the lesser of (i) 2,000,000, (ii) one and one-half percent (1.5%) of the number of shares of all classes of ~~common stock~~Common Stock of the Company outstanding on the first business day of such calendar year, or (iii) a lesser number determined by the Plan Administrator. During fiscal years ~~2004~~2007 and 2006, the number of shares of Lam Research Common Stock reserved for issuance under the 1999 ESPP increased by 2.0 million shares in each fiscal year, subject to repurchase of an equal number of shares in public market or private purchases. There were no increases to the reserve during fiscal year 2005.

During fiscal year ~~2006, 657,490~~2007, 564,332 shares of the Company’s Common Stock were sold to employees under the 1999 ESPP. A total of ~~9,680,601~~10,244,945 shares of the Company’s Common Stock have been issued under the 1999 ESPP ~~Plan~~ through June ~~25, 2006,~~24, 2007, at prices ranging from $4.11 to ~~$31.84~~$42.04 per share. At June ~~25, 2006, 3,313,227~~24, 2007, 4,748,883 shares were available for purchase under the 1999 ~~ESPP Plan.~~ESPP.

Prior to June 27, 2005, the Company accounted for its stock plans under the provisions of Accounting Principles Board Opinion No. 25, “Accounting for Stock Issued to Employees” (APB No. 25) and FASB Interpretation (FIN) No. 44, “Accounting for Certain Transactions Involving Stock Compensation — an Interpretation of APB Opinion No. 25” (FIN No. 44). The Company ~~adopted~~accounts for equity-based compensation in accordance with Statement of Financial Accounting Standards No. 123 (revised 2004), “Share-Based Payment” (SFAS No. 123R), ~~effective~~which the Company adopted as of June 27, 2005 using the modified prospective ~~transition~~ method. Under that transition method, equity-based compensation expense recognized during fiscal year 2006 includes: (a) ESPP awards with offering periods commencing, and stock options and restricted stock units granted, prior to, but not yet vested as of June 27, 2005, based on the grant-date fair value estimated in accordance with the original provisions of SFAS No. 123, and (b) ESPP with offering periods commencing and restricted stock units granted, subsequent to June 27, 2005, based on the grant-date fair value estimated in accordance with the provisions of SFAS No. 123R. Under the modified prospective transition method, results for prior periods are not restated.

The Company analyzed its equity-based compensation strategies prior to the adoption of SFAS No. 123R and made the decision to grant restricted stock units rather than stock options during fiscal year 2006. The Company recognized equity-based compensation expense of ~~$22.8~~$35.6 million during fiscal year ~~2006. Included in these amounts are expenses related to restricted stock units of $11.4~~2007 and $24.0 million during fiscal year 2006, which would have been included in the Company’s Consolidated Statements of Operations under the provisions of APB No. 25. As a result of adopting SFAS No. 123R, the company’s income before income taxes and net income for the year ended June 25, 2006, are $11.4 million and $9.3 million lower, respectively, than if it had continued to account for equity-based compensation under APB No. 25. Basic and diluted earnings per share for the year ended June 25, 2006 are $.07 and $.06 lower, respectively, than if the Company had continued to account for equity-based compensation under APB No. 25.

respectively. The income tax benefit recognized in the consolidated statements of operations related to equity-based compensation expense was ~~$4.3~~$5.8 million during fiscal year 2007 and $5.2 million during fiscal year 2006. The estimated fair value of the Company’s ~~equity-based~~stock-based awards, less expected forfeitures, is amortized over the awards’ vesting period on a straight-line basis for awards granted after the adoption of SFAS No. 123R and on a graded vesting basis for awards granted prior to the adoption of SFAS No. 123R.

ESPP

ESPP awards were valued using the Black-Scholes model. ESPP awards for offering periods subsequent to the adoption of SFAS No. 123R were valued using the Black-Scholes model with expected volatility calculated using implied volatility. Prior to the adoption of SFAS No. 123R, the Company used historical volatility in deriving its expected volatility assumption. The Company determined, for purposes of valuing ESPP awards, that implied volatility provides a more accurate reflection of market conditions and is a better indicator of expected volatility than historical volatility. During fiscal ~~year~~years 2007 and 2006 ESPP was valued assuming no expected dividends and the following weighted-average assumptions:


~~Expected life (years)~~	~~0.68~~
~~Expected stock price volatility~~	~~34.5~~	%
~~Risk-free interest rate~~	~~3.4~~	%


	Year Ended
	June 24,			June 25,
	2007			2006
Expected life (years)		0.68			0.68
Expected stock price volatility		44.5	%		34.5	%
Risk-free interest rate		5.0	%		3.4	%

As of June ~~25, 2006,~~24, 2007, there was ~~$0.8~~$1.2 million of total unrecognized compensation cost related to the ESPP that is expected to be recognized over a remaining vesting period of two months.

Note ~~14:~~15: Profit Sharing and Benefit Plans

Profit sharing is awarded to certain employees based upon performance against specific corporate financial and operating goals. Distributions to employees by the Company are based upon a percentage of earned compensation, provided that a threshold level of the Company’s financial and performance goals are met. In addition to profit sharing the Company has other bonus plans based on achievement of profitability and other specific performance criteria. Charges to expense under these plans were $102.0 million, $70.8 million, ~~$63.1 million,~~ and ~~$30.9~~$63.1 million during fiscal years 2007, 2006, ~~2005,~~ and ~~2004,~~2005, respectively.

The Company maintains a 401(k)-retirement savings plan for its full-time employees in North America. ~~Each~~Commencing September 1, 2006, each participant in the plan may elect to contribute from 2% to ~~20%~~75% of his or her annual salary to the plan, subject to statutory limitations. Prior to September 1, 2006, the contribution range was from 2% to 20%. The Company makes matching employee contributions in cash to the plan at the rate of 50% of the first 6% of salary contributed. Employees participating in the 401(k)-retirement savings plan are 100% vested in the Company matching contributions and investments are directed by participants. The Company made matching contributions of approximately $4.4 million, $3.5 million, ~~$3.2 million,~~ and ~~$3.0~~$3.2 million in fiscal years 2007, 2006, ~~2005,~~ and ~~2004,~~2005, respectively.

The Company adopted the provisions of FASB Statement of Financial Accounting Standards Number 158, “Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plans an amendment of FASB Statements No. 87, 88, 106, and 132(R)” (SFAS No. 158) as of June 24, 2007. The incremental effect of applying the recognition provisions of SFAS No. 158 was to record an other long-term liability of $0.8 million with a corresponding amount recorded as an adjustment to the balance of accumulated other comprehensive income.

117

Operating Leases

The Company leases most of its administrative, R&D and manufacturing facilities, regional sales/service offices and certain equipment under non-cancelable operating leases, which expire at various dates through 2021. Certain of the Company’s facility leases for buildings located at its Fremont, California headquarters and certain other facility leases provide the Company with an option to extend the leases for additional periods or to purchase the facilities. Certain of the Company’s facility leases provide for periodic rent increases based on the general rate of inflation. Rent expense was $11.0 million, $8.9 million, and $6.5 million during fiscal years 2007, 2006, and 2005, respectively.

Included in the operating leases ~~1-3 years~~less than 1 year section of the table above is $75.0 million in guaranteed residual values for lease agreements relating to certain properties at the Company’s Fremont, California campus. As part of the lease agreements, the Company has the option to purchase the remaining buildings at any time for a total purchase price for all remaining properties related to these leases of approximately $85.0 million. The Company is required to guarantee the lessor a residual value on the properties of up to $75.0 million at the end of the lease terms in fiscal year 2008 (in the event that the leases are not renewed, the Company does not exercise the purchase options, the lessor sells the properties and the sale price is less than the lessor’s costs). The Company maintains cash collateral of $85.0 million as part of the lease agreements as of June ~~25, 2006~~24, 2007 in separate, specified certificates of deposit and interest-bearing accounts which are recorded as restricted cash and investments in ~~its~~the Company’s Consolidated Balance Sheet. The lessor under the lease agreements is a substantive independent leasing company that does not have the characteristics of a variable interest entity (VIE) as defined by FASB Interpretation No. 46, “Consolidation of Variable Interest Entities” and is therefore not consolidated by the Company. The Company obtained compliance waivers from the lessor with respect to the Company’s obligation to deliver financial statements to the lessor under the terms provided in the lease agreements. Please see Note 23 “Subsequent Events” below for additional information regarding renewal of the leases noted above and entry into additional leases.

The remaining operating lease balances primarily relate to non-cancelable facility-related operating leases.

118

Purchase Obligations

Purchase obligations consist of significant contractual obligations either on an annual basis or over multi-year periods related to the Company’s outsourcing activities or other material commitments, including vendor-consigned inventories. The Company continues to enter into new agreements and maintain existing agreements to outsource certain activities, including elements of its manufacturing, warehousing, logistics, facilities maintenance, certain information technology functions, and certain transactional general and administrative functions. The contractual cash obligations and commitments table presented above contains the Company’s minimum obligations at June ~~25, 2006~~24, 2007 under these arrangements and others. Actual expenditures will vary based on the volume of transactions and length of contractual service provided. In addition to ~~minimum spending commitments,~~these obligations, certain of these agreements ~~provide for potential~~include early termination provisions and/or cancellation ~~charges.~~penalties which could increase or decrease amounts actually paid.

Consignment inventories, which are owned by vendors but located in the Company’s storage locations and warehouses and properly segregated and controlled, are not reported as the Company’s inventory until title is transferred to itthe Company or its purchase obligation is determined. At June ~~25, 2006,~~24, 2007, vendor-owned inventories held at the Company’s locations and not reported as its inventory ~~increased to approximately $31.1 million as compared to $14.8 million at June 26, 2005, due to the increased volume of the Company’s business.~~

~~Restructuring Liabilities~~

~~The Company’s total restructuring reserves as of June 25, 2006~~ were $1.6 million, which consists primarily of lease payments on vacated buildings. Through cash generated from operations, the Company expects the remaining balance to be paid over the next twelve months.$27.4 million.

Long-Term Debt and Interest Expense

On June 16, 2006, the Company’s wholly-owned subsidiary, Lam Research International SARL (LRI), as borrower, entered into a $350 million Credit Agreement (the LRI Credit Agreement).

Under the LRI Credit Agreement, on June 19, 2006, LRI borrowed $350 million in principal amount. The loan under the LRI Credit Agreement shall be fully repaid not later than five years following the closing ~~date. The loan under the Credit Agreement~~date and will bear interest at LIBOR plus a spread (applicable margin) ranging from 0.10% to 0.50%, depending upon a consolidated leverage ratio, as defined in the Credit Agreement. ~~The initial spread under the Credit Agreement is 0.10%.~~ LRI may prepay the loan under the LRI Credit Agreement in whole or in part at any time without penalty, subject to reimbursement of lenders’ breakage and redeployment costs in certain cases. The Company obtained compliance waivers from the lender with respect to the Company’s obligation to deliver financial statements to the lender under the terms provided in the Guarantee Agreement. The amounts in the table above include the remaining principal payment of ~~$350~~$250 million due on June 19, ~~2011 and interest payments estimated based~~

on2011. $100.0 million of the ~~current LIBOR rate of 5.55% and initial spread of ten basis points.~~original $350.0 million debt was repaid during fiscal year 2007. The fair value of long-term debt approximates its carrying value due to the variable interest rate applicable to the debt. Please see Note 23 “Subsequent Events” below for information regarding termination of the LRI Credit Agreement and the Company’s entry into a new credit agreement.

The Company used the proceeds from the credit facility entered into by LRI to facilitate a portion of the repatriation of $500 million of foreign earnings in ~~the June~~fiscal year 2006 ~~quarter~~ under the provisions of the American Jobs Creation ~~Act of 2004 (AJCA). The Company has now completed its repatriation of foreign earnings under the provisions of the AJCA.~~Act.

Note ~~16:~~17: Guarantees

The Company accounts for its guarantees in accordance with Financial Accounting Standards Board (FASB) Interpretation No. 45 “Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others” (FIN No. 45). FIN No. 45 requires a company that is a guarantor to make specific disclosures about its obligations under certain guarantees that it has issued. FIN No. 45 also requires a company (the Guarantor) to recognize, at the inception of a guarantee, a liability for the obligations it has undertaken in issuing the guarantee.

The Company leases several facilities at its headquarters location in Fremont, California. As part of certain of the lease agreements, the Company has the option to purchase the remaining buildings at any time for a total purchase price for all remaining properties related to these leases of approximately $85.0 million. The Company is required to guarantee the lessor a residual value on the properties of up to $75.0 million at the end of the lease terms in ~~fiscal year 2008 (in~~ the event that the leases are not renewed, the Company does not exercise the purchase options, the lessor sells the properties and the sale price is less than the lessor’s ~~costs). The Company maintains cash collateral of $85.0 million as part of the lease agreements as~~costs. As of June ~~25, 2006~~24, 2007, the Company had $85.0 million in separate, specified certificates of deposit and ~~interest-bearing~~interest bearing accounts, ~~which~~as collateral required under the lease agreements. These are recorded as restricted cash and investments in its Consolidated Balance Sheet. These lease terms expire in fiscal year 2008. The lessor under the lease agreements is a substantive independent leasing company that does not have the characteristics of a variable interest entity (VIE) as defined by FASB Interpretation No. 46, “Consolidation of Variable Interest Entities” and is therefore not consolidated by the Company. The Company obtained compliance waivers from the lessor with respect to the Company’s obligation to deliver financial statements to the lessor under the terms provided in the lease agreements. Please see Note 23 “Subsequent Events” for additional information regarding renewal of the leases noted above and entry into additional leases.

The Company has issued certain indemnifications to its lessors under some of its agreements. The Company has entered into certain insurance contracts which may limit its exposure to such indemnifications. As of June ~~25, 2006,~~24, 2007, the Company has not recorded any liability on its financial statements in connection with these indemnifications, as it does not believe, based on information available, that it is probable that any amounts will be paid under these guarantees.

On June 16, 2006, the Company’s wholly-owned subsidiary, LRI, as borrower, entered into the LRI Credit Agreement. In connection with the LRI Credit Agreement, ~~entered into by LRI note above,~~ the Company entered into a Guarantee Agreement (the ~~Guarantee Agreement)~~“Guarantee Agreement”) guaranteeing the obligations of LRI under the LRI Credit Agreement. The Company’s obligations under the Guarantee Agreement are collateralized by readily marketable securities in an amount equal to 110% of the outstanding balance of its obligations under the Guarantee Agreement, representing ~~$385.0~~$275.0 million at June ~~25, 2006.~~24, 2007 as the Company had paid down

119

the Company will credit equity. During fiscal year 2007 and 2006, the Company recorded a net credit to equity of ~~$27.8 million. The net operating loss and tax credit carryforwards related to these tax benefits of $125.2~~$62.4 million and ~~$106.0~~$17.3 million, ~~are not reflected in the Company’s deferred tax assets for fiscal years 2006 and 2005,~~ respectively.

At June ~~25, 2006,~~24, 2007, the Company had ~~federal tax loss carryforwards of approximately $188.4 million, non tax-effected, which will expire between fiscal years 2023 and 2026. The Company also has~~ federal and state tax credit carryforwards of approximately ~~$172.4~~$149.1 million, of which approximately ~~$119.6~~$98.7 million will expire in varying amounts between fiscal years 2011 and ~~2027.~~2028. The remaining balance of ~~$52.8~~$50.4 million of tax carryforwards may be carried forward indefinitely. The tax benefits relating to approximately $131.7 million of the tax credit carryforwards will be credited to equity when recognized, in accordance with SFAS No. 123R.

A reconciliation of income tax expense provided at the federal statutory rate (35% in fiscal years 2007, 2006 ~~2005,~~ and ~~2004)~~2005) to actual income expense ~~(benefit)~~ is as follows:


										Year Ended
	Year Ended									June 24,			June 25,			June 26,
	June 25,			June 26,			June 27,			2007			2006			2005
	2006			2005			2004						As restated (1)			As restated (1)
	(in thousands)									(in thousands)
Income tax expense computed at federal statutory rate	$	154,450		$	139,692		$	38,688		$	296,703		$	153,925		$	138,691
State income taxes, net of federal tax		(6,281	)		648			261			3,447			(6,349	)		549
Foreign income taxes at different rates		(70,704	)		(33,052	)		9,347			(122,574	)		(70,704	)		(33,052	)
Tax credits		(4,762	)		(5,726	)		(6,604	)		(9,156	)		(4,762	)		(5,726	)
Provision related to repatriation under AJCA		24,207			—			—			—			24,207			—
Other, net		8,622			(1,781	)		(1,341	)		(6,513	)		8,263			(1,452	)
Change in valuation allowance		—			—			(12,689	)

	$	105,532		$	99,781		$	27,662		$	161,907		$	104,580		$	99,010

The acquisition was accounted for as a business combination in accordance with Statement of Financial Accounting Standards Number 141, “Business Combinations” and all amounts were recorded at their estimated fair value. The Consolidated Financial Statements include the operating results from the date of acquisition. Pro forma results of operations have not been presented because the effects of the acquisition were not material to the Company’s results.

The purchase price was allocated to the fair value of assets acquired as follows, in thousands:


Cash consideration	$	173,893
Transaction costs		3,215

	$	177,108


Inventories	$	12,656
Property and equipment, net		32,696
Prepaid expenses and other current assets		4,392
Other assets		5,731
Accrued expenses and other current liabilities		(42	)
Customer relationships		35,226
Other intangible assets		30,193
Goodwill		56,256

	$	177,108

Note 20 — Goodwill and Intangible Assets

Goodwill

Total goodwill as of June 24, 2007 was $59.7 million and primarily consisted of goodwill recorded as a result of the Bullen Ultrasonics transaction of $56.3 million. Goodwill is tax deductible.

Intangible Assets

The following table provides details of the Company’s intangible assets subject to amortization as of June 24, 2007 (in thousands, except years):


								Weighted-
								Average
			Accumulated					Useful Life
	Gross		Amortization			Net		(years)
Customer relationships	$	35,226	$	(3,276	)	$	31,950		6.9
Other intangible assets		30,193		(3,556	)		26,637		4.6
Patents		15,000		(2,678	)		12,322		7.0

	$	80,419	$	(9,510	)	$	70,909		6.1

The following table provides details of the Company’s intangible assets subject to amortization as of June 25, 2006 (in thousands, except years):

Weighted-

Average

Accumulated

Useful Life

Gross

Amortization

Net

(years)

Patents

15,000

(357

)

14,643

7.0

The Company recognized $9.2 million and $0.3 million in intangible asset amortization expense during fiscal years 2007 and 2006, respectively.

The Company accounts for goodwill and other intangible assets in accordance with Statement of Financial Accounting Standards No. 142, “Goodwill and Other Intangible Assets,” (SFAS No. 142). SFAS No. 142 requires that goodwill and identifiable intangible assets with indefinite useful lives no longer be amortized, but instead be tested for impairment at least annually. SFAS No. 142 also requires that intangible assets with estimable useful lives be amortized over their respective estimated useful lives to their estimated residual values, and reviewed for impairment in accordance with SFAS No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets.” The Company reviews goodwill for impairment at least annually. In addition, the Company reviews goodwill and other intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount of these assets may not be recoverable.

123

The estimated future amortization expense of purchased intangible assets as of June 24, 2007 is as follows (in thousands):


Fiscal Year	Amount
2008		14,250
2009		14,081
2010		13,980
2011		10,999
2012		7,988
Thereafter		9,611

	$	70,909

Note ~~18:~~21: Segment, Geographic Information and Major Customers

The Company operates in one business segment: manufacturing and servicing of front-end wafer processing semiconductor manufacturing equipment. The Company’s material operating units qualify for aggregation under Statement of Financial Accounting Standards No. 131, “Disclosures about Segments of an Enterprise and Related Information,” due to their identical customer base and similarities in economic characteristics, nature of products and services, and processes for procurement, manufacturing and distribution.

The Company operates in ~~five~~six geographic regions: the United States, Europe, Taiwan, Korea, Japan, and Asia ~~Pacific, and Japan.~~Pacific. For geographical reporting, revenues are attributed to the geographic location in which the customers’ facilities are located while long-lived assets are attributed to the geographic locations in which the assets are located.


	Year Ended						Year Ended
	June 25,		June 26,		June 27,		June 24,		June 25,		June 26,
	2006		2005		2004		2007		2006		2005
	(in thousands)						(in thousands)
Net sales:
Revenue:
United States	$	238,009	$	234,112	$	164,528	$	408,631	$	238,009	$	234,112
Europe		208,369		184,014		177,380		237,716		208,369		184,014
Asia Pacific		470,912		582,033		397,681		451,487		193,181		292,501
Taiwan								573,875		277,731		289,532
Korea		366,939		280,605		92,063		531,310		366,939		280,605
Japan		357,942		221,689		104,294		363,557		357,942		221,689

Total net sales	$	1,642,171	$	1,502,453	$	935,946
Total revenue							$	2,566,576	$	1,642,171	$	1,502,453

Note ~~20:~~23: Subsequent Events

SEZ Transaction: On ~~July 12, 2006,~~March 11, 2008, the ~~Supreme Court~~Company completed the tender offer for the outstanding shares of ~~California denied review~~SEZ Holding AG (“SEZ”), the leading supplier of ~~lower~~single-wafer clean technology and ~~appellate court judgments~~products to the global semiconductor manufacturing industry. Upon the completion of the tender, the Company acquired approximately 94% of the outstanding shares of SEZ. The Company expects to take additional steps as necessary to acquire the SEZ shares that remain outstanding.

The tender offer was conducted pursuant to the terms of a Transaction Agreement entered into on December 10, 2007 by and between the Company and SEZ (the “Transaction Agreement”). Under the terms of the Transaction Agreement, the Company acquired all shares of SEZ that were tendered in ~~favor~~the offer at a price of ~~Lam~~CHF 38 per share in cash, for a total price of CHF 606 million, which approximated US$584 million.

In December 2007, the Company purchased a call option with ~~respect~~a notional amount of approximately CHF 641 million to hedge the currency exposure in connection with the anticipated purchase of the shares of SEZ as noted above. The call option premium cost was $10.3 million. The mark-to-market value of the call option as of December 23, 2007 was $3.1 million resulting in a $7.2 million unrealized loss recorded in other income (expense), net in the Company’s condensed consolidated statements of operations for the quarter ended December 23, 2007. In February 2008 the Company extended the expiration date of the call option at an additional premium cost of $2.4 million. The Company exercised the call option during March 2008 which resulted in a gain of $40.7 million which it will record in other income (expense), net in its condensed consolidated statements of operations for the quarter ending March 30, 2008.

Operating Leases: On December 18, 2007, the Company entered into a series of two operating leases (the “Livermore Leases”) regarding certain improved properties in Livermore, California. On December 21, 2007, the Company entered into a series of four amended and restated operating leases (the “New Fremont Leases,” and collectively with the Livermore Leases, the “Operating Leases”) with regard to certain improved properties at the Company’s headquarters in Fremont, California. Each of the Operating Leases is an off-balance sheet arrangement.

The Operating Leases (and associated documents for each Operating Lease) were entered into by the Company and BNP Paribas Leasing Corporation (“BNPPLC”).

Each Livermore Lease facility has an approximately seven-year term (inclusive of an initial construction period during which BNPPLC’s and the Company’s obligations will be governed by the Construction Agreement entered into with regard to such Livermore Lease facility) ending on the first business day in January 2015. Total scheduled rent payments under the Livermore Leases are estimated to be approximately $25.7 million in the aggregate (based on one-month LIBOR rates at the time of entering into the leases), following completion of improvements to each property.

Under each Operating Lease, the Company may, at its discretion and with 30 days’ notice, elect to purchase the property that is the subject of the Operating Lease for an amount approximating the sum required to prepay the amount of BNPPLC’s investment in the property and any accrued but unpaid rent. Any such amount may also include an additional make-whole amount for early redemption of the outstanding investment, which will vary depending on prevailing interest rates at the time of prepayment.

The Company is required, pursuant to the terms of the Operating Leases and associated documents, to maintain collateral in an aggregate of approximately $165.0 million (upon completion of the Livermore construction) in separate interest-bearing accounts with BNPPLC (or a third party, currently State Street Bank and Trust, with regard to the Livermore Leases) as security for the Company’s obligations under the Operating Leases.

Upon expiration of the term of an Operating Lease, the property subject to that Operating Lease may be remarketed. The Company has guaranteed to BNPPLC that each property will have a certain minimum residual value, as set forth in the applicable Operating Lease. The aggregate guarantee made by the Company under the Operating Leases is no more than approximately $141.8 million (although, under certain default circumstances, the guarantee with regard to an Operating Lease may be 100% of BNPPLC’s investment in the applicable property; in the aggregate, the amounts payable under such guarantees will be no more than $165.0 million plus related indemnification or other obligations).

Under each Operating Lease and its associated documents, the Company is subject to a ~~lawsuit filed by Lam alleging breach~~financial covenant requiring it to maintain unrestricted cash, unencumbered cash investments, and unencumbered marketable securities of ~~purchase order contracts by one~~at least $300.0 million (not including the collateral maintained as security for the Company’s obligations under the Operating Leases).

125

The Operating Leases are subject to customary default provisions, including, without limitation, those relating to payment defaults under the Operating Leases and associated documents, payment defaults under other indebtedness of the Company, performance defaults under the Operating Leases (including cross-defaults between each of the Operating Leases), and events of bankruptcy. In the event that such defaults occur and are continuing, BNPPLC may accelerate repayment of a portion or all of its ~~customers.~~investment under the applicable Operating Leases; alternatively, BNPPLC may require the Company to pay all amounts due under one or more Operating Leases through the end of the term of the applicable Operating Leases.

Credit Agreement: On March 3, 2008, the Company, as borrower, entered into a $250 million Credit Agreement, dated as of March 3, 2008 (the “Credit Agreement”) with ABN AMRO BANK N.V (the “Agent”), as administrative agent for the lenders party to the Credit Agreement, and such lenders. Bullen Semiconductor Corporation, a wholly-owned domestic subsidiary of the Company (“Bullen”), entered into a guarantee (the “Bullen Guarantee”) to guarantee the obligations of the Company under the Credit Agreement. In connection with the Credit Agreement, the Company and Bullen entered into certain collateral documents (collectively, the “Collateral Documents”) including a Security Agreement by the Company (the “Security Agreement”), a Security Agreement by Bullen (the “Bullen Security Agreement”), a Pledge Agreement by the Company (the “Pledge Agreement”) and other Collateral Documents to secure the Company’s obligations under the Credit Agreement. The Collateral Documents encumber current and future accounts receivables, inventory, equipment and related assets of the Company and Bullen, as well as 100% of the Company’s ownership interest in Bullen and 65% of the Company’s ownership interest in Lam Research International BV, a wholly-owned subsidiary of the Company. In addition, the Credit Agreement provides that any future domestic subsidiaries of the Company will also enter into a similar guarantee and collateral documents to encumber the foregoing type of assets.

Under the Credit Agreement, the Company borrowed $250 million in principal amount for general corporate purposes. The loan under the Credit Agreement is a non-revolving term loan with the following repayment terms: (a) $12.5 million of the principal amount due on each of (i) September 30, 2008, (ii) March 31, 2009 and (iii) September 30, 2009 and (b) the payment of the remaining principal amount on March 6, 2010. The outstanding principal amount bears interest at LIBOR plus 0.75% per annum or, alternatively, at the Agent’s “prime rate.” The Company may prepay the loan under the Credit Agreement in whole or in part at any time without penalty. The Credit Agreement contains customary representations, warranties, affirmative covenants and events of default, as well as various negative covenants (including maximum leverage ratio, minimum liquidity and minimum EBITDA).

Section 409A: As a result of the ~~denied~~determinations from a voluntary independent stock option review, the ~~prior rulings~~Company considered the application of Section 409A of the IRC to certain stock option grants where, under APB No. 25, intrinsic value existed at the time of grant. In the event such stock option grants are not considered as issued at fair market value at the original grant date under the IRC and applicable regulations thereunder, these options are subject to Section 409A. On March 30, 2008, the Board of Directors of the Company authorized the Company to assume the liability of any and all employees, including the Company’s Chief Executive Officer and certain executive officers, with options subject to Section 409A. The liability is currently estimated to be in the range of approximately $50 million to $55 million. The determinations from the ~~trial~~voluntary independent stock option review are more fully described in Note 3, “Restatement of Consolidated Financial Statements” to Consolidated Financial Statements in Item 8 and ~~appellate courts stand resulting~~“Management’s Discussion and Analysis of Financial Condition and Results of Operations” in ~~a judgment in favor~~Item 7 of ~~Lam of approximately $15.8 million, which includes approximately $2.0 million in post-judgment interest. The Company plans to record this amount in other income (expense), net during~~ the ~~quarter ending September 24, 2006.~~Company’s 2007 Form 10-K.

62126

Report of Independent Registered Public Accounting Firm

The Board of Directors and Stockholders of Lam Research Corporation

We have audited the accompanying consolidated balance sheets of Lam Research Corporation as of June 24, 2007 and June 25, 2006 ~~and June 26, 2005,~~(restated), and the related consolidated statements of ~~income, shareholders’~~operations, stockholders’ equity, and cash flows for ~~each of~~ the ~~three~~ years ~~in the period~~ ended June 24, 2007, June 25, ~~2006.~~2006 (restated) and June 26, 2005 (restated). Our audits also included the financial statement schedule listed in the Index at Item 15(a). These financial statements and schedule are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements and ~~schedules~~schedule based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Lam Research Corporation at June 24, 2007 and June 25, 2006 ~~and June 26, 2005,~~(restated), and the consolidated results of its operations and its cash flows for ~~each of~~ the ~~three~~ years ~~in the period~~ ended June 24, 2007, June 25, 2006 (restated) and June 26, 2005 (restated), in conformity with U.S. generally accepted accounting principles. Also, in our opinion, the related financial statement schedule, when considered in relation to the basic financial statements taken as a whole, present fairly in all material respects the information set forth therein.

As discussed in Note 3, “Restatement of Consolidated Financial Statements” the Company has restated previously issued financial statements as of June 25, 2006 and for each of the years in the two year period ended June 25, 2006.

As discussed in Note 2 to the Notes to Consolidated Financial Statements, under the heading Equity-Based Compensation-Employee Stock Purchase Plan and Employee Stock Plans, in fiscal 2006 Lam Research Corporation changed its method of accounting for stock-based compensation.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), ~~the effectiveness of~~ Lam Research Corporation’s internal control over financial reporting as of June ~~25, 2006,~~24, 2007, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated ~~August 14, 2006~~March 31, 2008 expressed an unqualified opinion thereon.

As discussed in Note 2 to the Notes to Consolidated Financial Statements, under the heading Equity-Based Compensation – Employee Stock Purchase Plan and Employee Stock Plans, in fiscal 2006 Lam Research Corporation changed its method of accounting for stock-based compensation.

/s/ ERNST & YOUNG LLP

San Jose, California
~~August 14, 2006~~March 31, 2008

63127

Report of Independent Registered Public Accounting Firm on Internal Control over Financial Reporting

The Board of Directors and Stockholders of Lam Research Corporation

We have audited ~~management’s assessment, included in the accompanying Management’s Report on Internal Control Over Financial Reporting, that~~ Lam Research ~~Corporation maintained effective~~Corporation’s internal control over financial reporting as of June ~~25, 2006,~~24, 2007, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (the COSO criteria). Lam Research Corporation’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial ~~reporting.~~reporting included in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on ~~management’s assessment and an opinion on the effectiveness of~~ the company’s internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, ~~evaluating management’s assessment,~~assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our opinion, management’s assessment that Lam Research Corporation maintained effective internal control over financial reporting as of June 25, 2006, is fairly stated, in all material respects, based on the COSO criteria. Also, in our opinion, Lam Research Corporation maintained, in all material respects, effective internal control over financial reporting as of June ~~25, 2006,~~24, 2007, based on the COSO ~~criteria.~~criteria.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of Lam Research Corporation as of June 24, 2007 and June 25, 2006 ~~and June 26, 2005,~~(restated), and the related consolidated statements of operations, stockholders’ equity and cash flows for ~~each of~~ the ~~three~~ years ~~in the period~~ ended June 24, 2007, June 25, 2006 (restated) and June 26, 2005 (restated) of Lam Research Corporation and our report dated ~~August 14, 2006~~March 31, 2008 expressed an unqualified opinion thereon.

/s/Ernst & Young LLP

San Jose, California
~~August 14, 2006~~March 31, 2008

64128

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Stephen G. Newberry and Martin B. Anstice, jointly and severally, his attorney-in-fact, each with the power of substitution, for him in any and all capacities, to sign any amendments to this Report of Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorney-in-fact, or his substitute or substitutes, may do or cause to be done by virtue thereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the date indicated.


Signatures	Title	Date
/s/ Stephen G. Newberry Stephen G. Newberry	President and Chief Executive Officer, Director	~~August 16, 2006~~March 31, 2008

/s/ Martin B. Anstice Martin B. Anstice	~~Group~~Senior Vice President, Chief Financial Officer, and Chief Accounting Officer	~~August 16, 2006~~March 31, 2008

/s/ James W. Bagley James W. Bagley	Executive Chairman	~~August 16, 2006~~March 31, 2008

/s/ Dr. Seiichi Watanabe Dr. Seiichi Watanabe	Director	~~August 16, 2006~~March 31, 2008

/s/ David G. Arscott David G. Arscott	Director	~~August 16, 2006~~March 31, 2008

/s/ Robert M. Berdahl Robert M. Berdahl	Director	~~August 16, 2006~~March 31, 2008

/s/ Richard J. Elkus, Jr. Richard J. Elkus, Jr.	Director	~~August 16, 2006~~March 31, 2008

/s/ Jack R. Harris Jack R. Harris	Director	~~August 16, 2006~~March 31, 2008

/s/ Grant M. Inman Grant M. Inman	Director	~~August 16, 2006~~March 31, 2008

/s/ Catherine P. Lego Catherine P. Lego	Director	~~August 16, 2006~~March 31, 2008

/s/ Patricia S. Wolpert Patricia S. Wolpert	Director	March 31, 2008

66129

LAM RESEARCH CORPORATION

ANNUAL REPORT ON FORM 10-K

FOR THE FISCAL YEAR ENDED JUNE ~~25, 2006~~24, 2007

EXHIBIT INDEX


Exhibit		Description
3.1(22)		Certificate of Incorporation of the Registrant, dated September 7, 1989; as amended by the Agreement and Plan of Merger, Dated February 28, 1990; the Certificate of Amendment dated October 28, 1993; the Certificate of Ownership and Merger dated December 15, 1994; the Certificate of Ownership and Merger dated June 25, 1999 and the Certificate of Amendment effective as March 7, 2000.

~~3.2(33)~~3.2		~~Amended and Restated By Laws~~Bylaws of the Registrant, as amended, dated ~~June 27, 2005.~~December 12, 2007.

3.3(22)		Certificate of Designation, Preferences and Rights of Series A Junior Participating Preferred Stock dated January 27, 1997.

4.2(1)*		Amended 1984 Incentive Stock Option Plan and Forms of Stock Option Agreements.

4.4(5)*		Amended 1991 Stock Option Plan and Forms of Stock Option Agreements.

4.8(35)*		Amended and restated 1997 Stock Incentive Plan.

4.11(18)*		Amended and restated 1996 Performance-Based Restricted Stock Plan.

4.12(34)*		Amended and restated 1999 Stock Option Plan.

4.13(34)*		Lam Research Corporation 1999 Employee Stock Purchase Plan, as amended.

~~4.14(35)~~4.14(39)*		Lam Research Corporation 2004 Executive Incentive Plan, as amended.

4.15(40)*		Lam Research Corporation 2007 Stock Incentive Plan, as amended.

10.1(38)		Asset Purchase Agreement dated October 5, 2006 by and among Lam Research Corporation, Bullen Ultrasonics, Inc., Eaton 122 Ltd., Bullen Semiconductor (Suzhou) Co., Ltd., Mary A. Bullen and Vicki Brown.

10.2(38)		First Amendment to Asset Purchase Agreement dated October 5, 2006 by and among Lam Research Corporation, Bullen Ultrasonics, Inc., Eaton 122 Ltd., Bullen Semiconductor (Suzhou) Co., Ltd., Mary A. Bullen and Vicki Brown.

10.3(2)		Form of Indemnification Agreement.

10.12(3)		ECR Technology License Agreement and Rainbow Technology License Agreement by and between ~~Registrant~~Lam Research Corporation and Sumitomo Metal Industries, Ltd.

10.16(4)		License Agreement effective January 1, 1992 between the ~~Registrant~~Lam Research Corporation and Tokyo Electron Limited.

10.30(6)		1996 Lease Agreement ~~Between~~between Lam Research Corporation and the Industrial Bank of Japan, Limited, dated March 27, 1996.

10.35(7)		Agreement and Plan of Merger by and among Lam Research Corporation, Omega Acquisition Corporation and OnTrak Systems, Inc., dated as of March 24, 1997.

10.38(8)		Consent and Waiver Agreement between Lam Research Corporation and IBJTC Leasing Corporation-BSC, The Industrial Bank of Japan, Limited, Wells Fargo Bank, N.A., The Bank of Nova Scotia, and the Nippon Credit Bank, Ltd., dated March 28, 1997.
	��
10.46(9)		Receivables Purchase Agreement between Lam Research Co., Ltd. and ABN AMRO Bank N.V., Tokyo Branch, dated December 26, 1997.

68131


Exhibit		Description
10.66(14)		Substitution Certificate for Loan Agreement dated September 30, 1998 between ABN AMRO BANK, N.V. and Lam Research Corporation, dated March 19, 1999.

10.67(15)		OTS Issuer Stock Option Master Agreement between Lam Research Corporation and Goldman Sachs & Co., and Collateral Appendix thereto, dated June 1999.

10.68(15)		Form of ISDA Master Agreement and related documents between Lam Research Corporation and Credit Suisse Financial Products, dated June 1999.

10.69(17)		The First Amendment Agreement between Lam Research Corporation and Credit Suisse Financial Products, dated August 31, 1999.

10.70(19)		Lease Agreement between Lam Research Corporation and Scotiabanc Inc., dated January 10, 2000.

10.71(19)		Participation Agreement between Lam Research Corporation, Scotiabanc Inc., and The Bank of Nova Scotia, dated January 19, 2000.

10.73(20)		Lease Agreement Between Lam Research Corporation and Cushing 2000 Trust, dated December 6, 2000.

10.74(20)		Participation Agreement Between Lam Research Corporation and Cushing 2000 Trust, Dated December 6, 2000.

10.75(21)		Indenture between Lam Research Corporation and LaSalle Bank, National Association, as Trustee, dated May 22, 2001.

10.76(21)		Registration Rights Agreement among Lam Research Corporation, Credit Suisse First Boston Corporation and ABN Amro Rothschild LLC, dated May 22, 2001.

10.77(23)		Warrant to Purchase Common Stock of Lam Research Corporation, dated December 19, 2001, issued to Varian Semiconductor Equipment Associates, Inc.

10.78(24)		Promissory Note between Lam Research Corporation and Stephen G. Newberry dated May 8, 2001.

10.79(25)		Amendment to Stock Option Grant for James W. Bagley dated October 16, 2002.

10.80(26)		Amended and Restated Master Lease and Deed of Trust Between Lam Research Corporation and SELCO Service Corporation, dated March 25, 2003.

10.81(26)		Lease Supplement No. 1 Between Lam Research Corporation and SELCO Service Corporation, dated March 25, 2003.

10.82(26)		Participation Agreement Between Lam Research Corporation, SELCO Service Corporation and Key Corporate Capital Inc., dated March 25, 2003.

10.83(26)		Amendment to Participation Agreement Between Lam Research Corporation, Scotiabanc Inc. and The Bank of Nova Scotia, dated December 27, 2002.

10.84(26)		Amendment to Participation Agreement Between Lam Research Corporation, the Cushing 2000 Trust, Scotiabanc Inc, The Bank of Nova Scotia and Fleet National Bank, dated December 27, 2002.

70133


Exhibit		Description
10.85(26)*		Employment Agreement for Stephen G. Newberry, dated January 1, 2003.

10.86(27)*		Amended and Restated Master Lease and Deed of Trust Between Lam Research Corporation and SELCO Service Corporation, dated as of June 1, 2003.

10.87(27)		Lease Supplement No. 1 Between Lam Research Corporation and SELCO Service Corporation, dated as of June 1, 2003.

10.88(27)		Lease Supplement No. 2 Between Lam Research Corporation and SELCO Service Corporation, dated as of June 1, 2003.

10.89(27)		Lease Supplement No. 3 Between Lam Research Corporation and SELCO Service Corporation, dated as of June 1, 2003.

10.94(27)		Participation Agreement Between Lam Research Corporation and SELCO Service Corporation, and Key Corporate Capital Inc., dated as of June 1, 2003.

10.95(27)*		Employment Agreement for Ernest Maddock, dated April 15, 2003.

10.96(28)*		Employment Agreement for Nicolas J. Bright, dated August 1, 2003.

10.97(32)		Second Amendment to Second Amended and Restated Uncommitted Insured Trade Receivables Purchase Agreement between ABN Amro Bank, N.V. and Lam Research Corporation, dated June 2, 2004.

10.98(32)		Amended and Restated Guaranty between ABN Amro Bank, N.V. and Lam Research Corporation, dated June 2, 2004.

10.99(32)		Form of Nonstatutory Stock Option Agreement — Lam Research Corporation 1997 Stock Incentive Plan.

10.100(31)		Third Amended and Restated Uncommitted Insured Trade Receivables Purchase Agreement between Lam Research Corporation, Lam Research International SARL and ABN Amro Bank N.V., dated March 22, 2005.

10.101(31)		Third Amended and Restated Guaranty between Lam Research Corporation and ABN Amro Bank N.V., dated March 22, 2005.

10.102(36)		Form of Restricted Stock Unit Award Agreement (U.S. Agreement A) – Lam Research Corporation 1997 Stock Incentive Plan.

10.103(36)		Form of Restricted Stock Unit Award Agreement (non-U.S. Agreement I-A) – Lam Research Corporation 1997 Stock Incentive Plan.

10.104(37)		$350,000,000 Credit Agreement among Lam Research International SARL, as Borrower, The Several Lenders from Time to Time Parties Hereto, and ABN Amro Bank N.V., as Administrative Agent, dated June 16, 2006.

~~10.105(38)~~10.105(37)		Guarantee Agreement made by Lam Research Corporation in favor of ABN Amro Bank N.V., as Administrative Agent for the Lenders, dated June 16, 2006.

10.106(42)*		Form of Restricted Stock Unit Award Agreement (U.S. Agreement) – Lam Research Corporation 2007 Stock Incentive Plan

10.107(43)		Form of Restricted Stock Unit Award Agreement – Outside Directors (U.S. Agreement) – Lam Research Corporation 2007 Stock Incentive Plan.

10.108(43)		Form of Restricted Stock Unit Award Agreement – Outside Directors (non-U.S. Agreement) – Lam Research Corporation 2007 Stock Incentive Plan.

10.109(43)		Summary of Compensation Arrangement with Nicolas J. Bright, effective as of March 1, 2007.

10.110(44)		Transaction Agreement dated December 10, 2007 by and between Lam Research Corporation and SEZ Holding AG

10.111(45)		Credit Agreement dated as of March 3, 2008 among Lam Research Corporation, as the Borrower, ABN Amro Bank N.V., as Administrative Agent, and the other Lenders Party thereto

134


Exhibit		Description
10.112(45)		Unconditional Guaranty dated as of March 3, 2008 by Bullen Semiconductor Corporation to ABN AMRO Bank N.V.

10.113(45)		Security Agreement dated as of March 3, 2008 between Lam Research Corporation and ABN AMRO Bank N.V.

10.114(45)		Security Agreement dated as of March 3, 2008 between Bullen Semiconductor Corporation and ABN AMRO Bank N.V.

10.115(45)		Pledge Agreement dated as of March 3, 2008 among Lam Research Corporation and ABN AMRO Bank N.V.

10.116(41)		Employment Agreement between James W. Bagley and Lam Research Corporation, dated December 11, 2006.

10.117		Lease Agreement (Fremont Building #1) between Lam Research Corporation and BNP Paribas Leasing Corporation, dated December 21, 2007.

10.118		Pledge Agreement (Fremont Building #1) between Lam Research Corporation and BNP Paribas Leasing Corporation, dated December 21, 2007.

10.119		Closing Certificate and Agreement (Fremont Building #1) between Lam Research Corporation and BNP Paribas Leasing Corporation, dated December 21, 2007.

10.120		Agreement Regarding Purchase and Remarketing Options (Fremont Building #1) between Lam Research Corporation and BNP Paribas Leasing Corporation, dated December 21, 2007.

10.121		Lease Agreement (Fremont Building #2) between Lam Research Corporation and BNP Paribas Leasing Corporation, dated December 21, 2007.

10.122		Pledge Agreement (Fremont Building #2) between Lam Research Corporation and BNP Paribas Leasing Corporation, dated December 21, 2007.

10.123		Closing Certificate and Agreement (Fremont Building #2) between Lam Research Corporation and BNP Paribas Leasing Corporation, dated December 21, 2007.

10.124		Agreement Regarding Purchase and Remarketing Options (Fremont Building #2) between Lam Research Corporation and BNP Paribas Leasing Corporation, dated December 21, 2007.

10.125		Lease Agreement (Fremont Building #3) between Lam Research Corporation and BNP Paribas Leasing Corporation, dated December 21, 2007.

10.126		Pledge Agreement (Fremont Building #3) between Lam Research Corporation and BNP Paribas Leasing Corporation, dated December 21, 2007.

10.127		Closing Certificate and Agreement (Fremont Building #3) between Lam Research Corporation and BNP Paribas Leasing Corporation, dated December 21, 2007.

10.128		Agreement Regarding Purchase and Remarketing Options (Fremont Building #3) between Lam Research Corporation and BNP Paribas Leasing Corporation, dated December 21, 2007.

10.129		Lease Agreement (Fremont Building #4) between Lam Research Corporation and BNP Paribas Leasing Corporation, dated December 21, 2007.

10.130		Pledge Agreement (Fremont Building #4) between Lam Research Corporation and BNP Paribas Leasing Corporation, dated December 21, 2007.

10.131		Closing Certificate and Agreement (Fremont Building #4) between Lam Research Corporation and BNP Paribas Leasing Corporation, dated December 21, 2007.

10.132		Agreement Regarding Purchase and Remarketing Options (Fremont Building #4) between Lam Research Corporation and BNP Paribas Leasing Corporation, dated December 21, 2007.

10.133		Lease Agreement (Livermore/Parcel 6) between Lam Research Corporation and BNP Paribas Leasing Corporation, dated December 18, 2007.

135


Exhibit		Description
24		Power of Attorney (See Signature page)

31.1		Rule 13a — 14(a) / 15d — 14(a) Certification (Principal Executive Officer)

31.2		Rule 13a — 14(a) / 15d — 14(a) Certification (Principal Financial Officer)

32.1		Section 1350 Certification — (Principal Executive Officer)

32.2		Section 1350 Certification — (Principal Financial Officer)


(1)		Incorporated by reference to Post Effective Amendment No. 1 to the Registrant’s Registration Statement on Form S-8 (No. 33-32160) filed with the Securities and Exchange Commission on May 10, 1990.

(2)		Incorporated by reference to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended April 3, 1988.

(3)		Incorporated by reference to Registrant’s Quarterly Report on Form 10-Q for the quarter ended December 31, 1989.

(4)		Incorporated by reference to Registrant’s Quarterly Report on Form 10-Q for the quarter ended December 31, 1991.

(5)		Incorporated by reference to Registrant’s Quarterly Report on Form 10-Q for the quarter ended December 31, 1995.

(6)		Incorporated by reference to Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 1996.

(7)		Incorporated by reference to Registrant’s Report on Form 8-K dated March 31, 1997.

(8)		Incorporated by reference to Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 1997.

(9)		Incorporated by reference to Registrant’s Quarterly Report on Form 10-Q for the quarter ended December 31, 1997.

(10)		Incorporated by reference to Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 1998.

(11)		Incorporated by reference to Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 1998.

(12)		Incorporated by reference to Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 30, 1998.

(13)		Incorporated by reference to Registrant’s Quarterly Report on Form 10-Q for the quarter ended December 31, 1998.

(14)		Incorporated by reference to Registrant’s Quarterly Report on Form 10-Q/A for the quarter ended March 31, 1999.

(15)		Incorporated by reference to Registrant’s Report on Form 8-K dated June 22, 1999.

(16)		Incorporated by reference to Registrant’s Report on Form S-8 dated November 5, 1998.

137


	Page
Explanatory Note		2
Part I.		4
Item 1. Business		14
Item 1A. Risk Factors		811
Item 1B. Unresolved Staff Comments		19
Item 2. Properties		1619
Item 3. Legal Proceedings		1619
Item 4. Submission of Matters to a Vote of Security Holders		1619
Part II.		19
Item 5. Market for the Registrant’s Common ~~Stock and~~Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities		1619
Item 6. Selected ~~Consolidated~~ Financial Data		1722
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations		2035
Item 7A. Quantitative and Qualitative Disclosures about Market Risk		3254
Item 8. ~~Consolidated~~ Financial Statements and Supplementary Data		3356
Item 9. Changes in and Disagreements ~~with~~With Accountants on Accounting and Financial Disclosure		3356
Item 9A. Controls and Procedures		3356
Item 9B. Other Information		3457
Part III.		58
Item 10. Directors, ~~and~~ Executive Officers ~~of the Registrant~~and Corporate Governance		3558
Item 11. Executive Compensation		3565
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters		3585
Item 13. Certain Relationships and Related Transactions, and Director Independence		3587
Item 14. Principal ~~Independent Registered Public~~ Accounting ~~Firm~~ Fees and Services		3587
Part IV.		89
Item 15. Exhibits, ~~Consolidated~~ Financial Statement Schedules ~~and Reports on Form 8-K~~		3689
Signatures		65129
Exhibit Index		68131
EXHIBIT 3.2
EXHIBIT 10.117
EXHIBIT 10.118
EXHIBIT 10.119
EXHIBIT 10.120
EXHIBIT 10.121
EXHIBIT 10.122
EXHIBIT 10.123
EXHIBIT 10.124
EXHIBIT 10.125
EXHIBIT 10.126
EXHIBIT 10.127
EXHIBIT 10.128
EXHIBIT 10.129
EXHIBIT 10.130
EXHIBIT 10.131
EXHIBIT 10.132
EXHIBIT 10.133
EXHIBIT 10.134
EXHIBIT 10.135
EXHIBIT 10.136
EXHIBIT 10.137
EXHIBIT 10.138
EXHIBIT 10.139
EXHIBIT 10.140
EXHIBIT 10.141
EXHIBIT 10.142
EXHIBIT 21
EXHIBIT 23.1
EXHIBIT 31.1
EXHIBIT 31.2
EXHIBIT 32.1
EXHIBIT 32.2


	Three Months Ended
	June 26,		March 27,		December 26,		September 26,
	2005		2005		2004		2004
	(in thousands, except per share data)
QUARTERLY FISCAL YEAR 2005:
Total revenue	$	353,767	$	349,337	$	379,800	$	419,549
Gross margin		175,859		174,570		198,902		214,761
Restructuring charges, net(1)		—		14,201		—		—
Operating income		82,531		78,625		108,570		121,276
Net income		66,526		59,451		83,614		89,750
Net income per share
Basic	$	0.48	$	0.42	$	0.61	$	0.66
Diluted	$	0.47	$	0.41	$	0.59	$	0.64
Price range per share	$	24.24-$31.78	$	25.35-$32.26	$	20.88-$29.70	$	19.71-$26.84
Number of shares used in per share calculations:

Basic		138,208		139,967		137,255		135,478
Diluted		142,518		144,756		142,268		139,808

										��
							Long-term								Long-term
	Operating		Purchase		Restructuring		Debt and				Operating		Purchase		Debt and
	Leases		Obligations		Liabilities		Interest Expense		Total		Leases		Obligations		Interest Expense		Total
	(in thousands)										(in thousands)
Payments due by period:
Less than 1 year	$	14,821	$	154,482	$	1,590	$	20,050	$	190,943	$	86,543	$	178,815	$	13,851	$	279,209
1-3 years		86,613		42,905		—		40,209		169,727		6,117		62,253		27,401		95,771
4-5 years		2,142		8,306		—		390,044		400,492
3-5 years												1,745		29,792		263,738		295,275
Over 5 years		2,175		—		—		—		2,175		1,743		39,273		—		41,016

Total	$	105,751	$	205,693	$	1,590	$	450,303	$	763,337	$	96,148	$	310,133	$	304,990	$	711,271

•		legal or technical challenges to our products and technology;

•		changes in import/export regulations;

•		transportation, communication, demand, information technology or supply disruptions based on factors outside our control such as acts of God, wars, terrorist activities, and natural disasters;

•		legislative, tax, accounting, or regulatory changes or changes in their interpretation;

•		procurement shortages;

•		manufacturing difficulties;

•		the failure of our suppliers or outsource providers to perform their obligations in a manner consistent with our expectations;

•		changes in our estimated effective tax rate;

•		new or modified accounting ~~regulations;~~regulations and practices; and

•		exchange rate fluctuations.

•		trade balance issues;

•		economic and political conditions;

•		changes in currency controls;

•		differences in the enforcement of intellectual property and contract rights in varying jurisdictions;

•		our ability to develop relationships with local suppliers;

•		compliance with U.S. and international laws and regulations, including U.S. export restrictions;

•		fluctuations in interest and currency exchange rates;

•		the need for technical support resources in different locations; and

•		our ability to secure and retain qualified people for the operation of our business.


	Total Number				Average		Amount Available
	of Shares		Total Cost of		Price Paid		For Repurchase
Period	Repurchased		Repurchase		Per Share		Under the Plan
	(in thousands, except per share data)
As of June 26, 2005		5,855	$	167,081	$	28.54	$	82,919
Additional authorization of $500 million — August 24, 2005							$	582,919
Quarter Ending September 25, 2005		2,644		78,690		29.76	$	504,229
Quarter Ending December 25, 2005		1,848		61,917		33.50	$	442,312
Quarter Ending March 26, 2006		1,698		73,602		43.36	$	368,710
Quarter Ending June 25, 2006		788		37,002		46.93	$	331,708

Total		12,833	$	418,292	$	32.59


*		$100 invested on 6/30/02 in stock or index-including reinvestment of dividends. Fiscal year ending June 30.


~~(1)~~		~~Fiscal year 2005 restructuring charges consist only of additional liabilities related to prior restructuring plans.~~


Quarter Ended June 25, 2006	As
(in thousands, except per share data)	reported		Adjustments (1)			As restated
Total revenue	$	525,596	$	—		$	525,596
Cost of goods sold		251,445		(27	)		251,418

Gross margin		274,151		27			274,178

Research and development		60,824		11			60,835
Selling, general and administrative		53,921		(23	)		53,898

Total operating expenses		114,745		(12	)		114,733

Operating income		159,406		39			159,445
Other income, net		9,398		—			9,398

Income before income taxes		168,804		39			168,843
Income tax expense		46,655		(260	)		46,395

Net income	$	122,149	$	299		$	122,448

Net income per share:
Basic net income per share	$	0.87				$	0.87

Diluted net income per share	$	0.84				$	0.85

Number of shares used in per share calculations:
Basic		141,168		—			141,168

Diluted		144,683		25			144,708


Consolidated Statement of Operations

Quarter Ended March 26, 2006	As
(in thousands, except per share data)	reported		Adjustments (1)			As restated
Total revenue	$	437,423	$	—		$	437,423
Cost of goods sold		217,769		140			217,909

Gross margin		219,654		(140	)		219,514

Research and development		61,083		148			61,231
Selling, general and administrative		48,303		328			48,631

Total operating expenses		109,386		476			109,862

Operating income		110,268		(616	)		109,652
Other income, net		7,828		—			7,828

Income before income taxes		118,096		(616	)		117,480
Income tax expense		31,759		(281	)		31,478

Net income	$	86,337	$	(335	)	$	86,002

Net income per share:
Basic net income per share	$	0.62				$	0.61

Diluted net income per share	$	0.60				$	0.59

Number of shares used in per share calculations:
Basic		140,122		—			140,122

Diluted		144,846		(103	)		144,743


Consolidated Statement of Operations

Quarter Ended December 25, 2005	As
(in thousands, except per share data)	reported		Adjustments (1)			As restated
Total revenue	$	358,245	$	—		$	358,245
Cost of goods sold		180,735		178			180,913

Gross margin		177,510		(178	)		177,332

Research and development		55,742		178			55,920
Selling, general and administrative		44,859		142			45,001

Total operating expenses		100,601		320			100,921

Operating income		76,909		(498	)		76,411
Other income, net		9,308		—			9,308

Income before income taxes		86,217		(498	)		85,719
Income tax expense		8,439		(201	)		8,238

Net income	$	77,778	$	(297	)	$	77,481

Net income per share:
Basic net income per share	$	0.57				$	0.57

Diluted net income per share	$	0.55				$	0.54

Number of shares used in per share calculations:
Basic		136,572		—			136,572

Diluted		142,525		(86	)		142,439


Consolidated Statement of Operations

Quarter Ended September 25, 2005	As
(in thousands, except per share data)	reported		Adjustments (1)			As restated
Total revenue	$	320,907	$	—		$	320,907
Cost of goods sold		164,828		91			164,919

Gross margin		156,079		(91	)		155,988

Research and development		51,242		150			51,392
Selling, general and administrative		45,155		181			45,336

Total operating expenses		96,397		331			96,728

Operating income		59,682		(422	)		59,260
Other income, net		8,488		—			8,488

Income before income taxes		68,170		(422	)		67,748
Income tax expense		18,679		(210	)		18,469

Net income	$	49,491	$	(212	)	$	49,279

Net income per share:
Basic net income per share	$	0.36				$	0.36

Diluted net income per share	$	0.35				$	0.35

Number of shares used in per share calculations:
Basic		136,453		—			136,453

Diluted		141,430		330			141,760


September 24, 2006	As
(in thousands)	reported			Adjustment (1)			As restated
ASSETS
Cash and cash equivalents	$	1,031,348		$	—		$	1,031,348
Short-term investments		233,284			—			233,284
Accounts receivable, net		379,869			—			379,869
Inventories		188,179			—			188,179
Deferred income taxes		47,206			—			47,206
Prepaid expenses and other current assets		40,714			—			40,714

Total current assets		1,920,600			—			1,920,600

Property and equipment, net		56,786			—			56,786
Restricted cash and investments		470,038			—			470,038
Deferred income taxes		38,533			14,038			52,571
Other assets		48,404			—			48,404

Total assets	$	2,534,361		$	14,038		$	2,548,399


LIABILITIES AND STOCKHOLDERS’ EQUITY
Trade accounts payable	$	125,550		$	—		$	125,550
Accrued expenses and other current liabilities		305,571			1,423			306,994
Deferred profit		153,123			—			153,123

Total current liabilities		584,244			1,423			585,667

Long-term debt		350,000			—			350,000
Long-term liabilities less current portion		924			—			924

Total liabilities		935,168			1,423			936,591

Commitments and contingencies
Stockholders’ equity:
Preferred stock		—			—			—
Common stock		142			—			142
Additional paid-in capital		983,253			78,460			1,061,713
Treasury stock		(410,718	)		—			(410,718	)
Accumulated other comprehensive loss		(6,483	)		—			(6,483	)
Retained earnings		1,032,999			(65,845	)		967,154

Total stockholders’ equity		1,599,193			12,615			1,611,808

Total liabilities and stockholders’ equity	$	2,534,361		$	14,038		$	2,548,399


March 26, 2006	As
(in thousands)	reported			Adjustments (1)			As restated
ASSETS
Cash and cash equivalents	$	757,845		$	—		$	757,845
Short-term investments		233,528			—			233,528
Accounts receivable, net		319,150			—			319,150
Inventories		144,259			—			144,259
Deferred income taxes		50,813			—			50,813
Prepaid expenses and other current assets		34,173			—			34,173

Total current assets		1,539,768			—			1,539,768

Property and equipment, net		43,903			—			43,903
Restricted cash		85,038			—			85,038
Deferred income taxes		36,409			24,226			60,635
Other assets		33,707			—			33,707

Total assets	$	1,738,825		$	24,226		$	1,763,051


LIABILITIES AND STOCKHOLDERS’ EQUITY
Trade accounts payable	$	107,142		$	—		$	107,142
Accrued expenses and other current liabilities		280,999			1,530			282,529
Deferred profit		119,168			—			119,168

Total current liabilities		507,309			1,530			508,839

Long-term liabilities less current portion		1,605			—			1,605

Total liabilities		508,914			1,530			510,444

Commitments and contingencies
Stockholders’ equity:
Preferred stock		—			—			—
Common stock		140			—			140
Additional paid-in capital		896,437			88,840			985,277
Treasury stock		(386,101	)		—			(386,101	)
Accumulated other comprehensive loss		(10,811	)		—			(10,811	)
Retained earnings		730,246			(66,144	)		664,102

Total stockholders’ equity		1,229,911			22,696			1,252,607

Total liabilities and stockholders’ equity	$	1,738,825		$	24,226		$	1,763,051


December 25, 2005	As
(in thousands)	reported			Adjustments (1)			As restated
ASSETS
Cash and cash equivalents	$	633,782		$	—		$	633,782
Short-term investments		258,463			—			258,463
Accounts receivable, net		279,185			—			279,185
Inventories		114,051			—			114,051
Deferred income taxes		64,724			—			64,724
Prepaid expenses and other current assets		30,288			—			30,288

Total current assets		1,380,493			—			1,380,493

Property and equipment, net		41,652			—			41,652
Restricted cash		85,038			—			85,038
Deferred income taxes		40,433			23,945			64,378
Other assets		34,655			—			34,655

Total assets	$	1,582,271		$	23,945		$	1,606,216


LIABILITIES AND STOCKHOLDERS’ EQUITY
Trade accounts payable	$	73,363		$	—		$	73,363
Accrued expenses and other current liabilities		267,869			1,299			269,168
Deferred profit		97,959			—			97,959

Total current liabilities		439,191			1,299			440,490

Long-term liabilities less current portion		1,279			—			1,279

Total liabilities		440,470			1,299			441,769

Commitments and contingencies
Stockholders’ equity:
Preferred stock		—			—			—
Common stock		138			—			138
Additional paid-in capital		828,836			88,455			917,291
Treasury stock		(317,883	)		—			(317,883	)
Accumulated other comprehensive loss		(14,067	)		—			(14,067	)
Retained earnings		644,777			(65,809	)		578,968

Total stockholders’ equity		1,141,801			22,646			1,164,447

Total liabilities and stockholders’ equity	$	1,582,271		$	23,945		$	1,606,216


September 25, 2005	As
(in thousands)	reported			Adjustments (1)			As restated
ASSETS
Cash and cash equivalents	$	514,818		$	—		$	514,818
Short-term investments		273,998			—			273,998
Accounts receivable, net		220,955			—			220,955
Inventories		113,702			—			113,702
Deferred income taxes		64,077			—			64,077
Prepaid expenses and other current assets		35,386			—			35,386

Total current assets		1,222,936			—			1,222,936

Property and equipment, net		40,010			—			40,010
Restricted cash		85,038			—			85,038
Deferred income taxes		40,433			23,744			64,177
Other assets		36,257			—			36,257

Total assets	$	1,424,674		$	23,744		$	1,448,418


LIABILITIES AND STOCKHOLDERS’ EQUITY
Trade accounts payable	$	56,898		$	—		$	56,898
Accrued expenses and other current liabilities		244,007			1,159			245,166
Deferred profit		63,744			—			63,744

Total current liabilities		364,649			1,159			365,808

Long-term liabilities less current portion		1,364			—			1,364

Total liabilities		366,013			1,159			367,172

Commitments and contingencies
Stockholders’ equity:
Preferred stock		—			—			—
Common stock		136			—			136
Additional paid-in capital		760,868			—			760,868
Treasury stock		(255,966	)		88,097			(167,869	)
Accumulated other comprehensive loss		(12,382	)		—			(12,382	)
Retained earnings		566,005			(65,512	)		500,493

Total stockholders’ equity		1,058,661			22,585			1,081,246

Total liabilities and stockholders’ equity	$	1,424,674		$	23,744		$	1,448,418


Net income	$	335.8		$	685.8
Non-cash charges:
Depreciation and amortization		22.0			38.1
Equity-based compensation		22.8			35.6
Other, net		2.3
Income tax benefit on equity-based compensation plans		27.8
Excess tax benefit on equity-based compensation plans		(17.8	)
Decrease in deferred tax assets		27.7
Net tax benefit on equity-based compensation plans					17.4
Deferred income taxes					17.1
Change in other working capital accounts		(59.9	)		29.0
Other					0.6

	$	360.7		$	823.6


Stephen G. Newberry
President and Chief
Executive Officer
	Voluntary
	Termination		Involuntary Termination
Executive Benefits and
Payments Upon			Disability or				Not for		Change in
Termination			Death		For Cause		Cause		Control
Compensation
Severance	$	—	$	800,000	$	—	$	1,000,000	$	—
Short-term Incentive	$	—	$	—	$	—	$	—	$	—
Long-term Incentives
2006-2007 MYIP	$	—	$	—	$	—	$	—	$	—
2007-2008 MYIP	$	—	$	—	$	—	$	—	$	—
Stock Options (Unvested and Accelerated)	$	—	$	—	$	—	$	—	$	—
Restricted Stock Units (Unvested and Accelerated)	$	—	$	—	$	—	$	—	$	—
Benefits and Perquisites
Health and Welfare Benefit Continuation (1)	$	73,000	$	73,000	$	—	$	73,000	$	73,000

Total	$	73,000	$	873,000	$	—	$	1,073,000	$	73,000


	Page
Consolidated Balance Sheets –— June 24, 2007 and June 25, 2006 ~~and June 26, 2005~~		3790

Consolidated Statements of Operations –— Years Ended June 24, 2007, June 25, 2006, and June 26, 2005 ~~and June 27, 2004~~		3891

Consolidated Statements of Cash Flows — Years Ended June 24, 2007, June 25, 2006, and June 26, 2005 ~~and June 27, 2004~~		3992

Consolidated Statements of Stockholders’ Equity — Years Ended June 24, 2007, June 25, 2006, and June 26, 2005 ~~and June 27, 2004~~		4093

Notes to Consolidated Financial Statements		4194

Report of Independent Registered Public Accounting Firm		63127

Report of Independent Registered Public Accounting Firm on Internal Control Over Financial Reporting		64128

2. Index to Financial Statement Schedules

Schedule II –— Valuation and Qualifying Accounts		67130


						Adjustment to income
	Adjustment to		Adjustment to			tax expense (benefit)
	stock-based		payroll tax			relating to stock-based			Total
Fiscal	compensation		expense			compensation and			restatement
Year	expense		(benefit)			payroll tax expense			expense

1997	$	1,770	$	—		$	(668	)	$	1,102
1998		2,352		226			(219	)		2,359
1999		5,291		136			(1,286	)		4,141
2000		19,151		1,511			(6,953	)		13,709
2001		23,395		220			(6,792	)		16,823
2002		13,056		159			(4,082	)		9,133
2003		15,739		(355	)		(4,942	)		10,442
2004		10,448		(1,061	)		(3,885	)		5,502

Cumulative through June 27, 2004		91,202		836			(28,827	)		63,211

2005		2,724		136			(771	)		2,089
2006		1,225		272			(952	)		545

Total	$	95,151	$	1,244		$	(30,550	)	$	65,845


Fiscal	Common Stock & Additional			Deferred Stock-Based			Retained			Net Impact to Stockholders’
Year	Paid-in Capital			Compensation			Earnings			Equity

1997	$	3,067		$	(1,490	)	$	(1,102	)	$	475
1998		3,336			(1,019	)		(2,359	)		(42	)
1999		23,168			(17,922	)		(4,141	)		1,105
2000		13,671			5,466			(13,709	)		5,428
2001		38,866			(19,347	)		(16,823	)		2,696
2002		12,135			570			(9,133	)		3,572
2003		(1,712	)		17,068			(10,442	)		4,914
2004		(1,055	)		11,067			(5,502	)		4,510

Subtotal		91,476			(5,607	)		(63,211	)		22,658
2005		(2,425	)		4,239			(2,089	)		(275	)
2006		(10,591	)		1,368			(545	)		(9,768	)

Total	$	78,460		$	—		$	(65,845	)	$	12,615


	Options Outstanding						Options Exercisable
			Weighted-
			Average		Weighted-				Weighted-
Range of	Number of		Remaining		Average		Number of		Average
Exercise	Options		Life		Exercise		Options		Exercise
Prices	Outstanding		(Years)		Price		Exercisable		Price
$ 3.33-6.33		529,242		2.53	$	6.31		529,242	$	6.31
6.38-9.67		442,519		2.81		8.62		434,853		8.61
9.96-18.46		929,191		3.98		14.25		540,262		13.36
18.58-21.97		253,183		4.84		20.78		81,333		20.27
22.00-22.05		1,611,317		2.69		22.05		1,579,417		22.05
22.07-25.66		733,825		4.37		24.07		434,480		24.68
25.72-28.04		649,490		4.02		26.84		626,440		26.87
28.06-50.46		368,101		5.24		37.76		368,101		37.76
51.50-51.50		7,000		3.72		51.50		7,000		51.50
53.00-53.00		4,070		3.75		53.00		4,070		53.00

$ 3.33-53.00		5,527,938		3.55	$	20.04		4,605,198	$	20.16


(1)		See Note 3 “Restatements of Consolidated Financial Statements” to Consolidated Financial Statements
(2)		Includes previously reported stock-based compensation expense, net of related tax effects, of $0.6 million for fiscal year ended June 26, 2005.


	Options						ESPP						Options			ESPP
	June 26,			June 27,			June 26,			June 27,			June 26,			June 26,
	2005			2004			2005			2004			2005			2005
Expected life (years)		2.8			3.3			0.6			0.6			2.8			0.6
Expected stock price volatility		73.3	%		74.1	%		74.0	%		74.1	%		73.3	%		74.0	%
Risk-free interest rate		2.8	%		2.3	%		2.9	%		2.3	%		2.8	%		2.9	%


LAM RESEARCH CORPORATION
By	/s/ Stephen G. Newberry
			Stephen G. Newberry,
		President and Chief Executive Officer


	ADDITIONS									ADDITIONS
	BALANCE		CHARGED					BALANCE		BALANCE		CHARGED					BALANCE
	AT		TO					AT		AT		TO					AT
	BEGINNING		COSTS					END		BEGINNING		COSTS					END
	OF		AND		DEDUCTIONS			OF		OF		AND		DEDUCTIONS			OF
DESCRIPTION	PERIOD		EXPENSES		DESCRIBE			PERIOD		PERIOD		EXPENSES		DESCRIBE			PERIOD
YEAR ENDED JUNE 24, 2007
Deducted from asset accounts:
Allowance for doubtful accounts										$	3,822,000	$	20,000	$	9,000	(1)	$	3,851,000
YEAR ENDED JUNE 25, 2006
Deducted from asset accounts:
Allowance for doubtful accounts	$	3,865,000	$	51,000	$	94,000	(1)	$	3,822,000	$	3,865,000	$	51,000	$	94,000	(1)	$	3,822,000
YEAR ENDED JUNE 26, 2005
Deducted from asset accounts:
Allowance for doubtful accounts	$	3,865,000	$	83,000	$	83,000	(1)	$	3,865,000	$	3,865,000	$	83,000	$	83,000	(1)	$	3,865,000
YEAR ENDED JUNE 27, 2004
Deducted from asset accounts:
Allowance for doubtful accounts	$	3,789,000	$	701,000	$	625,000	(1)	$	3,865,000


(1)		$~~0.1~~ 0.0 million, $0.1 million, and ~~$0.6~~$0.1 million, of specific customer accounts written-off in fiscal 2007, 2006, ~~2005,~~ and ~~2004,~~2005, respectively.


Exhibit		Description
10.49(9)		Guaranty to the Receivables Purchase Agreement between Lam Research Co., Ltd. and ABN AMRO Bank N.V., Tokyo Branch, dated December 26, 1997.

10.50(10)		License Agreement between Lam Research Corporation and Trikon Technologies, Inc., dated March 18, 1998.

10.51(10)		Loan Agreement between Lam Research Corporation and The Industrial Bank of Japan, Limited, dated March 30, 1998.

10.52(11)		Credit Agreement between Lam Research Corporation and Deutsche Bank AG, New York Branch and ABN AMRO Bank N.V., San Francisco Branch, dated April 13, 1998.

10.53(11)		First Amendment to Credit Agreement between Lam Research Corporation and ABN AMRO Bank N.V., San Francisco Branch, dated August 10, 1998.

10.58(12)		Loan Agreement between Lam Research Co., Ltd. and ABN AMRO Bank N.V., dated September 30, 1998.

10.59(12)		Guaranty to Loan Agreement between Lam Research Co., Ltd and ABN AMRO Bank N.V., dated September 30, 1998.

10.61(13)		Second Amendment to Credit Agreement between ABN AMRO BANK, N.V. and Lam Research Corporation, dated December 18, 1998.

10.62(13)		First Amendment to Guaranty between ABN AMRO BANK, N.V. and Lam Research Corporation, dated December 25, 1998.

10.63(13)		Supplemental Agreement of Receivables Purchase Agreement dated December 26, 1997 between ABN AMRO BANK, N.V. and Lam Research Corporation, dated December 25, 1998.

10.64(13)		Supplemental Agreement of Loan Agreement dated September 30, 1998 between ABN AMRO BANK, N.V. and Lam Research Corporation, dated December 25, 1998.


Exhibit		Description
10.134		Pledge Agreement (Livermore/Parcel 6) between Lam Research Corporation and BNP Paribas Leasing Corporation, dated December 18, 2007.

10.135		Closing Certificate and Agreement (Livermore/Parcel 6) between Lam Research Corporation and BNP Paribas Leasing Corporation, dated December 18, 2007.

10.136		Agreement Regarding Purchase and Remarketing Options (Livermore/Parcel 6) between Lam Research Corporation and BNP Paribas Leasing Corporation, dated December 18, 2007.

10.137		Construction Agreement (Livermore/Parcel 6) between Lam Research Corporation and BNP Paribas Leasing Corporation, dated December 18, 2007.

10.138		Lease Agreement (Livermore/Parcel 7) between Lam Research Corporation and BNP Paribas Leasing Corporation, dated December 18, 2007.

10.139		Pledge Agreement (Livermore/Parcel 7) between Lam Research Corporation and BNP Paribas Leasing Corporation, dated December 18, 2007.

10.140		Closing Certificate and Agreement (Livermore/Parcel 7) between Lam Research Corporation and BNP Paribas Leasing Corporation, dated December 18, 2007.

10.141		Agreement Regarding Purchase and Remarketing Options (Livermore/Parcel 7) between Lam Research Corporation and BNP Paribas Leasing Corporation, dated December 18, 2007.

10.142		Construction Agreement (Livermore/Parcel 7) between Lam Research Corporation and BNP Paribas Leasing Corporation, dated December 18, 2007.

21		Subsidiaries of the Registrant.

23.1		Consent of Independent Registered Public Accounting Firm.


(17)		Incorporated by reference to Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 26, 1999.

(18)		Incorporated by reference to Registrant’s Quarterly Report on Form 10-Q for the quarter ended December 26, 1999.

(19)		Incorporated by reference to Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 26, 2000.

(20)		Incorporated by reference to Registrant’s Quarterly Report on Form 10-Q for the quarter ended December 24, 2000.

(21)		Incorporated by reference to Registrant’s Registration Statement on Form S-3 dated July 27, 2001.

(22)		Incorporated by reference to Registrant’s Amendment No. 2 to its Annual Report on Form 10K/A for the fiscal year ended June 25, 2000.

(23)		Incorporated by reference to Registrant’s Registration Statement on Form S-3 dated January 30, 2002.

(24)		Incorporated by reference to Registrant’s Annual Report on Form 10-K for the fiscal year ended June 30, 2002.

(25)		Incorporated by reference to Registrant’s Quarterly Report on Form 10-Q for the quarter ended December 29, 2002.

(26)		Incorporated by reference to Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 30, 2003.

(27)		Incorporated by reference to Registrant’s Annual Report on Form 10-K for the fiscal year ended June 29, 2003.

(28)		Incorporated by reference to Registrant’s Quarterly Report on Form 10-Q for the quarter ended September 28, 2003.


(29)		Incorporated by reference to Appendix A of the Registrant’s Proxy Statement filed on October 14, 2003.

(30)		Incorporated by reference to Appendix B of the Registrant’s Proxy Statement filed on October 14, 2003.

(31)		Incorporated by reference to Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 27, 2005.

(32)		Incorporated by reference to Registrant’s Annual Report on Form 10-K for the fiscal year ended June 27, 2004.

(33)		Incorporated by reference to Registrant’s Report on Form 8-K dated June 26, 2005.

(34)		Incorporated by reference to Registrant’s Registration Statement on Form S-8 (No. 33-127936) filed with the Securities and Exchange Commission on August 28, 2005.

(35)		Incorporated by reference to Registrant’s Current Report on Form 8-K dated November 8, 2005.

(36)		Incorporated by reference to Registrant’s Current Report on Form 8-K dated February 6, 2006.

(37)		Incorporated by reference to Registrant’s Current Report on Form 8-K dated June 19, 2006.

(38)		Incorporated by reference to Registrant’s Current Report on Form 8-K dated October 10, 2006.


(39)		Incorporated by reference to Registrant’s Current Report on Form 8-K dated November 2, 2006.

(40)		Incorporated by reference to Registrant’s Registration Statement of Form S-8 (No. 333-138545) filed with the Securities and Exchange Commission on November 9, 2006.

(41)		Incorporated by reference to Registrant’s Current Report on Form 8-K dated December 15, 2006. This exhibit was originally filed with the 8-K as Exhibit Number 10.1.

(42)		Incorporated by reference to Registrant’s Quarterly Report on Form 10-Q for the quarter ended December 24, 2006.

(43)		Incorporated by reference to Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 25, 2007.

(44)		Incorporated by reference to Registrant’s Current Report on Form 8-K dated December 14, 2007.

(45)		Incorporated by reference to Registrant’s Current Report on Form 8-K dated March 7, 2008.

*		Indicates management contract or compensatory plan or arrangement in which executive officers of the Company are eligible to participate.